Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Bladder Cancer, January 2023

Free Subscription


Abstracts

Retrieve all available abstracts of the following 2957 articles:
HTML format


 

Single Articles

  1. MUKHERJEE N, Ji N, Tan X, Chen CL, et al
    KLRF1, a novel marker of CD56(bright) NK cells, predicts improved survival for patients with locally advanced bladder cancer.
    Cancer Med. 2022 Dec 29. doi: 10.1002/cam4.5579.
    Abstract     Related articles   

  2. WANG J, Chen S, Wang H, Cao J, et al
    Integrated molecular analyses of an interferon-gamma based subtype with regard to outcome, immune characteristics, and immunotherapy in bladder cancer and experimental verification.
    Heliyon. 2022;8:e12102.
    Abstract     Related articles   

  3. RIPPING TM, Rammant E, Witjes JA, Aaronson NK, et al
    Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer.
    Health Qual Life Outcomes. 2022;20:171.
    Abstract     Related articles   

  4. ZHONG W, Li J, Liu L, Hong P, et al
    Comparison of minimally invasive versus open pelvic organ-preserving radical cystectomy in female patients with bladder cancer: a multicenter propensity score matching analysis.
    World J Urol. 2022 Dec 29. doi: 10.1007/s00345-022-04232.
    Abstract     Related articles   

  5. ZHU X, Qin R, Qu K, Wang Z, et al
    Atomic Force Microscopy-based assessment of multimechanical cellular properties for classification of graded bladder cancer cells and cancer early diagnosis using machine learning analysis.
    Acta Biomater. 2022 Dec 26:S1742-7061(22)00838.
    Abstract     Related articles   

  6. HAO Y, Chen Y, He X, Han R, et al
    RGD peptide modified platinum nanozyme Co-loaded glutathione-responsive prodrug nanoparticles for enhanced chemo-photodynamic bladder cancer therapy.
    Biomaterials. 2022;293:121975.
    Abstract     Related articles   

  7. KANG Z, Dou Q, Huang T, Tu M, et al
    An angiogenesis‑related lncRNA signature for the prognostic prediction of patients with bladder cancer and LINC02321 promotes bladder cancer progression via the VEGFA signaling pathway.
    Mol Med Rep. 2023;27:38.
    Abstract     Related articles   

  8. ERIKSSON V, Holmkvist O, Huge Y, Johansson M, et al
    A Retrospective Analysis of the De Ritis Ratio in Muscle Invasive Bladder Cancer, with Focus on Tumor Response and Long-Term Survival in Patients Receiving Neoadjuvant Chemotherapy and in Chemo Naive Cystectomy Patients-A Study of a Clinical Multicent
    J Pers Med. 2022;12:1769.
    Abstract     Related articles   


  9. Non-Coding RNA NEAT1/miR-214-3p Contribute to Doxorubicin Resistance of Urothelial Bladder Cancer Preliminary Through the Wnt/beta-Catenin pathway [Retraction].
    Cancer Manag Res. 2022;14:3525-3526.
    Abstract     Related articles   

  10. TAO ZL, Wu W, Liang LC, Pan JF, et al
    Case report: Complete response of a bladder cancer patient with multiple hepatic and pelvic metastases treated by nab-paclitaxel combined with sintilimab.
    Front Oncol. 2022;12:1020793.
    Abstract     Related articles   

  11. AN B, Guo Z, Wang J, Zhang C, et al
    Derivation and external validation of dendritic cell-related gene signatures for predicting prognosis and immunotherapy efficacy in bladder urothelial carcinoma.
    Front Immunol. 2022;13:1080947.
    Abstract     Related articles   

  12. LI J, Wang Y, Zhang X, Yang X, et al
    Characterisation of a novel transcript LNPPS acting as tumour suppressor in bladder cancer via PDCD5-mediated p53 degradation blockage.
    Clin Transl Med. 2023;13:e1149.
    Abstract     Related articles   

  13. ZHANG B, He Y, Zheng D, Shang P, et al
    Clinical efficacy and prognostic analysis of radical cystectomy plus modified ureterosigmoidostomy (Mainz II) in bladder cancer.
    Asian J Surg. 2022 Dec 26:S1015-9584(22)01765.
    Abstract     Related articles   

  14. YILMAZ H, Cinar NB, Avci IE, Telli E, et al
    The systemic inflammation response index: An independent predictive factor for survival outcomes of bladder cancer stronger than other inflammatory markers.
    Urol Oncol. 2022 Dec 26:S1078-1439(22)00468.
    Abstract     Related articles   


  15. Expression of Concern: Downregulated Long Noncoding RNA PART1 Inhibits Proliferation and Promotes Apoptosis in Bladder Cancer.
    Technol Cancer Res Treat. 2022;21:15330338221146361.
    Abstract     Related articles   

  16. TAFURI A, Panunzio A, Soldano A, Mazzucato G, et al
    AB0 blood groups and oncological and functional outcomes in bladder cancer patients treated with radical cystectomy.
    Arch Ital Urol Androl. 2022;94:428-433.
    Abstract     Related articles   

  17. LORUSSO V, Doisy L, Granata AM, Gregori A, et al
    Could we safely omit a Repeat Transurethral Resection of the Bladder (re-TURB) after Hexaminolevulinate Photodynamic Diagnostics (PDD)-TURB?
    Arch Ital Urol Androl. 2022;94:424-427.
    Abstract     Related articles   

  18. KATSIMPERIS S, Tzelves L, Bellos T, Angelopoulos P, et al
    Diagnosis and management of intradiverticular bladder tumours: A pooled analysis of 498 cases.
    Arch Ital Urol Androl. 2022;94:486-491.
    Abstract     Related articles   

  19. CHEN D, Luo Z, Ye C, Luo Q, et al
    Constructing and validating nomograms to predict risk and prognostic factors of distant metastasis in urothelial bladder cancer patients: a population-based retrospective study.
    BMC Urol. 2022;22:212.
    Abstract     Related articles   

  20. DO MH, Thanh HD, To PK, Kim MS, et al
    CD46 protects the bladder cancer cells from cetuximab-mediated cytotoxicity.
    Sci Rep. 2022;12:22420.
    Abstract     Related articles   

  21. WANG F, Xiang YS, Wu P, Shen AJ, et al
    Evaluation of amide proton transfer imaging for bladder cancer histopathologic features: A comparative study with diffusion- weighted imaging.
    Eur J Radiol. 2022;159:110664.
    Abstract     Related articles   

  22. GINSBURG KB, Bell S, Bukavina L, Schober JP, et al
    The Phenomenon of "Therapeutic" Nodal Yield at Cystectomy for Bladder Cancer: Do Not Discount the Will Rogers Effect.
    Eur Urol Open Sci. 2022;47:43-47.
    Abstract     Related articles   

  23. AL HUSSEIN AL AWAMLH B, Chang SS
    Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer.
    Curr Oncol Rep. 2022 Dec 26:1-9. doi: 10.1007/s11912-022-01350.
    Abstract     Related articles   

  24. GUPTA R, Mahajan M, Sharma P, Bhardwaj S, et al
    Application of Vesical Imaging-Reporting and Data System in Evaluation of Urinary Bladder Cancer Using Multiparametric Magnetic Resonance Imaging: A Hospital-Based Cross-Sectional Study.
    Avicenna J Med. 2022;12:162-168.
    Abstract     Related articles   

  25. MUNGMUNPUNTIPANTIP R, Wiwanitkit V
    MNS16A VNTR polymorphic sequence variations of the TERT gene and bladder cancer: Correspondence.
    Curr Urol. 2022;16:116.
    Abstract     Related articles   

  26. ZHANG X, Zhang Y, Zhao L, Wang J, et al
    Exploitation of tumor antigens and construction of immune subtype classifier for mRNA vaccine development in bladder cancer.
    Front Immunol. 2022;13:1014638.
    Abstract     Related articles   

  27. MARTIN R, Renouf T, Rigby J, Hafeez S, et al
    Female sexual function in bladder cancer: A review of the evidence.
    BJUI Compass. 2022;4:5-23.
    Abstract     Related articles   

  28. DU X, Zhao X, Tang Y, Tang W, et al
    Construction of Pyroptosis-Related Prognostic and Immune Infiltration Signature in Bladder Cancer.
    Dis Markers. 2022;2022:6429993.
    Abstract     Related articles   

  29. TAO Y, Li X, Zhang Y, He L, et al
    TP53-related signature for predicting prognosis and tumor microenvironment characteristics in bladder cancer: A multi-omics study.
    Front Genet. 2022;13:1057302.
    Abstract     Related articles   

  30. LI S, Chen R, Raj A, Xue N, et al
    Impact of the time of surgical delay on survival in patients with muscle-invasive bladder cancer.
    Front Oncol. 2022;12:1001843.
    Abstract     Related articles   

  31. ESTESO G, Felgueres MJ, Garcia-Jimenez AF, Reyburn-Vales C, et al
    BCG-activation of leukocytes is sufficient for the generation of donor-independent innate anti-tumor NK and gammadelta T-cells that can be further expanded in vitro.
    Oncoimmunology. 2022;12:2160094.
    Abstract     Related articles   

  32. GAO F, Wang J, Yu Y, Yan J, et al
    Comprehensive optimization of urinary exfoliated tumor cells tests in bladder cancer with a promising microfluidic platform.
    Cancer Med. 2022 Dec 25. doi: 10.1002/cam4.5481.
    Abstract     Related articles   

  33. SALARI A, Ghahari M, Nowroozi A, Ghahari P, et al
    Log Odds of Positive Lymph Nodes (LODDS) as an Independent Predictor of Overall Survival Following Radical Cystectomy in Urothelial Bladder Cancer: Time to Rethink Conventional Node Staging.
    Clin Genitourin Cancer. 2022 Dec 7:S1558-7673(22)00259.
    Abstract     Related articles   

  34. OSSOLINSKI K, Ruman T, Ossolinski T, Ossolinska A, et al
    Monoisotopic silver nanoparticles-based mass spectrometry imaging of human bladder cancer tissue: Biomarker discovery.
    Adv Med Sci. 2022;68:38-45.
    Abstract     Related articles   

  35. AKSAKALLI T, Kozubaev B, Yapanoglu T, Utlu A, et al
    Bladder paraganglioma treated with open partial cystectomy: a case report.
    J Med Case Rep. 2022;16:479.
    Abstract     Related articles   

  36. LAI S, Wu P, Liu S, Seery S, et al
    Presence of secondary bladder cancer following radical nephroureterectomy for upper tract urothelial carcinoma: characteristics, risk factors, and predictive value.
    BMC Urol. 2022;22:211.
    Abstract     Related articles   

  37. XV Y, Qiu M, Liu Z, Xiao M, et al
    Development of a 7-miRNA prognostic signature for patients with bladder cancer.
    Aging (Albany NY). 2022;14.
    Abstract     Related articles   

  38. ZHOU W, Dang L, Chong C, Cheng X, et al
    Ureteral tumor with morphological features analogous to phyllodes tumor: a unique case with concomitant urothelial carcinoma.
    Diagn Pathol. 2022;17:94.
    Abstract     Related articles   

  39. WARRICK JI, Hu W, Yamashita H, Walter V, et al
    Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.
    Nat Commun. 2022;13:7920.
    Abstract     Related articles   

  40. KARIM NA, Ullah A, Wang H, Shoukier M, et al
    A Phase I Study of the Non-Receptor Kinase Inhibitor Bosutinib in Combination with Pemetrexed in Patients with Selected Metastatic Solid Tumors.
    Curr Oncol. 2022;29:9461-9473.
    Abstract     Related articles   

  41. LIU K, Zhao H, Alvarez-Maestro M, Gravas S, et al
    Concomitant Bladder Tumor Is a Risk Factor for Bladder Recurrence but Not Upper Tract.
    Curr Oncol. 2022;29:9284-9293.
    Abstract     Related articles   

  42. YAMASAKI H, Uematsu Y, Okano K, Ichikawa M, et al
    Establishment and characterization of urothelial carcinoma cell lines with and without BRAF mutation (V595E) in dogs.
    In Vitro Cell Dev Biol Anim. 2022;58:898-911.
    Abstract     Related articles   

  43. MURUGESAN K, Necchi A, Burn TC, Gjoerup O, et al
    Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations.
    ESMO Open. 2022;7:100641.
    Abstract     Related articles   

  44. BITARAF M, Muhammadnejad S, Azimzadeh A, Tanourlouee SB, et al
    Evaluation of direct intramural injection to the bladder wall as a method for developing orthotopic tumor models.
    Animal Model Exp Med. 2022;5:575-581.
    Abstract     Related articles   

  45. HE J, Dong C, Zhang H, Jiang Y, et al
    The oncogenic role of TFAP2A in bladder urothelial carcinoma via a novel long noncoding RNA TPRG1-AS1/DNMT3A/CRTAC1 axis.
    Cell Signal. 2023;102:110527.
    Abstract     Related articles   

  46. BUBE SH, Brix R, Christensen MB, Thostrup M, et al
    Surgical experience is predictive for bladder tumour resection quality.
    Scand J Urol. 2022;56.
    Abstract     Related articles   

  47. MAULHARDT H, Verco S, Baltezor M, Marin A, et al
    Local administration of large surface area microparticle docetaxel to solid carcinomas induces direct cytotoxicity and immune-mediated tumoricidal effects: preclinical and clinical studies.
    Drug Deliv Transl Res. 2023;13:503-519.
    Abstract     Related articles   

  48. MALM C, Jaremko G, Brehmer M
    S-phase - an independent prognostic marker in upper tract urothelial carcinoma.
    Scand J Urol. 2022;56.
    Abstract     Related articles   

  49. MERCIER BD, Castro DV, Pal SK
    Defining the Mycobiome in Bladder Cancer.
    Eur Urol Open Sci. 2022;48:70-71.
    Abstract     Related articles   

  50. NAKAMURA R, Hasegawa G, Ohashi K, Hashimoto T, et al
    Primary lung cancer treatable with radical resection after complete remission with pembrolizumab therapy following gemcitabine and carboplatin chemotherapy for multiple metastases of bladder cancer.
    IJU Case Rep. 2022;6:85-88.
    Abstract     Related articles   

  51. HAYAKAWA N, Kikuchi E
    A case of pseudoprogression in avelumab maintenance therapy for metastatic bladder cancer.
    IJU Case Rep. 2022;6:5-7.
    Abstract     Related articles   

  52. LI K, Yao T, Wang Z
    lncRNA-mediated ceRNA network in bladder cancer.
    Noncoding RNA Res. 2022;8:135-145.
    Abstract     Related articles   

  53. OSSOLINSKI K, Ruman T, Copie V, Tripet BP, et al
    Metabolomic and elemental profiling of blood serum in bladder cancer.
    J Pharm Anal. 2022;12:889-900.
    Abstract     Related articles   

  54. ZHANG P, Wu G, Zhang D, Lai WF, et al
    Mechanisms and strategies to enhance penetration during intravesical drug therapy for bladder cancer.
    J Control Release. 2023 Jan 2:S0168-3659(23)00001.
    Abstract     Related articles   

  55. MORE SL, Fung ES, Mathis C, Schulte AM, et al
    Dermal exposure and hair dye: Assessing potential bladder cancer risk from permanent hair dye.
    Regul Toxicol Pharmacol. 2023 Jan 2:105331. doi: 10.1016/j.yrtph.2022.105331.
    Abstract     Related articles   

  56. DENG X, Liu X, Hu B, Liu J, et al
    Upregulation of MTHFD2 is associated with PD‑L1 activation in bladder cancer via the PI3K/AKT pathway.
    Int J Mol Med. 2023;51:14.
    Abstract     Related articles   

  57. KOSHKIN VS, Almassi N, Aragon-Ching JB
    Editorial: Radical cystectomy in bladder cancer patients.
    Front Oncol. 2022;12:1113112.
    Abstract     Related articles   

  58. HAGGSTROM C, Hagberg O, Gardmark T, Aljabery F, et al
    Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0.
    BMJ Open. 2022;12:e064898.
    Abstract     Related articles   

  59. MASONE MC
    A CAF subcluster regulates bladder cancer stemness.
    Nat Rev Urol. 2023 Jan 4. doi: 10.1038/s41585-022-00713.
    Abstract     Related articles   

  60. MOLONY RD, Wu CH, Lee YF
    E-liquid exposure induces bladder cancer cells to release extracellular vesicles that promote non-malignant urothelial cell transformation.
    Sci Rep. 2023;13:142.
    Abstract     Related articles   

  61. LI G, Wu S, Chen W, Duan X, et al
    Designing Intelligent Nanomaterials to Achieve Highly Sensitive Diagnoses and Multimodality Therapy of Bladder Cancer.
    Small Methods. 2023 Jan 4:e2201313. doi: 10.1002/smtd.202201313.
    Abstract     Related articles   

  62. DAWID DE VERA MT, Prieto Cuadra JD, Alvarez Perez M, Garrido-Aranda A, et al
    PD-L1 immunoexpression and molecular characterization of histological subtypes in urothelial carcinoma.
    Rev Esp Patol. 2023;56:10-20.
    Abstract     Related articles   

  63. ZHANG Y, Wang Z, Yang X, Zhao Q, et al
    The influence of serum sodium concentration on prognosis in patients with urothelial carcinoma treated by radical cystectomy.
    Medicine (Baltimore). 2022;101:e31973.
    Abstract     Related articles   

  64. SHIBATA T, Takata E, Sakamoto J, Shioya A, et al
    A retrospective study of immunotherapy using the cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guerin (BCG-CWS) for cervical cancer.
    Medicine (Baltimore). 2022;101:e32481.
    Abstract     Related articles   

  65. XIANG X, Guo Y, Chen Z, Zhang F, et al
    A prognostic risk prediction model based on ferroptosis-related long non-coding RNAs in bladder cancer: A bulk RNA-seq research and scRNA-seq validation.
    Medicine (Baltimore). 2022;101:e32558.
    Abstract     Related articles   

  66. FENG F, Zhong YX, Huang JH, Lin FX, et al
    Identifying stage-associated hub genes in bladder cancer via weighted gene co-expression network and robust rank aggregation analyses.
    Medicine (Baltimore). 2022;101:e32318.
    Abstract     Related articles   

  67. CHHAYA S, Watts I, Ng K, Mustapha R, et al
    Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer.
    Oncol Ther. 2023 Jan 3. doi: 10.1007/s40487-022-00218.
    Abstract     Related articles   

  68. MONTEIRO-REIS S, Miranda-Goncalves V, Guimaraes-Teixeira C, Martins-Lima C, et al
    Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transition.
    Int J Biol Sci. 2023;19:1-12.
    Abstract     Related articles   

  69. SHIMIZU T, Kobayashi Y, Fujiyoshi K, Yato Y, et al
    Tuberculous spondylitis following intravesical Bacillus Calmette-Guerin therapy for bladder cancer surgically treated through the anterior approach.
    BMJ Case Rep. 2022;15:e251075.
    Abstract     Related articles   

  70. SAPONARO M, Flottmann S, Eckstein M, Hommerding O, et al
    CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression.
    Sci Rep. 2023;13:73.
    Abstract     Related articles   

  71. ICHIHASI A, Inamoto T, Uchimoto T, Nakamura KO, et al
    Tissue Distribution of Cisplatin by Intra-arterial Infusion Route in Comparison to Systemic Route: Implication to Therapy for Node-positive Bladder Cancer.
    In Vivo. 2023;37:143-148.
    Abstract     Related articles   

  72. SOOROJEBALLY Y, Neuzillet Y, Roumiguie M, Lamy PJ, et al
    Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review.
    World J Urol. 2023 Jan 2. doi: 10.1007/s00345-022-04253.
    Abstract     Related articles   

  73. CHEN Z, Qin C, Wang G, Shang D, et al
    A tumor microenvironment preoperative nomogram for prediction of lymph node metastasis in bladder cancer.
    Front Oncol. 2022;12:1099965.
    Abstract     Related articles   

  74. NONATO MB, Moraes RS, Bandeira Herenio YM, Nunes TF, et al
    Management of a Giant Urinary Bladder Clot with Intravesical Thrombolysis.
    J Vasc Interv Radiol. 2023;34:154-155.
    Abstract     Related articles   

  75. CHENG W, Zhou Y, Chu X, Huang S, et al
    Effect of intravesical mitomycin compared with gemcitabine on the treatment non-muscle invasive bladder cancer: A meta-analysis.
    Actas Urol Esp (Engl Ed). 2022 Dec 28:S2173-5786(22)00142.
    Abstract     Related articles   

  76. YAMASHITA T, Higashi M, Sugiyama H, Morozumi M, et al
    Cancer antigen 125 expression enhances the gemcitabine/cisplatin-resistant tumor microenvironment in bladder cancer.
    Am J Pathol. 2022 Dec 28:S0002-9440(22)00419.
    Abstract     Related articles   

  77. ZHOU M, Yang B, Zhou S, Yu P, et al
    Will repeat resection after initial transurethral en bloc resection benefit patients with high-risk non-muscle-invasive bladder cancer? A propensity score matching analysis.
    J Cancer Res Clin Oncol. 2022 Dec 31. doi: 10.1007/s00432-022-04564.
    Abstract     Related articles   

  78. NISHIMURA N, Miyake M, Miyamoto T, Tomizawa M, et al
    The Japanese health care system-based cost-effectiveness of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer.
    Jpn J Clin Oncol. 2022 Dec 30:hyac203. doi: 10.1093.
    Abstract     Related articles   

  79. XU Y, Tong Y, Lei Z, Zhu J, et al
    Abietic acid induces ferroptosis via the activation of the HO-1 pathway in bladder cancer cells.
    Biomed Pharmacother. 2022;158:114154.
    Abstract     Related articles   

  80. VAN DER FELS CAM, Leliveld A, Buikema H, van den Heuvel MC, et al
    VEGF, EGFR and PSMA as possible imaging targets of lymph node metastases of urothelial carcinoma of the bladder.
    BMC Urol. 2022;22:213.
    Abstract     Related articles   

  81. LEVY JJ, Liu X, Marotti JD, Kerr DA, et al
    Uncovering additional predictors of urothelial carcinoma from voided urothelial cell clusters through a deep learning-based image preprocessing technique.
    Cancer Cytopathol. 2023;131:19-29.
    Abstract     Related articles   

  82. TANG L, Wang S, Wang Y, Li K, et al
    LncRNA-UCA1 regulates lung adenocarcinoma progression through competitive binding to miR-383.
    Cell Cycle. 2023;22:213-228.
    Abstract     Related articles   

  83. SASAKI Y, Takahashi M, Hashimoto K, Fukuta K, et al
    Efficacy of the Mercedes-Benz closure technique for vaginal reconstruction in female robot-assisted radical cystectomy.
    Asian J Endosc Surg. 2023;16:23-27.
    Abstract     Related articles   

  84. NAYA Y, Takaha N, Hayashi I, Mori M, et al
    Preliminary study of the safety of acrinol in probe-based confocal laser endomicroscopy during transurethral resection of bladder tumors.
    Asian J Endosc Surg. 2023;16:143-146.
    Abstract     Related articles   

  85. GARCIA JH, Morshed RA, Chung J, Millares Chavez MA, et al
    Factors associated with preoperative and postoperative seizures in patients undergoing resection of brain metastases.
    J Neurosurg. 2022 Apr 29:1-8. doi: 10.3171/2022.3.JNS212285.
    Abstract     Related articles   

  86. MAIBOM SL, Joensen UN, Aasvang EK, Rohrsted M, et al
    Robot-assisted laparoscopic radical cystectomy with intracorporeal ileal conduit diversion versus open radical cystectomy with ileal conduit for bladder cancer in an ERAS setup (BORARC): protocol for a single-centre, double-blinded, randomised feasibi
    Pilot Feasibility Stud. 2023;9:7.
    Abstract     Related articles   

  87. CHEN CC, Fa YC, Kuo YY, Liu YC, et al
    Thiolated Mesoporous Silica Nanoparticles as an Immunoadjuvant to Enhance Efficacy of Intravesical Chemotherapy for Bladder Cancer.
    Adv Sci (Weinh). 2023 Jan 13:e2204643. doi: 10.1002/advs.202204643.
    Abstract     Related articles   

  88. LIU B, Su J, Fan B, Ni X, et al
    High expression of KIF20A in bladder cancer as a potential prognostic target for poor survival of renal cell carcinoma.
    Medicine (Baltimore). 2023;102:e32667.
    Abstract     Related articles   

  89. MORIBATA Y, Kurata Y, Nishio M, Kido A, et al
    Automatic segmentation of bladder cancer on MRI using a convolutional neural network and reproducibility of radiomics features: a two-center study.
    Sci Rep. 2023;13:628.
    Abstract     Related articles   

  90. DOHERTY N, Cardwell CR, Murchie P, Hill C, et al
    5-Alpha Reductase Inhibitors and Risk of Kidney and Bladder Cancers in Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2023 Jan 12:EPI-22-1109.
    Abstract     Related articles   

  91. LIU C, Wang XL, Shen EC, Wang BZ, et al
    Bioinformatics analysis of prognosis and immune microenvironment of immunological cell death-related gemcitabine-resistance genes in bladder cancer.
    Transl Androl Urol. 2022;11:1715-1728.
    Abstract     Related articles   

  92. TOMIYAMA E, Fujita K, Hashimoto M, Adomi S, et al
    Comparison of molecular profiles of upper tract urothelial carcinoma vs. urinary bladder cancer in the era of targeted therapy: a narrative review.
    Transl Androl Urol. 2022;11:1747-1761.
    Abstract     Related articles   

  93. JIA C, Zhang X, Qu T, Wu X, et al
    Depletion of PSMD14 suppresses bladder cancer proliferation by regulating GPX4.
    PeerJ. 2023;11:e14654.
    Abstract     Related articles   

  94. RIVEROS C, Chalfant V, Elshafei A, Bandyk M, et al
    Does care fragmentation in patients with bladder cancer lead to worse outcomes?
    Urol Oncol. 2023 Jan 9:S1078-1439(22)00432-X. doi: 10.1016/j.urolonc.2022.
    Abstract     Related articles   

  95. AFFERI L, Gallioli A, Del Giudice F, Pradere B, et al
    Comment on "Neoadjuvant systemic therapy in patients undergoing nephroureterectomy for urothelial cancer: a multidisciplinary systematic review and critical analysis" on behalf of the Young Academic Urologists - Urothelial Cancer Working Group.
    Minerva Urol Nephrol. 2022;74:813-815.
    Abstract     Related articles   

  96. LIM S, Park JH, Chang H
    Enhanced anti-tumor immunity of vaccine combined with anti-PD-1 antibody in a murine bladder cancer model.
    Investig Clin Urol. 2023;64:74-81.
    Abstract     Related articles   

  97. MEHTA P, Sinha S, Kashid S, Chakraborty D, et al
    Exploring Texture Analysis to Optimize Bladder Preservation in Muscle Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2022 Nov 18:S1558-7673(22)00241.
    Abstract     Related articles   

  98. HARA S, Honda M, Kawaharada A, Nakazono M, et al
    [A Case of Metastatic Ureteral Cancer Treated with Pembrolizumab without Relapse of Ocular Myasthenia Gravis].
    Hinyokika Kiyo. 2022;68:377-383.
    Abstract     Related articles   

  99. BAMIAS A, Merseburger A, Loriot Y, James N, et al
    New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors.
    J Immunother Cancer. 2023;11:e005977.
    Abstract     Related articles   

  100. WEI X, Wang B, Wu Z, Yang X, et al
    WD repeat protein 54-mediator of ErbB2-driven cell motility 1 axis promotes bladder cancer tumorigenesis and metastasis and impairs chemosensitivity.
    Cancer Lett. 2023 Jan 7:216058. doi: 10.1016/j.canlet.2023.216058.
    Abstract     Related articles   

  101. ZHOU H, Huang J, Wang F
    Increased transcription of hsa_circ_0000644 upon RUNX family transcription factor 3 downregulation participates in the malignant development of bladder cancer.
    Cell Signal. 2023 Jan 7:110590. doi: 10.1016/j.cellsig.2023.110590.
    Abstract     Related articles   

  102. YU ZY, Yan L, Wang HK, Hang G, et al
    Bladder triangle amyloidosis: A case report and literature review.
    Medicine (Baltimore). 2022;101:e32179.
    Abstract     Related articles   

  103. AIZAT SABRI I, Yusof MR, Jagwani AV, Fahmy O, et al
    [A rare case of bladder leiomyoma in pregnancy: a case report].
    Urologiia. 2022;:118-121.
    Abstract     Related articles   

  104. LIMA NF JR, Sampaio LAF, Xavier CB, Mattedi RL, et al
    Complete Response to Sequential Human Epidermal Growth Factor Receptor 2-Targeted Strategies in a Heavily Pretreated Patient With Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Bladder Cancer.
    JCO Precis Oncol. 2023;7:e2200414.
    Abstract     Related articles   

  105. FEIERTAG N, Barry E, Abramson M, Park JY, et al
    Urine Cytology Rarely Escalates Clinical Management in the Surveillance of Non-muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2022 Dec 23:S1558-7673(22)00262.
    Abstract     Related articles   

  106. WANG W, Hua S, Li J, Zhao J, et al
    Tumour microenvironment landscape and immunotherapy response in bladder cancer decoded by stromal MOXD1 based on copper-related genes signature.
    Front Oncol. 2022;12:1081091.
    Abstract     Related articles   

  107. SHI C, Zhang L, Chen D, Wei H, et al
    Prognostic value of TMEM59L and its genomic and immunological characteristics in cancer.
    Front Immunol. 2022;13:1054157.
    Abstract     Related articles   

  108. MOUSA FA, Jasim HA, Shakir F
    A Prognostic Impact of Interleukin 17 (IL-17) as an Immune-Marker in Patients with Bladder Cancer.
    Arch Razi Inst. 2022;77:1059-1065.
    Abstract     Related articles   

  109. ZHU Y, Zuo L, Xiong H, Li S, et al
    CircHGS enhances the progression of bladder cancer by regulating the miR-513a-5p/VEGFC axis and activating the AKT/mTOR signaling pathway.
    Cell Cycle. 2023 Jan 8:1-20. doi: 10.1080/15384101.2022.2164454.
    Abstract     Related articles   

  110. SPAGNUOLO C, Moccia S, Tedesco I, Crescente G, et al
    Phenolic Extract from Extra Virgin Olive Oil Induces Different Anti-Proliferative Pathways in Human Bladder Cancer Cell Lines.
    Nutrients. 2022;15:182.
    Abstract     Related articles   

  111. LI Z, Qi N, Gao Z, Ding L, et al
    How to Perform Intravesical Chemotherapy after Second TURBT for Non-Muscle-Invasive Bladder Cancer: A Single-Center Experience.
    J Clin Med. 2022;12:169.
    Abstract     Related articles   

  112. KUO MY, Yang WT, Ho YJ, Chang GM, et al
    Hispolon Methyl Ether, a Hispolon Analog, Suppresses the SRC/STAT3/Survivin Signaling Axis to Induce Cytotoxicity in Human Urinary Bladder Transitional Carcinoma Cell Lines.
    Int J Mol Sci. 2022;24:138.
    Abstract     Related articles   

  113. DOMINGOS-PEREIRA S, Sathiyanadan K, Polak L, Haefliger JA, et al
    Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies.
    Int J Mol Sci. 2022;24:123.
    Abstract     Related articles   

  114. GOUTAS D, Palamaris K, Stofas A, Politakis N, et al
    Immunohistochemical Study of Bladder Cancer Molecular Subtypes and Their Association with PD-L1 Expression.
    Cancers (Basel). 2022;15:188.
    Abstract     Related articles   

  115. MIYAGI H, Kwenda E, Ramnaraign BH, Chatzkel JA, et al
    Predicting Complete Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.
    Cancers (Basel). 2022;15:168.
    Abstract     Related articles   

  116. ZHANG W, Yang F, Zheng Z, Li C, et al
    Sulfatase 2 Affects Polarization of M2 Macrophages through the IL-8/JAK2/STAT3 Pathway in Bladder Cancer.
    Cancers (Basel). 2022;15:131.
    Abstract     Related articles   

  117. SMITH V, Mukherjee D, Tsakiroglou AM, Baker A, et al
    Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder Cancer.
    Cancers (Basel). 2022;15:41.
    Abstract     Related articles   

  118. GWON YN, Park JJ, Lee KS, Lee KH, et al
    Microbiome in Bladder Cancer: A Systematic Review.
    Diagnostics (Basel). 2022;13:84.
    Abstract     Related articles   

  119. CHEN S, Jian Y, Tang W, Gu H, et al
    Replacement of long-segment ureteral defect with tapered demucosalized ileum: medium-term outcomes of 4 patients.
    BMC Urol. 2023;23:7.
    Abstract     Related articles   

  120. LI W, Cheng M, Hu P, Jiang L, et al
    Prognosis of male lung cancer patients with urinary cancer: a study from a national population-based analysis.
    Sci Rep. 2023;13:283.
    Abstract     Related articles   

  121. TIAN C, Liu J, An L, Hong Y, et al
    Prognostic nomogram for overall survival in upper urinary tract urothelial carcinoma (UTUC) patients treated with chemotherapy: a SEER-based retrospective cohort study.
    BMC Urol. 2023;23:2.
    Abstract     Related articles   

  122. MASONE MC
    The prognostic role of stroma in UTUC.
    Nat Rev Urol. 2023;20:7.
    Abstract     Related articles   

  123. MASONE MC
    A non-invasive assay for UTUC diagnosis.
    Nat Rev Urol. 2023;20:8.
    Abstract     Related articles   

  124. KOTERAZAWA S, Kanno T, Kobori G, Ito K, et al
    Clinical outcomes following laparoscopic radical nephroureterectomy in octogenarians.
    Int J Clin Oncol. 2023;28:155-162.
    Abstract     Related articles   

  125. YU SL, Hsiao YJ, Cooper WA, Choi YL, et al
    The Ring Study: an international comparison of PD-L1 diagnostic assays and their interpretation in non-small cell lung cancer, head and neck squamous cell cancer and urothelial cancer.
    Pathology. 2023;55:19-30.
    Abstract     Related articles   

  126. TOMITA Y, Kobayashi K, Kimura G, Oya M, et al
    Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial.
    Jpn J Clin Oncol. 2023;53:16-25.
    Abstract     Related articles   

  127. LENNARTZ M, Ullmann VS, Gorbokon N, Uhlig R, et al
    Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumors.
    APMIS. 2023;131:77-91.
    Abstract     Related articles   

  128. HOLMES A, O'Kane D, Wombwell A, Grills R, et al
    Clinical Utility of a Single-Use Flexible Cystoscope Compared with a Standard Reusable Device: A Randomized Noninferiority Study.
    J Endourol. 2023;37:80-84.
    Abstract     Related articles   

  129. NAKAGAWA T, Shigehara K, Kato Y, Kawaguchi S, et al
    Are bladder washing samples suitable for investigation of HPV infection in urinary bladder? Comparison in HPV prevalence between urine and washing samples.
    J Med Virol. 2023;95:e28110.
    Abstract     Related articles   

  130. PENDELA VS, Said B, Kudaravalli P, Chhabria M, et al
    Interstitial Pneumonitis-A Newly Recognized Consequence of Intravesical Gemcitabine Therapy.
    Am J Ther. 2022;29:e752-e754.
    Abstract     Related articles   

  131. LIN W, Pan X, Zhang C, Ye B, et al
    Impact of Age at Diagnosis of Bladder Cancer on Survival: A Surveillance, Epidemiology, and End Results-Based Study 2004-2015.
    Cancer Control. 2023;30:10732748231152322.
    Abstract     Related articles   

  132. YUKSEL O, Tosun C, Gumrukcu G, Tokuc E, et al
    What is the role of CellDetect((R)) in detecting and monitoring bladder cancer?
    Urologia. 2023 Jan 20:3915603221150036. doi: 10.1177/03915603221150036.
    Abstract     Related articles   

  133. WU J, Wang X, Xu H, Tian J, et al
    Bioinformatics analysis of the correlation between m6A RNA methylation regulators and the immune infiltration and prognosis of bladder cancer.
    Ann Transl Med. 2022;10:1386.
    Abstract     Related articles   

  134. NAGATA M, Ishizaka K, Asano T
    CD169(+) Macrophages Residing in the Draining Lymph Nodes and Infiltrating the Tumor Play Opposite Roles in the Pathogenesis of Bladder Cancer.
    Res Rep Urol. 2023;15:1-7.
    Abstract     Related articles   

  135. WARLI SM, Prapiska FF, Siregar DIS, Wijaya WS, et al
    Association Between Interleukin-6 Levels and Lymph Node Metastasis in Bladder Cancer Patients.
    World J Oncol. 2022;13:365-369.
    Abstract     Related articles   

  136. CHAUHAN PS, Shiang A, Alahi I, Sundby RT, et al
    Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patients.
    NPJ Precis Oncol. 2023;7:6.
    Abstract     Related articles   

  137. BAXTER L, Gordon NS, Ott S, Wang J, et al
    Properties of non-coding mutation hotspots as urinary biomarkers for bladder cancer detection.
    Sci Rep. 2023;13:1060.
    Abstract     Related articles   

  138. WU X, Xu Q, Li T, Wei Y, et al
    Bladder Cancer Progression Is Suppressed Through the Heart and Neural Crest Derivatives Expressed 2-Antisense RNA 1/microRNA-93-5p/Defective in Cullin Neddylation 1 Domain Containing 3 Axis.
    Appl Biochem Biotechnol. 2023 Jan 19. doi: 10.1007/s12010-022-04295.
    Abstract     Related articles   

  139. ZHANG W, Zhou B, Deng J, Han G, et al
    Retrospective analysis of 1470-/980-nm dual-wavelength laser en bloc resection versus transurethral resection of bladder tumor for primary non-muscle-invasive bladder cancer.
    Lasers Med Sci. 2023;38:44.
    Abstract     Related articles   

  140. YADAV K, Agarwal P, Kumar M, Gupta S, et al
    Immunohistochemical appraisal of epithelial mesenchymal transition type III in gall bladder cancer.
    Indian J Pathol Microbiol. 2023;66:44-53.
    Abstract     Related articles   

  141. WANG S, Yu Z, Du P, Cao Y, et al
    Combination of hyperthermia and intravesical chemotherapy for the treatment of pT1 stage bladder cancer: A retrospectively clinical study.
    Asia Pac J Clin Oncol. 2023 Jan 19. doi: 10.1111/ajco.13931.
    Abstract     Related articles   

  142. GROBET-JEANDIN E, Pinar U, Parra J, Roupret M, et al
    Health-related quality of life after curative treatment for muscle-invasive bladder cancer.
    Nat Rev Urol. 2023 Jan 18. doi: 10.1038/s41585-022-00693.
    Abstract     Related articles   

  143. FU X, Yu G, Guo Y
    [Expression pattern of the histone lysine demethylase family and its potential role in bladder cancer: a multi-omics analysis].
    Nan Fang Yi Ke Da Xue Xue Bao. 2022;42:1822-1831.
    Abstract     Related articles   

  144. SELIM MS, Kassem AB, El-Bassiouny NA, Salahuddin A, et al
    Polymorphic renal transporters and cisplatin's toxicity in urinary bladder cancer patients: current perspectives and future directions.
    Med Oncol. 2023;40:80.
    Abstract     Related articles   

  145. WANG Y, Zhang W, Xiao W, Chen S, et al
    Feasibility of Early Evaluation for the Recurrence of Bladder Cancer after Trans-Urethral Resection: A Comparison between Magnetic Resonance Imaging and Multidetector Computed Tomography.
    Tomography. 2022;9:25-35.
    Abstract     Related articles   

  146. RAMMANT E, Fox L, Beyer K, Aaronson NK, et al
    The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients: a systematic review.
    Qual Life Res. 2023 Jan 17. doi: 10.1007/s11136-022-03335.
    Abstract     Related articles   

  147. RUBIN R
    New Gene Therapy for Certain Bladder Cancers.
    JAMA. 2023;329:201.
    Abstract     Related articles   

  148. GU J, He Z, Chen Z, Wu H, et al
    Efficacy and safety of 2-micron laser versus conventional trans-urethral resection of bladder tumor for non-muscle-invasive bladder tumor: A systematic review and meta-analysis.
    J Cancer Res Ther. 2022;18:1894-1902.
    Abstract     Related articles   

  149. JI J, Yao Y, Guan F, Sun L, et al
    Efficacy and adverse reactions of intra-arterial chemotherapy in patients with bladder cancer: A systematic review and meta-analysis.
    J Cancer Res Ther. 2022;18:1884-1893.
    Abstract     Related articles   

  150. RAADABADI M, Daroudi R, Zendehdel K, Haghdoost AA, et al
    Direct and indirect medical costs of bladder cancer in Iran.
    Cost Eff Resour Alloc. 2023;21:5.
    Abstract     Related articles   

  151. LUO M, Zhang Y, Xu Z, Lv S, et al
    Experimental analysis of bladder cancer-associated mutations in EP300 identifies EP300-R1627W as a driver mutation.
    Mol Med. 2023;29:7.
    Abstract     Related articles   

  152. CARVALHO LB, Capelo JL, Lodeiro C, Dhir R, et al
    Pathway-guided monitoring of the disease course in bladder cancer with longitudinal urine proteomics.
    Commun Med (Lond). 2023;3:8.
    Abstract     Related articles   

  153. SECHER MS, Hyldgaard J, Jensen JB
    The association between gender, stage and prognosis in bladder cancer patients undergoing radical cystectomy.
    Scand J Urol. 2023 Jan 16:1-5. doi: 10.1080/21681805.2023.2166103.
    Abstract     Related articles   

  154. LIU W, Xu Y, Bai S, Liao L, et al
    Bioinformatics analysis of key biomarkers for bladder cancer.
    Biomed Rep. 2022;18:14.
    Abstract     Related articles   

  155. VILLANUEVA H, Wells GA, Miller MT, Villanueva M, et al
    Characterizing treatment resistance in muscle invasive bladder cancer using the chicken egg chorioallantoic membrane patient-derived xenograft model.
    Heliyon. 2022;8:e12570.
    Abstract     Related articles   

  156. SHEFER HK, Masarwe I, Bejar J, Naamnih LH, et al
    Performance of CellDetect for detection of bladder cancer: Comparison with urine cytology and UroVysion.
    Urol Oncol. 2023 Jan 13:S1078-1439(22)00497.
    Abstract     Related articles   

  157. GOEBELL PJ, Kamat AM, Black PC, Dyrskjot L, et al
    Editorial: Cutting edge basic and clinical bladder cancer research - the IBCN updates.
    Urol Oncol. 2023 Jan 12:S1078-1439(22)00498.
    Abstract     Related articles   

  158. WU Q, Chen P, Li J, Lin Z, et al
    Inhibition of bladder cancer growth with homoharringtonine by inactivating integrin alpha5/beta1-FAK/Src axis: A novel strategy for drug application.
    Pharmacol Res. 2023;188:106654.
    Abstract     Related articles   

  159. WU J, Jin S, Gu C, Wei Y, et al
    Inherited mutations in Chinese patients with upper tract urothelial carcinoma.
    Cell Rep Med. 2023;4:100883.
    Abstract     Related articles   

  160. ORSI DL, Ferrara SJ, Siegel S, Friberg A, et al
    Discovery and characterization of orally bioavailable 4-chloro-6-fluoroisophthalamides as covalent PPARG inverse-agonists.
    Bioorg Med Chem. 2022;78:117130.
    Abstract     Related articles   

  161. KUJDOWICZ M, Perez-Guaita D, Chlosta P, Okon K, et al
    Evaluation of grade and invasiveness of bladder urothelial carcinoma using infrared imaging and machine learning.
    Analyst. 2022 Dec 16. doi: 10.1039/d2an01583.
    Abstract     Related articles   

  162. PETTITT GA, Hurst CD, Khan Z, McPherson HR, et al
    Development of resistance to FGFR inhibition in urothelial carcinoma via multiple pathways in vitro.
    J Pathol. 2023;259:220-232.
    Abstract     Related articles   

  163. HOGAN K, McKenney JK, Cox RM, Nguyen JK, et al
    Myxoid Pseudotumor Involving the Renal Sinus: Clinicopathologic Study of 33 Cases Supporting a Distinct Benign Non-neoplastic Lesion.
    Am J Surg Pathol. 2023;47:218-223.
    Abstract     Related articles   

  164. SHIMURA S, Matsumoto K, Ikeda M, Moroo S, et al
    A multi-institutional retrospective study of open versus laparoscopic nephroureterectomy focused on the intravesical recurrence.
    Asia Pac J Clin Oncol. 2023;19:71-78.
    Abstract     Related articles   

  165. ZHANG W, Yang F, Mao S, Wang R, et al
    Bladder cancer-associated microbiota: Recent advances and future perspectives.
    Heliyon. 2023;9:e13012.
    Abstract     Related articles   

  166. ALJABERY F, Shabo I, Saudi A, Holmbom M, et al
    The emerging role of cell cycle protein p53 expression by tumor cells and M2-macrophage infiltration in urinary bladder cancer.
    Urol Oncol. 2023 Jan 24:S1078-1439(22)00490.
    Abstract     Related articles   

  167. HOGLUND M, Bernardo C, Sjodahl G, Eriksson P, et al
    The Lund Taxonomy for Bladder Cancer Classification - From Gene Expression Clustering to Cancer Cell Molecular Phenotypes, and Back Again.
    J Pathol. 2023 Jan 26. doi: 10.1002/path.6062.
    Abstract     Related articles   

  168. WAN B, Ma N, Lu W
    Mendelian randomization investigation identified the causal relationship between body fat indexes and the risk of bladder cancer.
    PeerJ. 2023;11:e14739.
    Abstract     Related articles   

  169. MARTINS-LIMA C, Chianese U, Benedetti R, Altucci L, et al
    Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game?
    Front Mol Biosci. 2023;9:1070383.
    Abstract     Related articles   

  170. LI P, Mi Q, Yan S, Xie Y, et al
    Characterization of circSCL38A1 as a novel oncogene in bladder cancer via targeting ILF3/TGF-beta2 signaling axis.
    Cell Death Dis. 2023;14:59.
    Abstract     Related articles   

  171. YONG Z, Ang L, Wen-Zhang Z, Xu-Dong W, et al
    Incidental gall bladder cancer in the laparoscopic treatment and magnetic resonance imaging era: A single institution experience.
    J Minim Access Surg. 2023 Jan 9. doi: 10.4103.
    Abstract     Related articles   

  172. VAN PUFFELEN JH, Novakovic B, van Emst L, Kooper D, et al
    Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections.
    J Immunother Cancer. 2023;11:e005518.
    Abstract     Related articles   

  173. PAN J, Hong G, Zeng H, Liao C, et al
    An artificial intelligence model for the pathological diagnosis of invasion depth and histologic grade in bladder cancer.
    J Transl Med. 2023;21:42.
    Abstract     Related articles   

  174. JIN M, Lu S, Wu Y, Yang C, et al
    Retraction Note: Hsa_circ_0001944 promotes the growth and metastasis in bladder cancer cells by acting as a competitive endogenous RNA for miR-548.
    J Exp Clin Cancer Res. 2023;42:32.
    Abstract     Related articles   

  175. LIU HP, Jia W, Kadeerhan G, Xue B, et al
    Individualized prognosis stratification in muscle invasive bladder cancer: A pairwise TP53-derived transcriptome signature.
    Transl Oncol. 2023;29:101629.
    Abstract     Related articles   

  176. LAI AL, Law YM
    VI-RADS in bladder cancer: Overview, pearls and pitfalls.
    Eur J Radiol. 2023;160:110666.
    Abstract     Related articles   

  177. SHEN C, Yan Y, Yang S, Wang Z, et al
    Construction and validation of a bladder cancer risk model based on autophagy-related genes.
    Funct Integr Genomics. 2023;23:46.
    Abstract     Related articles   

  178. TALWAR HS, Panwar VK, Mittal A, Kishore S, et al
    A Clinicopathological Correlation of Bladder Cancer in Young and Old Patients: Our Experience and Review of Literature.
    Indian J Surg Oncol. 2022;13:915-923.
    Abstract     Related articles   

  179. AND ALTERNATIVE MEDICINE EC
    Retracted: Effect of Radical Laparoscopic Surgery and Conventional Open Surgery on Surgical Outcomes, Complications, and Prognosis in Elderly Patients with Bladder Cancer.
    Evid Based Complement Alternat Med. 2023;2023:9835627.
    Abstract     Related articles   

  180. YU X, Luo B, Lin J, Zhu Y, et al
    Alternative splicing event associated with immunological features in bladder cancer.
    Front Oncol. 2023;12:966088.
    Abstract     Related articles   

  181. CAI J, Xie H, Yan Y, Huang Z, et al
    A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer.
    Front Genet. 2023;13:1082691.
    Abstract     Related articles   

  182. XIAO Y, Xu D, Jiang C, Huili Y, et al
    Telomere maintenance-related genes are important for survival prediction and subtype identification in bladder cancer.
    Front Genet. 2023;13:1087246.
    Abstract     Related articles   

  183. DENG H, Deng D, Qi T, Liu Z, et al
    An IFN-gamma-related signature predicts prognosis and immunotherapy response in bladder cancer: Results from real-world cohorts.
    Front Genet. 2023;13:1100317.
    Abstract     Related articles   

  184. TANTRAY I, Ojha R, Sharma AP
    Non-coding RNA and autophagy: Finding novel ways to improve the diagnostic management of bladder cancer.
    Front Genet. 2023;13:1051762.
    Abstract     Related articles   

  185. ASHRAFIZADEH M, Zarrabi A, Karimi-Maleh H, Taheriazam A, et al
    (Nano)platforms in bladder cancer therapy: Challenges and opportunities.
    Bioeng Transl Med. 2022;8:e10353.
    Abstract     Related articles   

  186. HAN DS, Johnson JP, Schulster ML, Shah O, et al
    Indications for and results of renal autotransplantation.
    Curr Opin Nephrol Hypertens. 2023;32:183-192.
    Abstract     Related articles   

  187. TANABE T, Osawa T, Hotta K, Iwami D, et al
    [TREATMENT OF BLADDER UROTHELIAL CARCINOMA WITH LUNG METASTASIS AFTER RENAL TRANSPLANTATION].
    Nihon Hinyokika Gakkai Zasshi. 2022;113:37-41.
    Abstract     Related articles   

  188. IMAMURA T, Miyachi S, Horiuchi E, Ikeda T, et al
    [A CASE OF PRIMARY MUCOSA-ASSOCIATED LYMPHOID TISSUE (MALT) LYMPHOMA OF THE URINARY BLADDER].
    Nihon Hinyokika Gakkai Zasshi. 2022;113:28-32.
    Abstract     Related articles   

  189. KONDO Y, Takayama T
    [STUDY OF URINATION TREATMENT AFTER BCG INTRAVESICAL INSTILLATION THERAPY].
    Nihon Hinyokika Gakkai Zasshi. 2022;113:12-15.
    Abstract     Related articles   

  190. EL-MAHDY HA, Elsakka EGE, El-Husseiny AA, Ismail A, et al
    miRNAs role in bladder cancer pathogenesis and targeted therapy: Signaling pathways interplay - A review.
    Pathol Res Pract. 2023;242:154316.
    Abstract     Related articles   

  191. KOBAYASHI K, Matsuyama H, Oka S, Nakamura K, et al
    Risks and benefits of transurethral resection of the bladder tumor using photodynamic diagnosis with oral 5-aminolevulinic acid hydrochloride according to age and history of recurrence in patients with non-muscle invasive bladder cancer.
    Photodiagnosis Photodyn Ther. 2023;41:103294.
    Abstract     Related articles   

  192. YU C, Wang S, Lai WF, Zhang D, et al
    The Progress of Chitosan-Based Nanoparticles for Intravesical Bladder Cancer Treatment.
    Pharmaceutics. 2023;15:211.
    Abstract     Related articles   

  193. RU R, Chen G, Liang X, Cao X, et al
    Sea Cucumber Derived Triterpenoid Glycoside Frondoside A: A Potential Anti-Bladder Cancer Drug.
    Nutrients. 2023;15:378.
    Abstract     Related articles   

  194. NIKIC P, Dragicevic D, Jerotic D, Savic S, et al
    Polymorphisms of Antioxidant Enzymes SOD2 (rs4880) and GPX1 (rs1050450) Are Associated with Bladder Cancer Risk or Its Aggressiveness.
    Medicina (Kaunas). 2023;59:131.
    Abstract     Related articles   

  195. TRIFANESCU OG, Gales LN, Paun MA, Motas N, et al
    Long-Term Outcome of Patients with Stage II and III Muscle-Invasive Urothelial Bladder Cancer after Multimodality Approach. Which Is the Best Option?
    Medicina (Kaunas). 2022;59:50.
    Abstract     Related articles   

  196. YI L, Ai K, Li X, Li Z, et al
    Bone Metastasis in Bladder Cancer.
    J Pers Med. 2022;13:54.
    Abstract     Related articles   

  197. CABALLERO JM, Gili JM, Pereira JC, Gomariz A, et al
    Risk Factors Involved in the High Incidence of Bladder Cancer in an Industrialized Area in North-Eastern Spain: A Case-Control Study.
    J Clin Med. 2023;12:728.
    Abstract     Related articles   

  198. YANG S, Zhou H, Feng C, Xu N, et al
    Web-Based Nomograms for Overall Survival and Cancer-Specific Survival of Bladder Cancer Patients with Bone Metastasis: A Retrospective Cohort Study from SEER Database.
    J Clin Med. 2023;12:726.
    Abstract     Related articles   

  199. HUANG GK, Huang CC, Kang CH, Cheng YT, et al
    Genetic Interference of FGFR3 Impedes Invasion of Upper Tract Urothelial Carcinoma Cells by Alleviating RAS/MAPK Signal Activity.
    Int J Mol Sci. 2023;24:1776.
    Abstract     Related articles   

  200. LAZEWSKI D, Kucinska M, Potapskiy E, Kuzminska J, et al
    Enhanced Cytotoxic Activity of PEGylated Curcumin Derivatives: Synthesis, Structure-Activity Evaluation, and Biological Activity.
    Int J Mol Sci. 2023;24:1467.
    Abstract     Related articles   

  201. PEREZ-MONTIEL MD, Cerrato-Izaguirre D, Sanchez-Perez Y, Diaz-Chavez J, et al
    Mutational Landscape of Bladder Cancer in Mexican Patients: KMT2D Mutations and chr11q15.5 Amplifications Are Associated with Muscle Invasion.
    Int J Mol Sci. 2023;24:1092.
    Abstract     Related articles   

  202. DAS S, Hayden J, Sullivan T, Rieger-Christ K, et al
    The Roles of miRNAs in Predicting Bladder Cancer Recurrence and Resistance to Treatment.
    Int J Mol Sci. 2023;24:964.
    Abstract     Related articles   

  203. VARELA M, Lopez M, Ingold M, Alem D, et al
    New Nitric Oxide-Releasing Compounds as Promising Anti-Bladder Cancer Drugs.
    Biomedicines. 2023;11:199.
    Abstract     Related articles   

  204. BEJRANANDA T, Saetang J, Sangkhathat S
    Molecular Subtyping in Muscle-Invasive Bladder Cancer on Predicting Survival and Response of Treatment.
    Biomedicines. 2022;11:69.
    Abstract     Related articles   

  205. MONTEIRO-REIS S, Ferreira JPS, Pires RA, Lobo J, et al
    Bladder Wall Stiffness after Cystectomy in Bladder Cancer Patients: A Preliminary Study.
    Cancers (Basel). 2023;15:359.
    Abstract     Related articles   

  206. SONG FX, Xu X, Ding H, Yu L, et al
    Recent Progress in Nanomaterial-Based Biosensors and Theranostic Nanomedicine for Bladder Cancer.
    Biosensors (Basel). 2023;13:106.
    Abstract     Related articles   

  207. ZHANG Q, Liu S, Wang H, Xiao K, et al
    ETV4 Mediated Tumor-Associated Neutrophil Infiltration Facilitates Lymphangiogenesis and Lymphatic Metastasis of Bladder Cancer.
    Adv Sci (Weinh). 2023 Jan 20:e2205613. doi: 10.1002/advs.202205613.
    Abstract     Related articles   

  208. BEIJERT IJ, Hentschel AE, Brundl J, Comperat EM, et al
    Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum.
    Eur Urol Oncol. 2023 Jan 18:S2588-9311(23)00004.
    Abstract     Related articles   

  209. YEN A, Shen C, Albuquerque K
    The New Kid on the Block: Online Adaptive Radiotherapy in the Treatment of Gynecologic Cancers.
    Curr Oncol. 2023;30:865-874.
    Abstract     Related articles   

  210. ZALAY O, Yan M, Sigurdson S, Malone S, et al
    Adjuvant Radiotherapy for Upper Tract Urothelial Carcinoma: Systematic Review and Meta-Analysis.
    Curr Oncol. 2022;30:19-36.
    Abstract     Related articles   

  211. PATWARDHAN PP, Quiroga-Garza GM
    Extramammary paget disease of the penoscrotal region.
    Pathol Res Pract. 2023;241:154283.
    Abstract     Related articles   

  212. KANG SY, Heo YJ, Kwon GY, Lee J, et al
    Five-gene signature for the prediction of response to immune checkpoint inhibitors in patients with gastric and urothelial carcinomas.
    Pathol Res Pract. 2023;241:154233.
    Abstract     Related articles   

  213. MLICKA A, Mlicki P, Niewiadomski P, Zielinska W, et al
    Synergistic effect of metformin and doxorubicin on the metastatic potential of T24 cells.
    Acta Histochem. 2023;125:151975.
    Abstract     Related articles   

  214. HEROUT R, Baunacke M, Flegar L, Borkowetz A, et al
    Upper tract urothelial carcinoma in Germany: epidemiological data and surgical treatment trends in a total population analysis from 2006 to 2019.
    World J Urol. 2023;41:127-133.
    Abstract     Related articles   

  215. GUO B, Wang Y, Liu W, Zhang S, et al
    Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
    Clin Transl Oncol. 2023;25:535-554.
    Abstract     Related articles   

  216. HUANG L, Shao W, Wang X, Li F, et al
    TBX3 stimulates proliferation and stem cell self-renewal in bladder carcinoma.
    Histol Histopathol. 2023;38:65-72.
    Abstract     Related articles   

  217. KULLMANN F, Strissel PL, Strick R, Stoehr R, et al
    Frequency of microsatellite instability (MSI) in upper tract urothelial carcinoma: comparison of the Bethesda panel and the Idylla MSI assay in a consecutively collected, multi-institutional cohort.
    J Clin Pathol. 2023;76:126-132.
    Abstract     Related articles   

  218. XIANG L, Zeng Q, Liu J, Xiao M, et al
    MAFG-AS1/MAFG positive feedback loop contributes to cisplatin resistance in bladder urothelial carcinoma through antagonistic ferroptosis.
    Sci Bull (Beijing). 2021;66:1773-1788.
    Abstract     Related articles   

  219. KLEANTHOUS K, Alexopoulou E, Papadopoulos I, Mazioti A, et al
    Asymptomatic bladder neurofibroma in neurofibromatosis type I.
    Minerva Pediatr (Torino). 2022;74:799-801.
    Abstract     Related articles   

  220. QIU M, Yu L, Liang J, Xia J, et al
    Aloperine Prevents Migration, Invasion, and Adhesion by Upregulating TIMP-4 in Human Bladder Cancer Cells.
    Protein Pept Lett. 2023 Jan 24. doi: 10.2174/0929866530666230124112754.
    Abstract     Related articles   

  221. WANG Q, Li B, Zhang W, Li Z, et al
    Lethal activity of BRD4 PROTAC degrader QCA570 against bladder cancer cells.
    Front Chem. 2023;11:1121724.
    Abstract     Related articles   

  222. WU K, Jiang D, Zhang L, Jiang S, et al
    Efficacy and safety of a novel 450 nm blue diode laser versus plasmakinetic electrocautery for the transurethral resection of non-muscle invasive bladder cancer: The protocol and result of a multicenter randomized controlled trial.
    Front Oncol. 2023;12:1065735.
    Abstract     Related articles   

  223. LIU L, Li C, Wang Q, Yuan H, et al
    A model for predicting overall survival in bladder cancer patients with signet ring cell carcinoma: a population-based study.
    Eur J Med Res. 2023;28:61.
    Abstract     Related articles   

  224. LI DX, Feng DC, Wang XM, Wu RC, et al
    M7G-related molecular subtypes can predict the prognosis and correlate with immunotherapy and chemotherapy responses in bladder cancer patients.
    Eur J Med Res. 2023;28:55.
    Abstract     Related articles   

  225. MORENO-FONTELA MP, Pinazo-Rubio I, Garrido-Abad P
    Penoscrotal oedema as the first sign of metastatic urothelial bladder cancer.
    BMJ Case Rep. 2023;16:e254106.
    Abstract     Related articles   

  226. AGGARWAL A, Goel S, Sayed AI, Goel V, et al
    Interaortocaval Lymph Node Metastasis in Gall Bladder Cancer: Is It Regional Node or Metastatic Disease?
    J Gastrointest Cancer. 2023 Feb 2. doi: 10.1007/s12029-023-00914.
    Abstract     Related articles   

  227. LI Q, Luo Y, Liu D, Li B, et al
    Construction and prognostic value of enhanced CT image omics model for noninvasive prediction of HRG in bladder cancer based on logistic regression and support vector machine algorithm.
    Front Oncol. 2023;12:966506.
    Abstract     Related articles   

  228. WANG W, Huang G, Lin H, Ren L, et al
    Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis.
    Front Oncol. 2023;12:1102392.
    Abstract     Related articles   

  229. TAAFFE DR, McCombie SP, Galvao DA, Newton RU, et al
    Efficacy and Feasibility of Pre-surgical Exercise in Bladder Cancer Patients Scheduled for Open Radical Cystectomy.
    Med Sci Sports Exerc. 2023 Feb 2. doi: 10.1249/MSS.0000000000003137.
    Abstract     Related articles   

  230. PATEL SA, Liu Y, Solanki AA, Baumann BC, et al
    Bladder only versus bladder plus pelvic lymph node chemoradiation for muscle-invasive bladder cancer.
    Urol Oncol. 2023 Jan 30:S1078-1439(22)00494.
    Abstract     Related articles   


  231. Correction: Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections.
    J Immunother Cancer. 2023;11:e005518corr1.
    Abstract     Related articles   

  232. GETZ K, Hubbard RA, Linn KA
    Performance of Multiple Imputation Using Modern Machine Learning Methods in Electronic Health Records Data.
    Epidemiology. 2023;34:206-215.
    Abstract     Related articles   

  233. CHALFANT V, Blute ML Jr, Silberstein P
    Treatment trends of muscle invasive bladder cancer: Evidence from the Surveillance, Epidemiology, and End Results database, 1988 to 2013.
    Asian J Urol. 2023;10:9-18.
    Abstract     Related articles   

  234. ZHANG Y, Zhang X, Huang X, Tang X, et al
    Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma.
    Stem Cell Res Ther. 2023;14:15.
    Abstract     Related articles   

  235. KATLEBA KD, Tsamouri MM, Jathal M, Baek HB, et al
    Androgen receptor-dependent regulation of metabolism in high grade bladder cancer cells.
    Sci Rep. 2023;13:1762.
    Abstract     Related articles   

  236. CHEONG JK, Ooi EH, Chiew YS, Menichetti L, et al
    Gold nanorods assisted photothermal therapy of bladder cancer in mice: A computational study on the effects of gold nanorods distribution at the centre, periphery, and surface of bladder cancer.
    Comput Methods Programs Biomed. 2023;230:107363.
    Abstract     Related articles   

  237. WANG K, Wang G, Li G, Zhang W, et al
    m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation.
    Apoptosis. 2023 Jan 31. doi: 10.1007/s10495-023-01817.
    Abstract     Related articles   

  238. WU D, Lin J, Zhu Y, Zhang H, et al
    Retracted: Expression of Testis-Specific Gene Antigen 10 (TSGA10) is Associated with Apoptosis and Cell Migration in Bladder Cancer Cells and Tumor Stage and Overall Survival in Patients with Bladder Cancer.
    Med Sci Monit. 2023;29:e939596.
    Abstract     Related articles   

  239. ZAHIRI E, Ghorbani H, Moradi A, Mehrad-Majd H, et al
    Prognostic Significance of Substance P and Neurokinin-1 Receptor in Bladder Cancer.
    Rep Biochem Mol Biol. 2022;11:411-420.
    Abstract     Related articles   

  240. DONG S, Zheng L, Jiang T
    Loss of Lactate/Proton Monocarboxylate Transporter 4 Induces Ferroptosis via the AMPK/ACC Pathway and Inhibition of Autophagy on Human Bladder Cancer 5637 Cell Line.
    J Oncol. 2023;2023:2830306.
    Abstract     Related articles   

  241. CHEN W, Tan M, Yu C, Liao G, et al
    ARHGAP6 inhibits bladder cancer cell viability, migration, and invasion via beta-catenin signaling and enhances mitomycin C sensitivity.
    Hum Cell. 2023 Jan 30. doi: 10.1007/s13577-023-00860.
    Abstract     Related articles   

  242. CHEN T, Shi S, Zheng P, Zhan X, et al
    Predictive nomograms for early death in metastatic bladder cancer.
    Front Surg. 2023;9:1037203.
    Abstract     Related articles   

  243. WANG C, Jin W, Ma X, Dong Z, et al
    The different predictive value of mean platelet volume-to-lymphocyte ratio for postoperative recurrence between non-muscular invasive bladder cancer patients treated with intravesical chemotherapy and intravesical chemohyperthermia.
    Front Oncol. 2023;12:1101830.
    Abstract     Related articles   

  244. LIU T, Li S, Xia C, Xu D, et al
    TERT promoter mutations and methylation for telomerase activation in urothelial carcinomas: New mechanistic insights and clinical significance.
    Front Immunol. 2023;13:1071390.
    Abstract     Related articles   

  245. DING L, Deng X, Wang K, Xia W, et al
    Preoperative Systemic Inflammatory Markers as a Significant Prognostic Factor After TURBT in Patients with Non-Muscle-Invasive Bladder Cancer.
    J Inflamm Res. 2023;16:283-296.
    Abstract     Related articles   

  246. MAKRAKIS D, Wright JL, Roudier MP, Garcia J, et al
    A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2022 Dec 23:S1558-7673(22)00261.
    Abstract     Related articles   

  247. JIANG S, Zhang J, Fan Q, Li Z, et al
    A prognostic cuproptosis-related lncRNA predictive signature for bladder cancer patients.
    Hum Cell. 2023 Jan 29. doi: 10.1007/s13577-023-00863.
    Abstract     Related articles   

  248. MATHUR P, De Barros Santos C, Lachuer H, Patat J, et al
    Transcription factor EB regulates phosphatidylinositol-3-phosphate levels that control lysosome positioning in the bladder cancer model.
    Commun Biol. 2023;6:114.
    Abstract     Related articles   

  249. WANG Z, Huang Z, Cao X, Zhang F, et al
    A prognostic model based on necroptosis-related genes for prognosis and therapy in bladder cancer.
    BMC Urol. 2023;23:10.
    Abstract     Related articles   

  250. JING S, Feng Y, He XL, Wang Y, et al
    [Effects of lncRNA-UCA1 targeting miR-204-5p on the proliferation, migration, apoptosis and immune escape of endometrial carcinoma cells].
    Zhonghua Zhong Liu Za Zhi. 2023;45:56-63.
    Abstract     Related articles   

  251. ABDEL-HAFIZ SM, Sherif H, Romeih M, Elesaily K, et al
    Urine micro-RNA signature as a potential non-invasive diagnostic biomarker in bladder cancer.
    Asian Pac J Cancer Prev. 2023;24:121-131.
    Abstract     Related articles   

  252. TAHERI D, Jahanshahi F, Khajavi A, Kafi F, et al
    The Impact of Covid-19 Pandemic on Genitourinary Cancers Stage and Grade.
    Clin Genitourin Cancer. 2023;21:84-90.
    Abstract     Related articles   

  253. CHAWLA NS, Sayegh N, Tripathi N, Govindarajan A, et al
    Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors.
    Clin Genitourin Cancer. 2023;21:69-75.
    Abstract     Related articles   

  254. LIN Y, Lin L, Yang Y, Li M, et al
    DNA Methylation Architecture Provides Insight into the Pathogenesis of Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
    Clin Genitourin Cancer. 2023;21:32-42.
    Abstract     Related articles   

  255. LIN D, Luo S, Lin S, Zhong L, et al
    Avelumab Maintenance Treatment After First-line Chemotherapy in Advanced Urothelial Carcinoma-A Cost-Effectiveness Analysis.
    Clin Genitourin Cancer. 2023;21:8-15.
    Abstract     Related articles   

  256. UMEDA K, Tanaka N, Yasumizu Y, Takeda T, et al
    Site-Specific Differences in PD-1 Blockade Success and Biomarkers in Urothelial Carcinoma Treated with Pembrolizumab.
    Clin Genitourin Cancer. 2023;21:128-135.
    Abstract     Related articles   

  257. ISHIHARA H, Ishiyama Y, Nemoto Y, Nakamura K, et al
    Impact of Body Mass Index on Outcomes in an Asian population of Advanced Renal Cell Carcinoma and Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors.
    Clin Genitourin Cancer. 2023;21:136-145.
    Abstract     Related articles   

  258. DARIANE C, Timsit MO
    DNA-Damage-Repair Gene Alterations in Genitourinary Malignancies.
    Eur Surg Res. 2022;63:155-164.
    Abstract     Related articles   

  259. AVULOVA S, Benidir T, Cheville JC, Packiam VT, et al
    Prevalence, Predictors, and Oncologic Outcomes of Pelvic Organ Involvement in Women Undergoing Radical Cystectomy.
    Arch Pathol Lab Med. 2023;147:202-207.
    Abstract     Related articles   

  260. TU Y, Mao Z
    Identification and validation of molecular subtype and prognostic signature for bladder cancer based on neutrophil extracellular traps.
    Cancer Invest. 2023 Feb 10:1-12. doi: 10.1080/07357907.2023.2179063.
    Abstract     Related articles   

  261. TOMINAGA Y, Fujii M, Sadahira T, Katayama S, et al
    Bladder tuberculosis with ureteral strictures after bacillus Calmette‑Guerin therapy for urinary bladder cancer: A case report.
    Mol Clin Oncol. 2022;18:7.
    Abstract     Related articles   

  262. MITTAL S, Malik K, Raja A
    Nonbilharzial Squamous Cell Bladder Cancer: An Indian Experience.
    South Asian J Cancer. 2022;11:322-325.
    Abstract     Related articles   

  263. BRUMMELHUIS ISG, Crezee J, Witjes JA
    Evaluation of thermal dose effect in radiofrequency-induced hyperthermia with intravesical chemotherapy for nonmuscle invasive bladder cancer.
    Int J Hyperthermia. 2023;40:2157498.
    Abstract     Related articles   

  264. YIN L, Ying L, Guo R, Hao M, et al
    Ligustilide Induces Apoptosis and Reduces Proliferation in Human Bladder Cancer Cells by NFkappaB1 and Mitochondria Pathway.
    Chem Biol Drug Des. 2023 Feb 8. doi: 10.1111/cbdd.14207.
    Abstract     Related articles   

  265. AL-MAGHRABI JA, Khabaz MN
    Clinical significance of galectin-3 expression in urinary bladder carcinoma.
    J Int Med Res. 2023;51:3000605231153323.
    Abstract     Related articles   

  266. LV J, Li K, Yu H, Han J, et al
    HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1/PKM2 pathway.
    J Exp Clin Cancer Res. 2023;42:41.
    Abstract     Related articles   

  267. KESSLER ER, Schmiege SJ, Eguchi M, Singh S, et al
    Patterns of treatment in older patients with newly diagnosed advanced bladder cancer: A SEER dataset analysis.
    Aging Cancer. 2022;3:105-115.
    Abstract     Related articles   

  268. CHEN Z, Chen D, Song Z, Lv Y, et al
    Mapping the tumor microenvironment in bladder cancer and exploring the prognostic genes by single-cell RNA sequencing.
    Front Oncol. 2023;12:1105026.
    Abstract     Related articles   

  269. WANG X, Zhang S, Jin D, Luo J, et al
    mu-opioid receptor agonist facilitates circulating tumor cell formation in bladder cancer via the MOR/AKT/Slug pathway: a comprehensive study including randomized controlled trial.
    Cancer Commun (Lond). 2023 Feb 5. doi: 10.1002/cac2.12408.
    Abstract     Related articles   

  270. YANG K, Hu H, Wu J, Wang H, et al
    Letter to the Editor: clinical utility of urine DNA for noninvasive detection and minimal residual disease monitoring in urothelial carcinoma.
    Mol Cancer. 2023;22:25.
    Abstract     Related articles   

  271. NI W, Yi L, Dong X, Cao M, et al
    PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma.
    Sci Rep. 2023;13:2051.
    Abstract     Related articles   

  272. TABAEI S, Haghshenas MR, Webster TJ, Ghaderi A, et al
    Proteomic strategies for urothelial bladder cancer diagnosis, prognosis and treatment: Trends for tumor biomarker sources.
    Anal Biochem. 2023 Feb 2:115074. doi: 10.1016/j.ab.2023.115074.
    Abstract     Related articles   

  273. QUARESMA V, Marconi L, Jarimba R, Lima J, et al
    Immunotherapy in the Treatment of Metastatic Urothelial Carcinoma at a Tertiary Referral Center in Portugal.
    Acta Med Port. 2023;36:145-146.
    Abstract     Related articles   

  274. HELAL DS, Darwish SA, Awad RA, Ali DA, et al
    Immunohistochemical based molecular subtypes of muscle-invasive bladder cancer: association with HER2 and EGFR alterations, neoadjuvant chemotherapy response and survival.
    Diagn Pathol. 2023;18:11.
    Abstract     Related articles   

  275. COOPER OAE, Ghatnekar O, Piglowska N, Smith CA, et al
    Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC).
    Pharmacoecon Open. 2023 Feb 3. doi: 10.1007/s41669-023-00392.
    Abstract     Related articles   

  276. TISSOT G, Xylinas E
    Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Chemoradiotherapy Versus Chemoradiotherapy Alone in Muscle-invasive Bladder Cancer: The MK-3475-992/KEYNOTE-992 Trial.
    Eur Urol Focus. 2023 Feb 1:S2405-4569(22)00295-4. doi: 10.1016/j.euf.2022.
    Abstract     Related articles   

  277. REN S, Dai R, Zheng Z, Liu Q, et al
    A novel bidirectional perfusion-like administered system for NIR-II fluorescence imaging precision diagnosis of bladder cancer.
    Nanomedicine. 2023;49:102661.
    Abstract     Related articles   

  278. BUYUCEK S, Coskun SK, Onal B, Gamsizkan M, et al
    Receptor Tyrosine Kinase Pathway and Infiltrating Urothelial Carcinoma.
    J Environ Pathol Toxicol Oncol. 2023;42:65-77.
    Abstract     Related articles   

  279. NAKASE T, Hata T, Ikeshima R, Kawai K, et al
    [A Case of Robotic-Assisted Surgery for Simultaneous Triple Cancer of Rectum, Bladder, and Prostate].
    Gan To Kagaku Ryoho. 2022;49:1676-1677.
    Abstract     Related articles   

  280. IZUTANI Y, Nakata K, Takayama H, Miyake Y, et al
    [Case of Robot-Assisted Low Anterior Resection with Total Cystectomy for Rectal Cancer Invading the Urinary Bladder/Prostate in Collaboration with Urologists].
    Gan To Kagaku Ryoho. 2022;49:1565-1567.
    Abstract     Related articles   

  281. KUSAFUKA H, Ikeshima R, Kawai K, Hiraki M, et al
    [A Case of Laparoscopic Surgery for Sigmoid Colon Cancer after Cystectomy and Ileal Conduit Construction].
    Gan To Kagaku Ryoho. 2022;49:1870-1872.
    Abstract     Related articles   

  282. QU F, Yan X, Yu W
    Combination toripalimab and bevacizumab for an elderly urothelial carcinoma patient with brain metastasis who failed rapidly after radiotherapy: a case report and literature review.
    Anticancer Drugs. 2023;34:317-324.
    Abstract     Related articles   

  283. ZHANG Q, Liang Y, Zhang Y, Tao Z, et al
    A comparative study of attention mechanism based deep learning methods for bladder tumor segmentation.
    Int J Med Inform. 2023;171:104984.
    Abstract     Related articles   

  284. HETTERICH J, Schmidt V, Herth M, Merhof K, et al
    Urothelial carcinoma in a Russian tortoise (Testudohorsfieldii).
    J Comp Pathol. 2023;200:18-22.
    Abstract     Related articles   

  285. TANAKA S, Naritomi M, Monobe Y, Ariyasu S, et al
    The inclusion of nuclear area improves the Paris system for reporting urinary cytology.
    Cytopathology. 2023;34:106-112.
    Abstract     Related articles   

  286. DE KERVILER E, de Margerie-Mellon C, Dumont C, Pachev A, et al
    Salvage Percutaneous Cryoablation for Bleeding Upper Tract Urothelial Carcinoma.
    Cardiovasc Intervent Radiol. 2023;46:255-258.
    Abstract     Related articles   

  287. KOMAI Y, Nakajima K, Saito K, Tomioka Y, et al
    Development of a New Two-Arm Transurethral Surgical System for En Bloc Resection of Bladder Tumor: A Preclinical Study.
    J Endourol. 2023;37:165-170.
    Abstract     Related articles   

  288. DENG R, Zhang H, Li Y, Shi Y, et al
    Effect of Antacid Use on Immune Checkpoint Inhibitors in Advanced Solid Cancer Patients: A Systematic Review and Meta-analysis.
    J Immunother. 2023;46:43-55.
    Abstract     Related articles   

  289. HUANG YP, Huang EY, Chung HJ, Tai MC, et al
    Is Robotic Superior to Laparoscopic Approach for Radical Nephroureterectomy with Bladder Cuff Excision in Treating Upper Urinary Tract Urothelial Carcinoma?
    J Endourol. 2023;37:139-146.
    Abstract     Related articles   

  290. JIA K, Wang Y, Yang B, Wang H, et al
    Revisit the rare clinical cases of upper urinary tract metastases from gastrointestinal tumors.
    Asian J Surg. 2023;46:1103-1104.
    Abstract     Related articles   

  291. CHAO CW, Chung SD, Au CF
    Primary bladder amyloidosis mimicking bladder malignancy: A case report.
    Asian J Surg. 2023;46:1033-1035.
    Abstract     Related articles   

  292. CHENG TY, Tang TY, Hsu JM, Lin TF, et al
    Multifocal Xanthogranulomatous cystitis mimicking bladder malignancy: A case report and literature review.
    Asian J Surg. 2023;46:969-970.
    Abstract     Related articles   

  293. TAN Z, Wang H, Wang J
    A commentary on 'systematic review and meta-analysis of randomized controlled trials of perioperative outcomes and prognosis of transurethral en-bloc resection versus conventional transurethral resection for nonmuscle-invasive bladder cancer' (Int J S
    Int J Surg. 2023;109:208-210.
    Abstract     Related articles   

  294. YANG Y, Wang C, Li Z, Lu Q, et al
    Precise diagnosis and treatment of non-muscle invasive bladder cancer - A clinical perspective.
    Front Oncol. 2023;13:1042552.
    Abstract     Related articles   

  295. SEVIM NALKIRAN H, Akcora Yildiz D, Saydam F, Guzel AI, et al
    Targeting the anaphase-promoting complex/cyclosome (APC/C) enhanced antiproliferative and apoptotic response in bladder cancer.
    Saudi J Biol Sci. 2023;30:103564.
    Abstract     Related articles   

  296. TAPPERO S, Sorce G, Panunzio A, Hohenhorst L, et al
    Efficacy of chemotherapy on overall survival in metastatic sarcomatoid bladder cancer patients.
    Cent European J Urol. 2022;75:352-356.
    Abstract     Related articles   

  297. KOLL FJ, Banek S, Kluth L, Kollermann J, et al
    Tumor-associated macrophages and Tregs influence and represent immune cell infiltration of muscle-invasive bladder cancer and predict prognosis.
    J Transl Med. 2023;21:124.
    Abstract     Related articles   

  298. WANG L, Wu S, He H, Ai K, et al
    CircRNA-ST6GALNAC6 increases the sensitivity of bladder cancer cells to erastin-induced ferroptosis by regulating the HSPB1/P38 axis.
    Lab Invest. 2022;102:1323-1334.
    Abstract     Related articles   

  299. AL-ZUBI MT, Demour SA, Al-Rawashdah SF, Carbone A, et al
    Does post-void residual urine volume affect potential recurrence risk for non-muscle invasive bladder cancer?
    Future Sci OA. 2023;8:FSO823.
    Abstract     Related articles   

  300. MALEK-ESFANDIARI Z, Rezvani-Noghani A, Sohrabi T, Mokaberi P, et al
    Molecular Dynamics and Multi-Spectroscopic of the Interaction Behavior between Bladder Cancer Cells and Calf Thymus DNA with Rebeccamycin: Apoptosis through the Down Regulation of PI3K/AKT Signaling Pathway.
    J Fluoresc. 2023 Feb 14. doi: 10.1007/s10895-023-03169.
    Abstract     Related articles   

  301. LIU P, Xu L, Chen G, Shi B, et al
    Nomograms for predicting survival in patients with micropapillary bladder cancer: a real-world analysis based on the surveillance, epidemiology, and end results database and external validation in a tertiary center.
    BMC Urol. 2023;23:16.
    Abstract     Related articles   

  302. ZHANG Z, Mou Z, Xu C, Wu S, et al
    Correction: Autophagy-associated circular RNA hsa_circ_0007813 modulates human bladder cancer progression via hsa-miR-361-3p/IGF2R regulation.
    Cell Death Dis. 2023;14:113.
    Abstract     Related articles   

  303. VON DEIMLING M, Schuettfort VM, D'Andrea D, Pradere B, et al
    Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical Cystectomy.
    Clin Genitourin Cancer. 2023 Jan 26:S1558-7673(23)00031.
    Abstract     Related articles   

  304. ZHONG SJ, Gao JJ, Tang P, Liu YP, et al
    [The efficacy of radiotherapy based combined therapy for unresectable locally invasive bladder cancer and its associated factors analysis].
    Zhonghua Zhong Liu Za Zhi. 2023;45:175-181.
    Abstract     Related articles   

  305. VAN ZUTPHEN M, Hof JP, Aben KK, Kampman E, et al
    Adherence to lifestyle recommendations after non-muscle invasive bladder cancer diagnosis and risk of recurrence.
    Am J Clin Nutr. 2023 Feb 11:S0002-9165(23)04155.
    Abstract     Related articles   

  306. ZHU J, Huang X, Liu L, Wang N, et al
    Can the Vesical Imaging Reporting and Data System (VI-RADS) score be applied in conventional ultrasound and contrast-enhanced ultrasound to differentiate muscle-invasive bladder cancer?
    Med Ultrason. 2023 Feb 7. doi: 10.11152/mu-3841.
    Abstract     Related articles   

  307. WONG JL, Smith P, Angulo-Lozano J, Ranti D, et al
    IL-15 synergizes with CD40 agonist antibodies to induce durable immunity against bladder cancer.
    bioRxiv. 2023 Feb 1:2023.01.30.526266. doi: 10.1101/2023.01.30.526266.
    Abstract     Related articles   

  308. LI S, Jiang M, Yang L, Zheng F, et al
    Identification of platinum resistance-related gene signature for prognosis and immune analysis in bladder cancer.
    Front Genet. 2023;14:1062060.
    Abstract     Related articles   

  309. DE SOUZA AL, Mega AE, Douglass J, Olszewski AJ, et al
    Clinical features of patients with MTAP-deleted bladder cancer.
    Am J Cancer Res. 2023;13:326-339.
    Abstract     Related articles   

  310. LOPES S, Pabst L, Dory A, Klotz M, et al
    Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysis.
    Front Immunol. 2023;14:1070076.
    Abstract     Related articles   

  311. SHAFI S, Aung TN, Xirou V, Gavrielatou N, et al
    Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer.
    Lab Invest. 2022;102:1143-1149.
    Abstract     Related articles   

  312. LI F, Zheng Z, Chen W, Li D, et al
    Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms.
    Drug Resist Updat. 2023;68:100938.
    Abstract     Related articles   

  313. AMINOLTEJARI K, Hird AE, Klaassen Z, Satkunasivam R, et al
    Robotic Versus Open Cystectomy for Bladder Cancer: Synthesizing the Data from Current Systematic Reviews and Meta-Analyses.
    Ann Surg Oncol. 2023 Feb 11. doi: 10.1245/s10434-022-12692.
    Abstract     Related articles   

  314. TSILI AC, Varkarakis I, Pasoglou V, Anagnostou N, et al
    CT of the urinary tract revisited.
    Eur J Radiol. 2023;160:110717.
    Abstract     Related articles   

  315. ZHENG Q, Jiang Z, Ni X, Yang S, et al
    Machine Learning Quantified Tumor-Stroma Ratio Is an Independent Prognosticator in Muscle-Invasive Bladder Cancer.
    Int J Mol Sci. 2023;24:2746.
    Abstract     Related articles   

  316. GIANNIOU DD, Sklirou AD, Papadimitriou MA, Pilala KM, et al
    Evaluation of the Small Heat Shock Protein Family Members HSPB2 and HSPB3 in Bladder Cancer Prognosis and Progression.
    Int J Mol Sci. 2023;24:2609.
    Abstract     Related articles   

  317. TERANISHI K
    In Vivo Optical Imaging of Bladder Cancer Tissues in an MB49 Bladder Cancer Orthotopic Mouse Model Using the Intravesical or Intravenous Administration of Near-Infrared Fluorescence Probe.
    Int J Mol Sci. 2023;24:2349.
    Abstract     Related articles   

  318. HAGHAYEGH S, Liu Y, Zhang Y, Strohmaier S, et al
    Rotating Night Shift Work and Bladder Cancer Risk in Women: Results of Two Prospective Cohort Studies.
    Int J Environ Res Public Health. 2023;20:2202.
    Abstract     Related articles   

  319. KOWALD S, Huge Y, Tandiono D, Ali Z, et al
    Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer.
    Cells. 2023;12:508.
    Abstract     Related articles   

  320. AFONSO J, Goncalves C, Costa M, Ferreira D, et al
    Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy.
    Cancers (Basel). 2023;15:982.
    Abstract     Related articles   

  321. ZHANG Y, Wang W, Zhou H, Cui Y, et al
    Urinary Eubacterium sp. CAG:581 Promotes Non-Muscle Invasive Bladder Cancer (NMIBC) Development through the ECM1/MMP9 Pathway.
    Cancers (Basel). 2023;15:809.
    Abstract     Related articles   

  322. PAPAVASILIOU E, Sills VA, Calanzani N, Harrison H, et al
    Diagnostic Performance of Biomarkers for Bladder Cancer Detection Suitable for Community and Primary Care Settings: A Systematic Review and Meta-Analysis.
    Cancers (Basel). 2023;15:709.
    Abstract     Related articles   

  323. KAMECKI H, Debowska M, Poleszczuk J, Demkow T, et al
    Incidental Diagnosis of Urothelial Bladder Cancer: Associations with Overall Survival.
    Cancers (Basel). 2023;15:668.
    Abstract     Related articles   

  324. LIU J, Zhou Z, Jiang Y, Lin Y, et al
    EPHA3 Could Be a Novel Prognosis Biomarker and Correlates with Immune Infiltrates in Bladder Cancer.
    Cancers (Basel). 2023;15:621.
    Abstract     Related articles   

  325. LEONARDO C, Flammia RS, Lucciola S, Proietti F, et al
    Performance of Node-RADS Scoring System for a Standardized Assessment of Regional Lymph Nodes in Bladder Cancer Patients.
    Cancers (Basel). 2023;15:580.
    Abstract     Related articles   

  326. ESTEBAN-VILLARRUBIA J, Torres-Jimenez J, Bueno-Bravo C, Garcia-Mondaray R, et al
    Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer.
    Cancers (Basel). 2023;15:566.
    Abstract     Related articles   

  327. PAPPOT H, Ullen A
    Optimal Systemic Treatment of Advanced Bladder Cancer Calls for a Multidisciplinary Approach.
    Cancers (Basel). 2023;15:559.
    Abstract     Related articles   

  328. GANJI M, Bakhshi S, Shoari A, Ahangari Cohan R, et al
    Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer.
    J Transl Med. 2023;21:111.
    Abstract     Related articles   

  329. SUN Z, Jing C, Zhan H, Guo X, et al
    Identification of tumor antigens and immune landscapes for bladder urothelial carcinoma mRNA vaccine.
    Front Immunol. 2023;14:1097472.
    Abstract     Related articles   

  330. KIMURA Y, Fujimori M, Rajagopalan NR, Poudel K, et al
    Macrophage activity at the site of tumor ablation can promote murine urothelial cancer via transforming growth factor-beta1.
    Front Immunol. 2023;14:1070196.
    Abstract     Related articles   

  331. HATAKEYAMA S, Ohyama C
    [â…¡. Update on Guideline for Management of Metastatic Urothelial Carcinoma].
    Gan To Kagaku Ryoho. 2023;50:45-49.
    Abstract     Related articles   

  332. MOLLER K, Knoll M, Bady E, Schmerder MJ, et al
    PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samples.
    Cancer Biomark. 2023;36:177-191.
    Abstract     Related articles   

  333. SHIGETA K, Hasegawa M, Hishiki T, Naito Y, et al
    IDH2 stabilizes HIF-1alpha-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer.
    EMBO J. 2023;42:e110620.
    Abstract     Related articles   

  334. ANBARASAN T, Nissar S, Turbitt J, Walls K, et al
    Urinary bladder recurrences following ureteroscopic biopsies of upper tract urothelial cancers: a multi-centre observational study with genomic assessment for clonality.
    Scott Med J. 2023;68:4-13.
    Abstract     Related articles   

  335. YIRGA L, Hadaschik B, Burger M, Pullen L, et al
    [Photodynamic TUR-B: it looks better than it is : Comment on the randomized study].
    Urologie. 2023;62:181-183.
    Abstract     Related articles   

  336. RAHMAN SN, Lokeshwar SD, Syed JS, Javier-Desloges JF, et al
    Oncologic outcomes of neoadjuvant chemotherapy in patients with micropapillary variant urothelial carcinoma of the bladder.
    Urol Oncol. 2023;41:107.
    Abstract     Related articles   

  337. BIANCHI A, von Deimling M, Pallauf M, Yanagisawa T, et al
    Perspectives on the future of urothelial carcinoma therapy: chemotherapy and beyond.
    Expert Opin Pharmacother. 2023;24:177-195.
    Abstract     Related articles   

  338. ALSYOUF M, Ladi-Seyedian SS, Konety B, Pohar K, et al
    Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light?
    Urol Oncol. 2023;41:109.
    Abstract     Related articles   

  339. SMELSER WW, Tallman JE, Gupta VK, Al Hussein Al Awamlh B, et al
    Implementation of a comprehensive prehabilitation program for patients undergoing radical cystectomy.
    Urol Oncol. 2023;41:108.
    Abstract     Related articles   

  340. HUYNH MA, Tang C, Siva S, Berlin A, et al
    Review of Prospective Trials Assessing the Role of Stereotactic Body Radiation Therapy for Metastasis-directed Treatment in Oligometastatic Genitourinary Cancers.
    Eur Urol Oncol. 2023;6:28-38.
    Abstract     Related articles   

  341. MOMO OM, Otake S, Minamikawa S, Ohkusu K, et al
    Painless subcutaneous abscess caused by bacillus Calmette-Guerin osteomyelitis.
    Pediatr Int. 2023;65:e15381.
    Abstract     Related articles   

  342. YANG Z, Bi Y, Xu W, Guo R, et al
    Glabridin inhibits urothelial bladder carcinoma cell growth in vitro and in vivo by inducing cell apoptosis and cell cycle arrest.
    Chem Biol Drug Des. 2023;101:581-592.
    Abstract     Related articles   

  343. JARDIM DLF, Millis SZ, Ross JS, Lippman S, et al
    Comprehensive Landscape of Cyclin Pathway Gene Alterations and Co-occurrence with FGF/FGFR Aberrations Across Urinary Tract Tumors.
    Oncologist. 2023;28:e82-e91.
    Abstract     Related articles   

  344. TUO Z, Wang J, Zhang Y, Bi L, et al
    Learning Curve of a Novel Three-Port Laparoscopic Radical Cystectomy with Urinary Diversion: A Single-Center Retrospective Analysis.
    J Laparoendosc Adv Surg Tech A. 2023;33:188-193.
    Abstract     Related articles   

  345. SUN H, Wang X
    High-dimensional feature selection in competing risks modeling: A stable approach using a split-and-merge ensemble algorithm.
    Biom J. 2023;65:e2100164.
    Abstract     Related articles   

  346. ARITA Y, Yoshida S, Shigeta K, Kwee TC, et al
    Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology.
    Eur Urol Oncol. 2023;6:99-102.
    Abstract     Related articles   

  347. ACOSTA AM, Demicco EG, Dal Cin P, Hirsch MS, et al
    Pseudosarcomatous myofibroblastic proliferations of the urinary bladder are neoplasms characterized by recurrent FN1-ALK fusions.
    Mod Pathol. 2021;34:469-477.
    Abstract     Related articles   

  348. CHANG CH, Lin BJ, Chen CH, Nguyen NL, et al
    Stellettin B Induces Cell Death in Bladder Cancer Via Activating the Autophagy/DAPK2/Apoptosis Signaling Cascade.
    Mar Drugs. 2023;21:73.
    Abstract     Related articles   

  349. WU Z, Zeng J, Wu M, Liang Q, et al
    Identification and validation of the pyroptosis-related long noncoding rna signature to predict the prognosis of patients with bladder cancer.
    Medicine (Baltimore). 2023;102:e33075.
    Abstract     Related articles   

  350. GAISA NT, Hartmann A, Knuchel-Clarke R
    [New WHO classification 2022: urinary bladder cancer].
    Pathologie (Heidelb). 2023 Feb 24. doi: 10.1007/s00292-023-01183.
    Abstract     Related articles   

  351. SEISEN T, Labban M, Lipsitz SR, Preston MA, et al
    Assessment of the Ecological Association between Tobacco Smoking Exposure and Bladder Cancer Incidence over the Past Half-Century in the United States.
    Curr Oncol. 2023;30:1986-1998.
    Abstract     Related articles   

  352. BHARGAVA P
    Adjuvant intravesical chemohyperthermia or conventional chemotherapy in an era of bacillus Calmette-Guerin shortage for non-muscle invasive bladder cancer: The HIVEC-II trial.
    Indian J Urol. 2023;39:75-76.
    Abstract     Related articles   

  353. GRABENBAUER F, Flentje M
    [Organ-preserving treatment of muscle-invasive bladder cancer: 10-year data of the British BC2001 study].
    Strahlenther Onkol. 2023 Feb 23. doi: 10.1007/s00066-023-02052.
    Abstract     Related articles   

  354. ZHANG L, Liu B, Su J
    CCNB2 as a potential biomarker of bladder cancer via the high throughput technology.
    Medicine (Baltimore). 2023;102:e32825.
    Abstract     Related articles   

  355. WU P, Wu K, Li Z, Liu H, et al
    Multimodal investigation of bladder cancer data based on computed tomography, whole slide imaging, and transcriptomics.
    Quant Imaging Med Surg. 2023;13:1023-1035.
    Abstract     Related articles   

  356. MATIC M, Dmitrovic B, Matic S, Kurbel S, et al
    URINARY BLADDER CANCER RECURRENCE AND EXPRESSION OF LYNCH AND HER MARKERS: SEARCHING FOR IMMUNOHISTOCHEMICAL PATTERNS AMONG 113 TUMORS FROM 33 PATIENTS.
    Acta Clin Croat. 2022;61:239-247.
    Abstract     Related articles   

  357. AWADA H, Ali AH, Zeineddine MA, Nassereldine H, et al
    The status of bladder cancer research worldwide, a bibliometric review and recommendations.
    Arab J Urol. 2022;21:1-9.
    Abstract     Related articles   

  358. BENITEZ R, Yu K, Sirota M, Malats N, et al
    Characterization of the tumor-infiltrating immune repertoire in muscle invasive bladder cancer.
    Front Immunol. 2023;14:986598.
    Abstract     Related articles   

  359. LIU S, Yao Y, Wang ZK, Sun LJ, et al
    Prognostic value of the sarcomatoid component in bladder cancer: A propensity score matching study.
    Oncol Lett. 2023;25:103.
    Abstract     Related articles   

  360. SHAH SD, Gillard BM, Wrobel MM, Karasik E, et al
    Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer.
    Front Oncol. 2023;13:1120329.
    Abstract     Related articles   

  361. GOTSCHALL JW, Major CK, Jacobs LA, Blauch A, et al
    Salivary cotinine level and treatment response in muscle invasive bladder cancer: A pilot study.
    BJUI Compass. 2022;4:164-166.
    Abstract     Related articles   

  362. MIAN A, Wei J, Shi Z, Rifkin AS, et al
    Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort.
    BJUI Compass. 2022;4:156-163.
    Abstract     Related articles   

  363. ZHOU TL, Chen HX, Wang YZ, Wen SJ, et al
    Single-cell RNA sequencing reveals the immune microenvironment and signaling networks in cystitis glandularis.
    Front Immunol. 2023;14:1083598.
    Abstract     Related articles   

  364. KOSITZA J, Nguyen J, Hong T, Mantwill K, et al
    Identification of the KIF and MCM protein families as novel targets for combination therapy with CDK4/6 inhibitors in bladder cancer.
    Urol Oncol. 2023 Feb 20:S1078-1439(23)00010.
    Abstract     Related articles   

  365. FU S, Luan T, Jiang C, Huang Y, et al
    Corrigendum to "miR-3622a promotes proliferation and invasion of bladder cancer cells by downregulating LASS2" [Gene 701 (2019) 23-31].
    Gene. 2023;862:147266.
    Abstract     Related articles   

  366. PIGNOT G, Baboudjian M, Lebacle C, Chamouni A, et al
    Efficacy of hyperthermic intravesical chemotherapy (HIVEC) in patients with non-muscle invasive bladder cancer after BCG failure.
    World J Urol. 2023 Feb 22. doi: 10.1007/s00345-023-04332.
    Abstract     Related articles   

  367. SONG Y, Qin C, Zhang C, Peng Y, et al
    GNRH family genes contributed to gender-specific disparity of bladder cancer prognosis through exerting opposite regulatory roles between males and females.
    J Cancer Res Clin Oncol. 2023 Feb 19. doi: 10.1007/s00432-023-04640.
    Abstract     Related articles   

  368. ALSHEHRI E, Al-Dogmi AM, Al-Hazani TMI, Alwaili MA, et al
    Patterns of mutations in nine cancer-related genes and PAF development among smoking male patients diagnosed with bladder cancer.
    Tumour Biol. 2023;45:1-14.
    Abstract     Related articles   

  369. WANG N, Chen RX, Deng MH, Wei WS, et al
    m(5)C-dependent cross-regulation between nuclear reader ALYREF and writer NSUN2 promotes urothelial bladder cancer malignancy through facilitating RABL6/TK1 mRNAs splicing and stabilization.
    Cell Death Dis. 2023;14:139.
    Abstract     Related articles   

  370. MARQUES M, Corral S, Sanchez-Diaz M, Del Pozo N, et al
    Tumor and stromal cell targeting with Nintedanib and Alpelisib overcomes intrinsic bladder cancer resistance.
    Mol Cancer Ther. 2023 Feb 20:MCT-21-0667. doi: 10.1158/1535-7163.MCT-21-0667.
    Abstract     Related articles   

  371. GUNERI-SOZERI PY, Ozden-Yilmaz G, Kisim A, Cakiroglu E, et al
    FLI1 and FRA1 transcription factors drive the transcriptional regulatory networks characterizing muscle invasive bladder cancer.
    Commun Biol. 2023;6:199.
    Abstract     Related articles   

  372. INMAN BA, Hahn NM, Stratton K, Kopp R, et al
    A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guerin in Patients with High-risk Non-muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2023 Feb 15:S2588-9311(23)00032.
    Abstract     Related articles   

  373. CHENG TH, Lu ZH, Hsu CW
    Gross hematuria as the presentation of ureteral paraganglioma: a case report and literature review.
    BMC Urol. 2023;23:21.
    Abstract     Related articles   

  374. LI S, Zhang J, Tian Y, Zhu Y, et al
    De novo upper tract urothelial carcinoma after renal transplantation: a single-center experience in China.
    BMC Urol. 2023;23:23.
    Abstract     Related articles   

  375. LI X, Xiong W, Wang Y, Li Y, et al
    p53 Activates the Lipoxygenase Activity of ALOX15B via Inhibiting SLC7A11 to Induce Ferroptosis in Bladder Cancer Cells.
    Lab Invest. 2023;103:100058.
    Abstract     Related articles   

  376. YOHANA C, Bakuza JS, Kinung'hi SM, Nyundo BA, et al
    The trend of schistosomiasis related bladder cancer in the lake zone, Tanzania: a retrospective review over 10 years period.
    Infect Agent Cancer. 2023;18:10.
    Abstract     Related articles   

  377. SEOK J, Kwak HJ, Kwak Y, Lee M, et al
    Anti-oncogenic effects of dutasteride, a dual 5-alpha reductase inhibitor and a drug for benign prostate hyperplasia, in bladder cancer.
    J Transl Med. 2023;21:129.
    Abstract     Related articles   

  378. SARKIS J, Diamand R, Aoun F, Assenmacher G, et al
    Do perioperative blood transfusions impact oncological outcomes of robot-assisted radical cystectomy with intracorporeal urinary diversion? Results from a large multi-institutional registry.
    Minerva Urol Nephrol. 2023;75:50-58.
    Abstract     Related articles   

  379. JHAN JH, Ke HL, Liang PI, Hsu WC, et al
    High MRE11 Expression Level Predicts Poor Survival in Upper Tract Urothelial Carcinomas.
    Appl Immunohistochem Mol Morphol. 2023;31:94-100.
    Abstract     Related articles   

  380. KORGVEE A, Veskimae E, Huhtala H, Koskinen H, et al
    Posterior quadratus lumborum block versus epidural analgesia for postoperative pain management after open radical cystectomy: a randomized clinical trial.
    Acta Anaesthesiol Scand. 2022 Dec 22. doi: 10.1111/aas.14188.
    Abstract     Related articles   

  381. GUFFROY M, Trela B, Kambara T, Stawski L, et al
    Selective inhibition of integrin alphavbeta6 leads to rapid induction of urinary bladder tumors in cynomolgus macaques.
    Toxicol Sci. 2023;191:400-413.
    Abstract     Related articles   

  382. CHAU M, Thia I, Viswambaram P, Hawks C, et al
    Lymph node assessment technique matters in radical cystectomy for bladder cancer.
    ANZ J Surg. 2023 Mar 3. doi: 10.1111/ans.18292.
    Abstract     Related articles   

  383. IMAMVERDIYEV S, Qasimov E, Naghiyev R
    COMPARATIVE RESULTS OF MODERN EXAMINATION METHODS IN EARLY DIAGNOSIS OF BLADDER CANCER, DETERMINATION OF THE DEGREE OF INVASION AND SELECTION OF RADICAL TREATMENT TACTICS.
    Georgian Med News. 2023;:98-102.
    Abstract     Related articles   

  384. XU H, Liu Z, Weng S, Ren Y, et al
    Epigenetically regulated gene expression profiles recognized three molecular classifications with prognostic and therapeutic implications in bladder cancer.
    Clin Transl Med. 2023;13:e1145.
    Abstract     Related articles   

  385. IKEDA M, Uemura K, Araki Y, Iribe Y, et al
    [A Case of Long-Term Survival Following Multidisciplinary Therapy for Small Intestinal Metastasis of Bladder Cancer].
    Hinyokika Kiyo. 2023;69:55-58.
    Abstract     Related articles   

  386. DE HAAR-HOLLEMAN A, van Hoogstraten LMC, C C M Hulshof M, Tascilar M, et al
    Chemoradiation for muscle-invasive bladder cancer using 5-fluorouracil versus capecitabine: a nationwide cohort study.
    Radiother Oncol. 2023 Feb 28:109584. doi: 10.1016/j.radonc.2023.109584.
    Abstract     Related articles   

  387. TACAR SY, Yilmaz M, Baytekin HF, Tural D, et al
    Evaluation of predictive factors in patients with bladder cancer undergoing atezolizumab treatment: Case reports.
    Indian J Cancer. 2022;59:556-559.
    Abstract     Related articles   


  388. Retraction: CircRNA circPDSS1 promotes bladder cancer by downregulating miR-16.
    Biosci Rep. 2023;43:BSR-2019-1961.
    Abstract     Related articles   

  389. AN HW, Hou DY, Yang J, Wang ZQ, et al
    A bispecific glycopeptide spatiotemporally regulates tumor microenvironment for inhibiting bladder cancer recurrence.
    Sci Adv. 2023;9:eabq8225.
    Abstract     Related articles   

  390. YU Z, Lu C, Lai Y
    A serum miRNAs signature for early diagnosis of bladder cancer.
    Ann Med. 2023;55:736-745.
    Abstract     Related articles   

  391. MAZZASCHI G, Giudice GC, Coriano M, Campobasso D, et al
    Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario.
    Technol Cancer Res Treat. 2023;22:15330338231159753.
    Abstract     Related articles   

  392. LI X, Fu C, Li G, He H, et al
    RNA-seq reveals novel mechanistic targets of Livin in bladder cancer.
    BMC Urol. 2023;23:26.
    Abstract     Related articles   

  393. LI SH, Zhai GQ, He RQ, Chen G, et al
    Down-regulation and clinical significance of Sorbin and SH3 domain-containing protein 1 in bladder cancer tissues.
    IET Syst Biol. 2023 Feb 28. doi: 10.1049/syb2.12060.
    Abstract     Related articles   

  394. WANG XF, Liu DL, Geng L
    The PSCA rs2294008 (C/T) Polymorphism Increases the Risk of Gastric and Bladder Cancer: A Meta-Analysis.
    Genet Test Mol Biomarkers. 2023;27:44-55.
    Abstract     Related articles   

  395. MCELREE IM, Steinberg RL, Mott SL, O'Donnell MA, et al
    Comparison of Sequential Intravesical Gemcitabine and Docetaxel vs Bacillus Calmette-Guerin for the Treatment of Patients With High-Risk Non-Muscle-Invasive Bladder Cancer.
    JAMA Netw Open. 2023;6:e230849.
    Abstract     Related articles   

  396. YOUSSIEF MOHAMMED AA, Gamal DA, Abd Elzaher AR, Hasaballah A, et al
    Trimodality Therapy in which Concurrent Chemoradiation with Concomitant Boost in Muscle Invasive TCC Urinary Bladder Cancer.
    Asian Pac J Cancer Prev. 2023;24:517-524.
    Abstract     Related articles   

  397. FENG R, Li Z, Ge G, Wang C, et al
    Cancer-associated fibroblast-derived extracellular vesicles mediate immune escape of bladder cancer via PD-L1/PD-1 expression.
    Endocr Metab Immune Disord Drug Targets. 2023.
    Abstract     Related articles   

  398. WANG W, Chen L, Yang J, Hu D, et al
    Apatinib Inhibits Bladder Cancer through Suppression of The VEGFR2-PI3K-AKT Signaling Pathway as revealed by Network Pharmacology and In Vitro Experimental Verification.
    Comb Chem High Throughput Screen. 2023.
    Abstract     Related articles   

  399. KOKURA K, Watanabe J, Takuma T, Uketa S, et al
    A case of Avelumab response to multiple bone and lymph node metastases of plasmacytoid variant bladder cancer.
    Urol Case Rep. 2023;47:102358.
    Abstract     Related articles   

  400. LIU Y, Zhao YC, Lu Y, Goodarz D, et al
    The role of smoking in explaining racial/ethnic disparities in bladder cancer incidence in the United States.
    Urol Oncol. 2023 Feb 25:S1078-1439(23)00051.
    Abstract     Related articles   

  401. KERIOUI M, Bertrand J, Desmee S, Le Tourneau C, et al
    Assessing the Increased Variability in Individual Lesion Kinetics During Immunotherapy: Does It Exist, and Does It Matter?
    JCO Precis Oncol. 2023;7:e2200368.
    Abstract     Related articles   

  402. DUQUESNE I, Benamran D, Masson-Lecomte A, De La Taille A, et al
    Intraoperative complication of radical cystectomy for muscle-invasive bladder cancer: does the surgical approach matter? A retrospective multicenter study using the EAUiaiC classification.
    World J Urol. 2023 Feb 27. doi: 10.1007/s00345-023-04340.
    Abstract     Related articles   

  403. FRANCO N, Godono A, Clari M, Ciocan C, et al
    Occupational asbestos exposure and urinary bladder cancer: a systematic review and meta-analysis.
    World J Urol. 2023 Feb 27. doi: 10.1007/s00345-023-04327.
    Abstract     Related articles   

  404. GUPTA P, Sarangi SS, Singh M, Pandey H, et al
    To determine correlation between VIRADS scoring and pathological staging in bladder cancer: A prospective study and review of literature.
    Urologia. 2023 Feb 27:3915603231151738. doi: 10.1177/03915603231151738.
    Abstract     Related articles   

  405. WOLF P
    Inhibitor of apoptosis proteins as therapeutic targets in bladder cancer.
    Front Oncol. 2023;13:1124600.
    Abstract     Related articles   

  406. MAJA SG, Slavica KK, Suad A, Rubens J, et al
    Bladder mucinous adenocarcinoma as a diagnostic challenge: a case report.
    Pan Afr Med J. 2022;42:221.
    Abstract     Related articles   

  407. WANG Z, Wang J, Zhang W, Wang D, et al
    Case report: Urothelial carcinoma of the renal pelvis with trophoblastic differentiation: A rare case report and review of literature.
    Pathol Oncol Res. 2023;29:1610856.
    Abstract     Related articles   

  408. GUERRERO-RAMOS F
    BCG unresponsive non-muscle invasive bladder cancer: The beginning of a new era?
    Actas Urol Esp (Engl Ed). 2023 Feb 24:S2173-5786(23)00018.
    Abstract     Related articles   

  409. HE HL, Lai HY, Chan TC, Hsing CH, et al
    Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder.
    World J Surg Oncol. 2023;21:62.
    Abstract     Related articles   

  410. LIU Z, Song L, Xie J, Wu XR, et al
    Kavalactone Kawain Impedes Urothelial Tumorigenesis in UPII-Mutant Ha-Ras Mice via Inhibition of mTOR Signaling and Alteration of Cancer Metabolism.
    Molecules. 2023;28:1666.
    Abstract     Related articles   

  411. LEMINSKI A, Michalski W, Masojc B, Kaczmarek K, et al
    Combined Modality Bladder-Sparing Therapy for Muscle-Invasive Bladder Cancer: How (Should) We Do It? A Narrative Review.
    J Clin Med. 2023;12:1560.
    Abstract     Related articles   

  412. WEN P, Wen J, Huang X, Wang F, et al
    Development and Validation of Nomograms Predicting the 5- and 8-Year Overall and Cancer-Specific Survival of Bladder Cancer Patients Based on SEER Program.
    J Clin Med. 2023;12:1314.
    Abstract     Related articles   

  413. BOSCHI F, Malatesta M
    Nanoparticle-Based Techniques for Bladder Cancer Imaging: A Review.
    Int J Mol Sci. 2023;24:3812.
    Abstract     Related articles   

  414. SANGUEDOLCE F, Zanelli M, Palicelli A, Bisagni A, et al
    HER2 Expression in Bladder Cancer: A Focused View on Its Diagnostic, Prognostic, and Predictive Role.
    Int J Mol Sci. 2023;24:3720.
    Abstract     Related articles   

  415. YANG CC, Chuang FC, Chang CL, Huang CR, et al
    Melatonin-Assisted Cisplatin Suppresses Urinary Bladder Cancer Cell Proliferation and Growth through Inhibiting PrP(C)-Regulated Cell Stress and Cell Proliferation Signaling.
    Int J Mol Sci. 2023;24:3353.
    Abstract     Related articles   

  416. LIN PT, Hung WK, Chang YH, Hsieh ML, et al
    Replacement Instead of Discontinuation of Bacillus Calmette-Guerin Instillation in Non-Muscle-Invasive Bladder Cancer.
    Cancers (Basel). 2023;15:1345.
    Abstract     Related articles   

  417. LEE MC, Wang SY, Pan CT, Chien MY, et al
    Development of Deep Learning with RDA U-Net Network for Bladder Cancer Segmentation.
    Cancers (Basel). 2023;15:1343.
    Abstract     Related articles   

  418. LEE HW, Kwon WA, Nguyen NT, Phan DTT, et al
    Approaches to Clinical Complete Response after Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: Possibilities and Limitations.
    Cancers (Basel). 2023;15:1323.
    Abstract     Related articles   

  419. ABOUDARAM A, Chaltiel L, Pouessel D, Graff-Cailleaud P, et al
    Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis.
    Cancers (Basel). 2023;15:1161.
    Abstract     Related articles   

  420. GAO Y, Cao H, Huang D, Zheng L, et al
    RNA-Binding Proteins in Bladder Cancer.
    Cancers (Basel). 2023;15:1150.
    Abstract     Related articles   

  421. WANG H, Feng Y, Zheng X, Xu X, et al
    The Diagnostic and Therapeutic Role of snoRNA and lincRNA in Bladder Cancer.
    Cancers (Basel). 2023;15:1007.
    Abstract     Related articles   

  422. KOLL FJ, Metzger E, Hamann J, Ramos-Triguero A, et al
    Overexpression of KMT9alpha Is Associated with Aggressive Basal-like Muscle-Invasive Bladder Cancer.
    Cells. 2023;12:589.
    Abstract     Related articles   

  423. SHI Y, Mathis BJ, He Y, Yang X, et al
    The Current Progress and Future Options of Multiple Therapy and Potential Biomarkers for Muscle-Invasive Bladder Cancer.
    Biomedicines. 2023;11:539.
    Abstract     Related articles   

  424. JAIN M, Tivtikyan A, Kamalov D, Avdonin S, et al
    Development of a Sensitive Digital Droplet PCR Screening Assay for the Detection of GPR126 Non-Coding Mutations in Bladder Cancer Urine Liquid Biopsies.
    Biomedicines. 2023;11:495.
    Abstract     Related articles   

  425. GALINIAK S, Molon M, Biesiadecki M, Mokrzynska A, et al
    Oxidative Stress Markers in Urine and Serum of Patients with Bladder Cancer.
    Antioxidants (Basel). 2023;12:277.
    Abstract     Related articles   

  426. ZONA A, Fazzo L, Benedetti M, Bruno C, et al
    [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
    Epidemiol Prev. 2023;47.
    Abstract     Related articles   

  427. CINAR NB, Yilmaz H, Avci IE, Cakmak K, et al
    Reporting perioperative complications of radical cystectomy: the influence of using standard methodology based on ICARUS and EAU quality criteria.
    World J Surg Oncol. 2023;21:58.
    Abstract     Related articles   

  428. MARTINEZ-VIDAL L, Chighizola M, Berardi M, Alchera E, et al
    Micro-mechanical fingerprints of the rat bladder change in actinic cystitis and tumor presence.
    Commun Biol. 2023;6:217.
    Abstract     Related articles   

  429. JOSHI M, Tuanquin L, Zhu J, Walter V, et al
    Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023.
    J Immunother Cancer. 2023;11:e006551.
    Abstract     Related articles   

  430. TANG Q, Zuo W, Wan C, Xiong S, et al
    Comprehensive genomic profiling of upper tract urothelial carcinoma and urothelial carcinoma of the bladder identifies distinct molecular characterizations with potential implications for targeted therapy & immunotherapy.
    Front Immunol. 2023;13:1097730.
    Abstract     Related articles   

  431. ALRADHI M, Wen S, Safi M, Al-Danakh A, et al
    Molecular genetic and clinical characteristic analysis of primary signet ring cell carcinoma of urinary bladder identified by a novel OR2L5 mutation.
    Cancer Med. 2023;12:3931-3951.
    Abstract     Related articles   

  432. RASPOLLINI MR, Comperat EM, Lopez-Beltran A, Montironi R, et al
    News in the classification of WHO 2022 bladder tumors.
    Pathologica. 2022;115:32-40.
    Abstract     Related articles   

  433. BOULEFTOUR W, Sargos P, Magne N
    Nectin-4: a Tumor Cell Target and Status of Inhibitor Development.
    Curr Oncol Rep. 2023;25:181-188.
    Abstract     Related articles   

  434. HU X, Wang K, Sun M, Li C, et al
    Quantitative MRI in distinguishing bladder paraganglioma from bladder leiomyoma.
    Abdom Radiol (NY). 2023;48:1051-1061.
    Abstract     Related articles   

  435. PEREZ-MONTIEL D, Olivares-Mundo A, Jimenez-Rios MA, Morera CS, et al
    Influence of luminal and basal subtype in prognosis of high-grade non muscle invasive urothelial carcinoma.
    Ann Diagn Pathol. 2023;63:152081.
    Abstract     Related articles   

  436. BABAN F, Auen T, Eschbacher KL, Swanson AA, et al
    Invasive urothelial carcinoma with squamous differentiation and associated high-risk human papilloma virus infection: Clinical, cytologic, and histologic features of a rare entity.
    Ann Diagn Pathol. 2023;63:152103.
    Abstract     Related articles   

  437. FUJIKI T, Sakai Y, Ikawa Y, Takenaka M, et al
    Pediatric inflammatory myofibroblastic tumor of the bladder with ALK-FN1 fusion successfully treated by alectinib.
    Pediatr Blood Cancer. 2023;70:e30172.
    Abstract     Related articles   

  438. PETEINARIS A, Kallidonis P, Tsaturyan A, Pagonis K, et al
    The feasibility of robot-assisted radical cystectomy: an experimental study.
    World J Urol. 2023;41:477-482.
    Abstract     Related articles   

  439. SYED M, Mushtaq S, Loya A, Hassan U, et al
    Prognostic significance of minor high grade component in non-invasive papillary urothelial carcinoma of urinary bladder: (A study of 273 consecutive cases over a period of 3 years).
    Ann Diagn Pathol. 2023;63:152079.
    Abstract     Related articles   

  440. GAO S, Zhou XQ, Wu Q, Chen XD, et al
    Effects of Holliday Junction-Recognition Protein-Mediated C-Jun N-Terminal Kinase/ Signal Transducer and Activator of Transcription 3 Signaling Pathway on Cell Proliferation, Cell Cycle and Cell Apoptosis in Bladder Urothelial Carcinoma.
    Tohoku J Exp Med. 2023;259:209-219.
    Abstract     Related articles   

  441. HEKMAN MCH, Wijn SRW, Lotan Y, Govers TM, et al
    Bladder EpiCheck urine test in the follow-up of NMIBC: a cost analysis.
    World J Urol. 2023;41:471-476.
    Abstract     Related articles   

  442. BALAR AV, Castellano DE, Grivas P, Vaughn DJ, et al
    Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up.
    Ann Oncol. 2023;34:289-299.
    Abstract     Related articles   

  443. BREHMER M
    Register-based research. Accurate data and analysis, crucial for correct conclusions. Comment on "Incidence, mortality, and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 20
    Scand J Urol. 2023;57.
    Abstract     Related articles   

  444. BALAWENDER K, Wawrzyniak A, Walocha J, Mazur M, et al
    Leiomyoma: a case of a rare benign mesenchymal neoplasm of the urinary bladder.
    Pol Arch Intern Med. 2023;133:16381.
    Abstract     Related articles   

  445. KARTTUNEN E, Hervonen P, Hosseini Aliabad A, Oldenburg J, et al
    Incidence, mortality and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019.
    Scand J Urol. 2023;57.
    Abstract     Related articles   

  446. BOROWCZAK J, Szczerbowski K, Maniewski M, Zdrenka M, et al
    The prognostic role of p53 and its correlation with CDK9 in urothelial carcinoma.
    Clin Transl Oncol. 2023;25:830-840.
    Abstract     Related articles   

  447. ALTIERI MA, Sarmiento-Machado LM, Romualdo GR, de Moura NA, et al
    Dietary Capsaicin Reduces Chemically Induced Rat Urinary Bladder Carcinogenesis.
    Plant Foods Hum Nutr. 2023;78:93-99.
    Abstract     Related articles   

  448. MOEEN AM, Behnsawy HM, Faragallah MA, Gadelkareem RA, et al
    Functional evaluation of a spiral neobladder with an angled chimney; A prospective randomized comparative study.
    Eur J Surg Oncol. 2023;49:491-496.
    Abstract     Related articles   

  449. LIMONNIK V, Samiei A, Abel S, Wegner RE, et al
    Urachal carcinoma: A novel staging system utilizing the National Cancer Database.
    Cancer Med. 2023;12:2752-2760.
    Abstract     Related articles   

  450. MATSUBARA N, Yonese J, Kojima T, Azuma H, et al
    Japanese subgroup analysis of EV-301: An open-label, randomized phase 3 study to evaluate enfortumab vedotin versus chemotherapy in subjects with previously treated locally advanced or metastatic urothelial carcinoma.
    Cancer Med. 2023;12:2761-2771.
    Abstract     Related articles   

  451. SONPAVDE GP, Maughan BL, McGregor BA, Wei XX, et al
    Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma.
    Cancer Immunol Immunother. 2023;72:775-782.
    Abstract     Related articles   

  452. HUANG J, Huang D, Ruan X, Huang J, et al
    Association between cannabis use with urological cancers: A population-based cohort study and a mendelian randomization study in the UK biobank.
    Cancer Med. 2023;12:3468-3476.
    Abstract     Related articles   

  453. WU Y, Zhu W, Wang J, Liu L, et al
    Using machine learning for mortality prediction and risk stratification in atezolizumab-treated cancer patients: Integrative analysis of eight clinical trials.
    Cancer Med. 2023;12:3744-3757.
    Abstract     Related articles   

  454. ITO K, Kita Y, Yokomizo A, Miki J, et al
    Discontinuation of pembrolizumab for advanced urothelial carcinoma without disease progression: Nationwide cohort study.
    Cancer Med. 2023;12:2325-2332.
    Abstract     Related articles   

  455. BORET S, Lambert E, Charles VP, Philippe T, et al
    Vulvar pagetoid urothelial intraepithelial neoplasia: a case report.
    Acta Chir Belg. 2023;123:174-177.
    Abstract     Related articles   

  456. LENTZSCH AM, Siggel R, Schnorr C, Holtick U, et al
    LONG-TERM FOLLOW-UP OF ASYMMETRIC BILATERAL DIFFUSE UVEAL MELANOCYTIC PROLIFERATION IN A PATIENT WITH METASTASIZED UROTHELIAL CARCINOMA.
    Retin Cases Brief Rep. 2023;17:105-110.
    Abstract     Related articles   

  457. COCKRELL DC, Rose TL
    Current Status of Perioperative Therapy in Muscle-Invasive Bladder Cancer and Future Directions.
    Curr Oncol Rep. 2023 Mar 10. doi: 10.1007/s11912-023-01390.
    Abstract     Related articles   

  458. YANAGISAWA T, Matsukawa A, Iwatani K, Sato S, et al
    En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity Score-Matched Analysis.
    Ann Surg Oncol. 2023 Mar 10. doi: 10.1245/s10434-023-13227.
    Abstract     Related articles   

  459. GRABE-HEYNE K, Henne C, Odeyemi I, Pohlmann J, et al
    Evaluating the cost-utility of intravesical bacillus calmette-guerin versus radical cystectomy in patients with high-risk non-muscle-invasive bladder cancer in the UK.
    J Med Econ. 2023 Mar 10:1-19. doi: 10.1080/13696998.2023.2189860.
    Abstract     Related articles   

  460. HU X, Sun C, Ren X, Ge S, et al
    Contrast-enhanced Ultrasound Combined With Elastography for the Evaluation of Muscle-invasive Bladder Cancer in Rats.
    J Ultrasound Med. 2023 Mar 10. doi: 10.1002/jum.16216.
    Abstract     Related articles   

  461. YAMAMOTO Y, Kawashima A, Morishima T, Uemura T, et al
    Comparative Effectiveness of Radiation Versus Radical Cystectomy for Localized Muscle-Invasive Bladder Cancer.
    Adv Radiat Oncol. 2022;8:101157.
    Abstract     Related articles   

  462. WANG H, Li J, Zi X, Yuan X, et al
    Comprehensive analysis of cuproptosis-related genes on bladder cancer prognosis, tumor microenvironment invasion, and drug sensitivity.
    Front Oncol. 2023;13:1116305.
    Abstract     Related articles   

  463. WU S, Hong G, Xu A, Zeng H, et al
    Artificial intelligence-based model for lymph node metastases detection on whole slide images in bladder cancer: a retrospective, multicentre, diagnostic study.
    Lancet Oncol. 2023 Mar 6:S1470-2045(23)00061.
    Abstract     Related articles   

  464. MANDRIK O, Hahn AI, Catto JWF, Zauber AG, et al
    Critical Appraisal of Decision Models Used for the Economic Evaluation of Bladder Cancer Screening and Diagnosis: A Systematic Review.
    Pharmacoeconomics. 2023 Mar 8. doi: 10.1007/s40273-023-01256.
    Abstract     Related articles   

  465. ZUKOV RA, Savchenko AA, Slepov EV, Semenov EV, et al
    Phenotype of Urine Sediment Cells in Patients with Bladder Cancer.
    Bull Exp Biol Med. 2023 Mar 9. doi: 10.1007/s10517-023-05732.
    Abstract     Related articles   

  466. CARAMELO B, Zagorac S, Corral S, Marques M, et al
    Cancer-associated Fibroblasts in Bladder Cancer: Origin, Biology, and Therapeutic Opportunities.
    Eur Urol Oncol. 2023 Mar 6:S2588-9311(23)00043-3. doi: 10.1016/j.euo.2023.
    Abstract     Related articles   

  467. YAMADA Y, Kume H
    [Frailty and surgical tolerability in elderly patients undergoing robot-assisted radical cystectomy (RARC)].
    Nihon Ronen Igakkai Zasshi. 2023;60:38-42.
    Abstract     Related articles   

  468. JIN D, Qian L, Xia J, Zhang R, et al
    In vivo detection of circulating tumor cells predicts high-risk features in patients with bladder cancer.
    Med Oncol. 2023;40:113.
    Abstract     Related articles   

  469. FAN X, Yu H, Ni X, Chen G, et al
    Systematic radiomics analysis based on multiparameter MRI to preoperatively predict the expression of Ki67 and histological grade in patients with bladder cancer.
    Br J Radiol. 2023 Mar 8:20221086. doi: 10.1259/bjr.20221086.
    Abstract     Related articles   

  470. PASSALACQUA MI, Squeri A, Sciume C, Ieni A, et al
    Enfortumab Vedotin in metastatic bladder cancer: a case report of durable clinical efficacy in a pretreated patient.
    Acta Biomed. 2023;94.
    Abstract     Related articles   

  471. SHU TD, Schumacher FR, Conroy B, Ponsky L, et al
    Disparities in cause-specific mortality by race and sex among bladder cancer patients from the SEER database.
    Cancer Causes Control. 2023 Mar 8. doi: 10.1007/s10552-023-01679.
    Abstract     Related articles   

  472. TAPPERO S, Barletta F, Piccinelli ML, Cano Garcia C, et al
    Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder Cancer.
    Urol Oncol. 2023 Mar 5:S1078-1439(23)00015-7. doi: 10.1016/j.urolonc.2023.
    Abstract     Related articles   

  473. AKDEMIR E, Sweegers MG, Vrieling A, Rundqvist H, et al
    EffectiveNess of a multimodal preHAbilitation program in patieNts with bladder canCEr undergoing radical cystectomy: protocol of the ENHANCE multicentre randomised controlled trial.
    BMJ Open. 2023;13:e071304.
    Abstract     Related articles   

  474. JEONG SH, Ku JH
    Treatment strategies for the Bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer.
    Investig Clin Urol. 2023;64:103-106.
    Abstract     Related articles   

  475. NAGAHISA C, Iizuka J, Kobari Y, Minoda R, et al
    Efficacy of Combined Pembrolizumab and Pelvic Radiotherapy for Bladder Cancer With Rectal Metastases.
    In Vivo. 2023;37:912-915.
    Abstract     Related articles   

  476. CHEN L, Dong W, Zhou M, Yang C, et al
    PABPN1 regulates mRNA alternative polyadenylation to inhibit bladder cancer progression.
    Cell Biosci. 2023;13:45.
    Abstract     Related articles   

  477. CIARAMELLA A, Di Nardo E, Terracciano D, Conte L, et al
    A new biomarker panel of ultraconserved long non-coding RNAs for bladder cancer prognosis by a machine learning based methodology.
    BMC Bioinformatics. 2023;23.
    Abstract     Related articles   

  478. LEE YS, Ha MS, Tae JH, Chang IH, et al
    Gemcitabine-cisplatin versus MVAC chemotherapy for urothelial carcinoma: a nationwide cohort study.
    Sci Rep. 2023;13:3682.
    Abstract     Related articles   

  479. SCHMOKEL SS, Nordentoft I, Lindskrog SV, Lamy P, et al
    Improved protocol for single-nucleus RNA-sequencing of frozen human bladder tumor biopsies.
    Nucleus. 2023;14:2186686.
    Abstract     Related articles   

  480. JIN D, Qian L, Xia J, Zhang R, et al
    In vivo detection demonstrates circulating tumor cell reduction instead of baseline number has prognostic value in bladder cancer patients receiving neoadjuvant chemotherapy.
    Cell Oncol (Dordr). 2023 Mar 6. doi: 10.1007/s13402-023-00785.
    Abstract     Related articles   


  481. In brief: Adstiladrin - a gene therapy for bladder cancer.
    Med Lett Drugs Ther. 2023;65:e40-e41.
    Abstract     Related articles   

  482. YOSHIOKA F, Kato T, Shima Y, Hatano K, et al
    Drug-induced interstitial pneumonia after intravesical Bacillus Calmette-Guerin administration for bladder cancer with scleroderma.
    IJU Case Rep. 2023;6:133-136.
    Abstract     Related articles   

  483. COLLACOTT H, Krucien N, Heidenreich S, Catto JWF, et al
    Patient Preferences for Treatment of Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer: A Cross-country Choice Experiment.
    Eur Urol Open Sci. 2023;49:92-99.
    Abstract     Related articles   

  484. WU Y, Xu Y, He S, Li Y, et al
    Cytoskeleton regulator RNA expression on cancer-associated fibroblasts is associated with prognosis and immunotherapy response in bladder cancer.
    Heliyon. 2023;9:e13707.
    Abstract     Related articles   

  485. LI T, Jiang N, Bai Y, Liu T, et al
    Prediction of immune infiltration and prognosis for patients with urothelial bladder cancer based on the DNA damage repair-related genes signature.
    Heliyon. 2023;9:e13661.
    Abstract     Related articles   

  486. CHEN R, Jiang M, Hu B, Fu B, et al
    Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of PLOD Family in Bladder Cancer.
    Int J Gen Med. 2023;16:707-722.
    Abstract     Related articles   

  487. ST-LAURENT MP, Suderman J, Black PC
    Where To Draw the Line: Stratifying Risk for High-grade Ta Bladder Cancer.
    Eur Urol Oncol. 2023 Mar 3:S2588-9311(23)00035-4. doi: 10.1016/j.euo.2023.
    Abstract     Related articles   

  488. ANDRIKOS I, Stefanou K, Bellos C, Stergios G, et al
    EDIT Software: A tool for the semi-automatic 3D reconstruction of bladder cancer and urinary bladder of animal models.
    Comput Methods Programs Biomed. 2023;232:107448.
    Abstract     Related articles   

  489. WHYNOT EG, Tomko AM, Dupre DJ
    Anticancer properties of cannabidiol and Delta(9)-tetrahydrocannabinol and synergistic effects with gemcitabine and cisplatin in bladder cancer cell lines.
    J Cannabis Res. 2023;5:7.
    Abstract     Related articles   

  490. CARVALHO LB, Martinez JLC, Lodeiro C, Bento R, et al
    Biochemical network analysis of protein-protein interactions to follow-up T1 bladder cancer patients.
    J Proteomics. 2023 Mar 2:104865. doi: 10.1016/j.jprot.2023.104865.
    Abstract     Related articles   

  491. IZAWA M, Tanaka N, Murakami T, Anno T, et al
    Single-Cell Phenotyping of CD73 Expression Reveals the Diversity of the Tumor Immune Microenvironment and Reflects the Prognosis of Bladder Cancer.
    Lab Invest. 2023;103:100040.
    Abstract     Related articles   

  492. AMEEN YA, Badary DM, Abonnoor AEI, Hussain KF, et al
    Which data subset should be augmented for deep learning? a simulation study using urothelial cell carcinoma histopathology images.
    BMC Bioinformatics. 2023;24:75.
    Abstract     Related articles   

  493. BUKAVINA L, Isali I, Ginwala R, Sindhani M, et al
    Global Meta-analysis of Urine Microbiome: Colonization of Polycyclic Aromatic Hydrocarbon-degrading Bacteria Among Bladder Cancer Patients.
    Eur Urol Oncol. 2023 Mar 1:S2588-9311(23)00036-6. doi: 10.1016/j.euo.2023.
    Abstract     Related articles   

  494. LI KD, Chu CE, Patel M, Meng MV, et al
    Cxbladder Monitor testing to reduce cystoscopy frequency in patients with bladder cancer.
    Urol Oncol. 2023 Mar 1:S1078-1439(23)00009-1. doi: 10.1016/j.urolonc.2023.
    Abstract     Related articles   

  495. HERZOG RW, Suzuki M
    Adenoviral gene therapy for bladder cancer.
    Cell. 2023;186:893.
    Abstract     Related articles   

  496. ZENG SP, Sun YF, Ye JB, Zeng K, et al
    Transurethral en bloc resection of a bladder perivascular epithelioid cell tumor (PEComa): a case report.
    BMC Urol. 2023;23:28.
    Abstract     Related articles   

  497. FONTUGNE J, Wong J, Cabel L, Neyret-Kahn H, et al
    Progression-associated molecular changes in basal/squamous and sarcomatoid bladder carcinogenesis.
    J Pathol. 2023;259:455-467.
    Abstract     Related articles   

  498. GERALD T, Margulis V, Meng X, Bagrodia A, et al
    Actionable genomic landscapes from a real-world cohort of urothelial carcinoma patients.
    Urol Oncol. 2023;41:148.
    Abstract     Related articles   

  499. SETYO LC, Donahoe SL, Shearer PL, Wang P, et al
    Immunohistochemical analysis of expression of VEGFR2, KIT, PDGFR-beta, and CDK4 in canine urothelial carcinoma.
    J Vet Diagn Invest. 2023;35:109-115.
    Abstract     Related articles   

  500. MIYAKE M, Shimizu T, Oda Y, Tachibana A, et al
    Switch-maintenance avelumab immunotherapy following first-line chemotherapy for patients with advanced, unresectable or metastatic urothelial carcinoma: the first Japanese real-world evidence from a multicenter study.
    Jpn J Clin Oncol. 2023;53:253-262.
    Abstract     Related articles   

  501. BARLETTA F, Tappero S, Panunzio A, Incesu RB, et al
    Conditional survival after radical cystectomy for non-metastatic muscle-invasive squamous cell carcinoma of the urinary bladder: A population-based analysis.
    Urol Oncol. 2023;41:147.
    Abstract     Related articles   

  502. WOLDU SL, Labbate C, Murray KS, Rose K, et al
    Early experience with UGN-101 for the treatment of upper tract urothelial cancer - A multicenter evaluation of practice patterns and outcomes.
    Urol Oncol. 2023;41:147.
    Abstract     Related articles   

  503. MIYAKE M, Oda Y, Owari T, Iida K, et al
    Probiotics enhances anti-tumor immune response induced by gemcitabine plus cisplatin chemotherapy for urothelial cancer.
    Cancer Sci. 2023;114:1118-1130.
    Abstract     Related articles   

  504. CHEN Y, Fu J, Li Z, Chen Q, et al
    Cutoff values of PD-L1 expression in urinary cytology samples for predicting response to immune checkpoint inhibitor therapy in upper urinary tract urothelial carcinoma.
    Cancer Cytopathol. 2023;131:179-187.
    Abstract     Related articles   

  505. MATUTE GUERRERO A, Abanses Moreno P, Villasmil Chaparro I
    Pulmonary thrombotic microangiopathy caused by neoplastic urothelial carcinoma cells.
    Med Clin (Barc). 2023;160:226-227.
    Abstract     Related articles   

  506. QIWEI C, Jiajun S, Cheng L, Shengbo H, et al
    Comparison between renal pelvic and ureteral tumors in muscle-invasive upper tract urothelial carcinoma.
    Cancer Sci. 2023;114:984-994.
    Abstract     Related articles   

  507. PIERCONTI F, Rossi ED, Cenci T, Carlino A, et al
    DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group.
    Cancer Cytopathol. 2023;131:158-164.
    Abstract     Related articles   

  508. SEKINE Y, Iwasaki Y, Hakozaki N, Endo M, et al
    Prevalence and risk estimation of cancer-predisposing genes for upper urinary tract urothelial carcinoma in Japanese.
    Jpn J Clin Oncol. 2022;52:1441-1445.
    Abstract     Related articles   

  509. BLINOVA E, Samishina E, Deryabina O, Blinov D, et al
    Expression of p53 Protein Associates with Anti-PD-L1 Treatment Response on Human-Derived Xenograft Model of GATA3/CR5/6-Negative Recurrent Nonmuscular Invasive Bladder Urothelial Carcinoma.
    Int J Mol Sci. 2021;22:9856.
    Abstract     Related articles   

  510. LEE HW, Seo HK
    Fibroblast Growth Factor Inhibitors for Treating Locally Advanced/Metastatic Bladder Urothelial Carcinomas via Dual Targeting of Tumor-Specific Oncogenic Signaling and the Tumor Immune Microenvironment.
    Int J Mol Sci. 2021;22:9526.
    Abstract     Related articles   

  511. LOPEZ-CORTES R, Gomez BB, Vazquez-Estevez S, Perez-Fentes D, et al
    Blood-based protein biomarkers in bladder urothelial tumors.
    J Proteomics. 2021;247:104329.
    Abstract     Related articles   

  512. MARANDINO L, Raggi D, Calareso G, Alessi A, et al
    Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial.
    Clin Genitourin Cancer. 2021;19:457-465.
    Abstract     Related articles   

  513. POND GR, Agarwal A, Ornstein M, Garcia J, et al
    Clinical Outcomes of Platinum-ineligible Patients with Advanced Urothelial Carcinoma Treated With First-line PD1/L1 Inhibitors.
    Clin Genitourin Cancer. 2021;19:425-433.
    Abstract     Related articles   

  514. STOKKEL LE, Stokkel MPM, Donswijk ML, Lahaye MJ, et al
    The Diagnostic Value of FDG-PET/CT for Urachal Cancer.
    Clin Genitourin Cancer. 2021;19:373-380.
    Abstract     Related articles   

  515. RUNDO F, Bersanelli M, Urzia V, Friedlaender A, et al
    Three-Dimensional Deep Noninvasive Radiomics for the Prediction of Disease Control in Patients With Metastatic Urothelial Carcinoma treated With Immunotherapy.
    Clin Genitourin Cancer. 2021;19:396-404.
    Abstract     Related articles   

  516. CH'NG ES
    Mining The Cancer Genome Atlas gene expression data for lineage markers in distinguishing bladder urothelial carcinoma and prostate adenocarcinoma.
    Sci Rep. 2021;11:6765.
    Abstract     Related articles   

  517. LEE Y, Kim YS, Hong B, Cho YM, et al
    Comparison of clinical outcomes in patients with localized or locally advanced urothelial carcinoma treated with neoadjuvant chemotherapy involving gemcitabine-cisplatin and high dose-intensity MVAC.
    J Cancer Res Clin Oncol. 2021;147:3421-3429.
    Abstract     Related articles   

  518. AGNIHOTRI MA, Sathe PA
    Coexistent urothelial papilloma and ureteric calculus in an 8-year-old child: A rare co-occurrence.
    J Postgrad Med. 2021;67:182-183.
    Abstract     Related articles   

  519. HUANG Y, Xie C, Li Q, Huang X, et al
    Prognostic factors and nomogram for the overall survival of bladder cancer bone metastasis: A SEER-based study.
    Medicine (Baltimore). 2023;102:e33275.
    Abstract     Related articles   

  520. SEMENIUK-WOJTAS A, Poddebniak-Strama K, Modzelewska M, Baryla M, et al
    Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer.
    Cancer Immunol Immunother. 2023 Mar 16. doi: 10.1007/s00262-023-03376.
    Abstract     Related articles   

  521. KE M, Sun N, Lin Z, Zhang P, et al
    SNHG18 inhibits bladder cancer cell proliferation by increasing p21 transcription through destabilizing c-Myc protein.
    Cancer Cell Int. 2023;23:48.
    Abstract     Related articles   

  522. JARIMBA R, Quaresma V, Pedroso Lima J, Eliseu M, et al
    Predicting bladder cancer risk in patients with hematuria. A single-centre retrospective study.
    Arch Ital Urol Androl. 2023 Mar 15. doi: 10.4081/aiua.2023.11026.
    Abstract     Related articles   

  523. TZELVES L, Katsimperis S, Bellos T, Berdempes M, et al
    Anthropometric characteristics and relationship with non-muscle invasive bladder cancer in Greece: A case-control study.
    Arch Ital Urol Androl. 2023 Mar 15. doi: 10.4081/aiua.2023.11266.
    Abstract     Related articles   

  524. LI Z, Zhao J, Huang X, Wang J, et al
    An m7G-related lncRNA signature predicts prognosis and reveals the immune microenvironment in bladder cancer.
    Sci Rep. 2023;13:4302.
    Abstract     Related articles   

  525. VAN GINKEL N, van Gennep EJ, Oosterbaan L, Greidanus J, et al
    Added Clinical Value of (18)F-FDG-PET/CT to Stage Patients With High-Risk Non-Muscle Invasive Bladder Cancer Before Radical Cystectomy.
    Clin Genitourin Cancer. 2023 Feb 22:S1558-7673(23)00037.
    Abstract     Related articles   

  526. ZHANG W, Zhang Z, Xiao W, Wang Y, et al
    Multiple directional DWI combined with T2WI in predicting muscle layer and Ki-67 correlation in bladder cancer in 3.0-T MRI.
    Cancer Med. 2023 Mar 14. doi: 10.1002/cam4.5782.
    Abstract     Related articles   

  527. ZHU J, Livasy C, Donahue EE, Symanowski JT, et al
    Prognostic value of galectin-1 and galectin-3 expression in localized urothelial bladder cancer.
    Transl Androl Urol. 2023;12:228-240.
    Abstract     Related articles   

  528. TAN Z, Chen Z, Yao G, Mumin MA, et al
    Neoadjuvant and adjuvant chemotherapy share equivalent efficacy in improving overall survival and cancer-specific survival among muscle invasive bladder cancer patients who undergo radical cystectomy: a retrospective cohort study based on SEER databas
    Transl Androl Urol. 2023;12:330-346.
    Abstract     Related articles   

  529. YING Y, Wang Z, Tan Y, Cao H, et al
    Identification and validation of immunohistochemical marker panels to predict the prognosis of muscle invasive bladder cancer.
    Transl Androl Urol. 2023;12:176-186.
    Abstract     Related articles   

  530. YUAN F, Yin XY, Huang Y, Cai XW, et al
    Exosomal miR-93-5p as an important driver of bladder cancer progression.
    Transl Androl Urol. 2023;12:286-299.
    Abstract     Related articles   

  531. WANG SS, Zhai GQ, Huang ZG, Luo JY, et al
    Nitidine chloride regulates cell function of bladder cancer in vitro through downregulating Lymphocyte antigen 75.
    Naunyn Schmiedebergs Arch Pharmacol. 2023.
    Abstract     Related articles   

  532. VAN HOOGSTRATEN LMC, Vrieling A, van der Heijden AG, Kogevinas M, et al
    Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice.
    Nat Rev Clin Oncol. 2023 Mar 13. doi: 10.1038/s41571-023-00744.
    Abstract     Related articles   

  533. ZHANG X, Liu H, Zhang J, Wang Z, et al
    Fibronectin-1: A Predictive Immunotherapy Response Biomarker for Muscle‑Invasive Bladder Cancer.
    Arch Esp Urol. 2023;76:70-83.
    Abstract     Related articles   

  534. CATA ED, Andras I, Popa A, Medan P, et al
    Robotic Radical Cystectomy with Intracorporeal Urinary Diversion - Tips and Tricks.
    Chirurgia (Bucur). 2023;118:63-72.
    Abstract     Related articles   

  535. XU Y, Xia Z, Sun X, Wei B, et al
    Identification of a glutamine metabolism reprogramming signature for predicting prognosis, immunotherapy efficacy, and drug candidates in bladder cancer.
    Front Immunol. 2023;14:1111319.
    Abstract     Related articles   

  536. HU B, Chen R, Chen G, Zheng P, et al
    Prognostic nomogram for estimating survival in patients with resected muscle-invasive bladder cancer receiving chemotherapy.
    Front Surg. 2023;10:1121184.
    Abstract     Related articles   

  537. ILLIAS AM, Yu KJ, Wu SC, Cata JP, et al
    Association of regional anesthesia with oncological outcomes in patients receiving surgery for bladder cancer: A meta-analysis of observational studies.
    Front Oncol. 2023;13:1097637.
    Abstract     Related articles   

  538. BORDELEAU F, Brownell D, Chabaud S, Huot ME, et al
    Recreating heterogeneity of bladder cancer microenvironment to study its recurrences and progression.
    Stem Cell Investig. 2023;10:5.
    Abstract     Related articles   

  539. TIAN YQ, Yang JC, Hu JJ, Ding R, et al
    Trends and risk factors of global incidence, mortality, and disability of genitourinary cancers from 1990 to 2019: Systematic analysis for the Global Burden of Disease Study 2019.
    Front Public Health. 2023;11:1119374.
    Abstract     Related articles   

  540. YANAGISAWA T, Miki J, Matsukawa A, Iwatani K, et al
    ASO Author Reflections: Is T1HG Bladder Cancer a Good Candidate for En Bloc Resection?
    Ann Surg Oncol. 2023 Mar 12. doi: 10.1245/s10434-023-13291.
    Abstract     Related articles   

  541. LI J, Qiu Z, Cao K, Deng L, et al
    Predicting muscle invasion in bladder cancer based on MRI: A comparison of radiomics, and single-task and multi-task deep learning.
    Comput Methods Programs Biomed. 2023;233:107466.
    Abstract     Related articles   

  542. GROBET-JEANDIN E, Lenfant L, Mir C, Giannarini G, et al
    A Systematic Review of Oncological Outcomes Associated with Bladder-sparing Strategies in Patients Achieving Complete Clinical Response to Initial Systemic Treatment for Localized Muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2023 Mar 9:S2588-9311(23)00040-8. doi: 10.1016/j.euo.2023.
    Abstract     Related articles   

  543. PHILIPPS L, Porta N, James N, Huddart R, et al
    Differences in Quality of Life and Toxicity for Male and Female Patients following Chemo(radiotherapy) for Bladder Cancer.
    Clin Oncol (R Coll Radiol). 2023 Feb 11:S0936-6555(23)00052.
    Abstract     Related articles   

  544. ZHANG P, Sun Y, Shi L, Sun D, et al
    Effect of isorhamnetin on carbonic anhydrase IX expression and tumorigenesis of bladder cancer by activating PPARgamma/PTEN/AKT pathway.
    Tissue Cell. 2023;82:102048.
    Abstract     Related articles   

  545. ZHU H, Chen Q, Zhang Y, Zhao L, et al
    Glutathione S-transferase zeta 1 alters the HMGB1/GPX4 axis to drive ferroptosis in bladder cancer cells.
    Hum Exp Toxicol. 2023;42:9603271231161606.
    Abstract     Related articles   

  546. HANNA DH, Aziz MM, Shafee EE
    Effective-by-method for the preparation of folic acid coated TiO(2) nanoparticles with high targeting potential for apoptosis induction against bladder cancer cells (T24).
    Biotechnol Appl Biochem. 2023 Mar 11. doi: 10.1002/bab.2456.
    Abstract     Related articles   

  547. PEREIRA IOA, da Silva GN, Almeida TC, Lima APB, et al
    LncRNA JHDM1D-AS1 Is a Key Biomarker for Progression and Modulation of Gemcitabine Sensitivity in Bladder Cancer Cells.
    Molecules. 2023;28:2412.
    Abstract     Related articles   

  548. WANG Z, Wang T, Wu G, Zhu L, et al
    Clinical Significance and Tumor Microenvironment Characterization of a Novel Immune-Related Gene Signature in Bladder Cancer.
    J Clin Med. 2023;12:1892.
    Abstract     Related articles   

  549. FLAMMIA RS, Tufano A, Chierigo F, Wurnschimmel C, et al
    The Effect of Sex on Disease Stage and Survival after Radical Cystectomy in Non-Urothelial Variant-Histology Bladder Cancer.
    J Clin Med. 2023;12:1776.
    Abstract     Related articles   

  550. MURAKAMI K, Furuya H, Hokutan K, Goodison S, et al
    Association of SNPs in the PAI1 Gene with Disease Recurrence and Clinical Outcome in Bladder Cancer.
    Int J Mol Sci. 2023;24:4943.
    Abstract     Related articles   

  551. MA L, Chen H, Yang W, Ji Z, et al
    Crosstalk between Mesenchymal Stem Cells and Cancer Stem Cells Reveals a Novel Stemness-Related Signature to Predict Prognosis and Immunotherapy Responses for Bladder Cancer Patients.
    Int J Mol Sci. 2023;24:4760.
    Abstract     Related articles   

  552. TORTORA F, La Civita E, Trivedi P, Febbraio F, et al
    Emerging RNA-Based Therapeutic and Diagnostic Options: Recent Advances and Future Challenges in Genitourinary Cancers.
    Int J Mol Sci. 2023;24:4601.
    Abstract     Related articles   

  553. ZUCCHI A, Claps F, Pastore AL, Perotti A, et al
    Focus on the Use of Resveratrol in Bladder Cancer.
    Int J Mol Sci. 2023;24:4562.
    Abstract     Related articles   

  554. ZHU J, Li Y, Luo Y, Xu J, et al
    Correction: Zhu et al. A Feedback Loop Formed by ATG7/Autophagy, FOXO3a/miR-145 and PD-L1 Regulates Stem-like Properties and Invasion in Human Bladder Cancer. Cancers 2019, 11, 349.
    Cancers (Basel). 2023;15:1403.
    Abstract     Related articles   

  555. HURLE R, Soria F, Contieri R, Avolio PP, et al
    Evaluating the Protective Effect of Intravesical Bacillus Calmette-Guerin against SARS-CoV-2 in Non-Muscle Invasive Bladder Cancer Patients: A Multicenter Observational Trial.
    Cancers (Basel). 2023;15:1618.
    Abstract     Related articles   

  556. CELADA LUIS G, Albers Acosta E, de la Fuente H, Velasco Balanza C, et al
    A Comprehensive Analysis of Immune Response in Patients with Non-Muscle-Invasive Bladder Cancer.
    Cancers (Basel). 2023;15:1364.
    Abstract     Related articles   

  557. HU X, Xue Y, Zhu G
    Clinical Characteristics and Current Status of Treatment for Recurrent Bladder Cancer after Surgeries on Upper Tract Urothelial Carcinoma.
    Diagnostics (Basel). 2023;13:1004.
    Abstract     Related articles   

  558. VAROL N, Keles I, Yildiz H, Karaosmanoglu C, et al
    Methylation analysis of histone 4-related gene HIST1H4F and its effect on gene expression in bladder cancer.
    Gene. 2023;866:147352.
    Abstract     Related articles   

  559. ASCIONE CM, Napolitano F, Esposito D, Servetto A, et al
    Role of FGFR3 in bladder cancer: Treatment landscape and future challenges.
    Cancer Treat Rev. 2023;115:102530.
    Abstract     Related articles   

  560. WANG J, Meng X, Yu M, Li X, et al
    A novel microfluidic system for enrichment of functional circulating tumor cells in cancer patient blood samples by combining cell size and invasiveness.
    Biosens Bioelectron. 2023;227:115159.
    Abstract     Related articles   

  561. KUMAR R, Harilal S, Abdelgawad MA, Ghoneim MM, et al
    Urachal carcinoma: The journey so far and the road ahead.
    Pathol Res Pract. 2023;243:154379.
    Abstract     Related articles   

  562. WANG P, Shi Y, Zhang J, Shou J, et al
    UCseek: ultrasensitive early detection and recurrence monitoring of urothelial carcinoma by shallow-depth genome-wide bisulfite sequencing of urinary sediment DNA.
    EBioMedicine. 2023;89:104437.
    Abstract     Related articles   

  563. WANG L, Shi G, Zhao G, He W, et al
    Efficacy and safety of enfortumab vedotin in the treatment of advanced urothelial carcinoma: a systematic review and meta-analysis.
    Anticancer Drugs. 2023;34:473-478.
    Abstract     Related articles   

  564. JIN J, Yang Q, Yu Y, Chen L, et al
    Complete response to tislelizumab in a metastatic urothelial carcinoma after surgery associated with high tumor mutational burden: a case report.
    Anticancer Drugs. 2023;34:595-598.
    Abstract     Related articles   

  565. FATIMA A, Russell DH, Epstein JI
    Nested Subtype of Urothelial Carcinoma in the Upper Urinary Tract: A Series of 15 Cases.
    Am J Surg Pathol. 2023;47:461-468.
    Abstract     Related articles   

  566. CALEN L, Mesnard B, Hedhli O, Broudeur L, et al
    Robot-assisted laparoscopic cystectomy with non-continent urinary diversion for neurogenic lower urinary tract dysfunction: Midterm outcomes.
    Neurourol Urodyn. 2023;42:586-596.
    Abstract     Related articles   

  567. ZHAO Q, Wu L, Yang F, Han S, et al
    Application of Transvaginal Natural Orifice Specimen Extraction Surgery in Urological Surgery.
    J Laparoendosc Adv Surg Tech A. 2023;33:231-235.
    Abstract     Related articles   

  568. WU W, Jing Y, Xu Q, Hao J, et al
    MiR-9 promotes proliferation and inhibits apoptosis of bladder cancer cells via notch signaling pathway.
    Panminerva Med. 2023;65:114-115.
    Abstract     Related articles   

  569. STARRETT GJ, Yu K, Golubeva Y, Lenz P, et al
    Evidence for virus-mediated oncogenesis in bladder cancers arising in solid organ transplant recipients.
    Elife. 2023;12:e82690.
    Abstract     Related articles   

  570. GOLMOHAMMADI M, Elmaghraby DA, Ramirez-Coronel AA, Rakhimov N, et al
    A Comprehensive View on the Quercetin Impact on Bladder Cancer: Focusing on Oxidative stress, Cellular, and Molecular Mechanisms.
    Fundam Clin Pharmacol. 2023 Mar 24. doi: 10.1111/fcp.12896.
    Abstract     Related articles   

  571. WANG C, Cao Q, Zhang S, Liu H, et al
    Anlotinib Enhances the Therapeutic Effect of Bladder Cancer with GSDMB Expression: Analyzed from TCGA Bladder Cancer Database & Mouse Bladder Cancer Cell Line.
    Pharmgenomics Pers Med. 2023;16:219-228.
    Abstract     Related articles   

  572. ZHAO Z, Liu S, Sun R, Zhu W, et al
    The combination of oxaliplatin and anti-PD-1 inhibitor promotes immune cells infiltration and enhances anti-tumor effect of PD-1 blockade in bladder cancer.
    Front Immunol. 2023;14:1085476.
    Abstract     Related articles   

  573. ARRABAL POLO MA, Melgarejo Segura MT, Yanez Castillo Y, Morales Martinez A, et al
    Adjuvant intravesical treatment in patients with intermediate and high-risk non-muscle-invasive bladder cancer with BCG versus MMC applied with COMBAT or EMDA. Results of a prospective study.
    J Cancer Res Clin Oncol. 2023 Mar 23:1-7. doi: 10.1007/s00432-023-04688.
    Abstract     Related articles   

  574. BASILE G, de Angelis M, Leni R, Re C, et al
    Implications for diagnosis and treatment strategies in non-muscle invasive bladder cancer with variant histology: a systematic review.
    Minerva Urol Nephrol. 2023 Mar 22. doi: 10.23736/S2724-6051.23.05091.
    Abstract     Related articles   


  575. Corrigendum to "The Significance of Squamous Histology on Clinical Outcomes and PD-L1 Expression in Bladder Cancer".
    Int J Surg Pathol. 2023 Mar 22:10668969231164482. doi: 10.1177/10668969231164482
    Abstract     Related articles   

  576. CHENG F, Hansson VC, Georgolopoulos G, Mani K, et al
    Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior.
    Oncotarget. 2023;14:219-235.
    Abstract     Related articles   

  577. LI X, Li Y, Liu B, Chen L, et al
    P4HA2-mediated HIF-1alpha stabilization promotes erdafitinib-resistance in FGFR3-alteration bladder cancer.
    FASEB J. 2023;37:e22840.
    Abstract     Related articles   

  578. LEPARA Z, Alic J, Lepara O, Spahovic H, et al
    Antioxidant status in patients with bladder cancer regarding cancer stage and grade.
    Asian J Urol. 2023;10:182-188.
    Abstract     Related articles   

  579. ARSUFFI S, Cambianica A, Di Filippo E, Ripamonti D, et al
    Vascular graft infections caused by Mycobacterium bovis BCG after BCG immunotherapy for non-muscle-invasive bladder cancer: Case report and review of literature.
    J Clin Tuberc Other Mycobact Dis. 2023;31:100360.
    Abstract     Related articles   

  580. CHANG LW, Hung SC, Chen CS, Li JR, et al
    Geriatric nutritional risk index as a prognostic marker for patients with upper tract urothelial carcinoma receiving radical nephroureterectomy.
    Sci Rep. 2023;13:4554.
    Abstract     Related articles   

  581. DAZA J, Grauer R, Chen S, Lavallee E, et al
    Development of a predictive model for recurrence-free survival in pTa low-grade bladder cancer.
    Urol Oncol. 2023 Mar 18:S1078-1439(23)00047.
    Abstract     Related articles   

  582. EL SHARKAWI FZ, El Sabah M, Atya HB, Khaled HM, et al
    Urinary BLACAT1 as a non-invasive biomarker for bladder cancer.
    Mol Biol Rep. 2023 Mar 20. doi: 10.1007/s11033-023-08370.
    Abstract     Related articles   

  583. DROBNER JC, Lichtbroun BJ, Singer EA, Ghodoussipour S, et al
    Examining the Role of Microbiota-Centered Interventions in Cancer Therapeutics: Applications for Urothelial Carcinoma.
    Technol Cancer Res Treat. 2023;22:15330338231164196.
    Abstract     Related articles   

  584. HU W, Zhang Y, Ning J, Li M, et al
    Anti-tumor effect of AZD8055 against bladder cancer and bladder cancer-associated macrophages.
    Heliyon. 2023;9:e14272.
    Abstract     Related articles   

  585. ZHAO Y, Sun W, Ji Z, Liu X, et al
    Serum metabolites as early detection markers of non-muscle invasive bladder cancer in Chinese patients.
    Front Oncol. 2023;13:1061083.
    Abstract     Related articles   

  586. ALSHAHWAN MI, Bin Dukhi MM, Alotaibi SN, Aldarrab R, et al
    Plasmacytoid Variant Urothelial Cell Carcinoma: A Case of a Histological Variant of Urinary Bladder Cancer With Aggressive Behavior.
    Cureus. 2023;15:e36278.
    Abstract     Related articles   

  587. LIU J, Cheng C, Qi T, Xiao J, et al
    ACER2 forms a cold tumor microenvironment and predicts the molecular subtype in bladder cancer: Results from real-world cohorts.
    Front Genet. 2023;14:1148437.
    Abstract     Related articles   

  588. ANRAKU T, Hashidate H, Nakahara A, Imai T, et al
    Sarcomatoid urothelial carcinoma of the renal pelvis treated with immunotherapy.
    BMC Urol. 2023;23:38.
    Abstract     Related articles   

  589. FAN J, Ding Y, Huang H, Xiong S, et al
    High expression of ABCF1 is an independent predictor of poor prognosis in bladder cancer.
    BMC Urol. 2023;23:37.
    Abstract     Related articles   

  590. BOLGEO T, Ruta F, Gatti D, Gambalunga F, et al
    Management of the patient with urostomy: Caregiver needs during the three months after discharge. A qualitative study.
    Arch Ital Urol Androl. 2023;95.
    Abstract     Related articles   

  591. LEONARDI R, Vecco F, Iacona G, Calarco A, et al
    TULA DUAL: Trans Urethral Laser Ablation of recurrent bladder tumors in outpatient setting.
    Arch Ital Urol Androl. 2023;95.
    Abstract     Related articles   

  592. LAGARDE-LENON MS, Aron M
    Reprint of: Female Urethral Carcinoma: A contemporary review of the clinicopathologic features, with emphasis on the histo-anatomic landmarks and potential staging issues.
    Hum Pathol. 2023;133:126-135.
    Abstract     Related articles   

  593. DE FALCO F, Cuccaro B, De Tullio R, Alberti A, et al
    Possible etiological association of ovine papillomaviruses with bladder tumors in cattle.
    Virus Res. 2023;328:199084.
    Abstract     Related articles   

  594. YOKOTA Y, Suzuki S, Gi M, Yanagiba Y, et al
    o-Toluidine metabolism and effects in the urinary bladder of humanized-liver mice.
    Toxicology. 2023;488:153483.
    Abstract     Related articles   

  595. SHENG Y, Wu J, Li X, Qiu J, et al
    iATMEcell: identification of abnormal tumor microenvironment cells to predict the clinical outcomes in cancer based on cell-cell crosstalk network.
    Brief Bioinform. 2023;24:bbad074.
    Abstract     Related articles   

  596. LEE A
    Nadofaragene Firadenovec: First Approval.
    Drugs. 2023;83:353-357.
    Abstract     Related articles   

  597. ZHAO L, Qi X, Chen Y, Qiao Y, et al
    Biological knowledge graph-guided investigation of immune therapy response in cancer with graph neural network.
    Brief Bioinform. 2023;24:bbad023.
    Abstract     Related articles   

  598. RYSANKOVA K, Hanzlikova P, Zidlik V, Vrtkova A, et al
    Is high accuracy of Vesical Imaging-Reporting and Data System (VI-RADS) sufficient for its implementation in the urological practice?
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023;167:85-90.
    Abstract     Related articles   

  599. WU J, Gao Y, Xiong Z, Xiao X, et al
    Comparison of different methods of obturator nerve block in transurethral resection of bladder tumors: A systematic review and network meta-analysis.
    Cancer Med. 2023;12:5420-5435.
    Abstract     Related articles   

  600. GOUDOURIS E, Aranda CS, Sole D
    Implications of the non-specific effect induced by Bacillus Calmette-Guerin (BCG) vaccine on vaccine recommendations.
    J Pediatr (Rio J). 2023;99 Suppl 1:S22-S27.
    Abstract     Related articles   

  601. FUKUOKAYA W, Yanagisawa T, Hashimoto M, Yamamoto S, et al
    Effectiveness of pembrolizumab in trial-ineligible patients with metastatic urothelial carcinoma.
    Cancer Immunol Immunother. 2023;72:841-849.
    Abstract     Related articles   

  602. MULLANE P, Joshi S, Bilen M, Osunkoya AO, et al
    Clinicopathologic analysis of patients undergoing repeat transurethral resection of bladder tumour following an initial diagnosis of urothelial carcinoma with lamina propria invasion and variant/divergent histology.
    J Clin Pathol. 2023;76:256-260.
    Abstract     Related articles   

  603. WU W, Jing Y, Xu Q, Hao J, et al
    MiR-9 promotes proliferation and inhibits apoptosis of bladder cancer cells via notch signaling pathway.
    Panminerva Med. 2023;65:114-115.
    Abstract     Related articles   

  604. SONG Q, Zhou Z, Bai J, Liu N, et al
    A comprehensive analysis of immunogenic cell death and its key gene HSP90AA1 in bladder cancer.
    Clin Transl Oncol. 2023 Mar 31. doi: 10.1007/s12094-023-03143.
    Abstract     Related articles   

  605. POURKERMAN M, Hajjar M, Naja F, Yunus F, et al
    Nutrient Patterns and Bladder Cancer: A Case-Control Study in Iran.
    Nutr Cancer. 2023 Mar 31:1-7. doi: 10.1080/01635581.2023.2191383.
    Abstract     Related articles   

  606. GHOLAMI L, Momtazi-Borojeni AA, Malaekeh-Nikouei B, Nikfar B, et al
    Selective Cellular Uptake and Cytotoxicity of Curcumin-encapsulated SPC and HSPC Liposome Nanoparticles on Human Bladder Cancer Cells.
    Curr Pharm Des. 2023 Mar 31. doi: 10.2174/1381612829666230331084848.
    Abstract     Related articles   

  607. REN C, Li Y, Cong Z, Li Z, et al
    Bioengineered bacterial outer membrane vesicles encapsulated Polybia-mastoparan I fusion peptide as a promising nanoplatform for bladder cancer immune-modulatory chemotherapy.
    Front Immunol. 2023;14:1129771.
    Abstract     Related articles   

  608. SEITO T, Ishikawa A, Tsuru I, Hikatsu M, et al
    Bladder Preservation After Bilateral Kidney Loss and Bladder Cancer After Renal Transplantation: A Case Report.
    Transplant Proc. 2023 Mar 28:S0041-1345(23)00087.
    Abstract     Related articles   

  609. TOLSTRUP LK, Als AB, Carus A, Dahlrot R, et al
    The iBLAD app protocol - a national, exploratory study on a multimodality smartphone app in bladder cancer for better understanding symptoms, quality of life and need for supportive care.
    Acta Oncol. 2023 Mar 30:1-5. doi: 10.1080/0284186X.2023.2194031.
    Abstract     Related articles   

  610. CUI X, Zhang C, Zhang L, Yan H, et al
    The prognostic and immunological role of MYB: from bladder cancer validation to pan-cancer analysis.
    Biosci Rep. 2023 Mar 30:BSR20222627. doi: 10.1042/BSR20222627.
    Abstract     Related articles   

  611. ZHAO H, Liu K, Giannakopoulos S, Yuruk E, et al
    Impact of previous malignancy at diagnosis on oncological outcomes of upper tract urothelial carcinoma.
    BMC Urol. 2023;23:49.
    Abstract     Related articles   

  612. AHLSCHLAGER L, McCabe S, Deal AM, Guo A, et al
    The effect of treatment on work productivity in patients with bladder cancer.
    Urol Oncol. 2023 Mar 27:S1078-1439(23)00056.
    Abstract     Related articles   

  613. YU D, Chen C, Sun L, Wu S, et al
    KRT13-expressing epithelial cell population predicts better response to chemotherapy and immunotherapy in bladder cancer: Comprehensive evidences based on BCa database.
    Comput Biol Med. 2023;158:106795.
    Abstract     Related articles   


  614. Canadian Bladder Cancer Forum 2023 Meeting Abstracts - Poster Presentations.
    Can Urol Assoc J. 2023;17.
    Abstract     Related articles   


  615. Canadian Bladder Cancer Forum 2023 Meeting Abstracts - Podium Presentations.
    Can Urol Assoc J. 2023;17.
    Abstract     Related articles   

  616. UFUK F, Yagci AB
    Letter to the Editor: "Prospective assessment of VI-RADS score in multiparametric MRI in bladder cancer: accuracy and the factors affecting the results".
    Diagn Interv Radiol. 2023;29:412-413.
    Abstract     Related articles   

  617. PAN SY, Lai CZ, Chen WC, Chen YH, et al
    Chondrosarcoma of Ureter in an Elderly Patient: A Case Report.
    Medicina (Kaunas). 2023;59:454.
    Abstract     Related articles   

  618. HEIDAR NA, Bhat TA, Shabir U, Hussein AA, et al
    The Urinary Microbiome and Bladder Cancer.
    Life (Basel). 2023;13:812.
    Abstract     Related articles   

  619. BARONE B, Finati M, Cinelli F, Fanelli A, et al
    Bladder Cancer and Risk Factors: Data from a Multi-Institutional Long-Term Analysis on Cardiovascular Disease and Cancer Incidence.
    J Pers Med. 2023;13:512.
    Abstract     Related articles   

  620. OFNER H, Laukhtina E, Hassler MR, Shariat SF, et al
    Blood-Based Biomarkers as Prognostic Factors of Recurrent Disease after Radical Cystectomy: A Systematic Review and Meta-Analysis.
    Int J Mol Sci. 2023;24:5846.
    Abstract     Related articles   

  621. WANG Q, Ke S, Liu Z, Shao H, et al
    HSPA5 Promotes the Proliferation, Metastasis and Regulates Ferroptosis of Bladder Cancer.
    Int J Mol Sci. 2023;24:5144.
    Abstract     Related articles   

  622. MEUNIER S, Frontczak A, Balssa L, Blanc J, et al
    Elevated Baseline Neutrophil Count Correlates with Worse Outcomes in Patients with Muscle-Invasive Bladder Cancer Treated with Chemoradiation.
    Cancers (Basel). 2023;15:1886.
    Abstract     Related articles   

  623. THOMPSON D, Lawrentschuk N, Bolton D
    New Approaches to Targeting Epigenetic Regulation in Bladder Cancer.
    Cancers (Basel). 2023;15:1856.
    Abstract     Related articles   

  624. ENGELMANN SU, Pickl C, Haas M, Kaelble S, et al
    Body Composition of Patients Undergoing Radical Cystectomy for Bladder Cancer: Sarcopenia, Low Psoas Muscle Index, and Myosteatosis Are Independent Risk Factors for Mortality.
    Cancers (Basel). 2023;15:1778.
    Abstract     Related articles   

  625. CULINE S, Harter V, Krucker C, Gravis G, et al
    Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial.
    Cancers (Basel). 2023;15:1742.
    Abstract     Related articles   

  626. SARKAR S, Min K, Ikram W, Tatton RW, et al
    Performing Automatic Identification and Staging of Urothelial Carcinoma in Bladder Cancer Patients Using a Hybrid Deep-Machine Learning Approach.
    Cancers (Basel). 2023;15:1673.
    Abstract     Related articles   

  627. WOOLBRIGHT BL, Rajendran G, Abbott E, Martin A, et al
    Pyruvate Dehydrogenase Kinase 4 Deficiency Increases Tumorigenesis in a Murine Model of Bladder Cancer.
    Cancers (Basel). 2023;15:1654.
    Abstract     Related articles   

  628. JHUO YC, Cha TL, Kao CC, Tsai YT, et al
    Circulating Tumor Cells Predict Response of Neoadjuvant Chemotherapy in Patients with Bladder Cancer: A Preliminary Study.
    Diagnostics (Basel). 2023;13:1032.
    Abstract     Related articles   

  629. OZDEN-YILMAZ G, Savas B, Bursali A, Eray A, et al
    Differential Occupancy and Regulatory Interactions of KDM6A in Bladder Cell Lines.
    Cells. 2023;12:836.
    Abstract     Related articles   

  630. KUDELSKI J, Tokarzewicz A, Gudowska-Sawczuk M, Mroczko B, et al
    The Significance of Matrix Metalloproteinase 9 (MMP-9) and Metalloproteinase 2 (MMP-2) in Urinary Bladder Cancer.
    Biomedicines. 2023;11:956.
    Abstract     Related articles   

  631. NOWAK L, Krajewski W, Dejnaka E, Malkiewicz B, et al
    Ubiquitin-Specific Proteases as Potential Therapeutic Targets in Bladder Cancer-In Vitro Evaluation of Degrasyn and PR-619 Activity Using Human and Canine Models.
    Biomedicines. 2023;11:759.
    Abstract     Related articles   

  632. XU X, Tian X, Song L, Xie J, et al
    Kawain Inhibits Urinary Bladder Carcinogenesis through Epigenetic Inhibition of LSD1 and Upregulation of H3K4 Methylation.
    Biomolecules. 2023;13:521.
    Abstract     Related articles   

  633. LIU S, Chen H, Zheng Z, He Y, et al
    Development of a Molecular-Subtype-Associated Immune Prognostic Signature That Can Be Recognized by MRI Radiomics Features in Bladder Cancer.
    Bioengineering (Basel). 2023;10:318.
    Abstract     Related articles   

  634. KO WS, Kim SJ
    Predictive Value of 18F-FDG PET/CT for Assessment of Tumor Response to Neoadjuvant Chemotherapy in Bladder Cancer.
    Clin Nucl Med. 2023 Mar 27. doi: 10.1097/RLU.0000000000004639.
    Abstract     Related articles   

  635. KARABURUN MC, Ozkaya MF, Erguder BI, Suer E, et al
    Investigation of Atypical Cell Parameter in the Surveillance of Patients with NMIBC; Initial Outcomes of a Single Center Prospective Study.
    J Med Syst. 2023;47:41.
    Abstract     Related articles   

  636. PRATA F, Anceschi U, Taffon C, Rossi SM, et al
    Real-Time Urethral and Ureteral Assessment during Radical Cystectomy Using Ex-Vivo Optical Imaging: A Novel Technique for the Evaluation of Fresh Unfixed Surgical Margins.
    Curr Oncol. 2023;30:3421-3431.
    Abstract     Related articles   

  637. MURTHY PB, Naidu S, Davaro F, Spiess PE, et al
    Survival Benefits of Adjuvant Chemotherapy for Positive Soft Tissue Surgical Margins Following Radical Cystectomy in Bladder Cancer with Extravesical Extension.
    Curr Oncol. 2023;30:3223-3231.
    Abstract     Related articles   

  638. PRIJOVIC N, Acimovic M, Santric V, Stankovic B, et al
    Predictive Value of Inflammatory and Nutritional Indexes in the Pathology of Bladder Cancer Patients Treated with Radical Cystectomy.
    Curr Oncol. 2023;30:2582-2597.
    Abstract     Related articles   


  639. Retraction: MiR-301b promotes the proliferation, mobility, and epithelial-to-mesenchymal transition of bladder cancer cells by targeting EGR1.
    Biochem Cell Biol. 2023 Mar 28. doi: 10.1139/bcb-2023-0074.
    Abstract     Related articles   

  640. TAN Z, Chen X, Zuo J, Fu S, et al
    Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    J Transl Med. 2023;21:223.
    Abstract     Related articles   

  641. LI C, Xie W
    Identification and validation of tumor-infiltrating lymphocyte-related prognosis signature for predicting prognosis and immunotherapeutic response in bladder cancer.
    BMC Bioinformatics. 2023;24:118.
    Abstract     Related articles   

  642. RENNER S, Loussikian P, Foulquie P, Marrel A, et al
    Patient and Caregiver Perceptions of Advanced Bladder Cancer Systemic Treatments: Infodemiology Study Based on Social Media Data.
    JMIR Cancer. 2023;9:e45011.
    Abstract     Related articles   

  643. JIANG L, Sun G, Zou L, Guan Y, et al
    Noncoding RNAs as a potential biomarker for the prognosis of bladder cancer: a systematic review and meta-analysis.
    Expert Rev Mol Diagn. 2023 Mar 27. doi: 10.1080/14737159.2023.2195554.
    Abstract     Related articles   

  644. JHUANG JR, Chiu PC, Hsieh TC, Chen CH, et al
    Latency period of aristolochic acid-induced upper urinary tract urothelial carcinoma.
    Front Public Health. 2023;11:1072864.
    Abstract     Related articles   

  645. ZHU X, Qin R, Qu K, Wang Z, et al
    Corrigendum to 'Atomic force microscopy-based assessment of multimechanical cellular properties for classification of graded bladder cancer cells and cancer early diagnosis using machine learning analysis' Acta Biomaterialia 2023, 158, 358‒373.
    Acta Biomater. 2023 Mar 23:S1742-7061(23)00152.
    Abstract     Related articles   

  646. LONG G, Hu Z, Liu Z, Ye Z, et al
    Partial and radical cystectomy provides equivalent oncologic outcomes in bladder cancer when combined with adequate lymph node dissection: A population-based study.
    Urol Oncol. 2023 Mar 23:S1078-1439(23)00078.
    Abstract     Related articles   

  647. QIU Y, Wang X, Fan Y, Bao Y, et al
    A case of bilateral synchronous double primary lung cancer secondary to bladder cancer: From the next-generation sequencing prospect.
    Thorac Cancer. 2023 Mar 25. doi: 10.1111/1759-7714.14864.
    Abstract     Related articles   

  648. KRISHNATRY R, Maitre P, Kumar A, Telkhade T, et al
    Utilising alternative cystoscopic schedules to minimise cost and patient burden after trimodality therapy for muscle-invasive bladder cancer.
    Cancer Med. 2023 Mar 25. doi: 10.1002/cam4.5840.
    Abstract     Related articles   

  649. TUONG MNE, Prillaman GE, Culp SH, Nelson M, et al
    India Ink Tattooing of Ureteroenteric Anastomoses.
    Tomography. 2023;9:449-458.
    Abstract     Related articles   

  650. GRIMM MO, Grun CB, Niegisch G, Pichler M, et al
    Tailored immunotherapy approach with nivolumab with or without ipilimumab in patients with advanced transitional cell carcinoma after platinum-based chemotherapy (TITAN-TCC): a multicentre, single-arm, phase 2 trial.
    Lancet Oncol. 2023;24:347-359.
    Abstract     Related articles   

  651. KOMATSU M, Funakoshi T, Aki T, Unuma K, et al
    Aristolochic acid induces an inflammatory response with prostaglandin E2 production and apoptosis in NRK-52E proximal tubular cells.
    Toxicol Lett. 2023;378:39-50.
    Abstract     Related articles   

  652. BERGENGREN O, Belozerov A, Bill-Axelson A, Garmo H, et al
    Short term outcomes after robot assisted and open cystectomy - A nation-wide population-based study.
    Eur J Surg Oncol. 2023;49:868-874.
    Abstract     Related articles   

  653. LEIBRANDT RC, Tu MJ, Yu AM, Lara PN, et al
    ATR Inhibition in Advanced Urothelial Carcinoma.
    Clin Genitourin Cancer. 2023;21:203-207.
    Abstract     Related articles   

  654. MAKRAKIS D, Bakaloudi DR, Talukder R, Lin GI, et al
    Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
    Clin Genitourin Cancer. 2023;21:286-294.
    Abstract     Related articles   

  655. HARRIS KT, Villela NA, Alam R, Wu WJ, et al
    The exstrophy experience: A national survey assessing urinary continence, bladder management, and oncologic outcomes in adults.
    J Pediatr Urol. 2023;19:178.
    Abstract     Related articles   

  656. RAMAHI YO, Shiekh M, Shah AA, Houenstein H, et al
    Uretero-enteric Strictures After Robot Assisted Radical Cystectomy: Prevalence and Management Over Two Decades.
    Clin Genitourin Cancer. 2023;21:e19-e26.
    Abstract     Related articles   

  657. NECCHI A, Joshi M, Bangs R, Makaroff L, et al
    Disparities in Access to Novel Systemic Therapies in Patients With Urinary Tract Cancer: Propagating Access, Policies and Resources Uniformly.
    Clin Genitourin Cancer. 2023;21:301-308.
    Abstract     Related articles   

  658. HALD OC, Phan YC, Carter CJM, Klatte T, et al
    Bladder tumor Resection Weight as a Prognostic Factor for Recurrence and Progression in Patients With High-Risk Non-Muscle Invasive Bladder Treated With BCG.
    Clin Genitourin Cancer. 2023;21:e70-e77.
    Abstract     Related articles   

  659. LI DX, Feng DC, Shi X, Wu RC, et al
    Identification of endothelial-related molecular subtypes for bladder cancer patients.
    Front Oncol. 2023;13:1101055.
    Abstract     Related articles   

  660. MIYAKE M, Nishimura N, Nakahama T, Nishimoto K, et al
    Additional oncological benefit of photodynamic diagnosis with blue light cystoscopy in transurethral resection for primary non-muscle-invasive bladder cancer: A comparative study from experienced institutes.
    BJUI Compass. 2023;4:305-313.
    Abstract     Related articles   

  661. CONROY S, Pang K, Jubber I, Hussain SA, et al
    Hyperthermic intravesical chemotherapy with mitomycin-C for the treatment of high-risk non-muscle-invasive bladder cancer patients.
    BJUI Compass. 2022;4:314-321.
    Abstract     Related articles   

  662. WOODCOCK VK, Chen JL, Purshouse K, Butcher C, et al
    PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non-muscle-invasive bladder cancer.
    BJUI Compass. 2023;4:322-330.
    Abstract     Related articles   

  663. MINAMI T, Fujita K, Hashimoto M, Nishimoto M, et al
    External beam radiotherapy combination is a risk factor for bladder cancer in patients with prostate cancer treated with brachytherapy.
    World J Urol. 2023 Apr 6. doi: 10.1007/s00345-023-04380.
    Abstract     Related articles   

  664. HAN S, Ji Z, Jiang J, Fan X, et al
    Neoadjuvant therapy with camrelizumab plus gemcitabine and cisplatin for patients with muscle-invasive bladder cancer: A multi-center, single-arm, phase 2 study.
    Cancer Med. 2023 Apr 6. doi: 10.1002/cam4.5900.
    Abstract     Related articles   

  665. FAN Y, Hao Y, Zhu C, Hu B, et al
    PLCepsilon promotes the Warburg effect and tumorigenesis through AKT/GSK3beta/Cdc25a in bladder cancer.
    Biotechnol Genet Eng Rev. 2023 Apr 5:1-15. doi: 10.1080/02648725.2023.2199188.
    Abstract     Related articles   

  666. JIN S, Shang Z, Wang W, Gu C, et al
    Immune Co-inhibitory Receptors CTLA-4, PD-1, TIGIT, LAG-3, and TIM-3 in Upper Tract Urothelial Carcinomas: A Large Cohort Study.
    J Immunother. 2023;46:154-159.
    Abstract     Related articles   

  667. VANARSA K, Castillo J, Wang L, Lee KH, et al
    Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and staging.
    BMC Med. 2023;21:133.
    Abstract     Related articles   

  668. LI S, Xin K, Pan S, Wang Y, et al
    Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer.
    Cell Mol Biol Lett. 2023;28:28.
    Abstract     Related articles   

  669. LOK W, Zhang J, Zheng X, Lin T, et al
    Comparison of the survival outcomes between primary and secondary muscle-invasive bladder cancer: a propensity score-matched study.
    Chin Med J (Engl). 2023 Apr 5. doi: 10.1097/CM9.0000000000002512.
    Abstract     Related articles   

  670. LING Y, Li J, Zhou L
    Smoking-related epigenetic modifications are associated with the prognosis and chemotherapeutics of patients with bladder cancer.
    Int J Immunopathol Pharmacol. 2023;37:3946320231166774.
    Abstract     Related articles   

  671. HUANG KC, Chandra D, McGrath S, Dixit V, et al
    Correction: Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non-Muscle Invasive Murine Bladder Cancer.
    Mol Cancer Ther. 2023;22:551.
    Abstract     Related articles   

  672. LI L, Zhang J, Zhe X, Chang H, et al
    An MRI-based radiomics nomogram in predicting histologic grade of non-muscle-invasive bladder cancer.
    Front Oncol. 2023;13:1025972.
    Abstract     Related articles   

  673. CHEMI J, Villoldo GM
    Should continuous bladder irrigation be recommended when single instillation of intravesical chemotherapy cannot be used after transurethral resection in low-risk non-muscle invasive bladder cancer?
    Bladder (San Franc). 2023;10:e21200002.
    Abstract     Related articles   

  674. WANG X, Bai Y, Zhang F, Li D, et al
    Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation.
    Front Immunol. 2023;14:955949.
    Abstract     Related articles   

  675. JAKUS D, Cepin P, Vrhovac I, Jakus IA, et al
    Influence of the grade and invasiveness of bladder cancer on disease course severity in patients with bladder tamponade resulting from a bleeding bladder cancer.
    Urol Ann. 2023;15:27-30.
    Abstract     Related articles   

  676. ZHENG Q, Guo L, Yang R, Chen Z, et al
    Identification of essential genes and drug discovery in bladder cancer and inflammatory bowel disease via text mining and bioinformatics analysis.
    Curr Comput Aided Drug Des. 2023 Mar 30. doi: 10.2174/1573409919666230330154008.
    Abstract     Related articles   

  677. KOOL R, Marcq G, Breau RH, Black PC, et al
    Radiation-based Therapy for Muscle-invasive Bladder Cancer: Contemporary Outcomes Across Tertiary Centers.
    Eur Urol Oncol. 2023 Mar 31:S2588-9311(23)00068.
    Abstract     Related articles   

  678. GONTERO P, Livoti S, Soria F
    A Restaging Transurethral Resection of the Bladder Is Always Necessary for High-grade T1 Non-muscle-invasive Bladder Cancer: Con.
    Eur Urol Focus. 2023 Mar 31:S2405-4569(23)00076.
    Abstract     Related articles   

  679. YING X, Huang Y, Liu B, Hu W, et al
    Targeted m(6)A demethylation of ITGA6 mRNA by a multisite dCasRx-m(6)A editor inhibits bladder cancer development.
    J Adv Res. 2023 Mar 30:S2090-1232(23)00092-9. doi: 10.1016/j.jare.2023.
    Abstract     Related articles   

  680. GERETTO P, DE Cillis S, Phe V
    Voiding patterns following radical cystectomy and orthotopic neobladder: is intermittent self-catheterization worth the hype?
    Minerva Urol Nephrol. 2023;75:246-247.
    Abstract     Related articles   

  681. SORIA F, Delacruz JE, Aznar-Cervantes SD, Aranda J, et al
    Animal model assessment of a new design for a coated mitomycin-eluting biodegradable ureteral stent for intracavitary instillation as an adjuvant therapy in upper urothelial carcinoma.
    Minerva Urol Nephrol. 2023;75:194-202.
    Abstract     Related articles   

  682. CANCRINI F, Osman N, Doizi S, Guillot-Tantay C, et al
    Incidence of urological cancers in neurological patients: a review of the literature from the EAU Young Academic Urologist Functional Group.
    Minerva Urol Nephrol. 2023;75:163-171.
    Abstract     Related articles   

  683. FALLARA G, Maida FD, Bravi CA, DE Groote R, et al
    A systematic review and meta-analysis of robot-assisted vs. open radical cystectomy: where do we stand and future perspective.
    Minerva Urol Nephrol. 2023;75:134-143.
    Abstract     Related articles   

  684. CO JL, Goco MLL, So JS
    Paraganglioma in The Urinary Bladder: A Pitfall in Histopathologic Diagnosis.
    Acta Med Indones. 2023;55:95-100.
    Abstract     Related articles   

  685. SCHLACK K
    [Perioperative systemic treatment of urothelial cancer].
    Urologie. 2023;62:407-417.
    Abstract     Related articles   

  686. COLE K, Al-Kadhimi Z, Talmadge JE
    Highlights into historical and current immune interventions for cancer.
    Int Immunopharmacol. 2023;117:109882.
    Abstract     Related articles   

  687. HUANG C, Li Y, Ling Q, Wei C, et al
    Establishment of a risk score model for bladder urothelial carcinoma based on energy metabolism-related genes and their relationships with immune infiltration.
    FEBS Open Bio. 2023;13:736-750.
    Abstract     Related articles   

  688. EGGER M, Seiler R
    Which Patients To Consider for Bladder Preservation After a Complete Response to Neoadjuvant Chemotherapy.
    Eur Urol Focus. 2023;9:229-231.
    Abstract     Related articles   

  689. KAWADA T, Yanagisawa T, Mostafaei H, Sari Motlagh R, et al
    Impact of Performance Status on Oncologic Outcomes in Patients with Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitor: A Systematic Review and Meta-analysis.
    Eur Urol Focus. 2023;9:264-274.
    Abstract     Related articles   

  690. SUGIYAMA Y, Naiki T, Tasaki Y, Mimura Y, et al
    GNRI Sustainability during One Cycle of First-Line Chemotherapy as a Prognostic Indicator in Patients with Metastatic Urothelial Carcinoma.
    Oncology. 2023;101:224-233.
    Abstract     Related articles   

  691. LANGE S, Calleris G, Matin SF, Roupret M, et al
    Optimizing Lymph Node Dissection at the Time of Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma.
    Eur Urol Focus. 2023;9:280-282.
    Abstract     Related articles   

  692. DENG Q, Xie J, Kong S, Tang T, et al
    Long-Term Retention Microbubbles with Three-Layer Structure for Floating Intravesical Instillation Delivery.
    Small. 2023;19:e2205630.
    Abstract     Related articles   

  693. FELSNER M, Grubmuller B
    [One clip too many].
    Urologie. 2023;62:389-391.
    Abstract     Related articles   

  694. IACOVELLI R, Cicala CM, Ciccarese C, Sacco E, et al
    Management of metastatic urothelial carcinoma: Current approach, emerging agents, and future perspectives.
    Urologia. 2023;90:3-10.
    Abstract     Related articles   

  695. KAWADA T, Laukhtina E, Quhal F, Yanagisawa T, et al
    Oncologic and Safety Outcomes for Endoscopic Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An Updated Systematic Review and Meta-analysis.
    Eur Urol Focus. 2023;9:236-240.
    Abstract     Related articles   

  696. ZHAO H, Peng P, Luo Z, Liu H, et al
    Comparison of hexaminolevulinate (HAL) -guided versus white light transurethral resection for NMIBC: A systematic review and meta-analysis of randomized controlled trials.
    Photodiagnosis Photodyn Ther. 2023;41:103220.
    Abstract     Related articles   

  697. INGERSOLL MA
    Does immune cell exhaustion lie at the heart of BCG-unresponsive disease?
    Nat Rev Urol. 2023;20:201-202.
    Abstract     Related articles   

  698. LAUKHTINA E, Kawada T, Quhal F, Yanagisawa T, et al
    Oncologic and Safety Outcomes for Retrograde and Antegrade Endoscopic Surgeries for Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis.
    Eur Urol Focus. 2023;9:258-263.
    Abstract     Related articles   

  699. HASUI KI, Kawakami Y, Miyake T, Hirai Y, et al
    Cutaneous toxicity with suprabasal blisters and dyskeratosis following administration of enfortumab vedotin.
    J Dermatol. 2022 Nov 22. doi: 10.1111/1346-8138.16646.
    Abstract     Related articles   

  700. CHEN CJ, Hang JF, Chen YA, Lin SJ, et al
    The diagnostic utility of trichorhinophalangeal syndrome type 1 immunohistochemistry for metastatic breast carcinoma in effusion cytology specimens.
    Cancer Cytopathol. 2023;131:226-233.
    Abstract     Related articles   

  701. SCHONE M, Uhthoff H, Schone S
    [Cystoscopy in the outpatient clinical routine: things to keep in mind].
    Aktuelle Urol. 2023;54:129-134.
    Abstract     Related articles   

  702. AMBEGODA M, Shiyanth S, Vidanapathirana S, Kumara S, et al
    Outcome of transurethral resection of bladder tumour under spinal anaesthesia combined with obturator nerve block in Sri Lanka.
    Urologia. 2023;90:80-82.
    Abstract     Related articles   

  703. LOKESHWAR SD, Rahman SN, Choksi A, Press BH, et al
    Patient tolerability during office cystoscopy and bladder tumor cauterization: a multivariate analysis of risk factors.
    Actas Urol Esp (Engl Ed). 2023;47:165-171.
    Abstract     Related articles   

  704. PENG J, Zhang X, Meng Y, Yang X, et al
    Urachal mucinous cystadenocarcinoma: A case report.
    Asian J Surg. 2023;46:1759-1760.
    Abstract     Related articles   

  705. CONTIERI R, Hurle R, Paciotti M, Casale P, et al
    Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG.
    Minerva Urol Nephrol. 2023;75:180-187.
    Abstract     Related articles   

  706. SUBIELA JD, Rodriguez Faba O, Aumatell J, Gonzalez-Padilla DA, et al
    Long-term Recurrence and Progression Patterns in a Contemporary Series of Patients with Carcinoma In Situ of the Bladder With or Without Associated Ta/T1 Disease Treated with Bacillus Calmette-Guerin: Implications for Risk-adapted Follow-up.
    Eur Urol Focus. 2023;9:325-332.
    Abstract     Related articles   

  707. NI RAGHALLAIGH H, Pineda-Turner A, Mather K, Chetwood A, et al
    Melanosis of the urinary bladder.
    Ann R Coll Surg Engl. 2023;105:386-387.
    Abstract     Related articles   

  708. IPPOLITI S, Bhatt NR, Ilie CP
    Transurethral resection of bladder tumour (TURBT) as a day-case: A real-world practice and patients' perspective from a district general hospital (DGH).
    Urologia. 2023;90:68-74.
    Abstract     Related articles   

  709. W AC, Gj N, T M, A A, et al
    The impact of socio-economic deprivation on recovery following robotic assisted radical cystectomy.
    Urologia. 2023;90:136-140.
    Abstract     Related articles   

  710. BICCI E, Mastrorosato M, Danti G, Lattavo L, et al
    Dual-Energy CT applications in urinary tract cancers: an update.
    Tumori. 2023;109:148-156.
    Abstract     Related articles   

  711. OK F, Durmus E
    Disease management in a patient diagnosed with COVID-19 disease during induction intravesical BCG therapy: A case report and review of the literature.
    Urologia. 2023;90:195-197.
    Abstract     Related articles   

  712. TRENTI E, Palermo S, Pycha A, Comploj E, et al
    [Sigmoid colon conduit volvulus: an extremely rare complication of a sigmoid colon conduit].
    Aktuelle Urol. 2023;54:148-150.
    Abstract     Related articles   

  713. THOLOMIER C, Martini A, Mokkapati S, Dinney CP, et al
    The current status of gene therapy in bladder cancer.
    Expert Rev Anticancer Ther. 2023 Apr 13. doi: 10.1080/14737140.2023.2203385.
    Abstract     Related articles   

  714. ELAYAT G, Punev I, Selim A
    An Overview of Angiogenesis in Bladder Cancer.
    Curr Oncol Rep. 2023 Apr 13. doi: 10.1007/s11912-023-01421.
    Abstract     Related articles   

  715. WU X, Xu Q, Li T, Wei Y, et al
    Correction to: Bladder Cancer Progression Is Suppressed Through the Heart and Neural Crest Derivatives Expressed 2‑Antisense RNA 1/microRNA‑93‑5p/Defective in Cullin Neddylation 1 Domain Containing 3 Axis.
    Appl Biochem Biotechnol. 2023 Apr 13. doi: 10.1007/s12010-023-04478.
    Abstract     Related articles   

  716. SHIN HM, Lee J, Lee DH, Kim SH, et al
    CT Evaluation of the Findings of Nutcracker Syndrome in Patients with Bladder Cancer after Radical Cystectomy and Ileal Neobladder Formation: A Correlation with Hematuria.
    J Korean Soc Radiol. 2023;84:409-417.
    Abstract     Related articles   

  717. TEIXEIRA-MARQUES A, Lourenco C, Oliveira MC, Henrique R, et al
    Extracellular Vesicles as Potential Bladder Cancer Biomarkers: Take It or Leave It?
    Int J Mol Sci. 2023;24:6757.
    Abstract     Related articles   

  718. SANGUEDOLCE F, Falagario UG, Zanelli M, Palicelli A, et al
    Clinicopathological Features and Survival Analysis in Molecular Subtypes of Muscle-Invasive Bladder Cancer.
    Int J Mol Sci. 2023;24:6610.
    Abstract     Related articles   

  719. GREBOWSKI R, Saluk J, Bijak M, Szemraj J, et al
    Variability, Expression, and Methylation of IL-6 and IL-8 Genes in Bladder Cancer Pathophysiology.
    Int J Mol Sci. 2023;24:6266.
    Abstract     Related articles   

  720. NEUHAUS J, Rabien A, Reinhold A, Koehler L, et al
    3D Tumor Models in Urology.
    Int J Mol Sci. 2023;24:6232.
    Abstract     Related articles   

  721. HU CY, Wu HT, Shan YS, Wang CT, et al
    Evodiamine Exhibits Anti-Bladder Cancer Activity by Suppression of Glutathione Peroxidase 4 and Induction of Ferroptosis.
    Int J Mol Sci. 2023;24:6021.
    Abstract     Related articles   

  722. BLANCA A, Lopez-Beltran A, Lopez-Porcheron K, Gomez-Gomez E, et al
    Risk Classification of Bladder Cancer by Gene Expression and Molecular Subtype.
    Cancers (Basel). 2023;15:2149.
    Abstract     Related articles   

  723. BERTUCCI A, Cartier L, Rollet A, Boustany R, et al
    Retrospective Analysis of a Cohort of Patients with Metastatic Bladder Cancer with Metastatic Sites Limited to the Pelvis and Retroperitoneum Treated at a Single Institution between 2009 and 2020.
    Cancers (Basel). 2023;15:2069.
    Abstract     Related articles   

  724. DEL GIUDICE F, Asero V, Bologna E, Scornajenghi CM, et al
    Efficacy of Different Bacillus of Calmette-Guerin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis.
    Cancers (Basel). 2023;15:1937.
    Abstract     Related articles   

  725. KIMURA K, Yoshida S, Tsuchiya J, Kitazume Y, et al
    Novel utility of Vesical Imaging-Reporting and Data System in multimodal treatment for muscle-invasive bladder cancer.
    Eur Radiol. 2023 Apr 13. doi: 10.1007/s00330-023-09627.
    Abstract     Related articles   

  726. GHALI F, Wright JL, Grivas P
    The Pursuit of Intravesical and Systemic Therapies in Non-muscle-invasive Bladder Cancer: Challenges and Opportunities.
    Eur Urol Oncol. 2023 Apr 10:S2588-9311(23)00071.
    Abstract     Related articles   

  727. WANG Z, Kwan ML, Haque R, Goniewicz M, et al
    Associations of dietary isothiocyanate exposure from cruciferous vegetable consumption with recurrence and progression of non-muscle invasive bladder cancer: Findings from The Be-Well Study.
    Am J Clin Nutr. 2023 Apr 10:S0002-9165(23)46835.
    Abstract     Related articles   

  728. ZHANG H, Liu J, Zheng Z
    Molecular subtypes, tumor microenvironment infiltration characterization and prognosis model based on cuproptosis in bladder cancer.
    PeerJ. 2023;11:e15088.
    Abstract     Related articles   

  729. YANAGISAWA T, Matsukawa A, Iwatani K, Sato S, et al
    ASO Visual Abstract: En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity Score-Matched Analysis.
    Ann Surg Oncol. 2023 Apr 11. doi: 10.1245/s10434-023-13395.
    Abstract     Related articles   

  730. XIA Y, Xu DF, Huang T, Zhao CH, et al
    Exploring the application of bladder-preservation treatment in patients with T2N0M0 bladder cancer and establish a nomogram model: A SEER-based study.
    Asian J Surg. 2023 Apr 8:S1015-9584(23)00486.
    Abstract     Related articles   

  731. BILE-SILVA A, Lopez-Beltran A, Blanca A, Lopez-Rios F, et al
    Clinical utility of checkpoint inhibitors against metastatic bladder cancer: overcoming challenges to find a way forward.
    Expert Opin Biol Ther. 2023 Apr 10:1-12. doi: 10.1080/14712598.2023.2201371.
    Abstract     Related articles   

  732. QUIGNOT N, Jiang H, Doobaree IU, Lehmann J, et al
    Healthcare Resource Utilization and Cost Burden of BCG-Treated Non-Muscle Invasive Bladder Cancer Patients in Germany: A Retrospective Claims Analysis.
    Clinicoecon Outcomes Res. 2023;15:227-237.
    Abstract     Related articles   

  733. BAI X, Chen G, Shang S, Li S, et al
    Survival prediction among pathologic T4 bladder cancer patients following cytoreductive cystectomy: A retrospective single-center study.
    Front Surg. 2023;10:1121357.
    Abstract     Related articles   

  734. FRESHOUR SL, Chen THP, Fisk B, Shen H, et al
    Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer.
    bioRxiv. 2023 Mar 29:2023.03.28.534561. doi: 10.1101/2023.03.28.534561.
    Abstract     Related articles   

  735. ZHANG X, Zhang A, Hu L, Xiong W, et al
    An innovative risk index based on neutrophils and macrophages can effectively predict prognosis and immunotherapy response in patients with muscle-invasive bladder cancer.
    Transl Cancer Res. 2023;12:536-549.
    Abstract     Related articles   

  736. PYRGIDIS N, Sokolakis I, Haltmair G, Hatzichristodoulou G, et al
    The Short- and Long-Term Effect of Radical Cystectomy in Frail Patients With Bladder Cancer.
    Clin Genitourin Cancer. 2023 Mar 11:S1558-7673(23)00063.
    Abstract     Related articles   

  737. DONG ZX, Chan SH, Chen SN, Li M, et al
    TJP1 promotes vascular mimicry in bladder cancer by facilitating VEGFA expression and transcriptional activity through TWIST1.
    Transl Oncol. 2023;32:101666.
    Abstract     Related articles   

  738. MONTORSI F, Moschini M, Briganti A
    Re: Wei Shan Tan, Gary Steinberg, J. Alfred Witjes, et al. Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group. Eur Urol Oncol 2022;5:505-16.
    Eur Urol Oncol. 2023 Apr 6:S2588-9311(23)00073-1. doi: 10.1016/j.euo.2023.
    Abstract     Related articles   

  739. WU J, He D, Yu F, Huang Y, et al
    Mycoplasma infection mimicking a malignancy in a waldenstrom macroglobulinemia patient.
    BMC Infect Dis. 2023;23:219.
    Abstract     Related articles   

  740. GAFFNEY CD, Katims A, D'Souza N, Bjurlin MA, et al
    Bladder Cancer Carcinogens: Opportunities for Risk Reduction.
    Eur Urol Focus. 2023 Apr 5:S2405-4569(23)00086-X. doi: 10.1016/j.euf.2023.
    Abstract     Related articles   

  741. ZHANG Y, Li Z, Zhang Y, Shen C, et al
    circSOBP Inhibits Bladder Cancer Proliferation and Metastasis by Regulating the miR-200a-3p/PTEN Axis and Participating in the Immune Response.
    Cell Transplant. 2023;32:9636897231165874.
    Abstract     Related articles   

  742. SHEN D, Deng Z, Liu W, Zhou F, et al
    Melatonin inhibits bladder tumorigenesis by suppressing PPARgamma/ENO1-mediated glycolysis.
    Cell Death Dis. 2023;14:246.
    Abstract     Related articles   

  743. PHILIPPS L, Porta N, James N, Huddart R, et al
    Correlation of Clinician- and Patient-Reported Outcomes in the BC2001 Trial.
    Clin Oncol (R Coll Radiol). 2023;35:331-338.
    Abstract     Related articles   

  744. GONZALEZ-FIERRO A, Romo-Perez A, Chavez-Blanco A, Dominguez-Gomez G, et al
    Does Therapeutic Repurposing in Cancer Meet the Expectations of Having Drugs at a Lower Price?
    Clin Drug Investig. 2023;43:227-239.
    Abstract     Related articles   

  745. JAIN RK, Singh AM, Wang X, Guevara-Patino JA, et al
    Emerging monoclonal antibody therapies in the treatment of metastatic urothelial carcinoma.
    Expert Opin Emerg Drugs. 2023;28:17-26.
    Abstract     Related articles   

  746. MASTROIANNI R, Tuderti G, Ferriero M, Anceschi U, et al
    Open vs robotic intracorporeal Padua ileal bladder: functional outcomes of a single-centre RCT.
    World J Urol. 2023;41:739-746.
    Abstract     Related articles   

  747. YAMADA Y, Nakagawa T, Miyakawa J, Kawai T, et al
    Subclassification of pT3 upper tract urothelial carcinoma: a multicenter retrospective study.
    World J Urol. 2023;41:767-776.
    Abstract     Related articles   

  748. BAHLINGER V, Hartmann A, Eckstein M
    Immunotherapy in Genitourinary Cancers: Role of Surgical Pathologist for Detection of Immunooncologic Predictive Factors.
    Adv Anat Pathol. 2023;30:203-210.
    Abstract     Related articles   

  749. GAYA JM, Territo A, Basile G, Gallioli A, et al
    Optimizing decision-making process of benign uretero-enteric anastomotic stricture treatment after radical cystectomy.
    World J Urol. 2023;41:733-738.
    Abstract     Related articles   

  750. BLACKMUR JP, Chew E, Trail M, Brodie K, et al
    Assessment of association between lower ureteric excision technique and oncological outcomes for upper urinary tract urothelial carcinoma: retrospective analysis from the Scottish Renal Cancer Consortium.
    World J Urol. 2023;41:757-765.
    Abstract     Related articles   

  751. KIM H, Jeong BC, Hong J, Kwon GY, et al
    Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder.
    Cancer Res Treat. 2023;55:636-642.
    Abstract     Related articles   

  752. FAN B, Zheng X, Wang Y, Hu X, et al
    Predicting prognosis and clinical efficacy of immune checkpoint blockade therapy via interferon-alpha response in muscle-invasive bladder cancer.
    Pathol Oncol Res. 2023;29:1611117.
    Abstract     Related articles   

  753. TAN D, Jiang W, Hu R, Li Z, et al
    Detection of the ADGRG6 hotspot mutations in urine for bladder cancer early screening by ARMS-qPCR.
    Cancer Med. 2023 Apr 20. doi: 10.1002/cam4.5879.
    Abstract     Related articles   

  754. CATTO JWF, Rogers Z, Downing A, Mason SJ, et al
    Lifestyle Factors in Patients with Bladder Cancer: A Contemporary Picture of Tobacco Smoking, Electronic Cigarette Use, Body Mass Index, and Levels of Physical Activity.
    Eur Urol Focus. 2023 Apr 18:S2405-4569(23)00101.
    Abstract     Related articles   

  755. SONG SH, Lee J, Ko YH, Kim JW, et al
    TNM-Based Head-to-Head Comparison of Urachal Carcinoma and Urothelial Bladder Cancer : Stage-Matched Analysis of a Large Multicenter National Cohort.
    Cancer Res Treat. 2023 Apr 17. doi: 10.4143/crt.2023.
    Abstract     Related articles   

  756. COCKRELL DC, Rose TL
    Correction to: Current Status of Perioperative Therapy in Muscle‑Invasive Bladder Cancer and Future Directions.
    Curr Oncol Rep. 2023 Apr 20. doi: 10.1007/s11912-023-01409.
    Abstract     Related articles   

  757. YOSHINO H, Yokoyama S, Tamai M, Okamura S, et al
    Characterization and treatment of gemcitabine- and cisplatin-resistant bladder cancer cells with a pan-RAS inhibitor.
    FEBS Open Bio. 2023 Apr 20. doi: 10.1002/2211-5463.13616.
    Abstract     Related articles   

  758. VERRI P, Baboudjian M, Diana P, Gallioli A, et al
    Reduced- vs full-dose BCG in bladder cancer: A systematic review and meta-analysis.
    Actas Urol Esp (Engl Ed). 2023;47:4-14.
    Abstract     Related articles   

  759. MORENO-CORTES JC, Herranz-Amo F, Bataller-Monfort V, Esteban-Labrador L, et al
    Development of an immune-nutritional prognostic index in patients with muscle-infiltrating bladder cancer candidates for radical cystectomy.
    Actas Urol Esp (Engl Ed). 2023;47:34-40.
    Abstract     Related articles   

  760. SHEENU VS, Paul RS, Pushpa M, Ami EM, et al
    Histopathological spectrum of adult renal tumours: A single center experience and review of literature.
    Indian J Pathol Microbiol. 2023;66:307-313.
    Abstract     Related articles   

  761. SCHALLENBERG S, Dragomir MP, Anders P, Ebner B, et al
    Intratumoral Heterogeneity of Molecular Subtypes in Muscle-invasive Bladder Cancer-An Extensive Multiregional Immunohistochemical Analysis.
    Eur Urol Focus. 2023 Apr 17:S2405-4569(23)00080.
    Abstract     Related articles   

  762. SANZ GOMEZ I, Huguet J, Bravo A, Robalino J, et al
    Sequential Treatment With Bacillus Calmette-Guerin (BCG) and Mitomycin C Administered With Electromotive Drug Administration (EMDA) in Patients With High-Risk Nonmuscle Invasive Bladder Cancer After BCG Failure.
    Clin Genitourin Cancer. 2023 Mar 17:S1558-7673(23)00061.
    Abstract     Related articles   

  763. YAN CL, Gallo RA, Pandiri M, Gallo SJ, et al
    Bladder squamous cell carcinoma in situ in the background of condyloma acuminatum in a kidney transplant recipient.
    Can J Urol. 2023;30:11505-11508.
    Abstract     Related articles   

  764. WANG W, Jiang X, Xia F, Chen X, et al
    Correction to: HYOU1 promotes cell proliferation, migration, and invasion via the PI3K/AKT/FOXO1 feedback loop in bladder cancer.
    Mol Biol Rep. 2023 Apr 18. doi: 10.1007/s11033-023-08325.
    Abstract     Related articles   

  765. CHEN J, Huang CP, Quan C, Zu X, et al
    The androgen receptor in bladder cancer.
    Nat Rev Urol. 2023 Apr 18. doi: 10.1038/s41585-023-00761.
    Abstract     Related articles   

  766. MINOLI M, Cantore T, Hanhart D, Kiener M, et al
    Bladder cancer organoids as a functional system to model different disease stages and therapy response.
    Nat Commun. 2023;14:2214.
    Abstract     Related articles   

  767. STORMOEN DR, Taarnhoj GA, Friis RB, Johansen C, et al
    Association of patient-reported pain with survival in bladder cancer: a post-hoc analysis of the iBLAD trial.
    Acta Oncol. 2023 Apr 18:1-6. doi: 10.1080/0284186X.2023.2199461.
    Abstract     Related articles   

  768. SU Y, Wang B, Huang J, Huang M, et al
    YTHDC1 positively regulates PTEN expression and plays a critical role in cisplatin resistance of bladder cancer.
    Cell Prolif. 2023 Apr 17:e13404. doi: 10.1111/cpr.13404.
    Abstract     Related articles   

  769. JIANG Y, Zhang M, Wang L, Zhang L, et al
    Potential mechanisms of osthole against bladder cancer cells based on network pharmacology, molecular docking, and experimental validation.
    BMC Complement Med Ther. 2023;23:122.
    Abstract     Related articles   

  770. STONE L
    Going in circles: circMGA-HNRNPL feedback loop in bladder cancer.
    Nat Rev Urol. 2023 Apr 17. doi: 10.1038/s41585-023-00771.
    Abstract     Related articles   

  771. MASONE MC
    Using AI to assist pathologists in bladder cancer metastases detection.
    Nat Rev Urol. 2023 Apr 14. doi: 10.1038/s41585-023-00769.
    Abstract     Related articles   

  772. YU X, Li W, Feng Y, Gao Z, et al
    The prognostic value of hedgehog signaling in bladder cancer by integrated bioinformatics.
    Sci Rep. 2023;13:6241.
    Abstract     Related articles   

  773. MOHAMMED SA, Hetta HF, Zahran AM, Tolba MEM, et al
    T cell subsets, regulatory T, regulatory B cells and proinflammatory cytokine profile in Schistosoma haematobium associated bladder cancer: First report from Upper Egypt.
    PLoS Negl Trop Dis. 2023;17:e0011258.
    Abstract     Related articles   

  774. JAHAN M, Mittal A, Rao S, Kishore S, et al
    Cytomorphologic visualization of circulating tumor cells in urinary bladder cancer patients using ScreenCell technology: Potential as a simple cytology test.
    Diagn Cytopathol. 2023 Apr 17. doi: 10.1002/dc.25141.
    Abstract     Related articles   

  775. WANG Y, Chen S, Zhang W, Xiao W, et al
    Image quality evaluation of diffusion-weighted imaging in bladder cancer: a comparison between integrated slice-specific dynamic shimming and single-shot echo-planar imaging.
    Quant Imaging Med Surg. 2023;13:2526-2537.
    Abstract     Related articles   

  776. JAKUS D, Situm M, Cepin P, Vrhovac I, et al
    The impact of antithrombotic therapy on the time of detection of bladder cancer.
    Cent European J Urol. 2023;76:33-37.
    Abstract     Related articles   

  777. XIONG X, Chen C, Li X, Yang J, et al
    Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer.
    Front Oncol. 2023;13:972558.
    Abstract     Related articles   

  778. CASTANEDA PR, Theodorescu D, Rosser CJ, Ahdoot M, et al
    Identifying novel biomarkers associated with bladder cancer treatment outcomes.
    Front Oncol. 2023;13:1114203.
    Abstract     Related articles   

  779. CHEN H, Yang W, Ji Z
    Machine learning-based identification of tumor-infiltrating immune cell-associated model with appealing implications in improving prognosis and immunotherapy response in bladder cancer patients.
    Front Immunol. 2023;14:1171420.
    Abstract     Related articles   

  780. HE Z, Chen K, An Y, He J, et al
    BSA modification of bacterial surface: a promising anti-cancer therapeutic strategy.
    BMC Microbiol. 2023;23:105.
    Abstract     Related articles   

  781. YANG J, Li K, Zhang Y, Hu J, et al
    Singe intraoperative instillation of chemotherapy during radical cystectomy for bladder cancer: Oncological outcome and survival predictors.
    Cancer Med. 2023 Apr 16. doi: 10.1002/cam4.5895.
    Abstract     Related articles   

  782. WISHAHI M, Hassan S, Hassan M, Badawy M, et al
    Telocytes and ezrin expression in normal-appearing tissues adjacent to urothelial bladder carcinoma as predictors of invasiveness and recurrence.
    Sci Rep. 2023;13:6179.
    Abstract     Related articles   

  783. CHANDRA M, Li R, Parwani A, Carson WE 3rd, et al
    Heterogeneity of BCG unresponsive bladder cancer clinical trials limits patients' access to novel therapeutics.
    Urol Oncol. 2023 Apr 13:S1078-1439(23)00094.
    Abstract     Related articles   

  784. WU R, Li D, Feng D, Han P, et al
    Transmembrane protein 132A (TMEM132A) predicts overall survival for bladder cancer patients.
    Asian J Surg. 2023 Apr 13:S1015-9584(23)00423.
    Abstract     Related articles   

  785. GARCIA-PORRERO G, Paricio Martinez JJ, Alvarez Gigli L, Abengozar Muela M, et al
    Osteoclast-rich undifferentiated carcinoma of the bladder and the diagnostic usefulness of immunohistochemistry. A case report.
    Rev Esp Patol. 2023;56:132-135.
    Abstract     Related articles   

  786. CONTIERI R, Lazzeri M, Hurle R
    When and How To Perform Active Surveillance for Low-risk Non-muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2023 Apr 12:S2405-4569(23)00095.
    Abstract     Related articles   

  787. SUN A, Luo Y, Xiao W, Zhu Z, et al
    Androgen receptor transcriptionally inhibits programmed death ligand-1 (PD-L1) expression and influences immune escape in bladder cancer.
    Lab Invest. 2023 Apr 12:100148. doi: 10.1016/j.labinv.2023.100148.
    Abstract     Related articles   

  788. MAMTANI R, Zhang H, Parikh RB, Patel K, et al
    Uptake of Maintenance Immunotherapy and Changes in Upstream Treatment Selection Among Patients With Urothelial Cancer.
    JAMA Netw Open. 2023;6:e238395.
    Abstract     Related articles   

  789. CHANG YL, Chen YT, Wang HH, Chiang PH, et al
    The prognostic impact of lymphovascular invasion for upper urinary tract urothelial carcinoma: A propensity score-weighted analysis.
    Medicine (Baltimore). 2023;102:e33485.
    Abstract     Related articles   

  790. ZHANG X, G Dapar ML, Zhang X, Chen Y, et al
    A pan-cancer analysis of the oncogenic role of YKT6 in human tumors.
    Medicine (Baltimore). 2023;102:e33546.
    Abstract     Related articles   

  791. JOENSEN UN, Kingo PS, Stormoen D, Carus A, et al
    [Not Available].
    Ugeskr Laeger. 2023;185:V02230082.
    Abstract     Related articles   

  792. OLIUSHINA EM, Zavalishina LE, Alekseenok EY, Oskina NA, et al
    [Investigation of the mutational status of the FGFR3 gene in urothelial bladder carcinoma].
    Arkh Patol. 2023;85:5-12.
    Abstract     Related articles   

  793. JIN X, Wang Q, Luo F, Pan J, et al
    Single-cell transcriptomic analysis of tumor heterogeneity and intercellular networks in human urothelial carcinoma.
    Chin Med J (Engl). 2023;136:690-706.
    Abstract     Related articles   

  794. YAJIMA S, Nakanishi Y, Yasujima R, Hirose K, et al
    Rapid geriatric screening tools predict inability to manage stoma by oneself after urinary diversion: G8 and IADL-modified G8.
    J Geriatr Oncol. 2023;14:101468.
    Abstract     Related articles   

  795. ZHU A, Berends JE, Daignault-Newton S, Kaye DR, et al
    Use of a physical activity monitor to track perioperative activity of radical cystectomy patients. Our first glimpse at what our patients are doing before and after surgery.
    Urol Oncol. 2023;41:206.
    Abstract     Related articles   

  796. SONG E, Suek T, Davaro F, Hamilton Z, et al
    Variant histology in upper tract carcinomas: Analysis of the National Cancer Database.
    Urol Oncol. 2023;41:206.
    Abstract     Related articles   

  797. ROSENZWEIG SJ, Ranti D, Mehrazin R, Sfakianos JP, et al
    Characteristics Contributing to Survival Differences Between Black and White Patients Following Cystectomy.
    Urol Oncol. 2023;41:207.
    Abstract     Related articles   

  798. MORA RM, Ghoreifi A, Ladi-Seyedian SS, Sheybaee Moghaddam F, et al
    Radical cystectomy and urinary diversion outcomes in patients with single vs. double renal unit: A 2:1 matched-pair analysis.
    Urol Oncol. 2023;41:207.
    Abstract     Related articles   

  799. SHORE ND, Gavaghan MB
    Clinical and economic impact of blue light cystoscopy in the management of NMIBC at US ambulatory surgical centers: what is the site-of-service disparity?
    Urol Oncol. 2023;41:207.
    Abstract     Related articles   

  800. HAO Z, Dang W, Zhu Q, Xu J, et al
    Long non-coding RNA UCA1 regulates MPP(+)-induced neuronal damage through the miR-671-5p/KPNA4 pathway in SK-N-SH cells.
    Metab Brain Dis. 2023;38:961-972.
    Abstract     Related articles   

  801. DE JONG JJ, Pijpers OM, van Kessel KEM, Boormans JL, et al
    A Urine-based Genomic Assay Improves Risk Stratification for Patients with High-risk Hematuria Stratified According to the American Urological Association Guidelines.
    Eur Urol Oncol. 2023;6:183-189.
    Abstract     Related articles   

  802. KOBAYASHI G, Hayashi T, Sentani K, Ikeda K, et al
    ANXA10 Expression Is Inversely Associated with Tumor Stage, Grade, and TP53 Expression in Upper and Lower Urothelial Carcinoma.
    Pathobiology. 2023;90:94-103.
    Abstract     Related articles   

  803. CASAGRANDE G, Ibrahimi M, Semproni F, Iacovacci V, et al
    Hydraulic Detrusor for Artificial Bladder Active Voiding.
    Soft Robot. 2023;10:269-279.
    Abstract     Related articles   

  804. GAUTAM KA, Raghav A, Sankhwar SN, Singh R, et al
    Genetic Polymorphisms of Gene Methionine Synthase Reductase (MTRR) and Risk of Urinary Bladder Cancer.
    Asian Pac J Cancer Prev. 2023;24:1137-1141.
    Abstract     Related articles   

  805. ECKE TH, Wirtz RM, Friedersdorff F, Fussel S, et al
    [Research in bladder cancer: translation into the clinic-report of 13th annual meeting of the German Research Group on Bladder Cancer (DFBK) in Berlin].
    Urologie. 2023 Apr 28. doi: 10.1007/s00120-023-02093.
    Abstract     Related articles   

  806. PENG C, Guo S, Yang Z, Li X, et al
    A prognostic model for bladder cancer based on cytoskeleton-related genes.
    Medicine (Baltimore). 2023;102:e33538.
    Abstract     Related articles   

  807. WU M, Zheng X, Wang X, Li X, et al
    The Efficacy and Safety of Tislelizumab as Adjuvant Treatment for Advanced or Metastatic Bladder Cancer in People Living With HIV: A Retrospective Multi-Center Study.
    Cancer Control. 2023;30:10732748231173475.
    Abstract     Related articles   

  808. AL-AZAB R, Al-Zubi M, Al Demour S, Khaled Al-Jamal S, et al
    Adherence to guidelines in the follow-up of non-muscle-invasive bladder cancer among urology trainers and trainees in Jordan: a cross-sectional study.
    Ann Med Surg (Lond). 2023;85:763-766.
    Abstract     Related articles   

  809. KANG Y, Park C, Lee H, Kang S, et al
    Natural Products as New Approaches for Treating Bladder Cancer: From Traditional Medicine to Novel Drug Discovery.
    Pharmaceutics. 2023;15:1117.
    Abstract     Related articles   

  810. ZHANG-YIN J, Girard A, Marchal E, Lebret T, et al
    PET Imaging in Bladder Cancer: An Update and Future Direction.
    Pharmaceuticals (Basel). 2023;16:606.
    Abstract     Related articles   

  811. WILCZAK M, Surman M, Przybylo M
    Altered Glycosylation in Progression and Management of Bladder Cancer.
    Molecules. 2023;28:3436.
    Abstract     Related articles   

  812. HU B, Chen R, Jiang M, Xiong S, et al
    MTX-211 Inhibits GSH Synthesis through Keap1/NRF2/GCLM Axis and Exerts Antitumor Effects in Bladder Cancer.
    Int J Mol Sci. 2023;24:7608.
    Abstract     Related articles   

  813. ZHU J, Tong H, Sun Y, Li T, et al
    YTHDF1 Promotes Bladder Cancer Cell Proliferation via the METTL3/YTHDF1-RPN2-PI3K/AKT/mTOR Axis.
    Int J Mol Sci. 2023;24:6905.
    Abstract     Related articles   

  814. PANEBIANCO V
    VI-RADS for the diagnosis and management of urinary bladder cancer.
    Eur Radiol. 2023 Apr 28. doi: 10.1007/s00330-023-09677.
    Abstract     Related articles   

  815. WANG Y, Ju L, Wang G, Qian K, et al
    DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC.
    Nat Commun. 2023;14:2421.
    Abstract     Related articles   

  816. ROBERTSON AG, Meghani K, Cooley LF, McLaughlin KA, et al
    Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer.
    Nat Commun. 2023;14:2126.
    Abstract     Related articles   

  817. MAGEE DE, Cheung DC, Hird AE, Chung P, et al
    Cost of Bladder Cancer Care: A Single Centre Comparison of Radical Cystectomy and Trimodal Therapy.
    Urol Pract. 2023 Apr 4:101097UPJ0000000000000403.
    Abstract     Related articles   

  818. SORIA F, D'Andrea D, Barale M, Gust KM, et al
    Sarcopenia Predicts Disease Progression in Patients with T1 High-grade Non-muscle-invasive Bladder Cancer Treated with Adjuvant Intravesical Bacillus Calmette-Guerin: Implications for Decision-making?
    Eur Urol Open Sci. 2023;50:17-23.
    Abstract     Related articles   

  819. FU Y, Liu K, Zhao L, Jiang X, et al
    Circular RNA Ubiquitin-associated Protein 2 Silencing Suppresses Bladder Cancer Progression by Downregulating DNA Topoisomerase 2-alpha Through Sponging miR-496.
    Eur Urol Open Sci. 2023;50:31-42.
    Abstract     Related articles   

  820. LI J, Qi Y, Li B, Liu Y, et al
    STIL/AURKA axis promotes cell proliferation by influencing primary cilia formation in bladder cancer.
    J Transl Med. 2023;21:281.
    Abstract     Related articles   

  821. HOLTEDAHL K, Borgquist L, Donker GA, Buntinx F, et al
    Symptoms and signs of urogenital cancer in primary care.
    BMC Prim Care. 2023;24:107.
    Abstract     Related articles   

  822. ADAMS-MARDI C, Sparks A, Whalen M
    Impact of Minimally Invasive Approach to Radical Cystectomy in Bladder Cancer Patients with Malnutrition.
    Nutr Cancer. 2023 Apr 26:1-6. doi: 10.1080/01635581.2023.2202432.
    Abstract     Related articles   

  823. GU S, Yang C
    Serum lactate dehydrogenase level predicts the prognosis in bladder cancer patients.
    BMC Urol. 2023;23:65.
    Abstract     Related articles   

  824. LEONG SW, Wang J, Okuda KS, Su Q, et al
    Discovery of a novel dual functional phenylpyrazole-styryl hybrid that induces apoptotic and autophagic cell death in bladder cancer cells.
    Eur J Med Chem. 2023;254:115335.
    Abstract     Related articles   

  825. HAGGSTROM C, Rowley M, Liedberg F, Coolen ACC, et al
    Latent heterogeneity of muscle-invasive bladder cancer in patient characteristics and survival: A population-based nation-wide study in the Bladder Cancer Data Base Sweden (BladderBaSe).
    Cancer Med. 2023 Apr 25. doi: 10.1002/cam4.5981.
    Abstract     Related articles   

  826. XU H, Lin T, Ai J, Zhang J, et al
    Utilizing the Lactate Dehydrogenase-to-Albumin Ratio for Survival Prediction in Patients with Bladder Cancer After Radical Cystectomy.
    J Inflamm Res. 2023;16:1733-1744.
    Abstract     Related articles   

  827. HALSTUCH D, Lotan P, Karchever I, Rubinshtein D, et al
    Single-Dose Post-Office Fulguration Mitomycin C Instillation Appears to Improve Recurrence-Free Survival in Patients With Low-Grade Noninvasive Bladder Cancer.
    Clin Genitourin Cancer. 2023 Mar 23:S1558-7673(23)00066.
    Abstract     Related articles   

  828. LIN Y, Li T, Li Z, Shen C, et al
    Comprehensive characterization of endoplasmic reticulum stress in bladder cancer revealing the association with tumor immune microenvironment and prognosis.
    Front Genet. 2023;14:1097179.
    Abstract     Related articles   

  829. JAMES C, Gomez K, Desai S, Patel HD, et al
    Impact of intravesical Bacillus Calmette-Guerin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer.
    Front Cell Infect Microbiol. 2023;13:1125809.
    Abstract     Related articles   

  830. ZHAO Y, Li M, Wu W, Miao W, et al
    Downregulated ESRP1/2 promotes lung metastasis of bladder carcinoma through altering FGFR2 splicing and macrophage polarization.
    Front Immunol. 2023;14:1161273.
    Abstract     Related articles   

  831. MARSH GM, Kruchten A
    A reevaluation of selected mortality risks in the updated NCI/NIOSH acrylonitrile cohort study.
    Front Public Health. 2023;11:1122346.
    Abstract     Related articles   

  832. JOYCE DD, Sharma V, Williams SB
    Cost-Effectiveness and Economic Impact of Bladder Cancer Management: An Updated Review of the Literature.
    Pharmacoeconomics. 2023 Apr 23. doi: 10.1007/s40273-023-01273.
    Abstract     Related articles   

  833. WU Q, Zhang H, You S, Xu Z, et al
    NEDD4L inhibits migration, invasion, cisplatin resistance and promotes apoptosis of bladder cancer cells by inactivating the p62/Keap1/Nrf2 pathway.
    Environ Toxicol. 2023 Apr 23. doi: 10.1002/tox.23796.
    Abstract     Related articles   

  834. MODOS O, Varadi M, Der B, Keszthelyi A, et al
    [Current diagnostic and treatment strategies for urachal cancer].
    Orv Hetil. 2023;164:602-609.
    Abstract     Related articles   

  835. CAI T, Lu J, Lin Z, Lup M, et al
    [Intravesical instillation of bacillus Calmette-Guerin for non-muscle invasive bladder cancer: outcomes of 421 patients in a single center].
    Nan Fang Yi Ke Da Xue Xue Bao. 2023;43:488-494.
    Abstract     Related articles   

  836. LU YT, Plets M, Morrison G, Cunha AT, et al
    Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314.
    Eur Urol Oncol. 2023 Apr 20:S2588-9311(23)00074.
    Abstract     Related articles   

  837. ASTUDILLO C, Garcia-Perdomo HA
    Electronic cigarette: is it a risk factor for the development of bladder cancer?
    Actas Urol Esp (Engl Ed). 2023 Apr 20:S2173-5786(23)00047.
    Abstract     Related articles   

  838. CHEN N, Li P, Liu L, Zhang J, et al
    Cucurbitacin IIb Extracted from Hemsleya penxianensis Induces Cell Cycle Arrest and Apoptosis in Bladder Cancer Cells by Regulating Cell Cycle Checkpoints and Mitochondrial Apoptotic Pathway.
    Plant Foods Hum Nutr. 2023 Apr 22. doi: 10.1007/s11130-023-01058.
    Abstract     Related articles   

  839. YILDIZ AK, Ozgur BC, Bayraktar AS, Demir DO, et al
    How has the COVID-19 pandemic affected patients with primary bladder cancer?
    Cir Cir. 2023;91:204-211.
    Abstract     Related articles   

  840. YASUI M, Cui L, Miyamoto H
    Recent advances in the understanding of urothelial tumorigenesis.
    Expert Rev Anticancer Ther. 2023;23:485-493.
    Abstract     Related articles   

  841. SHERMAN E, Lee JL, Debruyne PR, Keam B, et al
    Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors: a phase II, open-label, multicenter, multicohort study.
    ESMO Open. 2023;8:100877.
    Abstract     Related articles   

  842. JING W, Chen C, Wang G, Han M, et al
    Metabolic Modulation of Intracellular Ammonia via Intravesical Instillation of Nanoporter-Encased Hydrogel Eradicates Bladder Carcinoma.
    Adv Sci (Weinh). 2023;10:e2206893.
    Abstract     Related articles   

  843. GUO J, Liang X, Zheng Y, Ma J, et al
    Progress in the treatment of urethral adenocarcinoma.
    J Cancer Res Clin Oncol. 2023;149:2693-2698.
    Abstract     Related articles   

  844. SUN MY, Peng Y, Liu DW, Wang K, et al
    Ectopic prostate tissue at the bladder trigone accompanied by cystitis glandularis and hemorrhage detected by multiparametric MRI.
    Asian J Androl. 2023;25:438-439.
    Abstract     Related articles   

  845. ABDELRAHMAN I, Aboulkassem H, Elazab A, Abdallah AY, et al
    Evaluation of short-term outcomes of neoadjuvant chemotherapy followed by radical cystectomy in muscle-invasive bladder cancer: a single Egyptian institution experience.
    J Egypt Natl Canc Inst. 2023;35:13.
    Abstract     Related articles   

  846. REESINK DJ, van Melick HHE, van der Nat PB, Los M, et al
    Real-world outcomes of first-line chemotherapy for unresectable stage III and IV bladder cancer.
    World J Urol. 2023 May 5. doi: 10.1007/s00345-023-04408.
    Abstract     Related articles   

  847. DU KL, Ji WT, Jiang QH, Wang Y, et al
    Detection of Plasma Antibodies Against CD25-Derived Peptide Antigens in Bladder Cancer.
    Clin Lab. 2023;69.
    Abstract     Related articles   

  848. JIN Y, Li J, Tang C, He K, et al
    A risk signature of necroptosis-related lncRNA to predict prognosis and probe molecular characteristics for male with bladder cancer.
    Medicine (Baltimore). 2023;102:e33664.
    Abstract     Related articles   

  849. NOVA-CAMACHO LM, Val-Carreres Castellote A, Villafruela Mateos A
    Xanthogranulomatous Ureteritis: A Diagnostic Challenge in a Patient with Bladder Cancer.
    Int J Surg Pathol. 2023 May 4:10668969231169049. doi: 10.1177/10668969231169049.
    Abstract     Related articles   

  850. JIANG YK, Situai YJ, Deng HM, Zhang H, et al
    ARID1A Inactivation Increases Expression of circ0008399 and Promotes Cisplatin Resistance in Bladder Cancer.
    Curr Med Sci. 2023 May 5. doi: 10.1007/s11596-023-2731.
    Abstract     Related articles   

  851. FAULK A, Avulova S, Bree KK, Baak-Kukreja J, et al
    Pelvic Organ Preservation in Non-muscle-invasive Bladder Cancer: Less Is More.
    Eur Urol Focus. 2023 May 2:S2405-4569(23)00103-7. doi: 10.1016/j.euf.2023.
    Abstract     Related articles   

  852. PLAIS H, Dumont C, Gauthier H, Culine S, et al
    Short-course treatment after complete response to pembrolizumab in metastatic urothelial bladder cancer: a case series.
    Immunotherapy. 2023 May 4. doi: 10.2217/imt-2022-0283.
    Abstract     Related articles   

  853. LI Q, Qing L, Xu W, Yang Y, et al
    Berberine Affects the Proliferation, Migration, Invasion, Cell Cycle, and Apoptosis of Bladder Cancer Cells T24 and 5637 by Down-Regulating the HER2/PI3K/AKT Signaling Pathway.
    Arch Esp Urol. 2023;76:152-160.
    Abstract     Related articles   

  854. OKUCU E, Yucetas U, Karsiyakali N, Koseoglu H, et al
    Higher Serum Endothelial-Specific Molecule-1 (ESM-1/Endocan) Levels are Associated with Poor Pathological Outcomes in Primary Bladder Cancer: A Non-randomized, Prospective, Case-Control Study.
    Arch Esp Urol. 2023;76:132-138.
    Abstract     Related articles   

  855. SANCHEZ VERDES P, Fernandez-Pello Montes S, Gonzalez Rodriguez I, Suarez Sal PJ, et al
    Impact of a One-Stop Hematuria Clinic on Overall Survival and Bladder Tumor Recurrence.
    Arch Esp Urol. 2023;76:114-122.
    Abstract     Related articles   

  856. LU Y, Jiang S, Yin X, Guo J, et al
    Long-term effect of transurethral partial cystectomy with a 2-micrometer continuous-wave laser for non-muscle-invasive bladder cancer.
    Front Surg. 2023;10:1117997.
    Abstract     Related articles   

  857. SHI ZD, Han XX, Song ZJ, Dong Y, et al
    Integrative multi-omics analysis depicts the methylome and hydroxymethylome in recurrent bladder cancers and identifies biomarkers for predicting PD-L1 expression.
    Biomark Res. 2023;11:47.
    Abstract     Related articles   

  858. LONG F, Wang W, Li S, Wang B, et al
    The potential crosstalk between tumor and plasma cells and its association with clinical outcome and immunotherapy response in bladder cancer.
    J Transl Med. 2023;21:298.
    Abstract     Related articles   

  859. KAWADA T, Yanagisawa T, Bekku K, Laukhtina E, et al
    The efficacy and safety outcomes of lower dose BCG compared to intravesical chemotherapy in non-muscle-invasive bladder cancer: A network meta-analysis.
    Urol Oncol. 2023 May 1:S1078-1439(23)00118-7. doi: 10.1016/j.urolonc.2023.
    Abstract     Related articles   

  860. MARTINS PR, Santos TPMD, Menezes LM, Froede AG, et al
    Association of human papillomavirus (HPV), p16, p53 and p63 expression with non-bilharzia-associated squamous cell carcinoma of the bladder and algorithm construction for histopathological grading prediction.
    Einstein (Sao Paulo). 2023;21:eAO0109.
    Abstract     Related articles   

  861. RASTI A, Khalili M, Fakhr Yasseri AM, Nasirian N, et al
    Evaluation of IGF2, KRT14, and KRT20 as Urinary Biomarkers in Patients with Bladder Cancer.
    Rep Biochem Mol Biol. 2023;11:710-719.
    Abstract     Related articles   

  862. XIAO D, Xu S, Zhou X, Li D, et al
    Synergistic augmentation of osimertinib-induced autophagic death by proguanil or rapamycin in bladder cancer.
    MedComm (2020). 2023;4:e236.
    Abstract     Related articles   

  863. RAAD E, Helou S, Hage K, Daou M, et al
    Cost of bladder cancer in Lebanon before and after the economic collapse: a probabilistic modeling study.
    Int J Equity Health. 2023;22:77.
    Abstract     Related articles   

  864. LIU F, Han Z, Lu J, Zhong W, et al
    Development and validation of a tobacco smoking-related index for predicting overall survival and immunotherapy response in bladder cancer.
    Environ Sci Pollut Res Int. 2023 May 2. doi: 10.1007/s11356-023-27132.
    Abstract     Related articles   

  865. STANIMIR M, Lorge F, D'Hondt L, Nollevaux MC, et al
    Metastasis to the penis from a bladder carcinoma invading only the lamina propria: case report and description of the morphological aspects.
    Rom J Morphol Embryol. 2023;64:89-94.
    Abstract     Related articles   

  866. BUKAVINA L, Bell S, Packiam VT, Smaldone M, et al
    Sequential intravesical gemcitabine-docetaxel vs. bacillus Calmette-Guerin (BCG) in the treatment of non-muscle invasive bladder cancer: A preliminary cost-effectiveness analysis.
    Urol Oncol. 2023 Apr 29:S1078-1439(23)00119.
    Abstract     Related articles   

  867. YAN R, Shen Y, Zhang X, Xu P, et al
    Histopathological bladder cancer gene mutation prediction with hierarchical deep multiple-instance learning.
    Med Image Anal. 2023;87:102824.
    Abstract     Related articles   

  868. SHAHIDI M, Abazari O, Dayati P, Reza JZ, et al
    Using chitosan-stabilized, hyaluronic acid-modified selenium nanoparticles to deliver CD44-targeted PLK1 siRNAs for treating bladder cancer.
    Nanomedicine (Lond). 2023 Apr 26. doi: 10.2217/nnm-2022-0198.
    Abstract     Related articles   

  869. ZHANG Z, Chen P, Yun J
    Comprehensive analysis of a novel RNA modifications-related model in the prognostic characterization, immune landscape and drug therapy of bladder cancer.
    Front Genet. 2023;14:1156095.
    Abstract     Related articles   

  870. LI T, Hu W, Jin L, Yin X, et al
    Case Report: PD-L1-negative advanced bladder cancer effectively treated with anlotinib and tislelizumab: A report of two cases.
    Front Oncol. 2023;13:1164368.
    Abstract     Related articles   

  871. CHEN X, He F, Zhang W, Fu Y, et al
    Emerging trends of BCG immunotherapy for bladder cancer in last decade: a bibliometric and visualization analysis.
    Front Oncol. 2023;13:1092969.
    Abstract     Related articles   

  872. HUANG H, Zhang Y, Chen Z, Zeng X, et al
    Neoadjuvant therapy with Disitamab vedotin in treating muscle-invasive bladder cancer: A case report.
    Heliyon. 2023;9:e15157.
    Abstract     Related articles   

  873. SUN X, Dai T, Xu L
    Transurethral resection of bladder tumor-based bladder preservation therapy for refractory high risk non-muscle invasive bladder cancer: Current landscape and future directions.
    Front Surg. 2023;10:1143219.
    Abstract     Related articles   

  874. GAO W, Zhang J, Tian T, Fu Z, et al
    Uncovering the potential functions of lymph node metastasis-associated aberrant methylation differentially expressed genes and their association with the immune infiltration and prognosis in bladder urothelial carcinoma.
    PeerJ. 2023;11:e15284.
    Abstract     Related articles   

  875. MUNGMUNPUNTIPANTIP R, Wiwanitkit V
    Comment on "telomerase reverse transcriptase rs2736098 and rs2736100 in bladder cancer".
    Rep Pract Oncol Radiother. 2023;28:135.
    Abstract     Related articles   

  876. VANCAVAGE R, Siddiqui S, Bernstein A, Avulova S, et al
    Why has sexuality research in women with bladder cancer undergoing radical cystectomy been ignored for so long?
    J Sex Med. 2023;20:580-583.
    Abstract     Related articles   

  877. DE VRIES EGE, Ruschoff J, Lolkema M, Tabernero J, et al
    Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma.
    Cancer Med. 2023 Apr 29. doi: 10.1002/cam4.5893.
    Abstract     Related articles   

  878. MA X, Zhang L, Liu L, Ruan D, et al
    Hypermethylated ITGA8 Facilitate Bladder Cancer Cell Proliferation and Metastasis.
    Appl Biochem Biotechnol. 2023 Apr 29. doi: 10.1007/s12010-023-04512.
    Abstract     Related articles   

  879. PARAMANANTHAM Y, B M Said NA, Mun KS
    The correlation of EMT and p53 immunohistochemical markers with cisplatin resistance in muscle invasive bladder cancer patients: A single-centred study.
    Malays J Pathol. 2023;45:19-29.
    Abstract     Related articles   

  880. DU C, Zheng M, Wang Z, Zhang J, et al
    Clinical characteristics and treatment outcomes of kidney transplant recipients with de novo urothelial carcinoma: thirty years of experience from a single center.
    BMC Urol. 2023;23:71.
    Abstract     Related articles   

  881. ZHOU L, Xu G, Huang F, Chen W, et al
    Apoptosis related genes mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide immunotherapy in bladder cancer.
    BMC Med Genomics. 2023;16:88.
    Abstract     Related articles   

  882. LAI HW, Yamamoto S, Fukuhara H, Ogura SI, et al
    Cell senescence-associated porphyrin metabolism affects the efficacy of aminolevulinic acid-photodynamic diagnosis in bladder cancer.
    Photodiagnosis Photodyn Ther. 2023 Apr 26:103581.
    Abstract     Related articles   

  883. SOBHANI S, Ghoreifi A, Douglawi A, Ahmadi H, et al
    Perioperative mortality for radical cystectomy in the modern Era: experience from a tertiary referral center.
    Int Braz J Urol. 2023;49:351-358.
    Abstract     Related articles   

  884. PRIJOVIC N, Santric V, Babic U, Stankovic B, et al
    Inflammatory Myofibroblastic Tumour of the Urinary Bladder in a Middle-Aged Man-A Case Report of an Unusual Localization of a Rare Tumour.
    Medicina (Kaunas). 2023;59:791.
    Abstract     Related articles   

  885. LUO HL, Chang YL, Liu HY, Wu YT, et al
    VCAN Hypomethylation and Expression as Predictive Biomarkers of Drug Sensitivity in Upper Urinary Tract Urothelial Carcinoma.
    Int J Mol Sci. 2023;24:7486.
    Abstract     Related articles   

  886. QIAO L, Zhang L, Wang H
    SPAG9 Expression Predicts Good Prognosis in Patients with Clear-Cell Renal Cell Carcinoma: A Bioinformatics Analysis with Experimental Validation.
    Genes (Basel). 2023;14:944.
    Abstract     Related articles   

  887. KHANJANI N, Moradabadi A, Najafi E, Hayati B, et al
    Geographic variation in urinary tract and genital cancers in Iran: a hypothesis involving exposure to solar radiation.
    BMC Res Notes. 2023;16:65.
    Abstract     Related articles   

  888. XIAO XY, Zhao H, Guo HQ, Wang C, et al
    [Tumor cell-based glycolytic metabolism and single-cell sequencing of urinary exfoliated cells for the diagnosis and molecular profiling of urothelial carcinoma].
    Zhonghua Bing Li Xue Za Zhi. 2023;52:472-479.
    Abstract     Related articles   

  889. ALTINTAS TASLICAY C, Sivrioglu AK
    Urinary Bladder Masslike Lesions.
    Radiographics. 2023;43:e230012.
    Abstract     Related articles   

  890. FARAG CM, Akosman S, Luu J, Haji-Momenian S, et al
    Hemoglobin, Albumin, Lymphocyte, and Platelet Count is a Significant Biomarker Surrogate for Nutritional Status to Predict Overall Survival in Patients Post-radical Cystectomy.
    Urol Pract. 2023;10:262-269.
    Abstract     Related articles   

  891. SHU TD, Prunty MC, Pominville R, Omil-Lima D, et al
    Bladder and Kidney Cancer Diagnosis and Survival Increase With Medicare Eligibility at Age 65.
    Urol Pract. 2023;10:59-65.
    Abstract     Related articles   

  892. ALTINTAS TASLICAY C, Cam I, Civriz AH, Kara O, et al
    18F-FDG PET-Positive Large Pelvic Granuloma Mimicking Malignant Bladder Tumor.
    Clin Nucl Med. 2023 Apr 25. doi: 10.1097/RLU.0000000000004676.
    Abstract     Related articles   

  893. JACKSON-SPENCE F, Toms C, O'Mahony LF, Choy J, et al
    IMvigor011: a study of adjuvant atezolizumab in patients with high-risk MIBC who are ctDNA+ post-surgery.
    Future Oncol. 2023;19:509-515.
    Abstract     Related articles   

  894. BAJORIN DF, Witjes JA, Gschwend JE, Schenker M, et al
    Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): a plain language summary.
    Future Oncol. 2023;19:413-426.
    Abstract     Related articles   

  895. GRIVAS P, Veeranki P, Chiu K, Pawar V, et al
    Preferences for first-line treatment of advanced urothelial carcinoma among US practicing oncologists and patients.
    Future Oncol. 2023;19:369-383.
    Abstract     Related articles   

  896. GUZMAN SJ, Kleinschmidt-DeMasters BK
    Urothelial carcinoma metastases impacting the CNS: A 20-year retrospective series.
    Ann Diagn Pathol. 2023;64:152109.
    Abstract     Related articles   

  897. PEREZ-AIZPURUA X, Monzo-Gardiner JI, Maqueda-Arellano J, Buendia-Gonzalez E, et al
    BCG shortage for intravesical instillation is associated with early tumoral recurrence in patients with high-risk non-muscle invasive bladder tumours.
    Actas Urol Esp (Engl Ed). 2023;47:250-258.
    Abstract     Related articles   

  898. VARADI M, Nagy N, Reis H, Hadaschik B, et al
    Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas.
    Cancer Med. 2023;12:9041-9054.
    Abstract     Related articles   

  899. JIANG Y, Peng Y, Ding S, Zheng Y, et al
    Kidney-sparing surgery for distal high-risk ureteral carcinoma: Clinical efficacy and preliminary experiences in 22 patients.
    Cancer Med. 2023;12:7835-7843.
    Abstract     Related articles   

  900. XU YK, Bai J
    Multiple urinary bladder tumors: A case report.
    Asian J Surg. 2023;46:2221-2222.
    Abstract     Related articles   

  901. DOMINGUEZ GARCIA A, Munoz Rodriguez J, Prats Lopez J, Almirall Daly J, et al
    Metabolic acidosis after ileal urinary diversion and radical cystectomy. Do we know as much as we think we do? A systematic review.
    Actas Urol Esp (Engl Ed). 2023;47:195-210.
    Abstract     Related articles   

  902. TERRITO A, Fontanet S, Meneghetti I, Gallioli A, et al
    Management of primary upper urinary tract carcinoma in situ diagnosed by ureteroscopic biopsy: Is bacillus Calmette-Guerin an alternative to nephroureterectomy?
    Actas Urol Esp (Engl Ed). 2023;47:221-228.
    Abstract     Related articles   

  903. ALLAEYS C, De Backer P, Decaestecker K, Berquin C, et al
    Peritoneal tuberculosis caused by intravesical instillation with Bacillus Calmette-Guerin (BCG) following nephroureterectomy in a patient with bladder and upper tract urothelial cancer: a case report.
    Acta Clin Belg. 2023;78:257-260.
    Abstract     Related articles   

  904. TANG YC, Yang CS, Liang MX, Zhang Y, et al
    Development and evaluation of an adenosine-to-inosine RNA editing-based prognostic model for survival prediction of bladder cancer patients.
    Medicine (Baltimore). 2023;102:e33719.
    Abstract     Related articles   

  905. SEILER R, Egger M, De Menna M, Wehrli S, et al
    Guidance of adjuvant instillation in intermediate-risk non-muscle invasive bladder cancer by drug screens in patient derived organoids: a single center, open-label, phase II trial.
    BMC Urol. 2023;23:89.
    Abstract     Related articles   

  906. ZHANG B, Liu T, He Y, Han D, et al
    Clinical application and efficacy analysis of partial cystectomy combined with intravesical chemotherapy in muscle-invasive bladder cancer.
    BMC Urol. 2023;23:91.
    Abstract     Related articles   

  907. ZHENG Y, Wang X, Yang X, Xing N, et al
    Single-cell RNA sequencing reveals the cellular and molecular characteristics of high-grade and metastatic bladder cancer.
    Cell Oncol (Dordr). 2023 May 11. doi: 10.1007/s13402-023-00820.
    Abstract     Related articles   

  908. NURMINEN P, Nummi A, Kesti O, Ettala O, et al
    Comparison of Bacillus Calmette-Guerin Maintenance Therapy with Monthly Instillations and the Southwest Oncology Group Protocol in the Treatment of Non-muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2023 May 9:S2405-4569(23)00110-4. doi: 10.1016/j.euf.2023.
    Abstract     Related articles   

  909. KENNELLEY GE, Amaye-Obu T, Foster BA, Tang L, et al
    Mechanistic review of sulforaphane as a chemoprotective agent in bladder cancer.
    Am J Clin Exp Urol. 2023;11:103-120.
    Abstract     Related articles   

  910. BAZARGANI S, Lall C, Gopireddy DR, Liu S, et al
    Extramural venous invasion: a novel magnetic resonance imaging biomarker for adverse pathology in bladder cancer.
    Am J Clin Exp Urol. 2023;11:185-193.
    Abstract     Related articles   

  911. ZHANG S, Li L, Yu P, Wu C, et al
    A deep learning model for drug screening and evaluation in bladder cancer organoids.
    Front Oncol. 2023;13:1064548.
    Abstract     Related articles   

  912. OHTSU A, Arai S, Fujizuka Y, Fukuda R, et al
    Retroperitoneal urothelial carcinoma arising after bladder diverticulectomy: a case report.
    BMC Urol. 2023;23:88.
    Abstract     Related articles   

  913. HINDERBERGER P, Winters N
    Mistletoe for Bladder Cancer: Call for More Case Reports Using the Intravesical Route.
    Altern Ther Health Med. 2023;29:18-19.
    Abstract     Related articles   

  914. TIAN G, Li Y, Nie L, Liu S, et al
    Cervical lymph node metastasis of bladder cancer: a case report and review of literature.
    Aging Male. 2023;26:2205935.
    Abstract     Related articles   

  915. JIANG T, Jin P, Huang G, Li SC, et al
    The function of guanylate binding protein 3 (GBP3) in human cancers by pan-cancer bioinformatics.
    Math Biosci Eng. 2023;20:9511-9529.
    Abstract     Related articles   

  916. YU J, Lee J, Ha S, Baek JW, et al
    Impact of Chart-Derived Frailty Index on 1-Year Mortality After Radical Cystectomy in 1004 Patients with Bladder Cancer.
    Ann Surg Oncol. 2023 May 9. doi: 10.1245/s10434-023-13565.
    Abstract     Related articles   

  917. WANG L, Huang S, Zhang P, Li H, et al
    The application of gemcitabine and pirarubicin in patients with non-muscle invasive bladder cancer.
    J Cancer Res Clin Oncol. 2023 May 9. doi: 10.1007/s00432-023-04739.
    Abstract     Related articles   

  918. HAJEBRAHIMI S, Talebpour A, Kabiri N, Ahmadian N, et al
    Promoting post-discharge telephone follow-up of patients with transurethral resection for bladder cancer: a best practice implementation project.
    JBI Evid Implement. 2023 May 10. doi: 10.1097/XEB.0000000000000374.
    Abstract     Related articles   

  919. REN L, Yang X, Liu J, Wang W, et al
    An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.
    Cancer Cell Int. 2023;23:85.
    Abstract     Related articles   

  920. LUO Y, Zhang Y, Pang S, Min J, et al
    PCBP1 protects bladder cancer cells from mitochondria injury and ferroptosis by inducing LACTB mRNA degradation.
    Mol Carcinog. 2023 May 8. doi: 10.1002/mc.23533.
    Abstract     Related articles   

  921. MOU Z, Chen Y, Zhang Z, Chen X, et al
    Cryoablation inhibits the recurrence and progression of bladder cancer by enhancing tumour-specific immunity.
    Clin Transl Med. 2023;13:e1255.
    Abstract     Related articles   

  922. ABUGOMAA A, Elbadawy M, Ishihara Y, Yamamoto H, et al
    Anti-cancer activity of Chaga mushroom (Inonotus obliquus) against dog bladder cancer organoids.
    Front Pharmacol. 2023;14:1159516.
    Abstract     Related articles   

  923. SHEN J, Hou H, Liang B, Guo X, et al
    Effect of renin-angiotensin-aldosterone system inhibitors on survival outcomes in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
    Front Immunol. 2023;14:1155104.
    Abstract     Related articles   

  924. DU Y, Liu Y, Cao J, Jiang X, et al
    LDL receptor related protein 1 is an adverse prognostic biomarker that correlates with stromal remodeling and macrophages infiltration in bladder cancer.
    Front Immunol. 2023;14:1113756.
    Abstract     Related articles   

  925. ZHAO S, Wang L, Ding W, Ye B, et al
    Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework.
    Front Endocrinol (Lausanne). 2023;14:1180404.
    Abstract     Related articles   

  926. ANWAR M, Ejaz M, Ijaz M, Ahmad G, et al
    Association of IL-17A promoter region SNP-rs2275913 with urinary bladder cancer.
    Int J Health Sci (Qassim). 2023;17:33-38.
    Abstract     Related articles   

  927. REVESZ J, Posfai B, Pajor L, Papdan T, et al
    Correlation between fibroblast growth factor receptor mutation, programmed death ligand-1 expression and survival in urinary bladder cancer based on real-world data.
    Pathol Oncol Res. 2023;29:1611077.
    Abstract     Related articles   

  928. WANG H, Gao Y, Qin L, Zhang M, et al
    Identification of a novel de novo mutation of SETBP1 and new findings of SETBP1 in tumorgenesis.
    Orphanet J Rare Dis. 2023;18:107.
    Abstract     Related articles   

  929. LORENZO JF, Lopez Arquillo IM, Rey JV
    Primary aortoenteric fistula after intravesical instillation of Bacillus Calmette-Guerin for bladder cancer.
    Vascular. 2023 May 6:17085381231174923. doi: 10.1177/17085381231174923.
    Abstract     Related articles   

  930. NAIK M, Rao BV, Challa S, Fonseca D, et al
    Utility of GATA-3 and associated immunohistochemical markers in the differential diagnosis of poorly differentiated urothelial carcinoma.
    J Cancer Res Ther. 2023;19.
    Abstract     Related articles   

  931. AHMAD U, Abdullah S, Chau M, Chia SL, et al
    Analysis of PPI networks of transcriptomic expression identifies hub genes associated with Newcastle disease virus persistent infection in bladder cancer.
    Sci Rep. 2023;13:7323.
    Abstract     Related articles   

  932. CZECH AK, Gronostaj K, Fronczek J, Frydrych J, et al
    Diagnostic accuracy of bimanual palpation in bladder cancer patients undergoing cystectomy: A prospective study.
    Urol Oncol. 2023 May 3:S1078-1439(23)00122-9. doi: 10.1016/j.urolonc.2023.
    Abstract     Related articles   

  933. HSIEH TY, Sung WW, Chang YC, Yu CY, et al
    Melatonin induces cell cycle arrest and suppresses tumor invasion in urinary bladder urothelial carcinoma.
    Aging (Albany NY). 2023;15:3107-3119.
    Abstract     Related articles   

  934. JANA S, Brahma S, Arora S, Wladyka CL, et al
    Transcriptional-translational conflict is a barrier to cellular transformation and cancer progression.
    Cancer Cell. 2023;41:853-870.
    Abstract     Related articles   

  935. BOLENZ C, Zengerling F
    [Neoadjuvant chemotherapy in patients with high-risk upper tract urothelial carcinoma: current evidence].
    Urologie. 2023;62:522-524.
    Abstract     Related articles   

  936. DAVIS D, Seely D, Morash C, Armstrong J, et al
    Complete Remission of BCG-Refractory High-grade Bladder CIS with Pharmacologic Ascorbate and Mistletoe.
    Altern Ther Health Med. 2023;29:6-17.
    Abstract     Related articles   

  937. ROUPRET M, Brouquet A, Colrat F, Diez-Andreu P, et al
    Population characteristics, management, and survival outcomes in muscle-invasive urothelial carcinoma undergoing radical resection: the MINOTAUR study.
    World J Urol. 2023;41:1069-1075.
    Abstract     Related articles   

  938. VAN WIJNGAARDEN C, Bus MTJ, Ruiter AEC, Lagerveld BW, et al
    A 6-month maintenance schedule of mitomycin C after radical nephroureterectomy for upper tract urothelial carcinoma for the prevention of intravesical recurrence: a retrospective, single center study.
    World J Urol. 2023;41:1077-1083.
    Abstract     Related articles   

  939. DENG Y, Fu Y, Chua SL, Khoo BL, et al
    Biofilm Potentiates Cancer-Promoting Effects of Tumor-Associated Macrophages in a 3D Multi-Faceted Tumor Model.
    Small. 2023;19:e2205904.
    Abstract     Related articles   

  940. KE C, Hu Z, Yang C
    Preoperative accuracy of diagnostic evaluation of urachal carcinoma.
    Cancer Med. 2023;12:9106-9115.
    Abstract     Related articles   

  941. MORI K, Yanagisawa T, Katayama S, Laukhtina E, et al
    Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis.
    World J Urol. 2023;41:909-919.
    Abstract     Related articles   

  942. DICKMAN KG, Chen CH, Grollman AP, Pu YS, et al
    Aristolochic acid-containing Chinese herbal medicine and upper urinary tract urothelial carcinoma in Taiwan: a narrative review.
    World J Urol. 2023;41:899-907.
    Abstract     Related articles   

  943. MURTHY V, Maitre P, Singh M, Pal M, et al
    Study Protocol of the Bladder Adjuvant RadioTherapy (BART) Trial: A Randomised Phase III Trial of Adjuvant Radiotherapy Following Cystectomy in Bladder Cancer.
    Clin Oncol (R Coll Radiol). 2023 May 5:S0936-6555(23)00178.
    Abstract     Related articles   

  944. YANG Y, Bai Y, Wang X, Guo Y, et al
    Clock gene NR1D1 might be a novel target for the treatment of bladder cancer.
    Urol Oncol. 2023 May 18:S1078-1439(23)00141.
    Abstract     Related articles   

  945. KUSMARTSEV S, Ku JH, Grizzi F
    Editorial: Tumor microenvironment in bladder cancer.
    Front Oncol. 2023;13:1208196.
    Abstract     Related articles   

  946. WANG Y, Xie K, Chen W, Fang Y, et al
    Synergistic ferroptosis-starvation therapy for bladder cancer based on hyaluronic acid modified metal-organic frameworks.
    Bioeng Transl Med. 2023;8:e10515.
    Abstract     Related articles   

  947. WEINBERG MS, Zafar A, Magdamo C, Chung SY, et al
    Association of BCG Vaccine Treatment With Death and Dementia in Patients With Non-Muscle-Invasive Bladder Cancer.
    JAMA Netw Open. 2023;6:e2314336.
    Abstract     Related articles   

  948. CHANTAPRASOPSUK S, Rees-Punia E, Patel AV
    Physical activity, obesity, and bladder cancer incidence.
    Cancer Causes Control. 2023 May 18. doi: 10.1007/s10552-023-01711.
    Abstract     Related articles   

  949. DAVARO F, Jain R, Li R
    Immune Checkpoint Inhibitor Toxicity Management in Non-muscle-invasive Bladder Cancer: What Urologists Need To Know.
    Eur Urol Focus. 2023 May 16:S2405-4569(23)00109.
    Abstract     Related articles   

  950. REN D, Li L, Wang S, Zuo Y, et al
    The c-MYC transcription factor conduces to resistance to cisplatin by regulating MMS19 in bladder cancer cells.
    Tissue Cell. 2023;82:102096.
    Abstract     Related articles   

  951. ZHAO F, Yang T, Zhou L, Li R, et al
    Sig1R activates extracellular matrix-induced bladder cancer cell proliferation and angiogenesis by combing beta-integrin.
    Aging (Albany NY). 2023;15.
    Abstract     Related articles   

  952. WARRICK JI, Al-Ahmadie H, Berman DM, Black PC, et al
    International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4: Molecular Subtypes of Bladder Cancer-Principles of Classification and Emerging Clinical Utility.
    Am J Surg Pathol. 2023 May 18. doi: 10.1097/PAS.0000000000002053.
    Abstract     Related articles   

  953. WANG J, Shi H, Fan Z, Yang J, et al
    Prognostic nutritional index combined with NLR to construct a survival prediction model and decision analysis of patients with muscle-invasive bladder cancer after surgery.
    Cancer Med. 2023 May 18. doi: 10.1002/cam4.6088.
    Abstract     Related articles   

  954. DAS S, Gu L, Eve CT, Parrish J, et al
    The Impact of Blue Light Cystoscopy Use Among Nonmuscle Invasive Bladder Cancer Patients in an Equal Access Setting: Implications on Recurrence and Time to Recurrence.
    Clin Genitourin Cancer. 2023 Apr 28:S1558-7673(23)00098.
    Abstract     Related articles   

  955. HEINZELBECKER J, Spieler N, Kuehn M, Fischer C, et al
    Adjuvant vs. progression-triggered treatment with gemcitabine in platinum-ineligible high-risk bladder cancer patients: Long-term follow-up of a randomized phase 3 trial.
    Urol Oncol. 2023 May 15:S1078-1439(23)00134.
    Abstract     Related articles   

  956. ZHANG C, Xiao J, Yuan T, He Y, et al
    Molecular vasculogenic mimicry-Related signatures predict clinical outcomes and therapeutic responses in bladder cancer: Results from real-world cohorts.
    Front Pharmacol. 2023;14:1163115.
    Abstract     Related articles   

  957. SHADAB R, Nerli RB, Bidi SR, Ghagane SC, et al
    Risk Factors for Bladder Cancer: Results of a Survey of Hospital Patients.
    J Cancer Allied Spec. 2023;9:485.
    Abstract     Related articles   

  958. KIMURA T, Ishikawa H, Nagumo Y, Sekino Y, et al
    Efficacy and safety of Bladder Preservation Therapy in combination with Atezolizumab and Radiation Therapy (BPT-ART) for invasive bladder cancer: Interim analysis from a multicenter, open-label, prospective phase II trial.
    Int J Radiat Oncol Biol Phys. 2023 May 15:S0360-3016(23)00461.
    Abstract     Related articles   

  959. LIN J, Zhan X, Chen R, Chen T, et al
    Increased Burden of Second Bladder Cancer and Rectal Cancer in Prostate Cancer Treated With Radiotherapy: Results From Surveillance, Epidemiology, and End Results.
    Cancer Control. 2023;30:10732748231177544.
    Abstract     Related articles   

  960. BOU ZERDAN M, Bratslavsky G, Jacob J, Ross J, et al
    Urothelial Bladder Cancer: Genomic Alterations in Fibroblast Growth Factor Receptor.
    Mol Diagn Ther. 2023 May 17. doi: 10.1007/s40291-023-00647.
    Abstract     Related articles   

  961. VAN STRATEN CGJI, Bruins MH, Dijkstra S, Cornel EB, et al
    The accuracy of cystoscopy in predicting muscle invasion in newly diagnosed bladder cancer patients.
    World J Urol. 2023 May 17. doi: 10.1007/s00345-023-04428.
    Abstract     Related articles   

  962. CELIK S, Gokbayrak O, Erol A, Yorukoglu K, et al
    Anna Karenina principle in personalized treatment of bladder cancer according to oncogram: which drug for which patient?
    Per Med. 2023 May 17. doi: 10.2217/pme-2022-0134.
    Abstract     Related articles   

  963. STRAUSS D, Kaplunov B, Kutikov A, Geynisman DM, et al
    Between the Hammer and Anvil: Resolution of unresectable muscle invasive bladder cancer in a renal transplant patient after cessation of immunosuppressive therapy.
    Urol Case Rep. 2023;48:102399.
    Abstract     Related articles   

  964. AN MH, Kim MS, Kim C, Noh TI, et al
    Association of 5alpha-Reductase Inhibitor Prescription With Bladder Cancer Progression in Males in South Korea.
    JAMA Netw Open. 2023;6:e2313667.
    Abstract     Related articles   

  965. RELOUW S, Dugbartey GJ, Sener A
    Non-Invasive Imaging Modalities in Intravesical Murine Models of Bladder Cancer.
    Cancers (Basel). 2023;15:2381.
    Abstract     Related articles   

  966. LEDDEROSE S, Rodler S, Eismann L, Ledderose G, et al
    P2X1 and P2X7 Receptor Overexpression Is a Negative Predictor of Survival in Muscle-Invasive Bladder Cancer.
    Cancers (Basel). 2023;15:2321.
    Abstract     Related articles   

  967. EL AZZOUZI M, El Ahanidi H, Hafidi Alaoui C, Chaoui I, et al
    The Evaluation of Vascular Endothelial Growth Factor A (VEGFA) and VEGFR2 Receptor as Prognostic Biomarkers in Bladder Cancer.
    Diagnostics (Basel). 2023;13:1471.
    Abstract     Related articles   

  968. LI X, Li L, Xiong X, Kuang Q, et al
    Identification of the Prognostic Biomarkers CBX6 and CBX7 in Bladder Cancer.
    Diagnostics (Basel). 2023;13:1393.
    Abstract     Related articles   

  969. VANEMAN J, van Beekhuizen HJ, Boormans JL, Ewing-Graham PC, et al
    Pelvic lymph node dissection for cervical or bladder cancer: embedding residual fat tissue offers no added value.
    Virchows Arch. 2023 May 15. doi: 10.1007/s00428-023-03559.
    Abstract     Related articles   

  970. LINDSKROG SV, Schmokel SS, Nordentoft I, Lamy P, et al
    Single-nucleus and Spatially Resolved Intratumor Subtype Heterogeneity in Bladder Cancer.
    Eur Urol Open Sci. 2023;51:78-88.
    Abstract     Related articles   

  971. VON DEIMLING M, Mertens LS, van Rhijn BWG, Lotan Y, et al
    Carboplatin Induction Chemotherapy in Clinically Lymph Node-positive Bladder Cancer.
    Eur Urol Open Sci. 2023;51:39-46.
    Abstract     Related articles   

  972. ZLOTTA AR, Ballas LK, Niemierko A, Lajkosz K, et al
    Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.
    Lancet Oncol. 2023 May 12:S1470-2045(23)00170.
    Abstract     Related articles   

  973. ARAYA M, Ishikawa H, Nishioka K, Maruo K, et al
    Proton beam therapy for muscle-invasive bladder cancer: A systematic review and analysis with Proton-Net, a multicenter prospective patient registry database.
    J Radiat Res. 2023 Apr 25:rrad027. doi: 10.1093.
    Abstract     Related articles   

  974. BLOUDEK L, Wright P, McKay C, Derleth CL, et al
    Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of First-Line Therapies (1L) for Locally Advanced/Metastatic Urothelial Carcinoma (la/mUC).
    Curr Oncol. 2023;30:3637-3647.
    Abstract     Related articles   

  975. YU J, Lee J, Ha S, Baek JW, et al
    ASO Visual Abstract: Impact of Chart-Derived Frailty Index (CFI) on 1-Year Mortality After Radical Cystectomy in 1004 Patients with Bladder Cancer.
    Ann Surg Oncol. 2023 May 15. doi: 10.1245/s10434-023-13618.
    Abstract     Related articles   


  976. Chen, Y, Zhang, W, Kadier, A, Zhang, H, Yao, X. MicroRNA-769-5p suppresses cell growth and migration via targeting NUSAP1 in bladder cancer. J Clin Lab Anal. 2020; 34:e23193.
    J Clin Lab Anal. 2023 May 14:e24893. doi: 10.1002/jcla.24893.
    Abstract     Related articles   

  977. ISHII M, Yamamoto Y, Yoshimura A, Hayashi T, et al
    [A Case of Primary Signet Ring Cell Carcinoma of the Urinary Bladder Showing Effectiveness of Chemotherapy with Gemcitabine and Cisplatin].
    Hinyokika Kiyo. 2023;69:107-112.
    Abstract     Related articles   

  978. HU B, Chen R, Jiang M, Xiong S, et al
    EIF4A3 serves as a prognostic and immunosuppressive microenvironment factor and inhibits cell apoptosis in bladder cancer.
    PeerJ. 2023;11:e15309.
    Abstract     Related articles   

  979. GU L, Guo H, Wu LX, Yuan JB, et al
    Prognostic analysis and validation of lncRNAs in bladder cancer on the basis of neutrophil extracellular traps.
    J Gene Med. 2023 May 13:e3525. doi: 10.1002/jgm.3525.
    Abstract     Related articles   

  980. GUDOWSKA-SAWCZUK M, Kudelski J, Olkowicz M, Mlynarczyk G, et al
    The Clinical Significance of Serum Free Light Chains in Bladder Cancer.
    J Clin Med. 2023;12:3294.
    Abstract     Related articles   

  981. MALKIEWICZ B, Jedrzejuk D, Gurwin A, Wilk K, et al
    Diagnostic Value of the Sentinel Lymph Node Technique in Patients with Muscle-Invasive Bladder Cancer.
    J Clin Med. 2023;12:3092.
    Abstract     Related articles   

  982. RYU D, Kim TM, Lee YH, Ha US, et al
    Longitudinal Analyses of Mutational Subclonal Architecture and Tumor Subtypes in Recurrent Bladder Cancer.
    Int J Mol Sci. 2023;24:8418.
    Abstract     Related articles   

  983. SZYDLAK R, Ovreeide IH, Luty M, Zielinski T, et al
    Bladder Cancer Cells Interaction with Lectin-Coated Surfaces under Static and Flow Conditions.
    Int J Mol Sci. 2023;24:8213.
    Abstract     Related articles   

  984. PACKEISER EM, Engels L, Nolte I, Goericke-Pesch S, et al
    MDR1 Inhibition Reverses Doxorubicin-Resistance in Six Doxorubicin-Resistant Canine Prostate and Bladder Cancer Cell Lines.
    Int J Mol Sci. 2023;24:8136.
    Abstract     Related articles   

  985. GANDIN V, Hoeschele JD, Margiotta N
    Special Issue "Cisplatin in Cancer Therapy: Molecular Mechanisms of Action 3.0".
    Int J Mol Sci. 2023;24:7917.
    Abstract     Related articles   

  986. KUBIK A, das Virgens IPA, Szabo A, Varadi M, et al
    Comprehensive Analysis of the Prognostic Value of Circulating MMP-7 Levels in Urothelial Carcinoma: A Combined Cohort Analysis, Systematic Review, and Meta-Analysis.
    Int J Mol Sci. 2023;24:7859.
    Abstract     Related articles   

  987. GRANT SR, Tang L, Wei L, Foster BA, et al
    Mutation Hotspots Found in Bladder Cancer Aid Prediction of Carcinogenic Risk in Normal Urothelium.
    Int J Mol Sci. 2023;24:7852.
    Abstract     Related articles   

  988. MIYAKE M, Nishimura N, Ohnishi S, Oda Y, et al
    Diagnostic and Prognostic Roles of Urine Nectin-2 and Nectin-4 in Human Bladder Cancer.
    Cancers (Basel). 2023;15:2565.
    Abstract     Related articles   

  989. NIE Z, Gao Y, Chen M, Peng Y, et al
    Genome-Wide Screening Identifies Gene AKR1C1 Critical for Resistance to Pirarubicin in Bladder Cancer.
    Cancers (Basel). 2023;15:2487.
    Abstract     Related articles   

  990. WANG Z, Zhao C, Li Y, Wang J, et al
    Photostable Cascade Activatable Peptide Self-assembly on a Cancer Cell Membrane for High-Performance Identification of Human Bladder Cancer.
    Adv Mater. 2023 May 12:e2210732. doi: 10.1002/adma.202210732.
    Abstract     Related articles   

  991. LI TY, Zhang B, Zhang J
    A case report and literature review on primary solitary fibrous tumor of the bladder.
    Medicine (Baltimore). 2023;102:e33708.
    Abstract     Related articles   

  992. HABIL MR, Hein DW
    Effects of dose and human N-acetyltransferase 1 genetic polymorphism in benzidine metabolism and genotoxicity.
    Arch Toxicol. 2023;97:1765-1772.
    Abstract     Related articles   

  993. PENG L, Mehmud I, Meng C, Tang D, et al
    ASO Author Reflections: Comparison of Perioperative Outcomes and Complications of Laparoscopic and Robotic Nephroureterectomy Approaches in Patients with Upper-Tract Urothelial Carcinoma.
    Ann Surg Oncol. 2023;30:3817-3818.
    Abstract     Related articles   

  994. EGGER V, Hutterer GC, Mischinger J, Seles M, et al
    Preoperative fibrinogen/CRP score predicts survival in upper urothelial tract carcinoma patients undergoing radical curative surgery.
    World J Urol. 2023;41:1359-1364.
    Abstract     Related articles   

  995. LEE JL, Desai C, Park SH, Tsuchiya N, et al
    Avelumab first-line maintenance plus best supportive care (BSC) vs. BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Asian subgroup analysis.
    Urol Oncol. 2023;41:256.
    Abstract     Related articles   

  996. BUSETTO GM, Finati M, Chirico M, Cinelli F, et al
    Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle?
    World J Urol. 2023;41:1329-1335.
    Abstract     Related articles   

  997. KOTERAZAWA S, Somiya S, Ito K, Haitani T, et al
    The efficacy of ultrasonography for the detection of upper tract urothelial carcinoma.
    J Med Ultrason (2001). 2023;50:197-203.
    Abstract     Related articles   

  998. PYCHA S, Trenti E, Mian C, Schwienbacher C, et al
    Diagnostic value of Xpert(R) BC Detection, Bladder Epicheck(R), Urovysion(R) FISH and cytology in the detection of upper urinary tract urothelial carcinoma.
    World J Urol. 2023;41:1323-1328.
    Abstract     Related articles   

  999. PENG L, Mehmud I, Meng C, Tang D, et al
    ASO Visual Abstract: Comparison of Perioperative Outcomes and Complications of Laparoscopic and Robotic Nephroureterectomy Approaches in Patients with Upper-Tract Urothelial Carcinoma.
    Ann Surg Oncol. 2023;30:3819.
    Abstract     Related articles   

  1000. PENG L, Mehmud I, Meng C, Tang D, et al
    Comparison of Perioperative Outcomes and Complications of Laparoscopic and Robotic Nephroureterectomy Approaches in Patients with Upper-Tract Urothelial Carcinoma.
    Ann Surg Oncol. 2023;30:3805-3816.
    Abstract     Related articles   

  1001. PARIMI V, Choi W, Feng M, Fong M, et al
    Comparison of clinicopathological characteristics, gene expression profiles, mutational analysis, and clinical outcomes of pure and mixed small-cell carcinoma of the bladder.
    Histopathology. 2023;82:991-1002.
    Abstract     Related articles   

  1002. JIN J, Li J, Peng C, Chen J, et al
    Case report: durable complete response to pembrolizumab plus lenvatinib in a metastatic upper tract urothelial carcinoma patient with high tumor mutational burden and an immune-active tumor microenvironment.
    Anticancer Drugs. 2023;34:797-802.
    Abstract     Related articles   

  1003. ROUMIGUIE M, Wong A, Belanger E, Wang G, et al
    Detection and resection of carcinoma in situ of the bladder: Implications for clinical trial design.
    Urol Oncol. 2023;41:254.
    Abstract     Related articles   

  1004. MIURA H, Hatakeyama S, Tanaka T, Fujita N, et al
    Oncological and functional outcomes of female reproductive organ-sparing radical cystectomy and ileal neobladder construction.
    Urol Oncol. 2023;41:254.
    Abstract     Related articles   

  1005. MORTON E, Kaul S, Fleishman A, Korets R, et al
    Urothelial carcinoma of the bladder with isolated lymph node metastasis: Natural history and outcomes following surgical resection.
    Urol Oncol. 2023;41:255.
    Abstract     Related articles   

  1006. MAISCH P, Koll F, Bolenz C, Chun FK, et al
    Combination of radiation and immunotherapy in the treatment of genitourinary malignancies: A systematic review and meta-analysis.
    Urol Oncol. 2023;41:219-232.
    Abstract     Related articles   

  1007. KUCKUCK EC, Hennenlotter J, Todenhofer T, Brunn LA, et al
    Discriminative capacity of guideline recommendations in the assessment of patients with asymptomatic microhematuria.
    Urol Oncol. 2023;41:254.
    Abstract     Related articles   

  1008. NEUMANN I, Borrelli M, Al Kallaa M, Parker RT, et al
    Rare periorbital, pseudocystic metastasis of squamous cell carcinoma of the bladder: Case report and review of the literature.
    Orbit. 2023;42:336-342.
    Abstract     Related articles   

  1009. TYAGI P, Moon CH, Connell M, Ganguly A, et al
    Intravesical Contrast-Enhanced MRI: A Potential Tool for Bladder Cancer Surveillance and Staging.
    Curr Oncol. 2023;30:4632-4647.
    Abstract     Related articles   

  1010. BITAM S, Hamadache M, Hanini S
    Targeting bladder cancer with Trigonella foenum-graecum: a computational study using network pharmacology and molecular docking.
    J Biomol Struct Dyn. 2023 May 26:1-8. doi: 10.1080/07391102.2023.2217926.
    Abstract     Related articles   

  1011. ZHAO J, Li J, Zhang R
    Off the fog to find the optimal choice: Research advances in biomarkers for early diagnosis and recurrence monitoring of bladder cancer.
    Biochim Biophys Acta Rev Cancer. 2023 May 23:188926.
    Abstract     Related articles   

  1012. LI W, Wang Z, Jiang Z, Yan Y, et al
    MiR-3960 inhibits bladder cancer progression via targeting of DEXI.
    Biochem Biophys Res Commun. 2023;668:8-18.
    Abstract     Related articles   

  1013. OSSOLINSKI K, Ruman T, Copie V, Tripet BP, et al
    Targeted and untargeted urinary metabolic profiling of bladder cancer.
    J Pharm Biomed Anal. 2023;233:115473.
    Abstract     Related articles   

  1014. WIRTZ HS, Hepp Z, Grewal S, Wright P, et al
    Health care resource utilization, quality metrics, and costs of bladder cancer within the Oncology Care Model.
    Am J Manag Care. 2023;29:e136-e142.
    Abstract     Related articles   

  1015. BENABDALLAH W, Ben Othmane M, Ouahchi I, Mestiri S, et al
    Plasmacytoid bladder cancer: a rare case report.
    Ann Med Surg (Lond). 2023;85:1885-1887.
    Abstract     Related articles   

  1016. MIRTO BF, Scafuri L, Sicignano E, Luca C, et al
    Nature's hidden gem: quercitrin's promising role in preventing prostate and bladder cancer.
    Future Sci OA. 2023;9:FSO867.
    Abstract     Related articles   

  1017. BAUDEWYNS A, Jabbour T, Bourgeno HA, Peltier A, et al
    Late-onset enteric fistula following radical cystectomy for bladder cancer: A case report.
    Urol Case Rep. 2023;49:102431.
    Abstract     Related articles   

  1018. HRBACEK J, Hanacek V, Kadleckova D, Cirbusova A, et al
    Urinary shedding of common DNA viruses and their possible association with bladder cancer: a qPCR-based study.
    Neoplasma. 2023;70:311-318.
    Abstract     Related articles   

  1019. UCHIDA H, Obinata D, Takada S, Yoshizawa T, et al
    Real-world retrospective review of monotherapy following platinum-based chemotherapy for metastatic urothelial cancer.
    J Int Med Res. 2023;51:3000605231173319.
    Abstract     Related articles   

  1020. MAAS M, Todenhofer T, Black PC
    Urine biomarkers in bladder cancer - current status and future perspectives.
    Nat Rev Urol. 2023 May 24. doi: 10.1038/s41585-023-00773.
    Abstract     Related articles   

  1021. HUDDART R, Hafeez S, Omar A, Alonzi R, et al
    Acute Toxicity of Hypofractionated and Conventionally Fractionated (Chemo)Radiotherapy Regimens for Bladder Cancer: An Exploratory Analysis from the RAIDER Trial.
    Clin Oncol (R Coll Radiol). 2023 May 9:S0936-6555(23)00180.
    Abstract     Related articles   

  1022. JOHANNSEN M, Klier J, Konig F, Schonfelder R, et al
    [National Registries for Urothelial Cancer (UroNAT) and Prostate Cancer (ProNAT) by d-uo].
    Aktuelle Urol. 2023;54:202-207.
    Abstract     Related articles   

  1023. DOEHN C, Johannsen M, Eichenauer R, Klier J, et al
    [The cancer registry notification seen from the perspective of the German Society of Uro-Oncologists (d-uo)].
    Aktuelle Urol. 2023;54:189-195.
    Abstract     Related articles   


  1024. [Not Available].
    Aktuelle Urol. 2023;54:185.
    Abstract     Related articles   

  1025. DE JONG FC, Laajala TD, Hoedemaeker RF, Jordan KR, et al
    Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guerin.
    Sci Transl Med. 2023;15:eabn4118.
    Abstract     Related articles   

  1026. DENG Z, Dong W, Xiong S, Jin D, et al
    Machine learning models combining computed tomography semantic features and selected clinical variables for accurate prediction of the pathological grade of bladder cancer.
    Front Oncol. 2023;13:1166245.
    Abstract     Related articles   

  1027. LONATI C, Soria F, Pradere B, D'Andrea D, et al
    Comment on: "Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG".
    Minerva Urol Nephrol. 2023;75:407-409.
    Abstract     Related articles   

  1028. ASERO V, Scornajenghi CM, Krajewski W, Szydelko T, et al
    Comment on: "Animal model assessment of a new design for a coated mitomycin-eluting biodegradable ureteral stent for intracavitary instillation as an adjuvant therapy in upper urothelial carcinoma".
    Minerva Urol Nephrol. 2023;75:401-403.
    Abstract     Related articles   

  1029. KHODADADI F, Khorashadizadeh M, Ghasemi F
    Thymoquinone enhanced the antitumor activity of cisplatin in human bladder cancer 5637 cells in vitro.
    Mol Biol Rep. 2023 May 23. doi: 10.1007/s11033-023-08472.
    Abstract     Related articles   

  1030. DE LIMA CSA, Rial-Hermida MI, de Freitas LF, Pereira-da-Mota AF, et al
    Mucoadhesive gellan gum-based and carboxymethyl cellulose -based hydrogels containing gemcitabine and papain for bladder cancer treatment.
    Int J Biol Macromol. 2023 May 20:124957. doi: 10.1016/j.ijbiomac.2023.124957.
    Abstract     Related articles   

  1031. LIU SS, Li JS, Xue M, Wu WJ, et al
    LncRNA UCA1 Participates in De Novo Synthesis of Guanine Nucleotides in Bladder Cancer by Recruiting TWIST1 to Increase IMPDH1/2.
    Int J Biol Sci. 2023;19:2599-2612.
    Abstract     Related articles   

  1032. XIE S, He J, Feng B, Rao D, et al
    A potential biological signature of 7-methylguanosine-related lncRNA to predict the immunotherapy effects in bladder cancer.
    Heliyon. 2023;9:e15897.
    Abstract     Related articles   

  1033. SCHELTES DA, van der Steen-Banasik EM, Smits GAHJ
    Quality of life of muscle-invasive bladder cancer patients after brachytherapy-based treatment: A cross-sectional study.
    J Contemp Brachytherapy. 2023;15:110-116.
    Abstract     Related articles   

  1034. WANG X, Zhang Y, Wu Y, Cheng H, et al
    The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy.
    Front Immunol. 2023;14:1202633.
    Abstract     Related articles   

  1035. LIU H, Xiang P, Miao W, Liu H, et al
    Analysis of the Regulatory Effect of ACTG2 on Biological Behavior of Bladder Cancer Cells Based on Database Screening.
    Cell Mol Biol (Noisy-le-grand). 2023;69:125-130.
    Abstract     Related articles   

  1036. LIU H, Wang X, Guo Z, Sun G, et al
    LncRNA BCLET variant confers bladder cancer susceptibility through alternative splicing of MSANTD2 exon 1.
    Cancer Med. 2023 May 21. doi: 10.1002/cam4.6072.
    Abstract     Related articles   

  1037. SARAVANABAVAN S, Prakash GJ, Joshi A, Pal M, et al
    Patterns of Utilization and Outcomes of Perioperative Chemotherapy in Patients With Locally Advanced-urothelial Bladder Cancer (LABC)-Real World Data From an Indian Tertiary Care Cancer Center.
    Clin Genitourin Cancer. 2023 Apr 11:S1558-7673(23)00082.
    Abstract     Related articles   

  1038. CHUNG R, Moran GW, Movassaghi M, Pohl D, et al
    Survival outcomes in patients with muscle invasive bladder cancer undergoing radical vs. partial cystectomy.
    Urol Oncol. 2023 May 18:S1078-1439(23)00137.
    Abstract     Related articles   

  1039. SANYA DRA, Onesime D
    Roles of non-coding RNAs in the metabolism and pathogenesis of bladder cancer.
    Hum Cell. 2023 May 20. doi: 10.1007/s13577-023-00915.
    Abstract     Related articles   

  1040. YUAN H, Xiu Y, Liu T, Fan Y, et al
    The cuproptosis-associated 11 gene signature as a predictor for outcomes and response to Bacillus Calmette-Guerin and immune checkpoint inhibitor therapies in bladder carcinoma.
    Front Immunol. 2023;14:1126247.
    Abstract     Related articles   

  1041. HUA X, Li J, Shang M, He W, et al
    Pathogenesis of psoriasis via miR-149-5p/AKT1axis by long noncoding RNA BLACAT1.
    Skin Res Technol. 2023;29:e13339.
    Abstract     Related articles   

  1042. WIECZOREK E, Wolniakowska A, Roszak J, Rodrigues RM, et al
    Gene-occupation interactions: a review of the literature on bladder and prostate cancer.
    Med Pr. 2023;74:127-144.
    Abstract     Related articles   

  1043. TAPPERO S, Cano Garcia C, Incesu RB, Piccinelli ML, et al
    Conditional survival for non-metastatic muscle-invasive adenocarcinoma of the urinary bladder after radical cystectomy.
    Surg Oncol. 2023;48:101947.
    Abstract     Related articles   

  1044. TAN WS, Tan MY, Alhalabi O, Campbell MT, et al
    Evolving systemic management of urothelial cancers.
    Curr Opin Oncol. 2023;35:186-199.
    Abstract     Related articles   

  1045. HOEH B, Flammia RS, Hohenhorst L, Sorce G, et al
    Regional differences in total hospital costs for radical cystectomy in the United States.
    Surg Oncol. 2023;48:101924.
    Abstract     Related articles   

  1046. LO YC, Bauer AH, Odintsov I, Siegmund SE, et al
    Integrating Molecular Sequencing Into the Pathological Diagnosis of Clinically Suspected Non-Small Cell Lung Carcinomas.
    Mod Pathol. 2023;36:100126.
    Abstract     Related articles   

  1047. MUSANGILE FY, Matsuzaki I, Iwamoto R, Sagan K, et al
    Targeted Next-Generation Sequencing of Flat Urothelial Lesions Reveals Putative Pathobiological Pathways, Potential Biomarkers, and Rational Therapeutic Targets.
    Mod Pathol. 2023;36:100120.
    Abstract     Related articles   

  1048. BASU M, Mukhopadhyay D, Chakraborty B, Ghosh S, et al
    Differential operation of MLH1/MSH2 and FANCD2 crosstalk in chemotolerant bladder carcinoma: a clinical and therapeutic intervening study.
    Mol Cell Biochem. 2023;478:1599-1610.
    Abstract     Related articles   

  1049. BRAVI CA, Piazza P, Mazzone E, Dell'Oglio P, et al
    Long-term oncologic outcomes of robot-assisted radical cystectomy: update series from a high-volume robotic center beyond 10 years of follow-up.
    J Robot Surg. 2023;17:1143-1150.
    Abstract     Related articles   

  1050. VISWAMBARAM P, McCombie SP, Hawks C, Wallace DMA, et al
    Centralization and prospective audit of cystectomy are necessary: a commentary on the case for centralization, supported by a contemporary series utilizing the ANZUP cystectomy database.
    Asia Pac J Clin Oncol. 2023;19:290-295.
    Abstract     Related articles   

  1051. YAMADA Y, Ikeda M, Hirayama T, Murakami Y, et al
    Noninferior oncological outcomes in adults aged 80 years or older compared with younger patients who underwent radical nephroureterectomy for upper tract urothelial carcinoma.
    Asia Pac J Clin Oncol. 2023;19:305-311.
    Abstract     Related articles   

  1052. GELLRICH AL, Eraky A, Hamann C, Hugelmann K, et al
    [Cystectomy of a young patient with squamous cell metaplasia of the bladder and manifestation of condyloma].
    Aktuelle Urol. 2023;54:223-227.
    Abstract     Related articles   

  1053. BAIRD B, Bilgili A, Anderson A, Carames G, et al
    Oncological outcomes of visibly complete transurethral resection prior to neoadjuvant chemotherapy for bladder cancer.
    Int Braz J Urol. 2023;49:479-489.
    Abstract     Related articles   

  1054. ELSAYED DH, Elfarargy OM, Elderey MS, Mandour D, et al
    Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer.
    Contemp Oncol (Pozn). 2023;27:1-9.
    Abstract     Related articles   

  1055. YANG C, Li Q, Chen X, Zhang Z, et al
    Correction for: Circular RNA circRGNEF promotes bladder cancer progression via miR-548/KIF2C axis regulation.
    Aging (Albany NY). 2023;undefined.
    Abstract     Related articles   

  1056. RETZ M, Kirchhoff FP, von Amsberg G, De Santis M, et al
    [Sequential therapy of advanced bladder cancer after prior perioperative systemic treatment : Recommendations from the Interdisciplinary Bladder Carcinoma Working Group (IABC) of the DKG e. V.].
    Urologie. 2023 Jun 1. doi: 10.1007/s00120-023-02098.
    Abstract     Related articles   

  1057. LIU Y, Hu B, Pei X, Li J, et al
    A non-G-Quadruplex DNA Aptamer Targeting NCL for Diagnosis and Therapy in Bladder Cancer.
    Adv Healthc Mater. 2023 Jun 1:e2300791. doi: 10.1002/adhm.202300791.
    Abstract     Related articles   

  1058. MACDONALD A, Mehrnoush V, Ismail A, Di Matteo L, et al
    History of infantile BCG immunization did not predict lamina propria invasion and/or high-grade in patients with non-muscle invasive bladder cancer.
    Arch Ital Urol Androl. 2023 May 31:11380. doi: 10.4081/aiua.2023.11380.
    Abstract     Related articles   

  1059. ZHANG L, Liu B, Deng QH, Li JX, et al
    Retraction Note: LncRNA BRE-AS1 acts as a tumor suppressor factor in bladder cancer via mediating STAT3.
    Eur Rev Med Pharmacol Sci. 2023;27:4326.
    Abstract     Related articles   

  1060. VAN HOOGSTRATEN LMC, Man CCO, Witjes JA, Meijer RP, et al
    Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer.
    World J Urol. 2023 May 31:1-9. doi: 10.1007/s00345-023-04443.
    Abstract     Related articles   

  1061. YAN B, Li X, Peng M, Zuo Y, et al
    The YTHDC1/GLUT3/RNF183 axis forms a positive feedback loop that modulates glucose metabolism and bladder cancer progression.
    Exp Mol Med. 2023 Jun 1. doi: 10.1038/s12276-023-00997.
    Abstract     Related articles   

  1062. CHAPPIDI MR, Escobar D, Meng MV, Washington SL 3rd, et al
    Readmissions trends following radical cystectomy for bladder cancer unchanged in the era of enhanced recovery after surgery (ERAS) protocols.
    Urol Oncol. 2023 May 29:S1078-1439(23)00172.
    Abstract     Related articles   

  1063. WANG D, Liu Y
    Comment on "The prognostic impact of tumor necrosis in non-muscle invasive bladder cancer".
    Rev Assoc Med Bras (1992). 2023;69:e20230295.
    Abstract     Related articles   

  1064. SIREGAR GP, Parwati I, Noegroho BS, Safridai F, et al
    The association between serum hypoxia inducible factor-1alpha level and urothelial bladder cancer: A preliminary study.
    Arch Ital Urol Androl. 2023 May 29:11292. doi: 10.4081/aiua.2023.11292.
    Abstract     Related articles   

  1065. SOHNGEN C, Thomas DJ, Skowron MA, Bremmer F, et al
    CD24 targeting with NK-CAR immunotherapy in testis, prostate, renal and (luminal-type) bladder cancer and identification of direct CD24 interaction partners.
    FEBS J. 2023 May 31. doi: 10.1111/febs.16880.
    Abstract     Related articles   

  1066. ZHANGHUANG C, Zhang Z, Wang J, Yao Z, et al
    Surveillance of prognostic risk factors in patients with SCCB using artificial intelligence: a retrospective study.
    Sci Rep. 2023;13:8727.
    Abstract     Related articles   

  1067. ZENG N, Xu MY, Sun JX, Liu CQ, et al
    Hyperthermia intravesical chemotherapy acts as a promising alternative to bacillus Calmette-Guerin instillation in non-muscle-invasive bladder cancer: a network meta-analysis.
    Front Oncol. 2023;13:1164932.
    Abstract     Related articles   

  1068. DU Y, Miao W, Jiang X, Cao J, et al
    Corrigendum: The epithelial to mesenchymal transition related gene calumenin is an adverse prognostic factor of bladder cancer correlated with tumor microenvironment remodeling, gene mutation, and ferroptosis.
    Front Oncol. 2023;13:1185029.
    Abstract     Related articles   

  1069. UEMATSU R, Teishima J, Sakata H, Mita Y, et al
    Peritoneal and pulmonary tuberculosis following intravesical administration of Bacillus Calmette-Guerin for bladder cancer.
    Int Cancer Conf J. 2023;12:221-225.
    Abstract     Related articles   

  1070. KONO S, Hashimoto Y, Shirai Y, Kunihiro Y, et al
    A long-term survival case of bladder cancer with distant metastases: abscopal effect of brain metastases after stereotactic radiotherapy with immune checkpoint blockade therapy to lung metastases.
    Int Cancer Conf J. 2023;12:205-209.
    Abstract     Related articles   

  1071. DOLNY M, Czajkowski M, Czajkowska K, Sokolowska-Wojdylo M, et al
    Penile metastasis secondary to urothelial bladder cancer.
    Urol Case Rep. 2023;49:102428.
    Abstract     Related articles   

  1072. TORTORA D, Roberts ME, Kumar G, Kotapalli SS, et al
    A genome-wide CRISPR screen maps endogenous regulators of PPARG gene expression in bladder cancer.
    iScience. 2023;26:106525.
    Abstract     Related articles   

  1073. COSTA L, Alexandre T, Mansinho A, Sousa R, et al
    Health outcomes and budget impact projection of anti-PD-(L)1s in cancer care in Portugal.
    Front Public Health. 2023;11:1133959.
    Abstract     Related articles   

  1074. ZHANG ZC, Zhao HF, Sun Z, Li Y, et al
    Tripartite motif-containing 9 promoted proliferation and migration of bladder cancer cells through CEACAM6-Smad2/3 axis.
    J Cell Commun Signal. 2023 May 30. doi: 10.1007/s12079-023-00766.
    Abstract     Related articles   

  1075. LIU Y, Yu H, Zeng B, Gou X, et al
    miR-383-5p serves as a tumor suppressor in bladder cancer by suppressing PI3K/AKT signaling pathway.
    Cancer Biomark. 2023 May 18. doi: 10.3233/CBM-220379.
    Abstract     Related articles   

  1076. ZHU PY, Wang L, Li KP, Yin S, et al
    Perioperative and oncologic outcomes of transperitoneal versus retroperitoneal laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma: a systematic review and pooled analysis of comparative outcomes.
    World J Surg Oncol. 2023;21:163.
    Abstract     Related articles   

  1077. MALALASEKERA A, Neththikumara N, Somasundaram P, Pathirana S, et al
    Clinical Exome Gene Panel Analysis of a Cohort of Urothelial Bladder Cancer Patients from Sri Lanka.
    Asian Pac J Cancer Prev. 2023;24:1533-1542.
    Abstract     Related articles   

  1078. CHEN Y, Zhang Y, Wang X, Qiao S, et al
    Methylseleninic acid induces apoptosis of human bladder cancer cells through the ROS-mediated mitochondrial pathway.
    J Biochem Mol Toxicol. 2023 May 29:e23387. doi: 10.1002/jbt.23387.
    Abstract     Related articles   

  1079. DOWNES MR, Hartmann A, Shen S, Tsuzuki T, et al
    International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 1: Comparison of Bladder Cancer Grading System Performance.
    Am J Surg Pathol. 2023 May 29. doi: 10.1097/PAS.0000000000002059.
    Abstract     Related articles   

  1080. ZHANG N, Bian Q, Gao Y, Wang Q, et al
    The Role of Fascin-1 in Human Urologic Cancers: A Promising Biomarker or Therapeutic Target?
    Technol Cancer Res Treat. 2023;22:15330338231175733.
    Abstract     Related articles   

  1081. GALLUZZO A, Danti G, Bicci E, Mastrorosato M, et al
    The Role of Dual-Energy CT in the Study of Urinary Tract Tumors: Review of Recent Literature.
    Semin Ultrasound CT MR. 2023;44:136-144.
    Abstract     Related articles   

  1082. SHI X, Dong A, Yang Y, Zheng G, et al
    Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on T-cell marker genes to predict prognosis and immunotherapy response in bladder cancer.
    J Cancer Res Clin Oncol. 2023 May 27. doi: 10.1007/s00432-023-04881.
    Abstract     Related articles   

  1083. CLAPS F, Rossin G, van Rhijn BWG, Mir MC, et al
    The Utility of Inflammatory Serum Markers in the Assessment of Perioperative Morbidity after Radical Cystectomy for Bladder Cancer.
    Medicina (Kaunas). 2023;59:926.
    Abstract     Related articles   

  1084. MOHANTY SK, Lobo A, Mishra SK, Cheng L, et al
    Precision Medicine in Bladder Cancer: Present Challenges and Future Directions.
    J Pers Med. 2023;13:756.
    Abstract     Related articles   

  1085. EINERHAND SMH, Zuur LG, Wondergem MJ, Boellaard TN, et al
    The Implementation of FDG PET/CT for Staging Bladder Cancer: Changes in the Detection and Characteristics of Occult Nodal Metastases at Upfront Radical Cystectomy?
    J Clin Med. 2023;12:3367.
    Abstract     Related articles   

  1086. SZALLASI A
    "ThermoTRP" Channel Expression in Cancers: Implications for Diagnosis and Prognosis (Practical Approach by a Pathologist).
    Int J Mol Sci. 2023;24:9098.
    Abstract     Related articles   

  1087. WATANABE R, Miura N, Kurata M, Kitazawa R, et al
    Spatial Gene Expression Analysis Reveals Characteristic Gene Expression Patterns of De Novo Neuroendocrine Prostate Cancer Coexisting with Androgen Receptor Pathway Prostate Cancer.
    Int J Mol Sci. 2023;24:8955.
    Abstract     Related articles   

  1088. SMITH V, Lee D, Reardon M, Shabbir R, et al
    Hypoxia Is Associated with Increased Immune Infiltrates and Both Anti-Tumour and Immune Suppressive Signalling in Muscle-Invasive Bladder Cancer.
    Int J Mol Sci. 2023;24:8956.
    Abstract     Related articles   

  1089. OKUNO Y, Hattori-Kato M, Tanaka H, Tonooka A, et al
    Relationship between the Reduced Expression of Zinc Finger Protein 668 in Bladder Cancer and Its Invasiveness.
    Int J Mol Sci. 2023;24:8668.
    Abstract     Related articles   

  1090. WANG BR, Chang WS, Liao CH, Wang YC, et al
    Impacts of Mir146a Genotypes on Bladder Cancer Risk in Taiwan.
    Biomedicines. 2023;11:1396.
    Abstract     Related articles   

  1091. SPIRITO L, Maturi R, Credendino SC, Manfredi C, et al
    Differential Expression of LncRNA in Bladder Cancer Development.
    Diagnostics (Basel). 2023;13:1745.
    Abstract     Related articles   

  1092. STRAUSS J, Deville JL, Sznol M, Ravaud A, et al
    First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma.
    J Immunother Cancer. 2023;11:e005813.
    Abstract     Related articles   

  1093. JIANG LJ, Guo SB, Huang ZY, Li XL, et al
    PHB promotes bladder cancer cell epithelial-mesenchymal transition via the Wnt/beta-catenin signaling pathway.
    Pathol Res Pract. 2023;247:154536.
    Abstract     Related articles   

  1094. YANG CH, Hsu CY, Lin YS, Tung MC, et al
    One-Step Robot-Assisted Complete Urinary Tract Extirpation in Man with End-Stage Renal Disease on Dialysis: The First Case Report.
    Curr Oncol. 2023;30:5093-5102.
    Abstract     Related articles   

  1095. DAI S, Liu C, Jiang Z, Teng X, et al
    Three-port approach vs conventional laparoscopic radical cystectomy with orthotopic neobladder: a single-center retrospective study.
    World J Surg Oncol. 2023;21:160.
    Abstract     Related articles   

  1096. SAVELEVA MS, Lobanov ME, Gusliakova OI, Plastun VO, et al
    Mucoadhesive Emulsion Microgels for Intravesical Drug Delivery: Preparation, Retention at Urothelium, and Biodistribution Study.
    ACS Appl Mater Interfaces. 2023;15:25354-25368.
    Abstract     Related articles   

  1097. TANG Q, Li S, Huang G, Liu H, et al
    Research progress on PD-1 and PD-L1 inhibitors in the treatment of metastatic urothelial carcinoma.
    Int Immunopharmacol. 2023;119:110158.
    Abstract     Related articles   

  1098. ANIS O, Yogev D, Dotan A, Tsur AM, et al
    Autoimmune disorders caused by intravesical bacillus Calmette-Guerine treatment: A systematic review.
    Autoimmun Rev. 2023;22:103329.
    Abstract     Related articles   

  1099. ZHONG B, Wang Y, Liao Y, Liang J, et al
    MLKL and other necroptosis-related genes promote the tumor immune cell infiltration, guiding for the administration of immunotherapy in bladder urothelial carcinoma.
    Apoptosis. 2023;28.
    Abstract     Related articles   

  1100. BAHCECI D, Nguyen JK, Sangoi AR, Stohr BA, et al
    Urothelial carcinoma in situ with "overriding" features can evade detection by mimicking umbrella cells.
    Hum Pathol. 2023;136:56-62.
    Abstract     Related articles   

  1101. GONZALEZ N, Rao N, Dean M, Lee D, et al
    Nitrated Polycyclic Aromatic Hydrocarbon (Nitro-PAH) Signatures and Somatic Mutations in Diesel Exhaust-Exposed Bladder Tumors.
    Cancer Epidemiol Biomarkers Prev. 2023;32:840-847.
    Abstract     Related articles   

  1102. SU R, Chen Z, Hong D, Jiang S, et al
    Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real-world study.
    Cancer Med. 2023;12:10587-10596.
    Abstract     Related articles   

  1103. MOON JH, Nikas IP, Moon KC, Kim B, et al
    Clinical application of the anti-human telomerase reverse transcriptase (hTERT) antibody (SCD-A7) immunocytochemistry in liquid-based urine cytology: A prospective, single institute study.
    Cancer Med. 2023;12:10363-10370.
    Abstract     Related articles   

  1104. TURAL D, Arslan C, Selcukbiricik F, Olmez OF, et al
    Five-Year Outcome and Safety in Patients Treated With Immune Checkpoint Blockade Therapies for Urothelial Carcinoma: Experience From Real-World Clinical Practice.
    Clin Genitourin Cancer. 2023;21:334-341.
    Abstract     Related articles   

  1105. PATEL KN, Salunke A, Sharma M, Puj K, et al
    Development and Internal Validation of a Nomogram Predicting Overall Survival Based on Log ODDS of Positive Lymph-Nodes for Post Radical Cystectomy Patients in Muscle Invasive Carcinoma of Bladder.
    Clin Genitourin Cancer. 2023;21:e153-e165.
    Abstract     Related articles   

  1106. GELLINGS P, Galeas-Pena M, Morici LA
    Mycobacterium bovis bacille Calmette-Guerin-derived extracellular vesicles as an alternative to live BCG immunotherapy.
    Clin Exp Med. 2023;23:519-527.
    Abstract     Related articles   

  1107. ZHENG P, Wu K, Gao Z, Li H, et al
    [Retracted] KIF4A promotes the development of bladder cancer by transcriptionally activating the expression of CDCA3.
    Int J Mol Med. 2023;52:62.
    Abstract     Related articles   

  1108. VAN DER KWAST TH, Bubendorf L, Cheng L
    International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer: Progresses and Challenges.
    Am J Surg Pathol. 2023 Jun 8. doi: 10.1097/PAS.0000000000002066.
    Abstract     Related articles   

  1109. ZHOU H, Wang P, Qin X, Zhang X, et al
    Comparative transcriptomic analysis and mechanistic characterization revealed the use of formononetin for bladder cancer treatment.
    Food Funct. 2023 Jun 8. doi: 10.1039/d2fo03962.
    Abstract     Related articles   

  1110. VOLZ Y, Trappmann R, Ebner B, Eismann L, et al
    Absence of detrusor muscle in TUR-BT specimen - can we predict who is at highest risk?
    BMC Urol. 2023;23:106.
    Abstract     Related articles   

  1111. ERDIK A, Cimen HI, Kose O, Ates OF, et al
    Can pelvic diameter measurement have an effect on surgical outcomes in radical cystectomy?
    BMC Urol. 2023;23:105.
    Abstract     Related articles   

  1112. LU J, Li X, Chen M, Yang P, et al
    Perivesical Fat Invasive Pattern as Prognostic Factor and Predictor of Response to Adjuvant Chemotherapy in T3 Stage Bladder Cancer.
    Clin Genitourin Cancer. 2023 May 7:S1558-7673(23)00105.
    Abstract     Related articles   

  1113. PETRAUSCH U, Spahn M, Schneider M, Hayoz S, et al
    Novel sequential treatment strategy for patients with muscle-invasive bladder cancer (MIBC): intravesical recombinant BCG, followed by neoadjuvant chemoimmunotherapy, radical cystectomy plus pelvic lymphadenectomy and adjuvant immunotherapy - protocol
    BMJ Open. 2023;13:e067634.
    Abstract     Related articles   

  1114. ZHANG W, Mao S, Shi D, Zhang J, et al
    Corrigendum: MicroRNA-153 decreases tryptophan catabolism and inhibits angiogenesis in bladder cancer by targeting indoleamine 2,3-dioxygenase 1.
    Front Oncol. 2023;13:1208728.
    Abstract     Related articles   

  1115. XU C, Zou W, Zhang L, Xu R, et al
    Real-world retrospective study of immune checkpoint inhibitors in combination with radiotherapy or chemoradiotherapy as a bladder-sparing treatment strategy for muscle-invasive bladder urothelial cancer.
    Front Immunol. 2023;14:1162580.
    Abstract     Related articles   

  1116. WU W, Chen L, Jia G, Tang Q, et al
    Inhibition of FGFR3 upregulates MHC-I and PD-L1 via TLR3/NF-kB pathway in muscle-invasive bladder cancer.
    Cancer Med. 2023 Jun 7. doi: 10.1002/cam4.6172.
    Abstract     Related articles   

  1117. XU C, Chen A, Mao C, Cui B, et al
    Construction of prognostic risk model of bladder cancer based on cuproptosis-related long non-coding RNAs.
    Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023;52:139-147.
    Abstract     Related articles   

  1118. LINDNER AK, Lackner F, Tymoszuk P, Barth DA, et al
    Sex hormones influence survival of patients with metastatic urothelial carcinoma undergoing immune checkpoint therapy.
    Biol Sex Differ. 2023;14:38.
    Abstract     Related articles   

  1119. WU R, Teng X, Song Q, Chen S, et al
    Single-cell RNA sequencing reveals sexual diversity in the human bladder and its prospective impacts on bladder cancer and urinary tract infection.
    BMC Med Genomics. 2023;16:122.
    Abstract     Related articles   

  1120. ZHENG J, Miao F, Wang Z, Ma Y, et al
    Identification of MDM2 as a prognostic and immunotherapeutic biomarker in a comprehensive pan-cancer analysis: A promising target for breast cancer, bladder cancer and ovarian cancer immunotherapy.
    Life Sci. 2023 Jun 3:121832. doi: 10.1016/j.lfs.2023.121832.
    Abstract     Related articles   

  1121. YANG CJ, Tan ZL, Yang JD, Hsu FT, et al
    Fluoxetine inactivates STAT3/NF-kappaB signaling and promotes sensitivity to cisplatin in bladder cancer.
    Biomed Pharmacother. 2023;164:114962.
    Abstract     Related articles   

  1122. DONG Y, Xu C, Su G, Li Y, et al
    Clinical value of anoikis-related genes and molecular subtypes identification in bladder urothelial carcinoma and in vitro validation.
    Front Immunol. 2023;14:1122570.
    Abstract     Related articles   

  1123. HERRANZ R, Oto J, Hueso M, Plana E, et al
    Bladder cancer patients have increased NETosis and impaired DNaseI-mediated NET degradation that can be therapeutically restored in vitro.
    Front Immunol. 2023;14:1171065.
    Abstract     Related articles   

  1124. DERGAMOUN H, El Gdaouni A, Taoufik A, Ziouziou I, et al
    Inflammatory myofibroblastic tumor of the urinary bladder: a case report.
    Pan Afr Med J. 2023;44:119.
    Abstract     Related articles   

  1125. LIU X, Li X, Kuang Q, Luo H, et al
    Screening of immunotherapy-related genes in bladder cancer based on GEO datasets.
    Front Oncol. 2023;13:1176637.
    Abstract     Related articles   

  1126. KAGAMI LP, Goncalves IL, da Silva AC, Silva AC, et al
    LaSOM 335, active against bladder cancer cells, interferes with Let-60 (hRas) and reduces CD73 expression/activity.
    Chem Biol Drug Des. 2023 Jun 5. doi: 10.1111/cbdd.14273.
    Abstract     Related articles   

  1127. SODA T, Tashiro Y, Koike S, Ikeuchi R, et al
    Evaluation of incidence, predictive factors and treatment considerations for asymptomatic genitourinary granulomas after intravesical bacillus Calmette-Guerin therapy.
    Actas Urol Esp (Engl Ed). 2023;47:317-326.
    Abstract     Related articles   

  1128. WANG S, Ge C
    High risk of non-cancer mortality in bladder cancer patients: evidence from SEER-Medicaid.
    J Cancer Res Clin Oncol. 2023 Jun 3. doi: 10.1007/s00432-023-04867.
    Abstract     Related articles   

  1129. LICHTBROUN B, Srivastava A, Ghodoussipour S
    A Restaging Transurethral Resection of Bladder Tumor Is Always Necessary For High-grade T1 Non-muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2023 Jun 1:S2405-4569(23)00121-9. doi: 10.1016/j.euf.2023.
    Abstract     Related articles   

  1130. WU S, Hong G, Lin T
    Artificial intelligence-based model for lymph node metastases detection in bladder cancer - Authors' reply.
    Lancet Oncol. 2023;24:e234.
    Abstract     Related articles   

  1131. MAI Z, Zhou Y, Zhou Z, Yan W, et al
    Artificial intelligence-based model for lymph node metastases detection in bladder cancer.
    Lancet Oncol. 2023;24:e233.
    Abstract     Related articles   

  1132. ZOU K, Lu M, Peng Y, Tang X, et al
    Artifical intelligence-based model for lymph node metastases detection in bladder cancer.
    Lancet Oncol. 2023;24:e232.
    Abstract     Related articles   

  1133. WANG C, Liu T, Wang J, Cheng C, et al
    CircHIPK3 negatively regulates autophagy by blocking VCP binding to the Beclin 1 complex in bladder cancer.
    Discov Oncol. 2023;14:86.
    Abstract     Related articles   

  1134. SUN YF, Chen L, Xia QJ, Wang TH, et al
    Identification of necroptosis-related long non-coding RNAs prognostic signature and the crucial lncRNA in bladder cancer.
    J Cancer Res Clin Oncol. 2023 Jun 3. doi: 10.1007/s00432-023-04886.
    Abstract     Related articles   

  1135. CHEN C, Chao Y, Zhang C, Hu W, et al
    TROP2 translation mediated by dual m(6)A/m(7)G RNA modifications promotes bladder cancer development.
    Cancer Lett. 2023 May 31:216246. doi: 10.1016/j.canlet.2023.216246.
    Abstract     Related articles   

  1136. HUANG EY, Tai MC, Chung HJ, Chang YH, et al
    Effects of different combinations of radical nephroureterectomy and bladder cuff excision procedures for upper tract urothelial carcinoma on bladder recurrence.
    Int Braz J Urol. 2023;49:469-478.
    Abstract     Related articles   

  1137. KRANZ J, Hoffmann M, Alexa R, Kuppe C, et al
    [Urothelial carcinoma of the upper urinary tract].
    Urologie. 2023;62:640-650.
    Abstract     Related articles   

  1138. GAVRILOVSKA-BRZANOV A, Seidi S, Stavridis S, Ivanovski O, et al
    Obturator Nerve Block for Transurethral Resection of Bladder Tumors.
    Med Arch. 2023;77:118-122.
    Abstract     Related articles   

  1139. KARTTUNEN E, Oldenburg J, Thoresen S, Ullen A, et al
    Response to M. Brehmer: Register-based research. Accurate data and analysis, crucial for correct conclusions. Comment on 'Incidence, mortality, and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic count
    Scand J Urol. 2023;58:20.
    Abstract     Related articles   

  1140. CHEN X, Cheng Y, Tian X, Li J, et al
    Urinary microbiota and metabolic signatures associated with inorganic arsenic-induced early bladder lesions.
    Ecotoxicol Environ Saf. 2023;259:115010.
    Abstract     Related articles   

  1141. SONG Y, Xu T
    Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder.
    World J Urol. 2023;41:1697-1698.
    Abstract     Related articles   

  1142. MAGOON R, Jose J, Suresh V
    Assessing postradical cystectomy outcomes in the enhanced recovery era: "enhancing" the corresponding research outlook.
    Urol Oncol. 2023;41:292.
    Abstract     Related articles   

  1143. VAHLENSIECK W
    [Interstitial cystitis/bladder pain syndrome (IC/BPS)].
    Urologie. 2023;62:582-589.
    Abstract     Related articles   

  1144. KUMAR R, Matulewicz R, Mari A, Moschini M, et al
    Impact of smoking on urologic cancers: a snapshot of current evidence.
    World J Urol. 2023;41:1473-1479.
    Abstract     Related articles   

  1145. BRUCH PG, Plage H, Hofbauer S, Kornienko K, et al
    Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder.
    Exp Mol Pathol. 2023;131:104860.
    Abstract     Related articles   

  1146. DIAMANTOPOULOS LN, Makrakis D, Korentzelos D, Alevizakos M, et al
    Development and validation of a prognostic nomogram for overall and disease-specific survival in patients with sarcomatoid urothelial carcinoma.
    Urol Oncol. 2023;41:296.
    Abstract     Related articles   

  1147. ZHU Y, Geng Z, Lin Q
    Primary intestinal adenocarcinoma after orthotopic ileal neobladder.
    Asian J Surg. 2023;46:2321-2322.
    Abstract     Related articles   

  1148. HARVEY SE, VandenBussche CJ
    Nuclear membrane irregularity in high-grade urothelial carcinoma cells can be measured by using circularity and solidity as morphometric shape definitions in digital image analysis of urinary tract cytology specimens.
    Cancer Cytopathol. 2023;131:351-359.
    Abstract     Related articles   

  1149. CHIN CP, Smith WH, Cesaretti J, Terk M, et al
    Clinical and treatment characteristics of secondary bladder malignancies following low dose rate brachytherapy for prostate cancer.
    Urol Oncol. 2023;41:296.
    Abstract     Related articles   

  1150. BAI SJ, Chen XB, Zeng TB
    Treatment progress of cystitis glandularis.
    Asian J Surg. 2023;46:2444.
    Abstract     Related articles   

  1151. SHEN H, Lv C
    Multiple primary trans-systemic triple carcinoma: A rare case report.
    Asian J Surg. 2023;46:2466-2467.
    Abstract     Related articles   

  1152. BAIRD BA, Taylor T, Brennan E, Borkar S, et al
    Disparities in access to high-volume centers and in hospital discharge status following radical cystectomy in Florida.
    Urol Oncol. 2023;41:294.
    Abstract     Related articles   

  1153. FONTANET S, Gallioli A, Baboudjian M, Huguet J, et al
    Topical instillation of BCG immunotherapy for biopsy-proven primary upper urinary tract carcinoma in situ: A single institution series and systematic review.
    Urol Oncol. 2023;41:274-283.
    Abstract     Related articles   

  1154. DUDINEC JV, Ortiz-Melo DI, Lipkin ME, Abern MR, et al
    Advanced chronic kidney disease; A comparison between nephroureterectomy and nephron-sparing surgery for upper tract urothelial carcinoma.
    Urol Oncol. 2023;41:295.
    Abstract     Related articles   

  1155. TAI P, Wang Z, Chen X, Chen A, et al
    Multi-omics analysis of the oncogenic value of copper Metabolism-Related protein COMMD2 in human cancers.
    Cancer Med. 2023;12:11941-11959.
    Abstract     Related articles   

  1156. VELEZ TORRES JM, Gonzalez ML, Duarte EM, Zein-Sabatto B, et al
    Urine Cytology Findings in Cases of Pseudocarcinomatous Urothelial Hyperplasia of the Bladder Often Represent a Diagnostic Challenge.
    Arch Pathol Lab Med. 2023;147:716-721.
    Abstract     Related articles   

  1157. YOO Y, Kim JM, Choi E, Park HS, et al
    The Effect of Complete Prostate Examination of Radical Cystoprostatectomy Specimen on the Final Stage of Urothelial Carcinoma of the Urinary Bladder and the Detection of Prostate Cancer.
    Arch Pathol Lab Med. 2023;147:665-675.
    Abstract     Related articles   

  1158. SHI T, Yuan Z, He Y, Zhang D, et al
    Competition between p53 and YY1 determines PHGDH expression and malignancy in bladder cancer.
    Cell Oncol (Dordr). 2023 Jun 16. doi: 10.1007/s13402-023-00823.
    Abstract     Related articles   

  1159. LIU X, Wu Y, Zhou Z, Huang M, et al
    [Corrigendum] Celecoxib inhibits the epithelial‑to‑mesenchymal transition in bladder cancer via the miRNA‑145/TGFBR2/Smad3 axis.
    Int J Mol Med. 2023;52:64.
    Abstract     Related articles   

  1160. CHEN H, Yang W, Li Y, Ma L, et al
    Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients.
    Front Immunol. 2023;14:1198878.
    Abstract     Related articles   

  1161. XUE Y, Zhao G, Pu X, Jiao F, et al
    Construction of T cell exhaustion model for predicting survival and immunotherapy effect of bladder cancer based on WGCNA.
    Front Oncol. 2023;13:1196802.
    Abstract     Related articles   

  1162. BOOT IWA, Wesselius A, Yu EYW, White E, et al
    Dietary vitamin D intake and the bladder cancer risk: A pooled analysis of prospective cohort studies.
    Clin Nutr. 2023 May 22:S0261-5614(23)00152-8. doi: 10.1016/j.clnu.2023.
    Abstract     Related articles   

  1163. YANG X, Zhang S, He J, Zhao L, et al
    Brazilin inhibits bladder cancer by promoting cell necroptosis.
    Clin Exp Pharmacol Physiol. 2023 Jun 15. doi: 10.1111/1440-1681.13800.
    Abstract     Related articles   

  1164. GALLAGHER K, Bhatt N, Clement K, Zimmermann E, et al
    Audit, Feedback, and Education to Improve Quality and Outcomes in Transurethral Resection and Single-Instillation Intravesical Chemotherapy for Nonmuscle Invasive Bladder Cancer Treatment: Protocol for a Multicenter International Observational Study W
    JMIR Res Protoc. 2023;12:e42254.
    Abstract     Related articles   

  1165. LIU S, Liu Z, Shang A, Xun J, et al
    CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosis.
    Sci Rep. 2023;13:9657.
    Abstract     Related articles   

  1166. STEELE TM, Tsamouri MM, Siddiqui S, Lucchesi CA, et al
    Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer.
    Sci Rep. 2023;13:9617.
    Abstract     Related articles   

  1167. STONE BV, Labban M, Filipas DK, Beatrici E, et al
    The Risk of Catastrophic Healthcare Expenditures Among Prostate and Bladder Cancer Survivors in the United States.
    Clin Genitourin Cancer. 2023 May 27:S1558-7673(23)00135.
    Abstract     Related articles   

  1168. LU XS, Huang ML, Chen LB, Liu SC, et al
    SCARA5 as a downstream factor of PCAT29, inhibits proliferation, migration, and invasion of bladder cancer.
    Genomics. 2023 Jun 12:110667. doi: 10.1016/j.ygeno.2023.110667.
    Abstract     Related articles   

  1169. JIANG C, Perimbeti S, Deng L, Xing J, et al
    Medicaid Expansion and Racial Disparity in Timely Multidisciplinary Treatment in Muscle Invasive Bladder Cancer.
    J Natl Cancer Inst. 2023 Jun 14:djad112. doi: 10.1093.
    Abstract     Related articles   

  1170. WANG L, Qi F, Bi L, Yan J, et al
    Targeted hollow pollen silica nanoparticles for enhanced intravesical therapy of bladder cancer.
    Biomater Sci. 2023 Jun 14. doi: 10.1039/d3bm00631.
    Abstract     Related articles   

  1171. DALJIT T, Melgandi W, Ansari FA, Rathi AK, et al
    Cutaneous metastasis in bladder cancer.
    J Cancer Res Ther. 2023;19:501-504.
    Abstract     Related articles   

  1172. ALAM MN, Agrawal S, Rastogi N, Saxena R, et al
    Chemotherapy or chemotherapy followed by consolidation chemoradiation in postoperative (simple cholecystectomy) gall bladder cancer with residual disease, unsuitable for revision surgery? Risk stratification and outcomes.
    J Cancer Res Ther. 2023;19:259-264.
    Abstract     Related articles   

  1173. WU C, Duan L, Li H, Liu X, et al
    PD1(hi) CD200(hi) CD4(+) exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial-mesenchymal transition in bladder cancer.
    Clin Transl Med. 2023;13:e1303.
    Abstract     Related articles   

  1174. AL-HUMAIRI RMA, Hashim Mohammad T, Thanoon Ahmed S, Ad'hiah AH, et al
    Systemic Interleukin-6 Response after Intravesical Instillation of Bacillus Calmette-Guerin and Mitomycin C in Superficial Bladder Cancer.
    Arch Razi Inst. 2023;78:353-360.
    Abstract     Related articles   

  1175. NAMIKI S, Ueda S, Takeuchi Y, Kawase M, et al
    [A Case of Refractory Lymphatic Leakage after Robot-Assisted Radical Cystectomy].
    Hinyokika Kiyo. 2023;69:137-142.
    Abstract     Related articles   

  1176. WANG Y, Song Y, Qin C, Zhang C, et al
    Effect of regional versus general anesthesia on recurrence of non-muscle invasive bladder cancer: a systematic review and meta-analysis of eight retrospective cohort studies.
    BMC Anesthesiol. 2023;23:201.
    Abstract     Related articles   

  1177. ROUPRET M, Burger M, Stenzl A
    Letter to the Editor on the systematic review "Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer".
    World J Urol. 2023 Jun 13. doi: 10.1007/s00345-023-04435.
    Abstract     Related articles   

  1178. KIM JY, Yoon JH, Yoo KB, Lee WR, et al
    Disparity of Bladder Cancer Incidence among Male Workers across Industries: A Population-based Cohort Study from South Korea.
    J Occup Environ Med. 2023 Jun 12. doi: 10.1097/JOM.0000000000002907.
    Abstract     Related articles   

  1179. WANG H, Ma X, Li S, Su J, et al
    KIF20A as a potential biomarker of renal and bladder cancers based on bioinformatics and experimental verification.
    Aging (Albany NY). 2023;15.
    Abstract     Related articles   

  1180. CHEN Y, Huang M, Lu J, Zhang Q, et al
    Establishment of a prognostic model to predict chemotherapy response and identification of RAC3 as a chemotherapeutic target in bladder cancer.
    Environ Toxicol. 2023 Jun 13. doi: 10.1002/tox.23860.
    Abstract     Related articles   

  1181. KUKREJA JB
    Non-muscle-invasive Bladder Cancer: Side-by-Side Guideline Comparison.
    Eur Urol Focus. 2023 Jun 10:S2405-4569(23)00115.
    Abstract     Related articles   

  1182. CHEN Y, Yin L, Hao M, Xu W, et al
    Medicarpin induces G1 arrest and mitochondria-mediated intrinsic apoptotic pathway in bladder cancer cells.
    Acta Pharm. 2023;73:211-225.
    Abstract     Related articles   

  1183. LIU B, Dan W, Wei Y, Zhang Y, et al
    beta-asarone inhibits the migration, invasion, and EMT of bladder cancer through activating ER stress.
    Cancer Med. 2023 Jun 12. doi: 10.1002/cam4.6059.
    Abstract     Related articles   

  1184. LIU YS, Thaliffdeen R, Han S, Park C, et al
    Use of machine learning to predict bladder cancer survival outcomes: a systematic literature review.
    Expert Rev Pharmacoecon Outcomes Res. 2023.
    Abstract     Related articles   

  1185. HONG KU, Hein DW
    N-acetyltransferase 2 haplotype modifies risks for both dyslipidemia and urinary bladder cancer.
    Pharmacogenet Genomics. 2023 May 29. doi: 10.1097/FPC.0000000000000500.
    Abstract     Related articles   

  1186. FAN X, He W, Huang J
    Bladder-sparing approaches for muscle invasive bladder cancer: a narrative review of current evidence and future perspectives.
    Transl Androl Urol. 2023;12:802-808.
    Abstract     Related articles   

  1187. HAO L, Fang J, Xu R, Liu S, et al
    Significance of the FGFR3 mutation in Chinese patients with bladder cancer.
    Transl Androl Urol. 2023;12:761-769.
    Abstract     Related articles   

  1188. HU W, Zhang Y, Ning J, Li M, et al
    Corrigendum to "Anti-tumor effect of AZD8055 against bladder cancer and bladder cancer-associated macrophages" [Heliyon 9(3) (March 2023) e14272].
    Heliyon. 2023;9:e15303.
    Abstract     Related articles   

  1189. NASSIR A, Saada H, Bakry S, Al-Zahrani S, et al
    Assessment of the knowledge and awareness of urinary bladder cancer among the general population in Western Saudi Arabia.
    Urol Ann. 2023;15:220-225.
    Abstract     Related articles   

  1190. ALBAKRI M, Abu-Hijlih R, Salah S, Al-Ibraheem A, et al
    Bladder cancer in young adults: Disease and treatment characteristics of patients treated at a tertiary cancer center.
    Urol Ann. 2023;15:207-210.
    Abstract     Related articles   

  1191. VILLOLDO GM, Pombo MT, Aris M, Chemi J, et al
    A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guerin in patients with non-muscle invasive bladder carcinoma: A retrospective study.
    Oncol Res. 2023;31:207-220.
    Abstract     Related articles   

  1192. ERIKSSON P, Berg J, Bernardo C, Bobjer J, et al
    Urodrill - a novel MRI-guided endoscopic biopsy technique to sample and molecularly classify muscle-invasive bladder cancer without fractionating the specimen during transurethral resection.
    Eur Urol Open Sci. 2023;53:78-82.
    Abstract     Related articles   

  1193. YIN J, Cai G, Wang H, Chen W, et al
    SIRT4 is an independent prognostic factor in bladder cancer and inhibits bladder cancer growth by suppressing autophagy.
    Cell Div. 2023;18:9.
    Abstract     Related articles   

  1194. XU PH, Chen S, Wang Y, Jin S, et al
    FGFR3 mutation characterization identifies prognostic and immune-related gene signatures in bladder cancer.
    Comput Biol Med. 2023;162:106976.
    Abstract     Related articles   

  1195. XIA Z, Wang Q, Lu P
    LncRNA LINC00885 promotes bladder cancer progression by targeting the miR-98-5p/PBX3 axis.
    Cell Mol Biol (Noisy-le-grand). 2023;69:163-168.
    Abstract     Related articles   

  1196. KHOURY R, Saleh K, Khalife N, Saleh M, et al
    Mechanisms of Resistance to Antibody-Drug Conjugates.
    Int J Mol Sci. 2023;24:9674.
    Abstract     Related articles   

  1197. PAPASAVVA M, Amvrosiou S, Pilala KM, Soureas K, et al
    Deregulated Expression of IL-37 in Patients with Bladder Urothelial Cancer: The Diagnostic Potential of the IL-37e Isoform.
    Int J Mol Sci. 2023;24:9258.
    Abstract     Related articles   

  1198. MEHUS AA, Jones M, Trahan M, Kinnunen K, et al
    Pevonedistat Inhibits SOX2 Expression and Sphere Formation but Also Drives the Induction of Terminal Differentiation Markers and Apoptosis within Arsenite-Transformed Urothelial Cells.
    Int J Mol Sci. 2023;24:9149.
    Abstract     Related articles   

  1199. ZHENG Q, Jian J, Wang J, Wang K, et al
    Predicting Lymph Node Metastasis Status from Primary Muscle-Invasive Bladder Cancer Histology Slides Using Deep Learning: A Retrospective Multicenter Study.
    Cancers (Basel). 2023;15:3000.
    Abstract     Related articles   

  1200. BACCHIANI M, Salamone V, Massaro E, Sandulli A, et al
    Assessing the Performance of 18F-FDG PET/CT in Bladder Cancer: A Narrative Review of Current Evidence.
    Cancers (Basel). 2023;15:2951.
    Abstract     Related articles   

  1201. SU YL, Xiao LY, Huang SY, Wu CC, et al
    Inhibiting WEE1 Augments the Antitumor Efficacy of Cisplatin in Urothelial Carcinoma by Enhancing the DNA Damage Process.
    Cells. 2023;12:1471.
    Abstract     Related articles   

  1202. NOEL OD, Stewart E, Cress R, Dall'Era MA, et al
    Underutilization of intravesical chemotherapy and immunotherapy for high grade non-muscle invasive bladder cancer in California between 2006-2018: Effect of race, age and socioeconomic status on treatment disparities.
    Urol Oncol. 2023 Jun 8:S1078-1439(23)00194-1. doi: 10.1016/j.urolonc.2023.
    Abstract     Related articles   

  1203. ALI MY, Aboelsaad AY, Abdel Gawad AM, Abouelgreed TA, et al
    HER2/neu expression status of post BCG recurrent non-muscle-invasive bladder urothelial carcinomas in relation to their primary ones.
    Arch Ital Urol Androl. 2023;95:11313.
    Abstract     Related articles   

  1204. GRIZZI F, Chiriva-Internati M, Miranda E, Zaharie R, et al
    Sperm protein antigen 17 and Sperm flagellar 1 cancer testis antigens are expressed in a rare case of ciliated foregut cyst of the common hepatic duct.
    Pathol Res Pract. 2023;247:154546.
    Abstract     Related articles   

  1205. CISTERNINO A, Capone L, Rosati A, Latiano C, et al
    New concept in urologic surgery: The total extended genital sparing radical cystectomy in women.
    Arch Ital Urol Androl. 2023;95:11058.
    Abstract     Related articles   

  1206. NAGAHISA C, Unagami K, Banno T, Oki R, et al
    Kidney Transplantation After Multiple Urinary Tract Conversion with an Ileal Conduit: A Case Report.
    Transplant Proc. 2023 May 14:S0041-1345(23)00252.
    Abstract     Related articles   

  1207. HANZE J, Schulte-Herbruggen J, Hofmann R, Hegele A, et al
    Modulation of immune checkpoint regulators in interferon gamma induced urothelial carcinoma and activated T-lymphocyte cells by cytostatics.
    Genes Immun. 2023;24:149-153.
    Abstract     Related articles   

  1208. DELL'OGLIO P, Tappero S, Panunzio A, Antonelli A, et al
    Age represents the main driver of surgical decision making in patients candidate to radical cystectomy.
    J Surg Oncol. 2023;128:142-154.
    Abstract     Related articles   

  1209. AMIR M, Javed S
    Elucidation of binding dynamics of tyrosine kinase inhibitor tepotinib, to human serum albumin, using spectroscopic and computational approach.
    Int J Biol Macromol. 2023;241:124656.
    Abstract     Related articles   

  1210. SPARWASSER P, Frey L, Fischer ND, Thomas A, et al
    First Comparison of Retroperitoneal Versus Transperitoneal Robot-Assisted Nephroureterectomy with Bladder Cuff: A Single Center Study.
    Ann Surg Oncol. 2023;30:4531-4539.
    Abstract     Related articles   

  1211. MATSUKAWA A, Kimura S, Koike Y, Ajisaka S, et al
    Feasibility of Novel Technique of Flexible Cystoscopic En Bloc Snare Resection of Bladder Tumor: f-ESRBT.
    J Endourol. 2023;37:713-717.
    Abstract     Related articles   

  1212. SAKUMO K, Morihashi K, Nakamura A, Nukaya T, et al
    The usefulness of nuclear area in the diagnosis of high-grade urothelial carcinoma cells in voided urine cytology.
    Cytopathology. 2023;34:295-301.
    Abstract     Related articles   

  1213. CHEN M, Yao K, Cao M, Liu H, et al
    HER2-targeting antibody-drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study.
    Cancer Immunol Immunother. 2023;72:2309-2318.
    Abstract     Related articles   

  1214. NIELSEN TJ, Varga MG, Cronister CT, Ring BZ, et al
    The 27-gene IO score is associated with efficacy of PD-1/L1 inhibitors independent of FGFR expression in a real-world metastatic urothelial carcinoma cohort.
    Cancer Immunol Immunother. 2023;72:2075-2086.
    Abstract     Related articles   

  1215. YAMADA S, Miyata H, Isono M, Hori K, et al
    Cisplatin resistance driver claspin is a target for immunotherapy in urothelial carcinoma.
    Cancer Immunol Immunother. 2023;72:2057-2065.
    Abstract     Related articles   

  1216. CHOUDHURY S, Kamble V, Jana D, Pal DK, et al
    Thulium laser enucleation of bladder tumour (Thulebt): Changing paradigm in the management of nonmuscle invasive urinary bladder carcinoma.
    Urologia. 2023;90:266-271.
    Abstract     Related articles   

  1217. SAMI MM, Sherief MH, El-Abaseri TB, El-Sakka AI, et al
    Expression of epidermal growth factor receptor and human epidermal growth factor receptor 2 in urothelial bladder carcinoma in an Egyptian cohort: Clinical implication and prognostic significance.
    Urologia. 2023;90:248-260.
    Abstract     Related articles   

  1218. FISCHER AH, Wong JY, Baris D, Koutros S, et al
    Urine pH and Risk of Bladder Cancer in Northern New England.
    Cancer Epidemiol Biomarkers Prev. 2023 Jun 23:EPI-22-0801.
    Abstract     Related articles   

  1219. DENG Z, Tang N, Xiong W, Lei X, et al
    Inflammation-related research within the field of bladder cancer: a bibliometric analysis.
    Front Oncol. 2023;13:1126897.
    Abstract     Related articles   

  1220. WU Y, Deng Y, Dai Z, Ma Y, et al
    Estimates of bladder cancer burden attributable to high fasting plasma glucose: Findings of the Global Burden of Disease Study 2019.
    Cancer Med. 2023 Jun 23. doi: 10.1002/cam4.6219.
    Abstract     Related articles   

  1221. ISALI I, Khooblall P, Helstrom E, Bukavina L, et al
    Targeting bladder cancer: A sex sensitive perspective in mutations and outcomes.
    Urol Oncol. 2023 Jun 20:S1078-1439(23)00166.
    Abstract     Related articles   

  1222. DIEFENBACH MA, Marziliano A, Siembida EJ, Mistretta T, et al
    Cancer Resource and Information Support (CRIS) for Bladder Cancer Survivors and Their Caregivers: Development and Usability Testing Study.
    JMIR Form Res. 2023;7:e41876.
    Abstract     Related articles   

  1223. AYDH A, Sari Motlagh R, Alamri A, Yanagisawa T, et al
    Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes.
    World J Urol. 2023 Jun 22. doi: 10.1007/s00345-023-04478.
    Abstract     Related articles   

  1224. HE L, Wang X, Chen P, Du C, et al
    Knockdown of ZNF280A inhibits cell proliferation and promotes cell apoptosis of bladder cancer.
    Histol Histopathol. 2023 Jun 13:18640. doi: 10.14670.
    Abstract     Related articles   

  1225. ZHI Y, Cai C, Xu T, Sun F, et al
    Silencing of FGF6 hampers aerobic glycolysis and angiogenesis in bladder cancer by regulating PI3K/Akt and MAPK signaling pathways.
    J Biochem Mol Toxicol. 2023 Jun 22:e23399. doi: 10.1002/jbt.23399.
    Abstract     Related articles   

  1226. GEDERAAS OA, Sharma A, Mbarak S, Sporsheim B, et al
    Proteomic analysis reveals mechanisms underlying increased efficacy of bleomycin by photochemical internalization in bladder cancer cells.
    Mol Omics. 2023 Jun 22. doi: 10.1039/d2mo00337.
    Abstract     Related articles   

  1227. LEE D, Lee W, Kim HP, Kim M, et al
    Accurate Detection of Urothelial Bladder Cancer Using Targeted Deep Sequencing of Urine DNA.
    Cancers (Basel). 2023;15:2868.
    Abstract     Related articles   

  1228. TICHANEK F, Forsti A, Hemminki A, Hemminki O, et al
    Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century.
    Cancers (Basel). 2023;15:2782.
    Abstract     Related articles   

  1229. YOU C, Li Q, Yang Y, Qing L, et al
    Extraperitoneal Versus Intraperitoneal Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2023 Jun 21. doi: 10.1245/s10434-023-13744.
    Abstract     Related articles   

  1230. BUNDELL S, Petric Howe N
    Why bladder cancer cells that shed their Y chromosome become more aggressive.
    Nature. 2023 Jun 21. doi: 10.1038/d41586-023-02069.
    Abstract     Related articles   

  1231. MEI Y, Wu Y, Ma L, Zhang H, et al
    Retraction Note: Overexpression of ROCK1 promotes cancer cell proliferation and is associated with poor prognosis in human urothelial bladder cancer.
    Mamm Genome. 2023 Jun 21. doi: 10.1007/s00335-023-10002.
    Abstract     Related articles   

  1232. MARK JR, Gomella LG, Lallas CD, Smentkowski KE, et al
    Enhancing bladder cancer care through the multidisciplinary clinic approach.
    Can J Urol. 2023;30:11526-11531.
    Abstract     Related articles   

  1233. GHALI F, Vakar-Lopez F, Roudier MP, Garcia J, et al
    Metastatic Bladder Cancer Expression and Subcellular Localization of Nectin-4 and Trop-2 in Variant Histology: A Rapid Autopsy Study.
    Clin Genitourin Cancer. 2023 May 25:S1558-7673(23)00132.
    Abstract     Related articles   

  1234. CASTRO-ALONSO FJ, Beas-Lozano E, Remolina-Bonilla YA, Flaig TW, et al
    Erdafitinib in the Treatment of Metastatic Urothelial Carcinoma.
    Oncology (Williston Park). 2023;37:256-261.
    Abstract     Related articles   

  1235. HANNA K
    Erdafitinib's Road to Approval and Use in Urothelial Carcinoma.
    Oncology (Williston Park). 2023;37:260-261.
    Abstract     Related articles   

  1236. YOU C, Dong Z
    ASO Author Reflections: A Safe and Feasible Procedure for Bladder Cancer-Extraperitoneal Radical Cystectomy.
    Ann Surg Oncol. 2023 Jun 21. doi: 10.1245/s10434-023-13789.
    Abstract     Related articles   

  1237. CHOI J, Jung TY, Kim JH, Maeng S, et al
    Efficacy of recombinant Bacillus Calmette-Guerin containing dltA in in vivo three-dimensional bio-printed bladder cancer-on-a-chip and ex vivo orthotopic mouse model.
    Investig Clin Urol. 2023;64:296-305.
    Abstract     Related articles   

  1238. WANG S, Yuan X, Shen Z, Zhao J, et al
    Therapeutic responses to chemotherapy or immunotherapy by molecular subtype in bladder cancer patients: A meta-analysis and systematic review.
    Investig Clin Urol. 2023;64:229-241.
    Abstract     Related articles   

  1239. KIM KH, Lee HW, Ha HK, Seo HK, et al
    Perioperative systemic therapy in muscle invasive bladder cancer: Current standard method, biomarkers and emerging strategies.
    Investig Clin Urol. 2023;64:202-218.
    Abstract     Related articles   

  1240. HU M, Pan D, Wei Y, Ye L, et al
    Atypical Recurrent Renal Cell Carcinoma of the Ipsilateral Ureter Showing Typical Symptoms of Upper Urinary Tract Urothelial Carcinoma: A Case Report and Literature Review.
    Arch Esp Urol. 2023;76:238-244.
    Abstract     Related articles   

  1241. ZHOU Y, Yang H, Liang Z
    Efficiency and Safety of Laparoscopic Radical Cystectomy for Muscle-Invasive Bladder Cancer, and Postoperative Recurrence.
    Arch Esp Urol. 2023;76:196-202.
    Abstract     Related articles   

  1242. LU X, Chen L, Liu S, Cao Y, et al
    m(6)A-mediated upregulation of lncRNA RMRP boosts the progression of bladder cancer via epigenetically suppressing SCARA5.
    Epigenomics. 2023 Jun 20. doi: 10.2217/epi-2023-0062.
    Abstract     Related articles   

  1243. VERGHOTE F, Van Praet C, De Maeseneer D, Berquin C, et al
    Radiotherapy Use in Muscle-Invasive Bladder Cancer: Review of the Guidelines and Impact of Increased Awareness in Patient Referral at a Tertiary Center in Belgium.
    Cancer Manag Res. 2023;15:511-521.
    Abstract     Related articles   

  1244. LU Z, Lu Z, Lai Y, Zhou H, et al
    A comprehensive analysis of FBN2 in bladder cancer: A risk factor and the tumour microenvironment influencer.
    IET Syst Biol. 2023 Jun 19. doi: 10.1049/syb2.12067.
    Abstract     Related articles   

  1245. WEI F, Li T, Li J, Zhang Y, et al
    Prognostic and Immunological Role of Asporin across Cancers and Exploration in Bladder Cancer.
    Gene. 2023 Jun 17:147573. doi: 10.1016/j.gene.2023.147573.
    Abstract     Related articles   

  1246. LA MAESTRA S, Benvenuti M, D'Agostini F, Micale RT, et al
    Comet-FISH analysis of urothelial cells. A screening opportunity for bladder cancer?
    Expert Rev Mol Diagn. 2023 Jun 21:1-11. doi: 10.1080/14737159.2023.2227381.
    Abstract     Related articles   

  1247. GRABE-HEYNE K, Henne C, Mariappan P, Geiges G, et al
    Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs.
    Front Oncol. 2023;13:1170124.
    Abstract     Related articles   

  1248. RADOSAVLJEVIC V, Milic N
    Bladder cancer screening: The new selection and prediction model.
    Open Med (Wars). 2023;18:20230723.
    Abstract     Related articles   

  1249. MUKHERJEE D, Romano E, Walshaw R, Zeef LAH, et al
    Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1.
    Oncoimmunology. 2023;12:2223094.
    Abstract     Related articles   

  1250. CRUPI E, de Padua TC, Marandino L, Raggi D, et al
    Circulating tumor DNA as a Predictive and Prognostic Biomarker in the Perioperative Treatment of Muscle-invasive Bladder Cancer: A Systematic Review.
    Eur Urol Oncol. 2023 Jun 15:S2588-9311(23)00111.
    Abstract     Related articles   

  1251. OH TJ, Lee JY, Seo Y, Woo MA, et al
    Evaluation of Sensitive Urine DNA-based PENK Methylation Test for Detecting Bladder Cancer in Patients with Hematuria.
    J Mol Diagn. 2023 Jun 15:S1525-1578(23)00131.
    Abstract     Related articles   

  1252. VANNESTE M, van der Heij B, Christiaansen CE, Berendsen CL, et al
    Implications of the COVID19 pandemic on the need and timing of second transurethral bladder tumour resection in high-grade non-muscle invasive bladder cancer.
    World J Urol. 2023 Jun 17. doi: 10.1007/s00345-023-04469.
    Abstract     Related articles   

  1253. ERYURUK U, Tasdemir MN, Aslan S
    Comparison of the diagnostic performance of biparametric and multiparametric MRI in detecting muscle invasion of bladder cancer located at the ureteral orifice.
    Abdom Radiol (NY). 2023 Jun 16. doi: 10.1007/s00261-023-03979.
    Abstract     Related articles   

  1254. NIZIOL J, Ossolinski K, Plaza-Altamer A, Kolodziej A, et al
    Untargeted urinary metabolomics for bladder cancer biomarker screening with ultrahigh-resolution mass spectrometry.
    Sci Rep. 2023;13:9802.
    Abstract     Related articles   

  1255. TAN WS, Hall E, Kamat AM, Kelly JD, et al
    Clinical trial design for non-muscle-invasive bladder cancer.
    Nat Rev Urol. 2023 Jun 16. doi: 10.1038/s41585-023-00789.
    Abstract     Related articles   

  1256. YANG L, Huang W, Bai X, Wang H, et al
    Androgen dihydrotestosterone promotes bladder cancer cell proliferation and invasion via EPPK1-mediated MAPK/JUP signalling.
    Cell Death Dis. 2023;14:363.
    Abstract     Related articles   

  1257. SINGH P, Rotte A, Golsorkhi AA, Girish S, et al
    Optimizing outcomes and managing adverse events in locally advanced or metastatic urothelial cancer: a clinical pharmacology perspective.
    Expert Rev Clin Pharmacol. 2023;16:533-548.
    Abstract     Related articles   

  1258. HUGAR LA, Geiss C, Chavez MN, Gore LR, et al
    Exploring knowledge, perspectives, and misperceptions of palliative care: A mixed methods analysis.
    Urol Oncol. 2023;41:327.
    Abstract     Related articles   

  1259. KHORSANDI N, Ding CC, VandenBussche CJ, Verduzco CS, et al
    Urine cytology in patients with gender confirmation surgery and hormone therapy: evaluation of urine cytology performance in an underserved patient population.
    J Am Soc Cytopathol. 2023;12:267-274.
    Abstract     Related articles   

  1260. ZHANG C, Wang M, Ying Y, Meng F, et al
    Knockdown of kinesin family member 4A inhibits cell proliferation, migration, and invasion while promoting apoptosis of urothelial bladder carcinoma cells.
    Cancer Med. 2023;12:12581-12592.
    Abstract     Related articles   

  1261. COOK EE, Harrison BT, Hirsch MS
    TRPS1 expression is sensitive and specific for primary extramammary Paget disease.
    Histopathology. 2023;83:104-108.
    Abstract     Related articles   

  1262. HENSLEY PJ, Seiler R, Herr H, Mouw KW, et al
    Bladder preservation after neoadjuvant therapy - 2021 IBCN updates part 1.
    Urol Oncol. 2023;41:307-312.
    Abstract     Related articles   

  1263. FERREIRA GM, Lima APB, Pereira GR, Silva GND, et al
    Synthesis, characterization and antiproliferative effects of naphtho [2,3-b] thiophen-4,9-quinone on bladder tumor cells.
    Nat Prod Res. 2023;37:2285-2292.
    Abstract     Related articles   

  1264. CHI Z, Balani J, Gopal P, Hammer S, et al
    GATA3 positivity is associated with poor prognosis in patients with oesophageal squamous cell carcinoma.
    J Clin Pathol. 2023;76:474-479.
    Abstract     Related articles   

  1265. ZHOU R, Zhou J, Muhuitijiang B, Zeng X, et al
    Construction and experimental validation of a B cell-related gene signature to predict the prognosis and immunotherapeutic sensitivity in bladder cancer.
    Aging (Albany NY). 2023;15.
    Abstract     Related articles   

  1266. BHONGIR AV, Sampath S, Bonthapally RK, Gudivada KK, et al
    Sequential Application and Post-Test Probability for Screening of Bladder Cancer Using Urinary Proteomic Biomarkers: A Review based Probabilistic Analysis.
    Asian Pac J Cancer Prev. 2023;24:2021-2027.
    Abstract     Related articles   

  1267. OFFICE FE
    Retraction: Long noncoding RNA SNHG1 activates autophagy and promotes cell invasion in bladder cancer.
    Front Oncol. 2023;13:1228367.
    Abstract     Related articles   

  1268. BOGUMIL D, Cortessis VK, Wilkens LR, Le Marchand L, et al
    Interethnic Differences in Bladder Cancer Incidence and the Association between Type 2 Diabetes and Bladder Cancer in the Multiethnic Cohort Study.
    Cancer Res Commun. 2023;3:755-762.
    Abstract     Related articles   

  1269. GUAN X, Lu D, Chen Z, Wang Z, et al
    Non-invasive detection of bladder cancer via microfluidic immunoassay of the protein biomarker NMP22.
    Anal Methods. 2023 Jun 28. doi: 10.1039/d3ay00664.
    Abstract     Related articles   

  1270. NIKULAINEN I, Salminen AP, Seikkula H, Hogerman M, et al
    Nationwide analysis of survival after radical cystectomy for bladder cancer in Finland.
    Acta Oncol. 2023 Jun 28:1-7. doi: 10.1080/0284186X.2023.2228446.
    Abstract     Related articles   

  1271. MYINT ZW, Chahine Z, Jayswal R, Bachert E, et al
    Association of CD47 Expression with Clinicopathologic Characteristics and Survival Outcomes in Muscle Invasive Bladder Cancer.
    J Pers Med. 2023;13:885.
    Abstract     Related articles   

  1272. GILYAZOVA I, Enikeeva K, Rafikova G, Kagirova E, et al
    Epigenetic and Immunological Features of Bladder Cancer.
    Int J Mol Sci. 2023;24:9854.
    Abstract     Related articles   

  1273. JORDAENS S, Oeyen E, Willems H, Ameye F, et al
    Protein Biomarker Discovery Studies on Urinary sEV Fractions Separated with UF-SEC for the First Diagnosis and Detection of Recurrence in Bladder Cancer Patients.
    Biomolecules. 2023;13:932.
    Abstract     Related articles   

  1274. LUI G, Minnar CM, Soon-Shiong P, Schlom J, et al
    Exploiting an Interleukin-15 Heterodimeric Agonist (N803) for Effective Immunotherapy of Solid Malignancies.
    Cells. 2023;12:1611.
    Abstract     Related articles   

  1275. ABDELAZIZ A, Sultan M, Hammad MA, Martinez JR Jr, et al
    Endophytic upper tract urothelial carcinoma in a solitary kidney treated by cryotherapy: an unorthodox case for successful management.
    BMC Urol. 2023;23:111.
    Abstract     Related articles   

  1276. LEE YJ, Kang SG, Kim CH
    Over-expression of Long Non-coding RNA Urothelial Cancer-associated 1 as a Predictive Marker for Prostate Cancer.
    In Vivo. 2023;37:1511-1516.
    Abstract     Related articles   

  1277. WILLIAMS SB, Janes JL, Howard LE, Yang R, et al
    Exposure to Agent Orange and Risk of Bladder Cancer Among US Veterans.
    JAMA Netw Open. 2023;6:e2320593.
    Abstract     Related articles   

  1278. SHIRONO Y, Bilim V, Anraku T, Kuroki H, et al
    Targeting Pro-Survival Autophagy Enhanced GSK-3beta Inhibition-Induced Apoptosis and Retarded Proliferation in Bladder Cancer Cells.
    Curr Oncol. 2023;30:5350-5365.
    Abstract     Related articles   

  1279. PANUNZIO A, Gozzo A, Mazzucato G, Ornaghi PI, et al
    Impairment in Activities of Daily Living Assessed by the Barthel Index Predicts Adverse Oncological Outcomes After Radical Cystectomy for Bladder Cancer.
    Clin Genitourin Cancer. 2023 Jun 9:S1558-7673(23)00141.
    Abstract     Related articles   

  1280. SHEN C, Zhang S, Zhang Z, Yang S, et al
    Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data.
    Funct Integr Genomics. 2023;23:211.
    Abstract     Related articles   

  1281. LEVY JJ, Chan N, Marotti JD, Rodrigues NJ, et al
    Examining longitudinal markers of bladder cancer recurrence through a semiautonomous machine learning system for quantifying specimen atypia from urine cytology.
    Cancer Cytopathol. 2023 Jun 26. doi: 10.1002/cncy.22725.
    Abstract     Related articles   

  1282. A BUENO AP, Clark O, Turnure M, Moreira ES, et al
    Physician reported treatment patterns and outcomes in metastatic bladder cancer in the USA: the CancerMPact((R)) Survey 2020.
    Future Oncol. 2023 Jun 26. doi: 10.2217/fon-2022-1066.
    Abstract     Related articles   

  1283. CAGLAYAN A, Horsanali MO
    Can Peripheral Blood Systemic Immune Response Parameters Predict Oncological Outcomes in Patients with Non-Muscle-Invasive Bladder Cancer?
    Niger J Clin Pract. 2023;26:591-598.
    Abstract     Related articles   

  1284. HONG BA, Zhao Q, Ji YP, Cao YD, et al
    [The preliminary efficacy of "quadri-combination" therapy on the treatment of bladder cancer].
    Zhonghua Yi Xue Za Zhi. 2023;103:1855-1859.
    Abstract     Related articles   

  1285. CAYUELA L, Medina-Lopez R, Lendinez-Cano G, Cayuela A, et al
    Bladder cancer mortality trends in Spain: 1980-2021.
    Actas Urol Esp (Engl Ed). 2023 Jun 22:S2173-5786(23)00070.
    Abstract     Related articles   

  1286. PYRGIDIS N, Sokolakis I, Haltmair G, Hatzichristodoulou G, et al
    The perioperative and long-term outcomes of patients with variant histology bladder cancer undergoing radical cystectomy: A propensity score-matched analysis with pure urothelial carcinoma.
    Actas Urol Esp (Engl Ed). 2023 Jun 22:S2173-5786(23)00071.
    Abstract     Related articles   

  1287. ZHAO Y, Lu K, Yin ZX, Peng YH, et al
    Systematic review and meta-analysis of completely retroperitoneoscopic nephroureterectomy versus traditional retroperitoneoscopic nephroureterectomy in upper tract urothelial carcinoma.
    Medicine (Baltimore). 2023;102:e34112.
    Abstract     Related articles   

  1288. SUN JX, Xia QD, Zhong XY, Liu Z, et al
    The bladder microbiome of NMIBC and MIBC patients revealed by 2bRAD-M.
    Front Cell Infect Microbiol. 2023;13:1182322.
    Abstract     Related articles   

  1289. SINGH AM, Guevara-Patino JA, Wang X, Li R, et al
    Antibody-Drug Conjugates in the Treatment of Urothelial Cancer.
    BioDrugs. 2023;37:505-520.
    Abstract     Related articles   

  1290. XIONG CC, Zhu SS, Yan DH, Yao YD, et al
    Rapid and precise detection of cancers via label-free SERS and deep learning.
    Anal Bioanal Chem. 2023;415:3449-3462.
    Abstract     Related articles   

  1291. TAGUCHI S, Kawai T, Buti S, Bersanelli M, et al
    Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumab.
    Immunotherapy. 2023;15:827-837.
    Abstract     Related articles   

  1292. SHI R, Le Tan MT, Lim GH, Du J, et al
    Prognostic Value of Tumor Budding in Urothelial Carcinoma: A Meta-Analysis and Systematic Review.
    Lab Invest. 2023;103:100136.
    Abstract     Related articles   

  1293. WONG MN, Wu DJ, Lee CT, Zynger DL, et al
    Renal Pelvic Urothelial Carcinoma With Invasion Into Renal Medulla Can Be Redefined as pT2 to Improve Correlation With Survival.
    Mod Pathol. 2023;36:100140.
    Abstract     Related articles   

  1294. KOWALEWSKI KF, Wieland VLS, Kriegmair MC, Uysal D, et al
    Robotic-assisted Versus Laparoscopic Versus Open Radical Cystectomy-A Systematic Review and Network Meta-analysis of Randomized Controlled Trials.
    Eur Urol Focus. 2023;9:480-490.
    Abstract     Related articles   

  1295. WANG LJ, Liu ZX, Hu W, Liu Y, et al
    [Research Progress in Preoperative Evaluation of Lymph Node Metastasis of Bladder Cancer].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2023;45:464-470.
    Abstract     Related articles   

  1296. ECKE TH, Meisl CJ, Schlomm T Prof, Rabien A, et al
    BTA stat(R), NMP22(R) BladderChek(R), UBC(R) Rapid Test, and CancerCheck(R) UBC(R) rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter study.
    Urol Oncol. 2023 Jul 3:S1078-1439(23)00225-9. doi: 10.1016/j.urolonc.2023.
    Abstract     Related articles   

  1297. ADOMI S, Fujita K, Kita H, Kuwahara K, et al
    Prognosis of Patients Receiving Chemotherapy for Metastatic Upper Tract Urothelial Carcinoma Compared With Metastatic Urinary Bladder Cancer.
    Cancer Diagn Progn. 2023;3:484-490.
    Abstract     Related articles   

  1298. SUHARA Y, Urabe F, Hashimoto M, Nakazono M, et al
    A case of eosinophilic cystitis coexisting of superficial bladder cancer, mimicking muscle-invasive cancer.
    IJU Case Rep. 2023;6:230-234.
    Abstract     Related articles   

  1299. MURATA Y, Shinojima T, Nakahira Y, Hamada M, et al
    Recurrent urethral tumor with neuroendocrine differentiation in a female patient after radical cystectomy for bladder cancer.
    IJU Case Rep. 2023;6:199-202.
    Abstract     Related articles   

  1300. NIE J, Liu T, Mao T, Yang H, et al
    Transcriptome sequencing and single-cell sequencing analysis identify GARS1 as a potential prognostic and immunotherapeutic biomarker for multiple cancers, including bladder cancer.
    Front Immunol. 2023;14:1169588.
    Abstract     Related articles   

  1301. SHAKHSSALIM N, Talebi A, Pahlevan-Fallahy MT, Sotoodeh K, et al
    Lifestyle and occupational risks assessment of bladder cancer using machine learning-based prediction models.
    Cancer Rep (Hoboken). 2023 Jul 5:e1860. doi: 10.1002/cnr2.1860.
    Abstract     Related articles   

  1302. ALAMEDDINE R, Mallea P, Shahab F, Zakharia Y, et al
    Antibody Drug Conjugates in Bladder Cancer: Current Milestones and Future Perspectives.
    Curr Treat Options Oncol. 2023 Jul 5. doi: 10.1007/s11864-023-01114.
    Abstract     Related articles   

  1303. SHOAYDAROV MA, Martov AG, Andronov AS, Dutov SV, et al
    [Experience in the use of confocal laser endomicroscopy for the diagnosis of bladder papillary tumors].
    Urologiia. 2023;:99-106.
    Abstract     Related articles   

  1304. GUIGNAND A, Bouleftour W, Vassal C, Tinquaut F, et al
    The Impact of an Enrolment in Clinical Trial on Tolerance and Pathological Response for Patients Treated by Neoadjuvant MVAC Against an Invasive Bladder Cancer. A Retrospective Comparative Study.
    Clin Genitourin Cancer. 2023 Jun 15:S1558-7673(23)00145.
    Abstract     Related articles   

  1305. RAFIEI S, Kheradkhah G, Kotronoulas G, Doustmehraban M, et al
    Quality of life in bladder cancer: systematic review and meta-analysis.
    BMJ Support Palliat Care. 2023 Jul 3:spcare-2023-004185.
    Abstract     Related articles   

  1306. LI Y, Chen T, Fu B, Luo Y, et al
    Survival nomogram for high-grade bladder cancer patients after surgery based on the SEER database and external validation cohort.
    Front Oncol. 2023;13:1164401.
    Abstract     Related articles   

  1307. ZHANG M, Zhu J, Zhang P, Li L, et al
    Development and validation of cancer-associated fibroblasts-related gene landscape in prognosis and immune microenvironment of bladder cancer.
    Front Oncol. 2023;13:1174252.
    Abstract     Related articles   

  1308. ZIANI I, Ibrahimi A, Zaoui Y, El Sayegh H, et al
    Role of preoperative neutrophil to lymphocyte ratio in prediction of recurrence, progression, and BCG failure in non-muscle invasive bladder cancer: a retrospective study.
    Pan Afr Med J. 2023;44:145.
    Abstract     Related articles   

  1309. AGRAWAL M, Malvi G, Agrawal N, Narayanaswamy S, et al
    Ileal neobladder adenocarcinoma occurring twenty-five years post ileocystoplasty: a case report.
    Pan Afr Med J. 2023;44:149.
    Abstract     Related articles   

  1310. ZHAN Y, Chen Z, Li Y, He A, et al
    Correction: Long non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149/MSI2 axis as a ceRNA.
    J Exp Clin Cancer Res. 2023;42:157.
    Abstract     Related articles   

  1311. LI Z, Fu H, Liu J, Song W, et al
    LncRNA PVT1 promotes bladder cancer progression by forming a positive feedback loop with STAT5B.
    Pathol Res Pract. 2023;248:154635.
    Abstract     Related articles   

  1312. JU M, Wu W, Qu J, Sun Y, et al
    Downregulation of circular RNA hsa_circ_0087856 sensitizes bladder cancer cells to cisplatin through targeting miR-1184/CITED2 signaling.
    Environ Mol Mutagen. 2023 Jul 1. doi: 10.1002/em.22561.
    Abstract     Related articles   

  1313. YANG L, Wu X, Zhou J, Song P, et al
    Second malignant tumors and non-tumor causes of death for patients with localized and regional kidney cancer after diagnosis.
    Eur J Med Res. 2023;28:206.
    Abstract     Related articles   

  1314. CANO VELASCO J, Polanco Pujol L, Moreno Cortes JC, Lafuente Puentedura A, et al
    Bladder Epicheck(R) for surveillance in high-risk non-muscle-invasive bladder cancer: Initial experience.
    Actas Urol Esp (Engl Ed). 2023 Jun 28:S2173-5786(23)00075.
    Abstract     Related articles   

  1315. QIU S, Qiu Y, Deng L, Nie L, et al
    Cell softness reveals tumorigenic potential via ITGB8/AKT/glycolysis signaling in a mice model of orthotopic bladder cancer.
    Chin Med J (Engl). 2023 Jun 30. doi: 10.1097/CM9.0000000000002710.
    Abstract     Related articles   

  1316. FENG J, Wang M, Du GS, Peng K, et al
    Crosstalk between autophagy and bladder transitional cell carcinoma by autophagy-related lncRNAs.
    Medicine (Baltimore). 2023;102:e34130.
    Abstract     Related articles   

  1317. TERLEVIC R, Ulamec M, Stimac G, Murgic J, et al
    Molecular classification of muscle-invasive bladder cancer based on a simplified immunohistochemical panel using GATA3, CK5/6 and p16.
    Biomol Biomed. 2023 Jun 21. doi: 10.17305/bb.2023.9242.
    Abstract     Related articles   

  1318. DIXON S, Hill H, Flight L, Khetrapal P, et al
    Cost-Effectiveness of Robot-Assisted Radical Cystectomy vs Open Radical Cystectomy for Patients With Bladder Cancer.
    JAMA Netw Open. 2023;6:e2317255.
    Abstract     Related articles   

  1319. TANG Y, Lin L, Xiao Y, Meng L, et al
    Predictors of trimodality therapy in patients with muscle-invasive bladder cancer and effect on survival.
    Clin Transl Oncol. 2023 Jun 30. doi: 10.1007/s12094-023-03264.
    Abstract     Related articles   

  1320. SATCHITHANANTHAM V, Babiker T, Riding G, Banihani M, et al
    A case of mycotic infrarenal abdominal aortic aneurysm after bacillus Calmette-Guerin immunotherapy for bladder cancer and a review of the literature.
    J Vasc Surg Cases Innov Tech. 2023;9:101213.
    Abstract     Related articles   

  1321. LONGEVITY OMAC
    Retracted: LINC00958 Inhibits Autophagy of Bladder Cancer Cells via Sponge Adsorption of miR-625-5p to Promote Tumor Angiogenesis and Oxidative Stress.
    Oxid Med Cell Longev. 2023;2023:9812826.
    Abstract     Related articles   


  1322. Y Chromosome Loss Drives Bladder Cancer Aggressiveness and Immune Evasion.
    Cancer Discov. 2023 Jun 30:OF1. doi: 10.1158/2159-8290.CD-RW2023.
    Abstract     Related articles   

  1323. YANG YJ, Xu XQ, Zhang YC, Hu PC, et al
    Establishment of a prognostic model related to tregs and natural killer cells infiltration in bladder cancer.
    World J Clin Cases. 2023;11:3444-3456.
    Abstract     Related articles   

  1324. SONG W, Li Z, Yang K, Gao Z, et al
    Antisense lncRNA-RP11-498C9.13 promotes bladder cancer progression by enhancing reactive oxygen species-induced mitophagy.
    J Gene Med. 2023 Jun 29:e3527. doi: 10.1002/jgm.3527.
    Abstract     Related articles   

  1325. ZHANG M, Qin J, Guo X, Li Z, et al
    Recognition Imaging of Trace E-cadherins on the Bladder Cancer Cells Surface during Epithelial-Mesenchymal Transition by Force-Distance Curve-Based AFM.
    Nano Lett. 2023 Jun 29. doi: 10.1021/acs.nanolett.3c01667.
    Abstract     Related articles   

  1326. PANER GP, Kamat A, Netto GJ, Samaratunga H, et al
    International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non
    Am J Surg Pathol. 2023 Jun 29. doi: 10.1097/PAS.0000000000002077.
    Abstract     Related articles   

  1327. KOTERAZAWA S, Somiya S, Ito K, Haitani T, et al
    The useful technique of laparoscopic segmental ureterectomy with ureteral reimplantation for distal upper tract urothelial carcinoma.
    Asian J Endosc Surg. 2023;16:666-672.
    Abstract     Related articles   

  1328. FRANZ A, Plage H, Fendler A, Schlomm T, et al
    [Precision oncology options in urological cancers].
    Urologie. 2023;62:696-704.
    Abstract     Related articles   

  1329. GRIMM MO, Foller S, Leeder M, Leucht K, et al
    [Antibody-drug conjugates as new therapeutic agents in uro-oncology].
    Urologie. 2023;62:679-684.
    Abstract     Related articles   

  1330. YAMAMOTO D, Kotake M, Ishibayashi K, Fujimori D, et al
    Robot-assisted low anterior resection for a rectal cancer patient with ileal conduit: A case report.
    Asian J Endosc Surg. 2023;16:608-612.
    Abstract     Related articles   

  1331. GALFFY G, Lugowska I, Poddubskaya EV, Cho BC, et al
    A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naive, cisplatin-ineligible urothelial cancer.
    ESMO Open. 2023;8:101173.
    Abstract     Related articles   

  1332. NAKAMURA K, Ishiyama Y, Nemoto Y, Ishihara H, et al
    Association between lung immune prognostic index and survival of patients with metastatic urothelial carcinoma treated with pembrolizumab.
    Int J Clin Oncol. 2023;28:913-921.
    Abstract     Related articles   

  1333. NAKAGAWA R, Nohara T, Naito R, Kadomoto S, et al
    Intravesical BCG therapy with photodynamic diagnosis-guided transurethral resection of bladder tumors improves recurrence-free survival.
    Photodiagnosis Photodyn Ther. 2023;42:103574.
    Abstract     Related articles   

  1334. MIYAKE M, Hori S, Fujii T, Nishimura N, et al
    Clinical practice of UroVysion(R) urine test in patients with bladder carcinoma in situ treated with intravesical Bacillus Calmette-Guerin.
    Jpn J Clin Oncol. 2023;53:629-632.
    Abstract     Related articles   

  1335. ROSE KM, Huelster HL, Meeks JJ, Faltas BM, et al
    Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic disease.
    Nat Rev Urol. 2023;20:406-419.
    Abstract     Related articles   

  1336. CASTELLARNAU S, Gaya JM, Espinosa J, Sierra P, et al
    Clinical impact of the suspension of the ERAS protocol on patients undergoing radical cystectomy during the COVID-19 pandemic.
    Actas Urol Esp (Engl Ed). 2023;47:369-375.
    Abstract     Related articles   

  1337. PANACH-NAVARRETE J, Devis-Peiro A, Lloret-Dura MA, Sanchez-Gimeno S, et al
    Quality of life in patients with non-muscle invasive bladder tumor undergoing adjuvant intravesical treatment.
    Actas Urol Esp (Engl Ed). 2023;47:360-368.
    Abstract     Related articles   

  1338. CHUNG CJ, Lee HL, Chang CH, Wu CD, et al
    Determination of potential sources of heavy metals in patients with urothelial carcinoma in central Taiwan: a biomonitoring case-control study.
    Environ Geochem Health. 2023;45:5401-5414.
    Abstract     Related articles   

  1339. MA J, Yu C, Li X, Zhang Y, et al
    A rare case of perivascular epithelioid-cell tumor of the bladder.
    Asian J Surg. 2023;46:2748-2749.
    Abstract     Related articles   

  1340. CHING D, Chiu SK, Van Vliet C, Jasim A, et al
    Primary ALK-Negative TP63-Rearranged Anaplastic Large Cell Lymphoma in the Bladder: Potential for Misdiagnosis.
    Int J Surg Pathol. 2023;31:612-615.
    Abstract     Related articles   

  1341. ELLERKAMP V, Schmidt A, Warmann SW, Eckert F, et al
    Detailed functional results after bladder-preserving surgery and high-dose-rate brachytherapy in pediatric bladder/prostate rhabdomyosarcoma.
    J Cancer Res Clin Oncol. 2023;149:3161-3170.
    Abstract     Related articles   

  1342. MELLGARD G, Patel VG, Zhong X, Joshi H, et al
    Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors.
    J Cancer Res Clin Oncol. 2023;149:2833-2841.
    Abstract     Related articles   

  1343. GILES M, Crabb SJ
    Systemic Treatment-Decision Algorithms in Muscle-Invasive Bladder Cancer: Clinical Complexities and Navigating for Improved Outcomes.
    Res Rep Urol. 2023;15:321-331.
    Abstract     Related articles   

  1344. ZHU Z, Li X, Liu D, Li Z, et al
    A novel signature of aging-related genes associated with lymphatic metastasis for survival prediction in patients with bladder cancer.
    Front Oncol. 2023;13:1140891.
    Abstract     Related articles   

  1345. TAN WS, Grajales V, Contieri R, Hensley P, et al
    Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes.
    Eur Urol Open Sci. 2023;53:16-22.
    Abstract     Related articles   

  1346. YU G, Rice S, Heer R, Lewis R, et al
    Photodynamic Diagnosis-guided Transurethral Resection of Bladder Tumour in Participants with a First Suspected Diagnosis of Intermediate- or High-risk Non-muscle-invasive Bladder Cancer: Cost-effectiveness Analysis Alongside a Randomised Controlled Tr
    Eur Urol Open Sci. 2023;53:67-77.
    Abstract     Related articles   

  1347. NAKAMURA R, Hasegawa G, Ikeda Y, Hara N, et al
    Complete remission following pembrolizumab therapy for a patient with nephroureterectomy positive-margin carcinoma in situ and bladder cancer unresponsive to Bacille Calmette-Guerin therapy.
    SAGE Open Med Case Rep. 2023;11:2050313X231185444.
    Abstract     Related articles   


  1348. Effect of SMYD3 on Biological Behavior and H3K4 Methylation in Bladder Cancer [Retraction].
    Cancer Manag Res. 2023;15:625-626.
    Abstract     Related articles   

  1349. YOU C, Li Q, Yang Y, Qing L, et al
    ASO Visual Abstract: Extraperitoneal Versus Intraperitoneal Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-analysis.
    Ann Surg Oncol. 2023 Jul 12. doi: 10.1245/s10434-023-13855.
    Abstract     Related articles   

  1350. ZHOU T, Chen H, Wang Y, Wen S, et al
    Key Molecules in Bladder Cancer Affect Patient Prognosis and Immunotherapy Efficacy: Further Exploration for CNTN1 and EMP1.
    JCO Precis Oncol. 2023;7:e2200630.
    Abstract     Related articles   

  1351. VISSING M, Munch Larsen L, Christensen AJ, Owall L, et al
    Calcium electroporation as an adjunct therapy for pembrolizumab-resistant bladder cancer: a case report.
    Acta Oncol. 2023 Jul 12:1-7. doi: 10.1080/0284186X.2023.2226330.
    Abstract     Related articles   

  1352. SHAKHSSALIM N, Dadpour M, Sharifiaghdas F, Narouie B, et al
    Evaluating the Effectiveness of Intravesical Instillation of BCG by Modified Maintenance Method in Patients With High-Risk Ta and T1 Bladder Cancer: A Randomized Clinical Trial.
    Clin Med Insights Oncol. 2023;17:11795549231184682.
    Abstract     Related articles   

  1353. XIONG S, Dong W, Deng Z, Jiang M, et al
    Value of the application of computed tomography-based radiomics for preoperative prediction of unfavorable pathology in initial bladder cancer.
    Cancer Med. 2023 Jul 11. doi: 10.1002/cam4.6225.
    Abstract     Related articles   

  1354. JIANG W, Pan C, Guo W, Xu Z, et al
    Pathologic collision of urinary bladder urothelial carcinoma with small cell carcinoma: a case report.
    Diagn Pathol. 2023;18:80.
    Abstract     Related articles   

  1355. WANG Y, Zhu H, Xu H, Qiu Y, et al
    Senescence-related gene c-Myc affects bladder cancer cell senescence by interacting with HSP90B1 to regulate cisplatin sensitivity.
    Aging (Albany NY). 2023;15.
    Abstract     Related articles   

  1356. CHANG TC, Shkolyar E, Del Giudice F, Eminaga O, et al
    Real-time Detection of Bladder Cancer Using Augmented Cystoscopy with Deep Learning: a Pilot Study.
    J Endourol. 2023 Jul 11. doi: 10.1089/end.2023.0056.
    Abstract     Related articles   

  1357. MIYAJIMA K, Suzuki H, Urabe F, Iwatani K, et al
    Clinical characteristics of secondary bladder cancer developing after low-/high-dose-rate brachytherapy to treat localized prostate cancer.
    Int J Clin Oncol. 2023 Jul 11. doi: 10.1007/s10147-023-02383.
    Abstract     Related articles   

  1358. FAROOQI AA, Venera R, Kapanova G, Tanbayeva G, et al
    TRAIL-mediated signaling in bladder cancer: realization of clinical efficacy of TRAIL-based therapeutics in medical oncology.
    Med Oncol. 2023;40:236.
    Abstract     Related articles   

  1359. PENG K, Ding D, Wang N, Du T, et al
    ITIH5, as a predictor of prognosis and immunotherapy response for P53-like bladder cancer, is related to cell proliferation and invasion.
    Mol Omics. 2023 Jul 11. doi: 10.1039/d2mo00322.
    Abstract     Related articles   

  1360. SINGH A, Osbourne AS, Koshkin VS
    Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer.
    Curr Treat Options Oncol. 2023 Jul 10. doi: 10.1007/s11864-023-01113.
    Abstract     Related articles   

  1361. COBELLIS G, Torino G, Lisi G, Ilari M, et al
    Pneumovesicoscopic management of bladder neoplasms in children: three case reports.
    Pediatr Med Chir. 2023;45.
    Abstract     Related articles   

  1362. GU Y, Zhuo H
    Identification of a cancer-associated fibroblast signature for predicting prognosis and immunotherapeutic responses in bladder urothelial carcinoma.
    Aging Male. 2023;26:2233609.
    Abstract     Related articles   

  1363. LI Z, Yao Y, Qi T, Wu Z, et al
    ACSM6 overexpression indicates a non-inflammatory tumor microenvironment and predicts treatment response in bladder cancer: results from multiple real-world cohorts.
    Front Pharmacol. 2023;14:1222512.
    Abstract     Related articles   

  1364. ZENG J, Funk J, Lee BR, Hsu CH, et al
    Gemcitabine as first-line therapy for high-grade non-muscle invasive bladder cancer: results from a tertiary center in the contemporary BCG-shortage era.
    Transl Androl Urol. 2023;12:960-966.
    Abstract     Related articles   

  1365. OKOBI TJ, Uhomoibhi TO, Akahara DE, Odoma VA, et al
    Immune Checkpoint Inhibitors as a Treatment Option for Bladder Cancer: Current Evidence.
    Cureus. 2023;15:e40031.
    Abstract     Related articles   

  1366. ZHONG Q, Jiang K, Zhang F, Tian Y, et al
    Exploring the correlation of glycolysis-related chondroitin polymerizing factor (CHPF) with clinical characteristics, immune infiltration, and cuproptosis in bladder cancer.
    Am J Cancer Res. 2023;13:2213-2233.
    Abstract     Related articles   

  1367. HUANG CP, Lu HL, Shyr CR
    Anti-tumor activity of intratumoral xenogeneic urothelial cell monotherapy or in combination with chemotherapy in syngeneic murine models of bladder cancer.
    Am J Cancer Res. 2023;13:2285-2306.
    Abstract     Related articles   

  1368. WU L, Chen W, Cao Y, Chen B, et al
    A novel cuproptosis-related lncRNAs signature predicts prognosis in bladder cancer.
    Aging (Albany NY). 2023;15.
    Abstract     Related articles   

  1369. JIANG Q, Zhou J, Chen Q, Huang Y, et al
    Construction and experimental validation of a macrophage cell senescence-related gene signature to evaluate the prognosis, immunotherapeutic sensitivity, and chemotherapy response in bladder cancer.
    Funct Integr Genomics. 2023;23:228.
    Abstract     Related articles   

  1370. ZENNAMI K, Takahara K, Nukaya T, Takenaka M, et al
    The Role of Lymph Node Dissection in Patients With Muscle-Invasive Bladder Cancer Who Underwent Radical Cystectomy Following Neoadjuvant Chemotherapy.
    Clin Genitourin Cancer. 2023 Jun 28:S1558-7673(23)00155.
    Abstract     Related articles   

  1371. JIANG H, Zhu S, Wu B, Su Y, et al
    CDK2 and CDK4 targeted liensinine inhibits the growth of bladder cancer T24 cells.
    Chem Biol Interact. 2023 Jul 7:110624. doi: 10.1016/j.cbi.2023.110624.
    Abstract     Related articles   

  1372. XIAO K, Peng S, Lu J, Zhou T, et al
    UBE2S interacting with TRIM21 mediates the K11-linked ubiquitination of LPP to promote the lymphatic metastasis of bladder cancer.
    Cell Death Dis. 2023;14:408.
    Abstract     Related articles   

  1373. KATES M, Chu X, Hahn N, Pietzak E, et al
    Background and Update for ECOG-ACRIN EA8212: A Randomized Phase 3 Trial of Intravesical Bacillus Calmette-Guerin (BCG) Versus Intravesical Docetaxel and Gemcitabine Treatment in BCG-naive High-grade Non-muscle-invasive Bladder Cancer (BRIDGE).
    Eur Urol Focus. 2023 Jul 6:S2405-4569(23)00146-3. doi: 10.1016/j.euf.2023.
    Abstract     Related articles   

  1374. LIU X, Liu L, Wang X, Jin Y, et al
    Necroptosis inhibits autophagy by regulating the formation of RIP3/p62/Keap1 complex in shikonin-induced ROS dependent cell death of human bladder cancer.
    Phytomedicine. 2023;118:154943.
    Abstract     Related articles   

  1375. ORJI P, Sun H, Isali I, Bell S, et al
    Female sexual function evaluation and intraoperative vaginal reconstruction in bladder cancer.
    World J Urol. 2023 Jul 7. doi: 10.1007/s00345-023-04502.
    Abstract     Related articles   

  1376. KATES M
    Doing Less with More: Towards a New Paradigm of Non-muscle-invasive Bladder Cancer Care.
    Eur Urol Focus. 2023 Jul 5:S2405-4569(23)00147-5. doi: 10.1016/j.euf.2023.
    Abstract     Related articles   

  1377. GUPTA S, Norgan AP, Erickson LA
    Schistosomiasis of the Urinary Bladder.
    Mayo Clin Proc. 2023;98:1100-1101.
    Abstract     Related articles   

  1378. LEE J, Kim SH, Jeong SH, Han JH, et al
    Pyuria as an independent predictor of intravesical recurrence after radical nephroureterectomy in patients with upper tract urothelial carcinoma.
    Investig Clin Urol. 2023;64:353-362.
    Abstract     Related articles   

  1379. KIM D, Nam W, Kyung YS, You D, et al
    Effect of decreased renal function on poor oncological outcome after radical cystectomy.
    Investig Clin Urol. 2023;64:346-352.
    Abstract     Related articles   

  1380. ESTEVES M, Duarte M, Oliveira PA, Gil da Costa RM, et al
    SKELETAL MUSCLE SENSITIVITY TO WASTING INDUCED BY UROTHELIAL CARCINOMA.
    Exp Oncol. 2023;45:107-119.
    Abstract     Related articles   

  1381. GARMANCHUK LV, Yakovlev PG, Ostrovska GV, Stupak YA, et al
    COMPARISON OF 2D AND 3D PRIMARY CELL CULTURES OBTAINED FROM EXPLANT OF HIGH-GRADE UROTHELIAL BLADDER CANCER.
    Exp Oncol. 2023;45:130-136.
    Abstract     Related articles   

  1382. TANG Z, Peng J, Wu S, Zhao F, et al
    Combined use of a 980‑nm diode laser and preoperative intravesical instillation of pirarubicin for the prevention of short‑term recurrence of non‑muscle invasive bladder cancer: A pilot study.
    Oncol Lett. 2023;26:322.
    Abstract     Related articles   

  1383. SU Y, Chen L, Yang J
    Network pharmacology and in vitro experiments reveal that Noscapine induces ROS-mediated apoptosis and cell cycle arrest via PI3K/Akt/FoxO3a signaling pathway in human bladder cancer cells.
    Curr Cancer Drug Targets. 2023 Jul 6. doi: 10.2174/1568009623666230706153936.
    Abstract     Related articles   

  1384. RODRIGUES L, Watson J, Feng Y, Lewis B, et al
    Shared hotspot mutations in oncogenes position dogs as an unparalleled comparative model for precision therapeutics.
    Sci Rep. 2023;13:10935.
    Abstract     Related articles   

  1385. YU H, Bai K, Cheng Y, Lv J, et al
    Clinical significance, tumor immune landscape and immunotherapy responses of ADAR in pan-cancer and its association with proliferation and metastasis of bladder cancer.
    Aging (Albany NY). 2023;15.
    Abstract     Related articles   

  1386. RELPH K, Arif M, Pandha H, Annels N, et al
    Analysis of ICAM-1 Expression on Bladder Carcinoma Cell Lines and Infectivity and Oncolysis by Coxsackie Virus A21.
    Methods Mol Biol. 2023;2684:319-327.
    Abstract     Related articles   

  1387. GRANDI P, Darilek A, Moscu A, Pradhan A, et al
    Intravesical Infusion of Oncolytic Virus CG0070 in the Treatment of Bladder Cancer.
    Methods Mol Biol. 2023;2684:303-317.
    Abstract     Related articles   

  1388. NIEGISCH G
    Antibody-Drug-Conjugates (ADC): A Novel Treatment Option in Urothelial Carcinoma.
    Methods Mol Biol. 2023;2684:293-301.
    Abstract     Related articles   

  1389. BAHLINGER V, Eckstein M, Hartmann A, Stohr R, et al
    Evaluation of FGFR Alteration Status in Urothelial Tumors.
    Methods Mol Biol. 2023;2684:283-291.
    Abstract     Related articles   

  1390. MENECEUR S, Grunewald CM, Niegisch G, Hoffmann MJ, et al
    Epigenetic Priming and Development of New Combination Therapy Approaches.
    Methods Mol Biol. 2023;2684:259-281.
    Abstract     Related articles   

  1391. BAHLINGER V, Hartmann A, Eckstein M
    Assessment of PD-L1 Status in Urothelial Cancer.
    Methods Mol Biol. 2023;2684:249-255.
    Abstract     Related articles   

  1392. NIKKOLA J, Black P
    Predictive Biomarkers of Response to Neoadjuvant Therapy in Muscle Invasive Bladder Cancer.
    Methods Mol Biol. 2023;2684:229-247.
    Abstract     Related articles   

  1393. ZVEREVA M, Hosen MI, Forey N, Sheikh M, et al
    Simplex Droplet Digital PCR Assays for the Detection of TERT Promoter Mutations in Urine Samples for the Non-invasive Diagnosis of Urothelial Cancer.
    Methods Mol Biol. 2023;2684:213-228.
    Abstract     Related articles   

  1394. ECKE TH, Benderska-Soder N, Bismarck E, van Rhijn BWG, et al
    Considering the Effects of Modern Point-of-Care Urine Biomarker Assays in Follow-Up of Patients with High-Risk Non-muscle-Invasive Bladder Cancer.
    Methods Mol Biol. 2023;2684:199-212.
    Abstract     Related articles   

  1395. NORDENTOFT I, Birkenkamp-Demtroder K, Dyrskjot L
    NGS-Based Tumor-Informed Analysis of Circulating Tumor DNA.
    Methods Mol Biol. 2023;2684:179-197.
    Abstract     Related articles   

  1396. DONELAN W, Crispen PL, Kusmartsev S
    Tissue Slice Culture and Analysis of Tumor-Associated Hyaluronan in Urothelial Carcinoma.
    Methods Mol Biol. 2023;2684:167-175.
    Abstract     Related articles   

  1397. MANTWILL K, Nawroth R
    Genome-Wide CRISPR Screening for the Identification of Therapy Resistance-Associated Genes in Urothelial Carcinoma.
    Methods Mol Biol. 2023;2684:155-165.
    Abstract     Related articles   

  1398. PARK Y, Lelo A, Harris B, Berry DL, et al
    Identification of STAG2-Mutant Bladder Cancers by Immunohistochemistry.
    Methods Mol Biol. 2023;2684:145-151.
    Abstract     Related articles   

  1399. RAMPIAS T, Klinakis A
    Using Sister Chromatid Exchange Assay to Detect Homologous Recombination Deficiency in Epigenetically Deregulated Urothelial Carcinoma Cells.
    Methods Mol Biol. 2023;2684:133-144.
    Abstract     Related articles   

  1400. SEILLIER L, Peifer M
    Reconstructing Phylogenetic Relationship in Bladder Cancer: A Methodological Overview.
    Methods Mol Biol. 2023;2684:113-132.
    Abstract     Related articles   

  1401. PETER C, Schulz WA, Whongsiri P
    Characterization of Native COMPASS Complex in Urothelial Carcinoma Cells by Size Exclusion Chromatography.
    Methods Mol Biol. 2023;2684:101-109.
    Abstract     Related articles   

  1402. MOKOU M, Narayanasamy S, Stroggilos R, Balaur IA, et al
    A Drug Repurposing Pipeline Based on Bladder Cancer Integrated Proteotranscriptomics Signatures.
    Methods Mol Biol. 2023;2684:59-99.
    Abstract     Related articles   

  1403. OLAH C, Szarvas T
    A Panel-Based Method for the Reproduction of Distinct Molecular Subtype Classifications of Muscle-Invasive Urothelial Bladder Cancer.
    Methods Mol Biol. 2023;2684:27-43.
    Abstract     Related articles   

  1404. BOSHERZ MS, Samarska IV, Gaisa NT
    Scoring Systems for Immunohistochemistry in Urothelial Carcinoma.
    Methods Mol Biol. 2023;2684:3-25.
    Abstract     Related articles   

  1405. REIGNIER PL, Gauthier H, Hennequin C, Aussedat Q, et al
    Survival after sequential neoadjuvant chemotherapy followed by trimodal treatment or radical cystectomy for muscle-invasive bladder cancer.
    World J Urol. 2023 Jul 6. doi: 10.1007/s00345-023-04506.
    Abstract     Related articles   

  1406. KAWADA T, Yanagisawa T, Bekku K, Laukhtina E, et al
    Low-dose or -number of BCG in non-muscle invasive bladder cancer: updated systematic review and meta-analysis.
    Immunotherapy. 2023;15:933-943.
    Abstract     Related articles   

  1407. FARSHADPOUR F, Taherkhani R, Farzaneh M
    Human papillomaviruses and bladder cancer risk: first report in south of Iran.
    Virusdisease. 2023;34:257-262.
    Abstract     Related articles   

  1408. BUDENBENDER B, Kother AK, Kriegmair MC, Grune B, et al
    Getting specific: participation preference in urooncological decision-making.
    BMC Med Inform Decis Mak. 2023;23:114.
    Abstract     Related articles   

  1409. GU YM, Liang XL, Zhang YG, Zhao HY, et al
    [Clinicopathological Features of Primary Small Cell Neuroendocrine Carcinoma of the Bladder].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2023;45:429-435.
    Abstract     Related articles   

  1410. PARK JY, Baek JW, Yu J, Kim CS, et al
    Vitamin C and catheter-related bladder discomfort after transurethral resection of bladder tumor: A double-blind, randomized, placebo-controlled study.
    J Clin Anesth. 2023;89:111191.
    Abstract     Related articles   

  1411. ABDELBARY AM, Atwa HA, Elfarargy OM, Qasem ER, et al
    Prognostic Implications of CD24, SOX2, and Nanog Expression in Invasive Urothelial Carcinoma.
    Appl Immunohistochem Mol Morphol. 2023;31:421-428.
    Abstract     Related articles   

  1412. KANNO T, Kobori G, Ito K, Nakagawa H, et al
    Atypical Oncologic Failure After Laparoscopic Radical Nephroureterectomy in a Japanese Multicenter Study.
    J Endourol. 2023;37:793-800.
    Abstract     Related articles   

  1413. YU J, Lee J, Kim CS, Park JY, et al
    ASO Author Reflections: Chart-Derived Frailty Index and 1-Year Mortality After Radical Cystectomy.
    Ann Surg Oncol. 2023;30:5304-5305.
    Abstract     Related articles   

  1414. MATTHEW-ONABANJO AN, Nortey G, Matulewicz RS, Basak R, et al
    Diversity, equity, and inclusion in genitourinary clinical trials leading to FDA novel drug approval: An assessment of the FDA center for drug evaluation and research drug trials snapshot.
    Curr Probl Cancer. 2023;47:100958.
    Abstract     Related articles   

  1415. HACKING SM, Pavlick D, Wang Y, Carneiro BA, et al
    Comprehensive Genomic Profiling of NF2-Mutated Kidney Tumors Reveals Potential Targets for Therapy.
    Oncologist. 2023;28:e508-e519.
    Abstract     Related articles   

  1416. SHI Y, Wang S, Liu W, Sherryn S, et al
    Single-Position Complete Retroperitoneoscopic Radical Nephroureterectomy with Bladder Cuff Excision for Upper Urinary Tract Urothelial Carcinoma.
    J Endourol. 2023;37:768-774.
    Abstract     Related articles   

  1417. ZHAO Q, Wu L, Yang F, Chen D, et al
    A Modified and Practical Surgical Technique for Pure Transperitoneal Laparoscopic Radical Nephroureterectomy in a Single Position and Research Outcomes.
    J Laparoendosc Adv Surg Tech A. 2023;33:691-697.
    Abstract     Related articles   

  1418. SUN JX, An Y, Xu MY, Liu CQ, et al
    Development of a dynamic risk system for predicting the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer after thulium laser resection of bladder tumor or transurethral resection of bladder tumor followed by intra
    Front Oncol. 2023;13:1133161.
    Abstract     Related articles   

  1419. CHAI J, Yin S, Feng W, Zhang T, et al
    The Role of Hypoxia-inducible Factor-1 in Bladder Cancer.
    Curr Mol Med. 2023 Jul 20. doi: 10.2174/1566524023666230720163448.
    Abstract     Related articles   

  1420. ALBARAKATI N, Al-Ghamdi H, Al-Sowayan B, Alshareeda A, et al
    Homologous recombination mRNAs (RAD21, RAD50 and BARD1) have a potentially poor prognostic role in ERBB2-low bladder cancer patients.
    Sci Rep. 2023;13:11738.
    Abstract     Related articles   

  1421. CHEN G, Fan X, Wang T, Zhang E, et al
    A machine learning model based on MRI for the preoperative prediction of bladder cancer invasion depth.
    Eur Radiol. 2023 Jul 20. doi: 10.1007/s00330-023-09960.
    Abstract     Related articles   

  1422. ANDRADE DL, Jalalizadeh M, Salustiano ACC, Reis LO, et al
    Bladder cancer immunomodulatory effects of intravesical Nitazoxanide, Rapamycin, Thalidomide and Bacillus Calmette-Guerin (BCG).
    World J Urol. 2023 Jul 20. doi: 10.1007/s00345-023-04526.
    Abstract     Related articles   

  1423. GOYAL S, Vias P, Periasamy K, Madan R, et al
    Delineating and sparing the ileal conduit in adjuvant radiotherapy for bladder cancer with modulated radiotherapy.
    J Cancer Res Ther. 2023;19:731-737.
    Abstract     Related articles   

  1424. KUMAR A, Kumar M, Semwal MK, Singh U, et al
    Management of surgically inoperable muscle-invasive bladder cancer in a resource constraint setting at a tertiary care center by bladder preservation protocol: Case series.
    J Cancer Res Ther. 2023;19:725-730.
    Abstract     Related articles   

  1425. MOHANTY P, Mohapatra AS, Sabat D, Nayak J, et al
    Unusual histomorphological spectrum of urinary bladder cancers and their treatment modalities revisited: Our experience with series of five cases.
    J Cancer Res Ther. 2023;19:617-623.
    Abstract     Related articles   

  1426. AKBULUT F, Pazir Y, Esmeray A, Erbin A, et al
    The efficacy of hyperthermic intravesical chemotherapy in high-risk non-muscle-invasive bladder cancer patients with BCG intolerance.
    Urologia. 2023 Jul 20:3915603231189022. doi: 10.1177/03915603231189022.
    Abstract     Related articles   

  1427. ECKE TH, Lotan Y, Massfelder T
    Editorial: Identifying novel biomarkers in bladder cancer.
    Front Oncol. 2023;13:1191736.
    Abstract     Related articles   

  1428. RAHMAN KMM, Foster BA, You Y
    Preclinical evaluation of singlet oxygen-cleavable prodrugs in combination with protoporphyrin IX-photodynamic therapy in an orthotopic rat model of non-muscle-invasive bladder cancer(dagger).
    Photochem Photobiol. 2023 Jul 20. doi: 10.1111/php.13838.
    Abstract     Related articles   

  1429. TAN WS, McElree IM, Davaro F, Steinberg RL, et al
    Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guerin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2023 Jul 18:S2588-9311(23)00143.
    Abstract     Related articles   

  1430. FARMANI F, Soleimani N, Razeghi M, Zamani A, et al
    Uninvited guest, Balantidium coli in urine in a patient with bladder cancer: A case report and review of the literature.
    Clin Case Rep. 2023;11:e7494.
    Abstract     Related articles   

  1431. ZHAN Y, Chen Z, He S, Gong Y, et al
    Correction: Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2.
    Mol Cancer. 2023;22:115.
    Abstract     Related articles   

  1432. GUAN H, Wang G, Wang W, Zhou Y, et al
    Postoperative adjuvant radiotherapy for patients with upper tract urothelial carcinoma (UTUC) who underwent kidney-sparing surgery (KSS): a single-center study.
    Radiat Oncol. 2023;18:120.
    Abstract     Related articles   

  1433. LIU W, Xiong J, Wang H, Li S, et al
    Racial disparities in conditional survival of patients with bladder cancer: a population-based study.
    BMC Urol. 2023;23:122.
    Abstract     Related articles   

  1434. KOUHEN F, Dahbi Z, Afif M, Chihabeddine M, et al
    Bladder carcinosarcoma treated by cystectomy and adjuvant chemotherapy with good outcomes: a case report.
    J Med Case Rep. 2023;17:320.
    Abstract     Related articles   

  1435. LAUKHTINA E, Shariat SF
    Smoking, ethnicity and bladder cancer - implications for public health and clinical practice.
    Nat Rev Urol. 2023 Jul 18. doi: 10.1038/s41585-023-00804.
    Abstract     Related articles   

  1436. WANG P, Joiner M, Dzul S, Miller SR, et al
    Adenocarcinoma involving the urinary bladder.
    BMJ Case Rep. 2023;16:e252747.
    Abstract     Related articles   

  1437. SHEN C, Liu J, Jiao W, Zhang X, et al
    A feed-forward loop based on aerobic glycolysis and TGF-beta between tumor-associated macrophages and bladder cancer cells promoted malignant progression and immune escape.
    J Cancer Res Clin Oncol. 2023 Jul 18. doi: 10.1007/s00432-023-05164.
    Abstract     Related articles   

  1438. RASTEGAR-POUYANI N, Montazeri V, Marandi N, Aliebrahimi S, et al
    The impact of Cancer-Associated Fibroblasts on drug resistance, stemness, and epithelial-mesenchymal transition in Bladder Cancer: A comparison between recurrent and non-recurrent patient-derived CAFs.
    Cancer Invest. 2023 Jul 18:1-16. doi: 10.1080/07357907.2023.2237576.
    Abstract     Related articles   

  1439. ABE T, Yamada S, Kikuchi H, Sazawa A, et al
    Impact of postoperative complications on long-term survival in bladder cancer patients.
    Jpn J Clin Oncol. 2023 Jul 17:hyad079. doi: 10.1093.
    Abstract     Related articles   

  1440. PING Q, Wang C, Cheng X, Zhong Y, et al
    TGF-beta1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells.
    J Transl Med. 2023;21:475.
    Abstract     Related articles   

  1441. ARTYMOWICZ M, Struck-Lewicka W, Wiczling P, Markuszewski M, et al
    Targeted quantitative metabolomics with a linear mixed-effect model for analysis of urinary nucleosides and deoxynucleosides from bladder cancer patients before and after tumor resection.
    Anal Bioanal Chem. 2023 Jul 18. doi: 10.1007/s00216-023-04826.
    Abstract     Related articles   

  1442. XIA T, Zhou F, Zhang D, Jin X, et al
    Deep-profiling of phospholipidome via rapid orthogonal separations and isomer-resolved mass spectrometry.
    Nat Commun. 2023;14:4263.
    Abstract     Related articles   

  1443. MURAOKA K, Fukasawa M, Fukushima M, Kumagai M, et al
    [The Effect of Naldemedine Tosylate on the Postoperative Course of Robot-Assisted Radical Cystectomy].
    Hinyokika Kiyo. 2023;69:147-150.
    Abstract     Related articles   

  1444. HE K, Wang J, Zhou Y, Huang Z, et al
    Network pharmacology analysis of icariside II against bladder cancer.
    Eur J Pharmacol. 2023 Jul 15:175914. doi: 10.1016/j.ejphar.2023.175914.
    Abstract     Related articles   

  1445. MATAR M, Prince G, Hamati I, Baalbaky M, et al
    Implication of KDM6A in bladder cancer.
    Pharmacogenomics. 2023 Jul 17. doi: 10.2217/pgs-2023-0027.
    Abstract     Related articles   

  1446. QI G, Liu J, Tao S, Fan W, et al
    A retrospective study on expression and clinical significance of PHH3, Ki67 and P53 in bladder exophytic papillary urothelial neoplasms.
    PeerJ. 2023;11:e15675.
    Abstract     Related articles   

  1447. ZHANG Y, Liu M, Wang J, Han K, et al
    Bibliometric analysis of the association between drinking water pollution and bladder cancer.
    Front Oncol. 2023;13:1170700.
    Abstract     Related articles   

  1448. YI X, Pi J, Liu C, Xiong Y, et al
    The relationship between inflammatory response markers and the prognosis of non-muscle invasive bladder cancer and the development of a nomogram model.
    Front Oncol. 2023;13:1189086.
    Abstract     Related articles   

  1449. WANG XX, Wu HY, Yang Y, Ma MM, et al
    CCNB1 is involved in bladder cancer pathogenesis and silencing CCNB1 decelerates tumor growth and improves prognosis of bladder cancer.
    Exp Ther Med. 2023;26:382.
    Abstract     Related articles   

  1450. WANG Y, Kong Q, Li M, Gu J, et al
    Prediction of immune and targeted drug efficacy in pain-related risk subtypes for bladder cancer patients.
    Heliyon. 2023;9:e17690.
    Abstract     Related articles   

  1451. SU Y, Ai J, Jia M, Yue G, et al
    The Relationship between VEGF and AGT Gene Single Nucleotide Polymorphisms and Susceptibility to Renal and Bladder Cancers.
    Arch Esp Urol. 2023;76:298-308.
    Abstract     Related articles   

  1452. SHAHAIT M, Abu-Hijlih R, Farkouh A, Obeidat S, et al
    Fluorodeoxyglucose positron emission tomography (18F-FDG PET)-computed tomography (CT) in the initial staging of bladder cancer: a single institution experience.
    J Egypt Natl Canc Inst. 2023;35:21.
    Abstract     Related articles   

  1453. TAPPERO S, Chierigo F, Parodi S, Bandini M, et al
    Radical cystectomy in bladder cancer patients previously treated for prostate cancer: Insights from a large European multicentric series.
    Surg Oncol. 2023;50:101973.
    Abstract     Related articles   

  1454. CHEN H, Yang W, Li Y, Ji Z, et al
    PLAGL2 promotes bladder cancer progression via RACGAP1/RhoA GTPase/YAP1 signaling.
    Cell Death Dis. 2023;14:433.
    Abstract     Related articles   

  1455. SUBRAMANYA SK, Li R, Wang Y, Miyamoto H, et al
    Deep learning for histopathological segmentation of smooth muscle in the urinary bladder.
    BMC Med Inform Decis Mak. 2023;23:122.
    Abstract     Related articles   

  1456. GRASSAUER J, Schmidt J, Cowan A, Gilbert SM, et al
    Downstaging and Survival Associated with Neoadjuvant Immunotherapy Before Radical Cystectomy for Muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2023 Jul 14:S2588-9311(23)00118.
    Abstract     Related articles   

  1457. WISSING MD, O'Flaherty A, Dragomir A, Tanguay S, et al
    Chronic prednisone, metformin, and nonsteroidal anti-inflammatory drug use and clinical outcome in a cohort of bladder cancer patients undergoing radical cystectomy in Quebec, Canada.
    BMC Urol. 2023;23:119.
    Abstract     Related articles   

  1458. CHEN H, Xu C, Fang Z, Mao S, et al
    Cell-Free DNA, MicroRNAs, Proteins, and Peptides as Liquid Biopsy Biomarkers in Prostate Cancer and Bladder Cancer.
    Methods Mol Biol. 2023;2695:165-179.
    Abstract     Related articles   

  1459. CUI Y, Cao M
    Liquid Biopsy in Bladder Cancer.
    Methods Mol Biol. 2023;2695:111-120.
    Abstract     Related articles   

  1460. YUAN P, Li S, Xiong S, Zheng F, et al
    Development of a butyrate metabolism-related gene-based molecular subtypes and scoring system for predicting prognosis and immunotherapy response in bladder cancer.
    J Cancer Res Clin Oncol. 2023 Jul 14. doi: 10.1007/s00432-023-05067.
    Abstract     Related articles   

  1461. BIERI U, Kranzbuhler B, Wettstein MS, Fankhauser CD, et al
    Limited Value of Bladder Wash Cytology During Follow-Up of Patients With Non-muscle Invasive Bladder Cancer.
    Cureus. 2023;15:e40283.
    Abstract     Related articles   

  1462. AVETA A, Cilio S, Contieri R, Spena G, et al
    Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review.
    Int J Mol Sci. 2023;24:10846.
    Abstract     Related articles   

  1463. JAKUS D, Solic I, Juric I, Borovac JA, et al
    The Impact of the Initial Clinical Presentation of Bladder Cancer on Histopathological and Morphological Tumor Characteristics.
    J Clin Med. 2023;12:4259.
    Abstract     Related articles   

  1464. DANESHDOUST D, Yin M, Luo M, Sundi D, et al
    Conditional Reprogramming Modeling of Bladder Cancer for Clinical Translation.
    Cells. 2023;12:1714.
    Abstract     Related articles   

  1465. FERRO M, Falagario UG, Barone B, Maggi M, et al
    Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement.
    Diagnostics (Basel). 2023;13:2308.
    Abstract     Related articles   

  1466. BOCA B, Caraiani C, Telecan T, Pintican R, et al
    MRI-Based Radiomics in Bladder Cancer: A Systematic Review and Radiomics Quality Score Assessment.
    Diagnostics (Basel). 2023;13:2300.
    Abstract     Related articles   

  1467. BORGHERESI A, Agostini A, Sternardi F, Cesari E, et al
    Vascular Enlargement as a Predictor of Nodal Involvement in Bladder Cancer.
    Diagnostics (Basel). 2023;13:2227.
    Abstract     Related articles   

  1468. MCELREE IM, Orzel J, Stubbee R, Steinberg RL, et al
    Sequential intravesical gemcitabine and docetaxel for treatment-naive and previously treated intermediate-risk nonmuscle invasive bladder cancer.
    Urol Oncol. 2023 Jul 11:S1078-1439(23)00228.
    Abstract     Related articles   

  1469. MA J, Roumiguie M, Hayashi T, Kohada Y, et al
    Long-term Recurrence Rates of Low-risk Non-muscle-invasive Bladder Cancer-How Long Is Cystoscopic Surveillance Necessary?
    Eur Urol Focus. 2023 Jul 11:S2405-4569(23)00153.
    Abstract     Related articles   

  1470. DAHL DM, Karrison TG, Michaelson MD, Pham HT, et al
    Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation.
    Eur Urol Oncol. 2023 Jul 11:S2588-9311(23)00115.
    Abstract     Related articles   

  1471. MIR MA, Pandith AA, Mansoor S, Baba SM, et al
    Differential expression of SLITRK6 gene as a potential therapeutic target for urothelial carcinoma in particular upper tract cancer.
    Gene. 2023;878:147583.
    Abstract     Related articles   

  1472. ABDEL-HAFIZ HA, Schafer JM, Chen X, Xiao T, et al
    Y chromosome loss in cancer drives growth by evasion of adaptive immunity.
    Nature. 2023;619:624-631.
    Abstract     Related articles   

  1473. GOBBO A, Fasulo V, Contieri R, Uleri A, et al
    Clinical and pathological predictors of persistent T1 HG at second resection.
    Urologia. 2023;90:482-490.
    Abstract     Related articles   

  1474. TIAN BW, Han CL, Wang HC, Yan LJ, et al
    Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysis.
    Clin Exp Metastasis. 2023;40:255-287.
    Abstract     Related articles   

  1475. YONESE I, Ito M, Waseda Y, Kobayashi S, et al
    Impact of diagnostic ureteral catheterization on intravesical tumour recurrence following radical nephroureterectomy for upper tract urothelial carcinoma.
    World J Urol. 2023;41:1869-1875.
    Abstract     Related articles   

  1476. YANAGISAWA T, Kawada T, Quhal F, Bekku K, et al
    Impact of sex on the efficacy of immune checkpoint inhibitors in kidney and urothelial cancers: a systematic review and meta-analysis.
    World J Urol. 2023;41:1763-1774.
    Abstract     Related articles   

  1477. MOAVRO DE, Andrini L, Iribarne A, Colaci P, et al
    HLA-G expression in transitional bladder carcinoma. Relationship with tumor invasion level and patient survival: Experience in a public hospital in Argentina.
    Hum Immunol. 2023;84:423-427.
    Abstract     Related articles   

  1478. CHEN M, Jiang J, Chen J, Wang M, et al
    The Clinical Safety and Efficacy of Targeted PD-L1 Therapy with Durvalumab in Solid Tumors.
    Curr Drug Targets. 2023;24:584-598.
    Abstract     Related articles   

  1479. CERRATO C, Pandolfo SD, Autorino R, Panunzio A, et al
    Gender-specific counselling of patients with upper tract urothelial carcinoma and Lynch syndrome.
    World J Urol. 2023;41:1741-1749.
    Abstract     Related articles   

  1480. CHAN TC, Pan CT, Hsieh HY, Vejvisithsakul PP, et al
    The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFbeta/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma.
    Cell Oncol (Dordr). 2023;46:933-951.
    Abstract     Related articles   

  1481. DJORDJEVIC D, Dragicevic S, Vukovic M
    Mini-laparotomy radical cystectomy with limited bowel externalization during ileal conduit urinary diversion reduces the rate of postoperative complications: a match-paired, single centered analysis.
    Acta Chir Belg. 2023;123:362-368.
    Abstract     Related articles   

  1482. REBEZ G, Runti O, Rizzo M, Trombetta C, et al
    Radical cystectomy and orthotopic neobladder in a patient with a preexisting three-components inflatable penile prosthesis.
    Urologia. 2023;90:584-586.
    Abstract     Related articles   

  1483. SYMVOULIDIS P, Tsioutis C, Zamboglou C, Agouridis AP, et al
    The Effect of Statins on the Incidence and Prognosis of Bladder Cancer: A Systematic Review and Meta-Analysis.
    Curr Oncol. 2023;30:6648-6665.
    Abstract     Related articles   

  1484. KODERA A, Mohammed M, Lim P, Abdalla O, et al
    The Management of Bacillus Calmette-Guerin (BCG) Failure in High-Risk Non-muscle Invasive Bladder Cancer: A Review Article.
    Cureus. 2023;15:e40962.
    Abstract     Related articles   

  1485. BUI TT, Jang E, Shin JH, Kim TH, et al
    Feasibility of Raman spectroscopic identification of gall bladder cancer using extracellular vesicles extracted from bile.
    Analyst. 2023 Jul 28. doi: 10.1039/d3an00806.
    Abstract     Related articles   

  1486. TABAEI S, Haghshenas MR, Ariafar A, Gilany K, et al
    Comparative proteomics analysis in different stages of urothelial bladder cancer for identification of potential biomarkers: highlighted role for antioxidant activity.
    Clin Proteomics. 2023;20:28.
    Abstract     Related articles   

  1487. XUE XL, Zhao S, Xu MC, Li Y, et al
    Circular RNA_0000326 accelerates breast cancer development via modulation of the miR-9-3p/YAP1 axis.
    Neoplasma. 2023;70:430-442.
    Abstract     Related articles   

  1488. CAO T, Zhou X, Wu X, Zou Y, et al
    Cutaneous immune-related adverse events to immune checkpoint inhibitors: from underlying immunological mechanisms to multi-omics prediction.
    Front Immunol. 2023;14:1207544.
    Abstract     Related articles   

  1489. WANG M, Zhang Z, Li Z, Zhu Y, et al
    E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies.
    Front Immunol. 2023;14:1226057.
    Abstract     Related articles   

  1490. ZHANG J, Duan H, Feng Z, Han X, et al
    Retraction Note: Acetyl-CoA synthetase 3 promotes bladder cancer cell growth under metabolic stress.
    Oncogenesis. 2023;12:39.
    Abstract     Related articles   

  1491. YANAGISAWA T, Kawada T, von Deimling M, Bekku K, et al
    Repeat Transurethral Resection for Non-muscle-invasive Bladder Cancer: An Updated Systematic Review and Meta-analysis in the Contemporary Era.
    Eur Urol Focus. 2023 Jul 24:S2405-4569(23)00173.
    Abstract     Related articles   

  1492. SINGH A, Choudhary A, Pai V, Viswanath K, et al
    Uncovering the Uncommon: Institutional Insights Into the Clinical and Epidemiological Characteristics of Rarer Forms of Bladder Cancer Beyond Transitional Cell Carcinoma.
    Cureus. 2023;15:e40879.
    Abstract     Related articles   

  1493. HOSHINA H, Taguchi S, Suyama H, Kishitani K, et al
    Surgical resection of retinoblastoma-associated bladder leiomyosarcoma during pregnancy: a case report.
    BMC Urol. 2023;23:125.
    Abstract     Related articles   

  1494. BARAL BK, Poudel PR, Rajbhandari M, Karki AJ, et al
    Ultrasound versus Nerve Stimulator Guided Obturator Nerve Block in Patients Undergoing Transurethral Resection of Bladder Tumor.
    J Nepal Health Res Counc. 2023;20:998-1002.
    Abstract     Related articles   

  1495. SASAKI Y, Daizumoto K, Fukuta K, Shiozaki K, et al
    Lymph node dissection during radical cystectomy for bladder cancer: A two-center comparative study of robotic versus open surgery.
    Asian J Endosc Surg. 2023 Jul 25. doi: 10.1111/ases.13234.
    Abstract     Related articles   

  1496. SHI ZD, Sun Z, Zhu ZB, Liu X, et al
    Integrated single-cell and spatial transcriptomic profiling reveals higher intratumour heterogeneity and epithelial-fibroblast interactions in recurrent bladder cancer.
    Clin Transl Med. 2023;13:e1338.
    Abstract     Related articles   

  1497. ALAM SM, Larson M, Srinivasan P, Genz N, et al
    Evaluation of sarcopenia in patients receiving intravesical Bacillus Calmette-Guerin for non-muscle invasive bladder cancer.
    Urol Oncol. 2023 Jul 22:S1078-1439(23)00198.
    Abstract     Related articles   

  1498. TANG NT, Robinson R, Snook RD, Brown M, et al
    Classification of formalin-fixed bladder cancer cells with laser tweezer Raman spectroscopy.
    Analyst. 2023 Jul 24. doi: 10.1039/d3an00119.
    Abstract     Related articles   

  1499. SONG Y, Xu T
    Letter to the editor for the article "Real-world outcomes of first-line chemotherapy for unresectable stage III and IV bladder cancer".
    World J Urol. 2023 Jul 24. doi: 10.1007/s00345-023-04541.
    Abstract     Related articles   

  1500. STEWART R, Richards HL, Houghton S, Sweeney P, et al
    'I Had It. I Don't Think I Have It...But I Do Feel It Will Come Back Somewhere': A Qualitative Investigation of the Experience of People With Non-Muscle Invasive Bladder Cancer.
    Qual Health Res. 2023 Jul 24:10497323231170089. doi: 10.1177/10497323231170089.
    Abstract     Related articles   

  1501. YAMAMOTO K, Yamamoto K, Nakai G, Fujitani T, et al
    Detection of the Vesical Arteries Using Three-dimensional Digital Subtraction Angiography Relevant to Intra-arterial Infusion Chemotherapy for Bladder Cancer Using Double-balloon Catheters.
    Interv Radiol (Higashimatsuyama). 2023;8:64-69.
    Abstract     Related articles   

  1502. XIAO X, Peng J, Chen Y, Lu X, et al
    Comprehensive Analysis of Differential Gene Expression and Correlated Immune Infiltration in Bladder Cancer.
    Iran J Public Health. 2023;52:1225-1237.
    Abstract     Related articles   

  1503. ERDIK A, Cimen HI, Atik YT, Gul D, et al
    Sarcopenia is an independent predictor of survival in patients undergoing radical cystectomy for bladder cancer: a single-centre, retrospective study.
    Cent European J Urol. 2023;76:81-89.
    Abstract     Related articles   

  1504. WASFIE T, Atherton JM, Villegas SJ, Korbitz H, et al
    Small bowel obstruction secondary to metastatic urothelial bladder cancer.
    SAGE Open Med Case Rep. 2023;11:2050313X231176356.
    Abstract     Related articles   

  1505. LI Y, Zheng H, Luo Y, Lin Y, et al
    An HGF-dependent positive feedback loop between bladder cancer cells and fibroblasts mediates lymphangiogenesis and lymphatic metastasis.
    Cancer Commun (Lond). 2023 Jul 22. doi: 10.1002/cac2.12470.
    Abstract     Related articles   

  1506. ELMEKAWY S, Taha DE, Nabeeh HE, Ibrahim A, et al
    Comparison of holmium laser, bipolar and conventional monopolar transurethral resection of bladder tumour in primary non-muscle invasive bladder cancer.
    J Pak Med Assoc. 2023;73.
    Abstract     Related articles   

  1507. AHMED NOR EM, Saied EM, Alshenawy HA, Shams Eldeen AA, et al
    The Value Of PD-L1 Immunohistochemical Expression In Egyptian Urinary Bladder Carcinoma Patients.
    J Pak Med Assoc. 2023;73.
    Abstract     Related articles   

  1508. MO R, Dawulieti J, Chi N, Wu Z, et al
    Self-polymerized platinum (II)-Polydopamine nanomedicines for photo-chemotherapy of bladder Cancer favoring antitumor immune responses.
    J Nanobiotechnology. 2023;21:235.
    Abstract     Related articles   

  1509. BOONCHAI S, Tanthanuch M, Bejrananda T
    Comparison of the Y-pouch orthotopic neobladder and the Studer technique after radical cystectomy: surgical and functional outcomes from a single-center series.
    World J Surg Oncol. 2023;21:218.
    Abstract     Related articles   

  1510. DE HERTOGH O
    [Bladder preservation treatments for bladder cancer: Trimodality therapy, an overview of clinical practices in 2023].
    Cancer Radiother. 2023 Jul 20:S1278-3218(23)00124.
    Abstract     Related articles   

  1511. JIANG P, Ning J, Yu W, Rao T, et al
    FLRT2 suppresses bladder cancer progression through inducing ferroptosis.
    J Cell Mol Med. 2023 Jul 21. doi: 10.1111/jcmm.17855.
    Abstract     Related articles   

  1512. LI L, Zhang Y, Hu W, Zou F, et al
    MTHFD2 promotes PD-L1 expression via activation of the JAK/STAT signalling pathway in bladder cancer.
    J Cell Mol Med. 2023 Jul 21. doi: 10.1111/jcmm.17863.
    Abstract     Related articles   

  1513. ZHU S, Li H, Fan Y, Tang C, et al
    Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma.
    BMC Urol. 2023;23:124.
    Abstract     Related articles   

  1514. WANG Z, Muthusamy V, Petrylak DP, Anderson KS, et al
    Tackling FGFR3-driven bladder cancer with a promising synergistic FGFR/HDAC targeted therapy.
    NPJ Precis Oncol. 2023;7:70.
    Abstract     Related articles   

  1515. WANG D, Wang C, Zhou FH
    Identification of the diagnostic value of urine SLC1A5 in bladder cancer based on GEO database.
    Asian J Surg. 2023 Jul 19:S1015-9584(23)01045.
    Abstract     Related articles   

  1516. ZHANG B, Yang L, He Y, Han D, et al
    Role and mechanisms of noncoding RNAs in the regulation of metabolic reprogramming in bladder cancer (Review).
    Int J Mol Med. 2023;52:79.
    Abstract     Related articles   

  1517. GHATALIA P, Kaur J, Sonpavde G
    Muscle invasive bladder cancer: where is the field headed?
    Expert Opin Biol Ther. 2023 Jul 21:1-15. doi: 10.1080/14712598.2023.2238607.
    Abstract     Related articles   

  1518. LI B, Hu Y, Li QY, Tang YM, et al
    Procoagulant genes may affect angiogenesis, epithelial-mesenchymal transition, survival prognosis and tumor immune microenvironment in patients with urothelial carcinoma.
    Aging (Albany NY). 2023;15:6429-6444.
    Abstract     Related articles   

  1519. SAINT-JACQUES N, Brown PE, Purcell J, Rainham DG, et al
    The Nova Scotia Community Cancer Matrix: A geospatial tool to support cancer prevention.
    Soc Sci Med. 2023;330:116038.
    Abstract     Related articles   

  1520. GUERRA NL, Matas-Garcia A, Serra-Garcia L, Morgado-Carrasco D, et al
    Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature.
    Autoimmun Rev. 2023;22:103375.
    Abstract     Related articles   

  1521. SAVIN Z, Kupershmidt A, Phollan D, Lazarovich A, et al
    The role of malnutrition universal screening tool in predicting outcomes after radical cystectomy.
    Surg Oncol. 2023;49:101962.
    Abstract     Related articles   

  1522. RAMOS KS, Li J, Wijdeveld LFJ, van Schie MS, et al
    Long Noncoding RNA UCA1 Correlates With Electropathology in Patients With Atrial Fibrillation.
    JACC Clin Electrophysiol. 2023;9.
    Abstract     Related articles   

  1523. CHOU LP, Hsu CW, Yang SF, Lee CT, et al
    Clinicopathologic Analysis of Micropapillary Urothelial Carcinoma of the Upper Urinary Tract: Implications for HER2-Targeted Therapy.
    Clin Genitourin Cancer. 2023;21:508.
    Abstract     Related articles   

  1524. SEKAR RR, Diamantopoulos LN, Bakaloudi DR, Khaki AR, et al
    Sarcomatoid Urothelial Carcinoma Is Associated With Limited Response to Neoadjuvant Chemotherapy and Poor Oncologic Outcomes After Radical Cystectomy.
    Clin Genitourin Cancer. 2023;21:507.
    Abstract     Related articles   

  1525. BELLMUNT J, Chang J, Pavilack-Kirker M, Cappelleri JC, et al
    Evaluating Real-World Characteristics of Patients With Advanced Urothelial Carcinoma Eligible for Avelumab Maintenance Therapy: A Multicountry Retrospective Medical Chart Review.
    Clin Genitourin Cancer. 2023;21:459-466.
    Abstract     Related articles   

  1526. SLOTMAN A, Xu M, Lindale K, Hardy C, et al
    Quantitative Nuclear Grading: An Objective, Artificial Intelligence-Facilitated Foundation for Grading Noninvasive Papillary Urothelial Carcinoma.
    Lab Invest. 2023;103:100155.
    Abstract     Related articles   

  1527. RAY CH, Davaro F, Hamilton ZA, Raza J, et al
    Perioperative outcomes of open versus robot-assisted radical cystectomy in octogenarians: a population based analysis.
    J Robot Surg. 2023;17:1629-1635.
    Abstract     Related articles   

  1528. CHENG L, Lopez-Beltran A, Wang M, Whaley RD, et al
    Frequent Telomerase Reverse Transcriptase Promoter and Fibroblast Growth Factor Receptor 3 Mutations Support the Precursor Nature of Papillary Urothelial Hyperplasia of the Urinary Bladder.
    Mod Pathol. 2023;36:100151.
    Abstract     Related articles   

  1529. LI KP, Chen SY, Wang CY, Wan S, et al
    Comparison between robot-assisted versus open nephroureterectomy for upper tract urothelial carcinoma: outcomes from a pooled analysis.
    J Robot Surg. 2023;17:1227-1238.
    Abstract     Related articles   

  1530. GUPTA N, Kucirka L, Semerjian A, Pierorazio PM, et al
    Practice Patterns Regarding Female Reproductive Organ-Sparing and Nerve-Sparing Radical Cystectomy Among Urologic Oncologists in the United States.
    Clin Genitourin Cancer. 2023;21:e236-e241.
    Abstract     Related articles   

  1531. SUN ZJ, Zhao JW, Zhao M, Chen Y, et al
    CD3 high and FoxP3 - tumor-infiltrating lymphocytes in the invasive margin as a favorable prognostic marker in patients with invasive urothelial carcinoma of the bladder.
    Anticancer Drugs. 2023;34:844-851.
    Abstract     Related articles   

  1532. HEALTHCARE ENGINEERING JO
    Retracted: Clinical Value Analysis of Xiaozheng Decoction Combined with Bladder Perfusion for Postoperative Treatment of Bladder Cancer and Its Effect on Serum miR-143 and miR-92a.
    J Healthc Eng. 2023;2023:9785158.
    Abstract     Related articles   

  1533. SUN Z, Sun X, Qin G, Li Y, et al
    FTO promotes proliferation and migration of bladder cancer via enhancing stability of STAT3 mRNA in an m6A-dependent manner.
    Epigenetics. 2023;18:2242688.
    Abstract     Related articles   

  1534. CHEN S, Ran J, Fan Z, Liu M, et al
    Functional status analysis of RNH1 in bladder cancer for predicting immunotherapy response.
    Sci Rep. 2023;13:12625.
    Abstract     Related articles   

  1535. KLOSKOWSKI T, Fekner Z, Szeliski K, Paradowska M, et al
    Effect of four fluoroquinolones on the viability of bladder cancer cells in 2D and 3D cultures.
    Front Oncol. 2023;13:1222411.
    Abstract     Related articles   

  1536. GIL DA COSTA RM, Levesque C, Bianchi-Frias D, Chatterjee P, et al
    Pharmacological NF-kappaB inhibition decreases cisplatin chemoresistance in muscle-invasive bladder cancer and reduces cisplatin-induced toxicities.
    Mol Oncol. 2023 Aug 3. doi: 10.1002/1878-0261.13504.
    Abstract     Related articles   

  1537. ALI AH, Benterud A, Holmoy T, Myro AZ, et al
    Progressive encephalomyelitis with rigidity and myoclonus (PERM) associated with anti-glycine receptor antibodies and urothelial carcinoma: a case report.
    J Med Case Rep. 2023;17:330.
    Abstract     Related articles   

  1538. FLEISCHMANN M, Rodel C
    [Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer].
    Strahlenther Onkol. 2023 Aug 2. doi: 10.1007/s00066-023-02134.
    Abstract     Related articles   

  1539. ZHONG J, Xu A, Xu P, Su M, et al
    Circ_0000235 targets MCT4 to promote glycolysis and progression of bladder cancer by sponging miR-330-5p.
    Cell Death Discov. 2023;9:283.
    Abstract     Related articles   

  1540. HAO Y, Zhu Y, Sun F, Xu D, et al
    MicroRNA-30c-5p arrests bladder cancer G2/M phase and suppresses its progression by targeting PRC1-mediated blocking of CDK1/Cyclin B1 axis.
    Cell Signal. 2023 Jul 31:110836. doi: 10.1016/j.cellsig.2023.110836.
    Abstract     Related articles   

  1541. CHENG Y, Yu H, Li K, Lv J, et al
    Hsa_circ_0003098 promotes bladder cancer progression via miR-377-5p/ACAT2 axis.
    Genomics. 2023 Jul 31:110692. doi: 10.1016/j.ygeno.2023.110692.
    Abstract     Related articles   

  1542. RIBEIRO DE SOUZA B, Brum Reis I, Cardoso de Arruda Camargo G, Oliveira G, et al
    A novel therapeutic strategy for non-muscle invasive bladder cancer: OncoTherad(R) immunotherapy associated with platelet-rich plasma.
    Int Immunopharmacol. 2023;123:110723.
    Abstract     Related articles   

  1543. MEHMANDAR-OSKUIE A, Jahankhani K, Rostamlou A, Arabi S, et al
    Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies.
    Biomed Pharmacother. 2023;165:115242.
    Abstract     Related articles   

  1544. DEMIRCI A, Ordu M
    The prognostic effect of immunohistochemical staining rates in patients with non-muscle-invasive bladder cancer.
    Indian J Pathol Microbiol. 2023;66:502-510.
    Abstract     Related articles   

  1545. LI Y, Kong Y, An M, Luo Y, et al
    ZEB1-mediated biogenesis of circNIPBL sustains the metastasis of bladder cancer via Wnt/beta-catenin pathway.
    J Exp Clin Cancer Res. 2023;42:191.
    Abstract     Related articles   

  1546. CHEN JQ, Salas LA, Wiencke JK, Koestler DC, et al
    Genome-scale methylation analysis identifies immune profiles and age acceleration associations with bladder cancer outcomes.
    Cancer Epidemiol Biomarkers Prev. 2023 Aug 1:EPI-23-0331.
    Abstract     Related articles   

  1547. FAN Z, Shi H, Luo J, Guo X, et al
    Diagnostic and therapeutic effects of fluorescence cystoscopy and narrow-band imaging in bladder cancer: A systematic review and network meta-analysis.
    Int J Surg. 2023 Aug 1. doi: 10.1097/JS9.0000000000000592.
    Abstract     Related articles   

  1548. KUANG X, Zhang Z, Li D, Bao W, et al
    Peptidase inhibitor (PI16) impairs bladder cancer metastasis by inhibiting NF-kappaB activation via disrupting multiple-site ubiquitination of NEMO.
    Cell Mol Biol Lett. 2023;28:62.
    Abstract     Related articles   

  1549. CHABALLOUT BH, Chang EM, Parikh NR, Min Y, et al
    Assessing utilities for muscle-invasive bladder cancer-related health states.
    Urol Oncol. 2023 Jul 29:S1078-1439(23)00239.
    Abstract     Related articles   

  1550. JIANG C, Xiao Y, Xu D, Huili Y, et al
    Prognosis Prediction of Disulfidptosis-Related Genes in Bladder Cancer and a Comprehensive Analysis of Immunotherapy.
    Crit Rev Eukaryot Gene Expr. 2023;33:73-86.
    Abstract     Related articles   

  1551. MICHAEL SN, Masood PF, Sharma U, Bhat FI, et al
    Giant right hydronephrosis with underlying double malignancy: a case report.
    Pan Afr Med J. 2023;45:21.
    Abstract     Related articles   

  1552. ELSAWY AA, Laymon M, Mansour I, Elghareeb A, et al
    Can we offer additional BCG therapy for three-month BCG refractory high grade/T1, Tis bladder cancer patients?
    Arab J Urol. 2023;21:142-149.
    Abstract     Related articles   

  1553. AWAD M, Harraz AM, Farg H, Gabr HS, et al
    Microscopic hematuria and pelvic ultrasonography could rule out flexible cystoscopy during surveillance for T1-low grade non-muscle invasive bladder cancer.
    Arab J Urol. 2023;21:150-155.
    Abstract     Related articles   

  1554. PICHLER R, Diem G, Hackl H, Koutnik J, et al
    Intravesical BCG in bladder cancer induces innate immune responses against SARS-CoV-2.
    Front Immunol. 2023;14:1202157.
    Abstract     Related articles   

  1555. KOLAT D, Kaluzinska-Kolat Z, Kosla K, Orzechowska M, et al
    LINC01137/miR-186-5p/WWOX: a novel axis identified from WWOX-related RNA interactome in bladder cancer.
    Front Genet. 2023;14:1214968.
    Abstract     Related articles   

  1556. JIN Y, Huang S, Wang Z
    Identify and validate RUNX2 and LAMA2 as novel prognostic signatures and correlate with immune infiltrates in bladder cancer.
    Front Oncol. 2023;13:1191398.
    Abstract     Related articles   

  1557. DOU X, Ma X, Meng W, Zhang W, et al
    HEATR3 involved in the cell proliferation, metastasis and cell cycle development of bladder cancer acts as a tumor suppressor.
    Mol Genet Genomics. 2023 Jul 31. doi: 10.1007/s00438-023-02046.
    Abstract     Related articles   

  1558. BRUCK K, Meijer RP, Boormans JL, Kiemeney LA, et al
    Disease-free survival of patients with muscle invasive bladder cancer treated with radical cystectomy versus bladder preserving therapy: a nationwide study.
    Int J Radiat Oncol Biol Phys. 2023 Jul 28:S0360-3016(23)07686.
    Abstract     Related articles   

  1559. WIBERG E, Vega A, Eriksson V, Banday V, et al
    A Validation Study of cT-Categories in the Swedish National Urinary Bladder Cancer Register-Norrland University Hospital.
    J Pers Med. 2023;13:1163.
    Abstract     Related articles   

  1560. HSU CY, Yang WT, Lin JH, Lu CH, et al
    Sertindole, an Antipsychotic Drug, Curbs the STAT3/BCL-xL Axis to Elicit Human Bladder Cancer Cell Apoptosis In Vitro.
    Int J Mol Sci. 2023;24:11852.
    Abstract     Related articles   

  1561. LUCCHESI CA, Vasilatis DM, Mantrala S, Chandrasekar T, et al
    Pesticides and Bladder Cancer: Mechanisms Leading to Anti-Cancer Drug Chemoresistance and New Chemosensitization Strategies.
    Int J Mol Sci. 2023;24:11395.
    Abstract     Related articles   

  1562. PARK EG, Lee DH, Kim WR, Lee YJ, et al
    Human Endogenous Retrovirus-H-Derived miR-4454 Inhibits the Expression of DNAJB4 and SASH1 in Non-Muscle-Invasive Bladder Cancer.
    Genes (Basel). 2023;14:1410.
    Abstract     Related articles   

  1563. OSTROWSKI DA, Chelluri RR, Herzig M, Xia L, et al
    Diminished Short-Term Efficacy of Reduced-Dose Induction BCG in the Treatment of Non-Muscle Invasive Bladder Cancer.
    Cancers (Basel). 2023;15:3746.
    Abstract     Related articles   

  1564. DROSOS Y, Konstantakou EG, Bassogianni AS, Nikolakopoulos KS, et al
    Microtubule Dynamics Deregulation Induces Apoptosis in Human Urothelial Bladder Cancer Cells via a p53-Independent Pathway.
    Cancers (Basel). 2023;15:3730.
    Abstract     Related articles   

  1565. LOZANO F, Raventos CX, Carrion A, Dinares C, et al
    Xpert Bladder Cancer Monitor for the Early Detection of Non-Muscle Invasive Bladder Cancer Recurrences: Could Cystoscopy Be Substituted?
    Cancers (Basel). 2023;15:3683.
    Abstract     Related articles   

  1566. MENG X, Li S, He K, Hu H, et al
    Evaluation of Whole-Tumor Texture Analysis Based on MRI Diffusion Kurtosis and Biparametric VI-RADS Model for Staging and Grading Bladder Cancer.
    Bioengineering (Basel). 2023;10:745.
    Abstract     Related articles   

  1567. YU J, Wu S, Li R, Jiang Y, et al
    Novel ADCs and combination therapy in urothelial carcinoma: latest updates from the 2023 ASCO-GU Cancers Symposium.
    J Hematol Oncol. 2023;16:85.
    Abstract     Related articles   

  1568. ZHAN Y, Lin J, Liu Y, Chen M, et al
    Correction: Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer.
    J Exp Clin Cancer Res. 2023;42:185.
    Abstract     Related articles   

  1569. LI H, Zhou J, Chen R, Zhu J, et al
    The efficacy and timing of adjuvant chemotherapy in upper tract urothelial carcinoma.
    Urol Oncol. 2023;41:356.
    Abstract     Related articles   

  1570. D'ANDREA D, Shariat SF, Soria F, DI Trapani E, et al
    Stage-dependent survival in patients treated with neoadjuvant chemotherapy and radical cystectomy.
    Minerva Urol Nephrol. 2023;75:452-459.
    Abstract     Related articles   

  1571. BURGESS EF, Livasy CA, Symanowski JT, Matulay JT, et al
    Low co-expression of PD-L1 and oncogenic receptor tyrosine kinases HER2 and cMET in urothelial carcinoma is associated with discordant expression between primary and metastatic sites.
    Urol Oncol. 2023;41:357.
    Abstract     Related articles   

  1572. CLARK-GARVEY S, Damrauer JS, Milowsky MI
    Cancer Associated Fibroblasts: An Understudied but Critical Component of the Tumor Microenvironment in Urothelial Cancer.
    Eur Urol Oncol. 2023;6:376-377.
    Abstract     Related articles   

  1573. TAKASE R, Hagiya H, Fujimori T, Yokoyama Y, et al
    Super acute-onset disseminated BCG infection: A case report.
    J Infect Chemother. 2023;29:919-921.
    Abstract     Related articles   

  1574. KAWAMURA K, Miyai K, Sato K, Matsukuma S, et al
    Copy number gain of ACTN4 is associated with poor prognosis in patients with upper urinary tract urothelial carcinoma.
    Cancer Sci. 2023;114:3411-3422.
    Abstract     Related articles   

  1575. MORGANS AK, Galsky MD, Wright P, Hepp Z, et al
    Real-world treatment patterns and clinical outcomes with first-line therapy in patients with locally advanced/metastatic urothelial carcinoma by cisplatin-eligibility.
    Urol Oncol. 2023;41:357.
    Abstract     Related articles   

  1576. NICOLETTI R, Gauhar V, Castellani D, Enikeev D, et al
    Current Techniques for En Bloc Transurethral Resection of Bladder Tumor: A Hands-on Guide Through the Energy Landscape.
    Eur Urol Focus. 2023;9:567-570.
    Abstract     Related articles   

  1577. MAFFEZZOLI M, Campobasso D, Rebuzzi SE, Banna GL, et al
    Prognostic models for patients with metastatic urothelial carcinoma: why use them?
    Minerva Urol Nephrol. 2023;75:419-421.
    Abstract     Related articles   

  1578. DRESSLER FF, Hinrichs S, Roesch MC, Perner S, et al
    EpCAM tumor specificity and proteoform patterns in urothelial cancer.
    J Cancer Res Clin Oncol. 2023;149:8913-8922.
    Abstract     Related articles   

  1579. LIMA W, Wang Y, Miyamoto H
    The impact of routine frozen section analysis during nephroureterectomy or segmental ureterectomy for urothelial carcinoma on final surgical margin status and long-term oncologic outcome.
    Urol Oncol. 2023;41:357.
    Abstract     Related articles   

  1580. WANG J, Zuo X, Zhang Y, Wang W, et al
    The impact of histological variants in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
    J Cancer Res Clin Oncol. 2023;149:8279-8288.
    Abstract     Related articles   

  1581. LIAO CI, Fang HC, Lee PT, Hsu CY, et al
    Trends in the incidence of urothelial carcinoma in Taiwan after the ban on aristolochic acid-containing Chinese herbal preparations, 2001-2018: a national population-based cohort study.
    J Cancer Res Clin Oncol. 2023;149:8201-8211.
    Abstract     Related articles   

  1582. CAO Y
    A case of rare metachronous four primary carcinoma.
    J Cancer Res Clin Oncol. 2023;149:7471-7477.
    Abstract     Related articles   

  1583. CHEN T, Zheng Y, Roskos L, Mager DE, et al
    Comparison of sequential and joint nonlinear mixed effects modeling of tumor kinetics and survival following Durvalumab treatment in patients with metastatic urothelial carcinoma.
    J Pharmacokinet Pharmacodyn. 2023;50:251-265.
    Abstract     Related articles   

  1584. SJODAHL G, Bernardo C, Eriksson P, Hoglund M, et al
    Tumor Biomarkers for Bacillus Calmette-Guerin Response: What We Get Is Not What We Want.
    Eur Urol Focus. 2023;9:582-583.
    Abstract     Related articles   

  1585. CELIK B, Kavas G
    Atypical Category of the Johns Hopkins Template Has Higher Risk of Malignancy than the Paris System but the Paris System Is More Applicable for Suspicious Category.
    Acta Cytol. 2023;67:425-433.
    Abstract     Related articles   

  1586. MUILWIJK T, Akand M, Raskin Y, Jorissen C, et al
    Quality Control Indicators for Transurethral Resection of Bladder Tumor: Results from an Embedded Belgian Multicenter Prospective Registry.
    Eur Urol Oncol. 2023;6:422-430.
    Abstract     Related articles   


  1587. Correction to "G-protein-coupled receptor 137 accelerates proliferation of urinary bladder cancer cells in vitro".
    Biotechnol Appl Biochem. 2023;70:1560.
    Abstract     Related articles   


  1588. Retraction Statement: KLF8 is required for bladder cancer cell proliferation and migration.
    Biotechnol Appl Biochem. 2023;70:1555.
    Abstract     Related articles   

  1589. LIU L, Sun FZ, Zhang PY, Xiao Y, et al
    Development and validation a model for predicting overall survival of bladder cancer with lung metastasis: a population-based study.
    Eur J Med Res. 2023;28:279.
    Abstract     Related articles   

  1590. DENG H, Deng L, Chao H, Yu Z, et al
    RAB14 promotes epithelial-mesenchymal transition in bladder cancer through autophagy‑dependent AKT signaling pathway.
    Cell Death Discov. 2023;9:292.
    Abstract     Related articles   

  1591. HOSOMI T, Shibasaki N, Otsuka H, Uketa S, et al
    [Advanced Bladder Cancer with Multiple Pulmonary Metastases Treated with Paclitaxel/Ifosfamide/Nedaplatin Therapy : Two Case Reports].
    Hinyokika Kiyo. 2023;69:183-188.
    Abstract     Related articles   

  1592. CONTIERI R, Hensley PJ, Tan WS, Grajales V, et al
    Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guerin or Early Radical Cystectomy.
    Eur Urol Oncol. 2023 Aug 7:S2588-9311(23)00157-8. doi: 10.1016/j.euo.2023.
    Abstract     Related articles   

  1593. FONTUGNE J, Xylinas E, Krucker C, Dixon V, et al
    RNA-seq profiling of upper tract urothelial carcinoma: bladder cancer consensus classification relevance, molecular heterogeneity and differential immune signatures.
    Mod Pathol. 2023 Aug 7:100300. doi: 10.1016/j.modpat.2023.100300.
    Abstract     Related articles   

  1594. DUMONT C, Aregui A, Hauchecorne M, Lefevre M, et al
    Safety and efficacy of preoperative chemotherapy for muscle-invasive bladder cancer in elderly patients.
    World J Urol. 2023 Aug 9. doi: 10.1007/s00345-023-04561.
    Abstract     Related articles   

  1595. SCANLON L, Canavan J, Babiker Z, Shilling C, et al
    Leiomyoma of the Bladder: A case report and review.
    Ir Med J. 2023;116:792.
    Abstract     Related articles   

  1596. RASMUSSEN AM, Okholm TLH, Knudsen M, Vang S, et al
    Circular stable intronic RNAs possess distinct biological features and are deregulated in bladder cancer.
    NAR Cancer. 2023;5:zcad041.
    Abstract     Related articles   

  1597. WANG J, Zhu J, Hu J, Wang Z, et al
    A novel in vitro prognostic model of bladder cancer based on urine-derived living tumor cells.
    Genes Dis. 2022;10:2586-2596.
    Abstract     Related articles   

  1598. TAN W, Gao L, Yuan Y, Huang H, et al
    Relationship between testosterone and male bladder cancer.
    Sci Rep. 2023;13:12881.
    Abstract     Related articles   

  1599. FU Z, Tian Z, Chen Y, Jia Z, et al
    Analysis of the efficacy of a single subumbilical stoma for bilateral cutaneous ureterostomy after radical cystectomy.
    Eur J Med Res. 2023;28:273.
    Abstract     Related articles   

  1600. GUO R, Wang L, Bai S, Kang D, et al
    Specific subsets of urothelial bladder carcinoma infiltrating T cells associated with poor prognosis.
    Sci Rep. 2023;13:12801.
    Abstract     Related articles   

  1601. LEOW JJ, Yong DZ, Chong YL
    Value-based healthcare for bladder cancer patients undergoing robot-assisted radical cystectomy.
    Eur J Surg Oncol. 2023;49:1329-1330.
    Abstract     Related articles   

  1602. HSU FT, Liu WL, Lee SR, Jeng LB, et al
    Unveiling nature's potential weapon: Magnolol's role in combating bladder cancer by upregulating the miR-124 and inactivating PKC-delta/ERK axis.
    Phytomedicine. 2023;119:154947.
    Abstract     Related articles   

  1603. DEL GIUDICE F, Belladelli F, Glover F, Basran S, et al
    5-alpha reductase inhibitors (5-ARi) with or without alpha-blockers (alpha-B) for Benign Prostatic Hyperplasia do NOT lower the risk of incident Bladder Cancer: United States insurance claims data.
    World J Urol. 2023 Aug 7. doi: 10.1007/s00345-023-04551.
    Abstract     Related articles   

  1604. JIA X, Shkolyar E, Laurie MA, Eminaga O, et al
    Tumor detection under cystoscopy with transformer-augmented deep learning algorithm.
    Phys Med Biol. 2023;68.
    Abstract     Related articles   

  1605. SUN C, Zhou X, Lou J
    A Survival Model for Patients with Upper Tract Urothelial Carcinoma.
    Arch Esp Urol. 2023;76:357-362.
    Abstract     Related articles   

  1606. SHUMAN L, Pham J, Wildermuth T, Wu XR, et al
    Urothelium-specific expression of mutationally activated Pik3ca initiates early lesions of non-invasive bladder cancer.
    Am J Pathol. 2023 Aug 4:S0002-9440(23)00272-9. doi: 10.1016/j.ajpath.2023.
    Abstract     Related articles   

  1607. HUANG L, Jia K, Yao K, Liu D, et al
    Effect of neoadjuvant chemotherapy on survival in patients with T1 high-grade non-muscle-invasive bladder cancer who underwent radical cystectomy.
    Medicine (Baltimore). 2023;102:e34501.
    Abstract     Related articles   

  1608. WARE AP, Satyamoorthy K, Paul B
    Integrated multiomics analysis of chromosome 19 miRNA cluster in bladder cancer.
    Funct Integr Genomics. 2023;23:266.
    Abstract     Related articles   

  1609. LIU H, Zhou Z, Yao H, Mao Q, et al
    Robot-assisted radical cystectomy vs open radical cystectomy in patients with bladder cancer: a systematic review and meta-analysis of randomized controlled trials.
    World J Surg Oncol. 2023;21:240.
    Abstract     Related articles   

  1610. ZHAO X, Chen J, Zhang C, Xie G, et al
    LncRNA AGAP2-AS1 interacts with IGF2BP2 to promote bladder cancer progression via regulating LRG1 mRNA stability.
    Cell Signal. 2023 Aug 2:110839. doi: 10.1016/j.cellsig.2023.110839.
    Abstract     Related articles   

  1611. ZLOTTA AR, Lajkosz K, Efstathiou JA
    Radical cystectomy vs trimodality therapy for muscle-invasive bladder cancer: further extensive evaluation needed - Authors' reply.
    Lancet Oncol. 2023;24:e325-e326.
    Abstract     Related articles   

  1612. JENA R, Issa R, Perry M
    Radical cystectomy vs trimodality therapy for muscle-invasive bladder cancer: further extensive evaluation needed.
    Lancet Oncol. 2023;24:e324.
    Abstract     Related articles   

  1613. PANT S, Schuler M, Iyer G, Witt O, et al
    Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study.
    Lancet Oncol. 2023;24:925-935.
    Abstract     Related articles   


  1614. [First-line maintenance therapy of adult patients with BCG-naive high-risk non-muscle-invasive bladder cancer - A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination with Cetrelimab or TAR-2
    Aktuelle Urol. 2023;54:272-273.
    Abstract     Related articles   

  1615. CHEN J, Zhang Z, Nie Z, Qiu J, et al
    Effects of intravenous chemotherapy after TURBT for high-risk nonmuscle invasive bladder cancer: results of a retrospective study.
    J Cancer Res Clin Oncol. 2023 Aug 4. doi: 10.1007/s00432-023-05206.
    Abstract     Related articles   

  1616. ZHENG B, Wang S, Zhang J, Ge C, et al
    Expression, Prognostic Value, and immune infiltration of MTHFD family in bladder cancer.
    Curr Cancer Drug Targets. 2023 Aug 4. doi: 10.2174/1568009623666230804152603.
    Abstract     Related articles   

  1617. ZENG Z, Wu X, Peng K, Ren D, et al
    Robot-assisted laparoscopic enucleation in the treatment of leiomyosarcoma of urinary bladder: A case report.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023;48:782-788.
    Abstract     Related articles   

  1618. SHIBUTANI K, Ishikawa K, Mori N
    Uncommon but Clinically Significant: Bacillus Calmette-Guerin (BCG) Infection of the Urinary Tract and its Impact on Quality of Life.
    Am J Case Rep. 2023;24:e940375.
    Abstract     Related articles   

  1619. JAIN K, Jain E, DiLena R, Saleeb R, et al
    Urachal xanthogranuloma: a rare but important case presenting as a urachal mass.
    BMC Urol. 2023;23:132.
    Abstract     Related articles   

  1620. TRIPATHI A, Lerner SP
    Poly (ADP-ribose) Polymerase Inhibition in Advanced Urothelial Carcinoma.
    JCO Precis Oncol. 2023;7:e2300293.
    Abstract     Related articles   

  1621. TURNER R, Powari M, Stevenson T
    From haematuria to nephroureterectomy via urine cytology-A case study.
    Cytopathology. 2023;34:494-496.
    Abstract     Related articles   

  1622. WANG S, Zhang D, Bai Y, Liu F, et al
    Clinical Outcomes of Pelvic Lymph Node Dissection Before Versus After Robot-Assisted Laparoscopic Radical Cystectomy.
    J Laparoendosc Adv Surg Tech A. 2023;33:776-781.
    Abstract     Related articles   

  1623. BAGHERY F, Lau LDW, Mohamadi M, Vazirinejad R, et al
    Risk of urinary tract cancers following arsenic exposure and tobacco smoking: a review.
    Environ Geochem Health. 2023;45:5579-5598.
    Abstract     Related articles   

  1624. ZHOU L, Shao Z, Liu Y, Yan X, et al
    HER2 Expression Associated with Clinical Characteristics and Prognosis of Urothelial Carcinoma in a Chinese Population.
    Oncologist. 2023;28:e617-e624.
    Abstract     Related articles   

  1625. XUE G, Liu Y, Ji X, Zhang H, et al
    Wound dehiscence in enhanced recovery after open radical cystectomy: A meta-analysis.
    Int Wound J. 2023;20:2634-2639.
    Abstract     Related articles   

  1626. EUGENIA L, Giovanni A, Andrea M, Maria Rosaria R, et al
    Mucinous appendiceal adenocarcinoma invading the bladder: not always an easy diagnosis. A case report.
    Anticancer Drugs. 2023;34:967-969.
    Abstract     Related articles   

  1627. SILVA JF, Pereira P, Macedo G
    A rare case of ulcerative colitis following Bacillus Calmette-Guerin therapy.
    Rev Esp Enferm Dig. 2023;115:403.
    Abstract     Related articles   

  1628. MJAESS G, Diamand R, Aoun F, Assenmacher G, et al
    Cost-analysis of robot-assisted radical cystectomy in Europe: A cross-country comparison.
    Eur J Surg Oncol. 2023;49:1511-1518.
    Abstract     Related articles   

  1629. GU L, Hu G, Hu J, Wen F, et al
    Construction and comprehensive analysis of a novel prognostic signature associated with immunogenic cell death molecular subtypes in patients with bladder cancer.
    Heliyon. 2023;9:e18848.
    Abstract     Related articles   

  1630. LIU C, Xu P, Shao S, Wang F, et al
    The value of urinary exosomal lncRNA SNHG16 as a diagnostic biomarker for bladder cancer.
    Mol Biol Rep. 2023 Aug 17. doi: 10.1007/s11033-023-08667.
    Abstract     Related articles   

  1631. MERTENS LS, Psutka SP, Mir MC
    Bladder cancer oligometastases - definition and treatment.
    Nat Rev Urol. 2023 Aug 17. doi: 10.1038/s41585-023-00815.
    Abstract     Related articles   

  1632. FONT A, Domenech M, Ramirez JL, Marques M, et al
    Predictive signature of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer integrating mRNA expression, taxonomic subtypes, and clinicopathological features.
    Front Oncol. 2023;13:1155244.
    Abstract     Related articles   

  1633. CHEN R, Hao X, Chen J, Zhang C, et al
    Integrated multi-omics analyses reveal Jorunnamycin A as a novel suppressor for muscle-invasive bladder cancer by targeting FASN and TOP1.
    J Transl Med. 2023;21:549.
    Abstract     Related articles   

  1634. XIA C, Zhao X, Li B, Qi B, et al
    Loneliness, spiritual well-being, and death perception, as well as their risk factors in urological cancer patients.
    Braz J Med Biol Res. 2023;56:e12915.
    Abstract     Related articles   

  1635. XING Z, Ji M, Shan Y, Dong Z, et al
    Using the Multidimensional Health Locus of Control Scale Form C to Investigate Health Beliefs About Bladder Cancer Prevention and Treatment Among Male Patients: Cross-Sectional Study.
    JMIR Form Res. 2023;7:e43345.
    Abstract     Related articles   

  1636. YANG C, Ou Y, Zhou Q, Liang Y, et al
    Methionine orchestrates the metabolism vulnerability in cisplatin resistant bladder cancer microenvironment.
    Cell Death Dis. 2023;14:525.
    Abstract     Related articles   

  1637. VANIN MORENO N, Whitehead M, Siemens DR
    Real-life benchmarking bladder cancer care: A population-based study.
    Can Urol Assoc J. 2023;17:268-273.
    Abstract     Related articles   

  1638. LIU W, Chen R, Liu X, Zhou B, et al
    Differentiation of bladder cancer stages using the vesical imaging -reporting and data system and apparent diffusion coefficient.
    Quant Imaging Med Surg. 2023;13:4897-4907.
    Abstract     Related articles   

  1639. LI HZ, Zhu J, Weng GJ, Li JJ, et al
    Application of nanotechnology in bladder cancer diagnosis and therapeutic drug delivery.
    J Mater Chem B. 2023 Aug 15. doi: 10.1039/d3tb01323.
    Abstract     Related articles   

  1640. ZHOU Q, Wu H, Miao F, Cao Y, et al
    Codelivery of ERCC2 small interfering RNA and cisplatin with macrophage-derived mimetic nanovesicles for enhanced bladder cancer treatment.
    Anticancer Drugs. 2023 Aug 15. doi: 10.1097/CAD.0000000000001528.
    Abstract     Related articles   

  1641. SLUSARCZYK A, Zapala P, Zapala L, Borkowski T, et al
    Cancer-Specific Survival of Patients with Non-Muscle-Invasive Bladder Cancer: A Population-Based Analysis.
    Ann Surg Oncol. 2023 Aug 14. doi: 10.1245/s10434-023-14051.
    Abstract     Related articles   

  1642. LIN F, Ke ZB, Xue YT, Chen JY, et al
    A novel CD8(+) T cell-related gene signature for predicting the prognosis and immunotherapy efficacy in bladder cancer.
    Inflamm Res. 2023 Aug 14. doi: 10.1007/s00011-023-01772.
    Abstract     Related articles   

  1643. WONG MCS, Huang J, Wang HHX, Yau STY, et al
    Risk prediction of bladder cancer among diabetes patients: a derivation and validation study.
    Diabet Med. 2023 Aug 14:e15199. doi: 10.1111/dme.15199.
    Abstract     Related articles   

  1644. CHANG S, Giannico GA, Haugen E, Jardaneh A, et al
    Multiparameter interferometric polarization-enhanced imaging differentiates carcinoma in situ from inflammation of the bladder: an ex vivo study.
    J Biomed Opt. 2023;28:102907.
    Abstract     Related articles   

  1645. ROHITH G, Gaur AS, Nayak P, Mandal S, et al
    Socio-economic, education, and insurance-related factors associated with the treatment completion rates in patients with nonmetastatic urinary bladder cancer: A Retrospective cohort study.
    Indian J Urol. 2023;39:228-235.
    Abstract     Related articles   

  1646. YAN D, He Q, Pei L, Yang M, et al
    The APC/C E3 ligase subunit ANAPC11 mediates FOXO3 protein degradation to promote cell proliferation and lymph node metastasis in urothelial bladder cancer.
    Cell Death Dis. 2023;14:516.
    Abstract     Related articles   

  1647. HSU CW, Cheng NC, Liao MY, Cheng TY, et al
    Correction: Hsu et al. Development of Folic Acid-Conjugated and Methylene Blue-Adsorbed Au@TNA Nanoparticles for Enhanced Photodynamic Therapy of Bladder Cancer Cells. Nanomaterials 2020, 10, 1351.
    Nanomaterials (Basel). 2023;13:2233.
    Abstract     Related articles   

  1648. FIORENTINO V, Pizzimenti C, Franchina M, Rossi ED, et al
    Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples.
    Int J Mol Sci. 2023;24:12489.
    Abstract     Related articles   

  1649. PATWARDHAN MV, Mahendran R
    The Bladder Tumor Microenvironment Components That Modulate the Tumor and Impact Therapy.
    Int J Mol Sci. 2023;24:12311.
    Abstract     Related articles   

  1650. MURALISANKAR M, Chen JR, Haribabu J, Ke SC, et al
    Effective and Selective Ru(II)-Arene Complexes Containing 4,4'-Substituted 2,2' Bipyridine Ligands Targeting Human Urinary Bladder Cancer Cells.
    Int J Mol Sci. 2023;24:11896.
    Abstract     Related articles   

  1651. SERRANO M, Munoz-Unceta N, Alonso LA, Azueta A, et al
    Neoadjuvant chemotherapy with dose-dense MVAC in muscle-invasive bladder cancer: a tertiary center experience.
    Clin Transl Oncol. 2023 Aug 11. doi: 10.1007/s12094-023-03277.
    Abstract     Related articles   

  1652. BASAK D, Mondal S, Srivastava SK, Sarkar D, et al
    Intratumoral PD1(+)CD38(+)Tim3(+) CD8(+) T Cells in Pre-BCG Tumor Tissues Are Associated with Poor Responsiveness to BCG Immunotherapy in Patients with Non-Muscle Invasive Bladder Cancer.
    Cells. 2023;12:1939.
    Abstract     Related articles   

  1653. RASTI A, Abazari O, Dayati P, Kardan Z, et al
    Identification of Potential Key Genes Linked to Gender Differences in Bladder Cancer Based on Gene Expression Omnibus (GEO) Database.
    Adv Biomed Res. 2023;12:157.
    Abstract     Related articles   

  1654. LV J, Wu Q, Li K, Bai K, et al
    Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascade.
    Int J Biol Sci. 2023;19:3744-3761.
    Abstract     Related articles   

  1655. CHENG H, Liu Y, Chen G
    Identification of potential DNA methylation biomarkers related to diagnosis in patients with bladder cancer through integrated bioinformatic analysis.
    BMC Urol. 2023;23:135.
    Abstract     Related articles   

  1656. STONE L
    Subtypes in small cell bladder cancer.
    Nat Rev Urol. 2023 Aug 10. doi: 10.1038/s41585-023-00813.
    Abstract     Related articles   

  1657. STONE L
    Proteomic characterization of bladder cancer.
    Nat Rev Urol. 2023 Aug 10. doi: 10.1038/s41585-023-00814.
    Abstract     Related articles   

  1658. ECKSTEIN M, Matek